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Abstract 
 
Denture-associated stomatitis (DS), a frequent infection in denture-wearers 
(up to 60%), presents as areas of palatal inflammation and is normally 
associated with denture biofilms containing Candida albicans. However, the 
contribution of co-existing bacteria in these biofilms to the infection remains 
unclear. As current DS management strategies are primarily directed towards 
Candida, research demonstrating the impact of specific bacteria upon infection 
prognosis is important to improve treatment regimes. This research evaluated 
the in vitro impact of bacteria on Candida virulence, and compared bacterial 
microbiomes at specific oral sites in DS and non-DS patients to determine 
associations with infection.  
In vitro biofilm studies assessed expression of C. albicans virulence factors 
(morphological transformation, adhesins, hydrolytic enzymes) and their impact 
on pathogenesis in an infection model. In clinical studies, microbiological 
samples were obtained from the tongue, palate and denture-fitting surface of 
19 denture-wearing patients (DS n=8, non-DS n=11). The presence of 
Candida was ascertained by PCR. Bacterial DNA was extracted and subjected 
to next generation sequencing using bacterial 16S rRNA gene targets, and 
differences in the bacterial microbiomes determined.  
Certain bacterial species in acrylic biofilms significantly (P<0.05) increased the 
expression of C. albicans virulence factors, and subsequently, enhanced 
tissue damage in model systems. Candida was detected in clinical samples of 
14 patients (DS n=6, non-DS n=8). Metataxonomic analyses revealed 
differences in relative abundance of bacterial species, but no significant 
differences in the bacterial microbiomes of the denture-fitting surface and 
palate between DS and non-DS patients. Importantly, a significant (P=0.007) 
increase in the number of bacterial species was evident for the tongue 
microbiome of non-DS patients.  
The in vitro modulating capacity of bacteria toward Candida virulence, and the 
observed species-level differences in bacteria between DS and non-DS 
patients highlight the need for consideration of the bacterial composition of oral 
biofilms in the pathogenesis of DS. 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Literature review 
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1.1 Biofilms 
1.1.1 Introduction to biofilms and their ubiquitous prevalence 
1.1.1.1 The makeup and structure of biofilms 
Microorganisms rarely exist in a free-living or planktonic state. Most often, 
microorganisms grow in the form of a biofilm, which can simply be defined as 
dynamically interacting aggregates of microorganisms, often attached to biotic 
or abiotic surfaces (Flemming & Wingender, 2010) (Fig. 1.1). Such biofilms 
may comprise of a single species (monotypic) or most often as a polymicrobial 
community of several species. A biofilm can have distinct three-dimensional 
components to its structure and will contain not only the microorganisms, but 
also a range of other components, detailed in Table 1.1, including biofilm-
derived extracellular polymeric substances (EPS) (Flemming et al., 2007; 
Costerton et al., 1999). 
 
 
Figure 1.1 Representative scanning electron microscopy image showing 
example of in vitro polymicrobial biofilm grown on denture acrylic 
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Component Proportion of matrix (%) 
Water Up to 97% 
Microbial cells 2-5% (mixed-species) 
Polysaccharides 
(homo- and heteropolysaccharides) 
<1-2% (neutral and polyanionic) 
Proteins 
(extracellular, and from cell lysis) 
<1-2% (including enzymes) 
DNA/RNA <1-2% (lysed cells) 
Ions Unknown (bound and free) 
Table 1.1 Typical components of biofilm matrices 
Table used with permission from Sutherland (2001) 
 
The EPS varies considerably in content depending on the environment in 
which it exists, and the microorganisms that make up the biofilm (often being 
species specific). For example, biofilms of the fungus Candida albicans 
typically contain a high percentage of carbohydrates (39.6%) relative to 
proteins (5%) or amino sugars such as hexosamines (3.3%). In contrast, 
Candida tropicalis biofilms contain much higher levels of hexosamines (27%) 
and lower levels of carbohydrates (3.3%) (Al-Fattani & Douglas, 2006). Paper 
mill-derived biofilms have also been shown to contain a substantial range of 
concentrations of various sugars, indicating the variability between biofilms 
formed by different microorganisms (Lindberg et al., 2001). This investigation 
found that the EPS of single-species biofilms of numerous different species of 
bacteria, including those of the genera Burkholderia, Bacillus and Alcaligenes, 
contained high levels and a large array of sugars including glucose, mannose, 
arabinose and galactose.  
 
Although the chemical makeup in relative proportions of the different 
components of EPS may vary, the typical constituents of biofilm EPS are 
water, carbohydrates, proteins and extracellular DNA (eDNA), which are 
secreted by the biofilm cells. In addition to these, the contents from lysed cells; 
proteins, cytoplasmic material, genomic DNA and other cell components will 
also be present (Sutherland, 2001).  
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The EPS, eloquently referred to by Flemming et al (2007) as the “house of 
biofilm cells”, is multi-functional. EPS provides a physical function by providing 
a ‘material scaffold’ allowing biofilm maturation and expansion in a three-
dimensional manner (Hall-Stoodley & Stoodley, 2002). The EPS protects 
biofilm cells from alteration of environmental factors including effects of 
temperature and pH. The EPS also serves as a source of nutrients for 
microorganisms (Flemming & Wingender, 2010). Additionally, increased 
tolerance of severe conditions, or the effects of antimicrobial compounds can 
be attributed to uptake of resistance genes by horizontal transfer of DNA from 
bacterium to bacterium, even of different genera, or by the active uptake of 
eDNA from the local environment (Hannan et al., 2010). 
 
1.1.1.2 The role of extracellular DNA in biofilms 
Extracellular DNA was originally thought to be present in biofilms as a result 
of previously interrupted horizontal transfer of DNA between microorganisms, 
or as a result of cell lysis, leading to externalisation of the DNA. However, it 
was more recently determined to be a much more significant contributor to 
biofilms, in that it supports structural integrity of biofilms as they develop (Mann 
et al., 2009; Hall-Stoodley et al., 2008; Jakubovics et al., 2013), enhances 
microbial attachment and co-aggregation, in addition to serving as a pool of 
genes of potential benefit to others for uptake as highlighted above. There are 
distinct sequential differences between eDNA and genomic DNA, further 
suggesting eDNA presence is not solely a result of cell lysis, but is actively 
produced and secreted by viable, metabolising cells (Flemming & Wingender, 
2010). The presence of eDNA is also a requirement for some bacterial species 
to be able to form biofilms (Vilain et al., 2009). 
 
As eDNA is negatively charged, it is thought to contribute to biofilm structure 
and integrity by acting as a bridging component, linking positively charged 
components within the EPS. The effects of bridging charged components 
could directly contribute to the active sequestering of similarly charged 
antimicrobial compounds, and provide some insight to explain their frequent 
inefficiency in treating biofilms. 
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Extracellular DNA is not restricted to bacterial biofilms, but has also been 
implicated in fungal biofilms involving C. albicans (Martins et al., 2010) where 
it serves a similar purpose as a contributor to biofilm structure and 
enhancement of genetic diversity of the biofilm community. 
 
1.1.1.3 Biofilms in nature 
Biofilms occur naturally in the environment, and are undoubtedly the outcome 
of microorganisms having millions of years of evolutionary experience for 
survival. Unsurprisingly, biofilms are ubiquitous in the natural world, and can 
be detected within environments such as The Great Barrier Reef (Witt et al., 
2011) and natural lakes (Fang et al., 2014). Biofilms are also found in man-
made locations such as paper mills (Al-Fattani & Douglas, 2006). Importantly, 
biofilms are also frequently detected in the human body where their presence 
can have a significant impact on human health both in a positive and negative 
manner, as discussed below. 
 
1.1.1.4 Biofilms in medicine 
Biofilm research is a relatively recent field of microbiology, with most research 
activity being from the 1980s and pioneered by the ‘father of biofilms’; Dr JW 
Costerton. Given their significance in clinical infection, and their recalcitrance 
to treatment, biofilms are now of significant research interest. Approximately 
65% of hospital acquired infections are estimated to have a biofilm origin 
(Costerton et al., 1999; Joo & Otto, 2013). It is well known that the impact of a 
biofilm-related infection can be highly significant, as highlighted in Fig. 1.2 and 
Table 1.2. Dental caries and periodontal disease affect a substantial portion of 
the global population, with caries present in approximately 35% of the general 
population, and severe periodontitis affecting 10% of people (Frencken et al., 
2017). This high prevalence appears to be in decline in developed countries, 
with continually improving clinical intervention and global prevention strategies 
outlined by the World Health Organisation (WHO). 
 
The necessary placement of medical devices, including endotracheal tubes in 
mechanical ventilation (Ramage et al., 2006; Sands et al., 2017), and use of 
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intravenous and urinary catheters (Donlan, 2001; Ganderton et al., 1992; 
Stickler et al., 1998), whilst vital for patient recovery can also serve as surfaces 
for biofilm formation, and therefore lead to increased patient morbidity, 
mortality and length of hospital stay (Sardi et al., 2013). Implanted devices also 
provide a route of access to additional locations within the body that would 
normally be inaccessible with the physical dermal barrier, and immune system 
as demonstrated in Fig 1.2. 
 
 
Figure 1.2 Diversity of biofilm-associated infections within the human body 
Examples of the many locations within the human body that biofilms can exist, 
and subsequently, biofilm-related infections can occur including (1) chronic 
sinusitis, (2) central nervous system shunt (3) contact lense keratitis, (4) 
chronic otitis, (5) cochlear implant, (6) burn, (7) intravascular catheter, (8) 
prosthetic valve endocarditis, (9) pacemaker, (10) electrophysiological wire 
endocarditis, (11) biliary stent, (12) dialysis catheter, (13) prosthetic joint, (14) 
urinary stent, (15) intravascular stent, (16) pulmonary infection in cystic fibrosis 
patient, (17) ventilator associated pneumonia, (18) breast implant. Image used 
with permission from del Pozo & Patel, 2007 
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Biofilm-related 
infection/disease 
Associated causative 
Microorganism(s) 
References 
Cystic fibrosis Pseudomonas aeruginosa Parsek & Singh, 2003; 
Lopes et al., 2012; 
Bagge et al., 2004 
Dental plaque Streptococcus spp., 
Actinomyces spp., 
Lactobacillus spp., Veillonella 
spp, Fusobacterium spp., 
Prevotella spp., 
Porphyromonas gingivalis, 
Firmicutes 
Bradshaw & Marsh, 
1995; Xie et al., 2010 
Dental caries/periodontitis Streptococci, Lactobacilli, 
Actinomyces spp., P. gingivalis, 
Tannerella forsythia, 
Treponema denticola, 
Prevotella intermedia, 
P. nigrescens, Fusobacterium 
nucleatum 
Colombo et al., 2014; 
van Houte, 1994 
Offenbacher et al., 2007 
  
Medical device-associated infection Medical device-
associated infection 
Denture-associated 
stomatitis 
C. albicans Samanarayake et al., 
2002; Sitheeque & 
Samanarayke, 2003; 
Williams & Lewis, 2011; 
Rogers et al., 2013 
Urinary catheters Proteus mirabilis, P. vulgaris, 
Klebsiella pneumoniae, 
Pseudomonas aeruginosa, C. 
albicans, Escherichia coli 
Stickler, 2014; 
Samanarayake et al., 
2014; 
Subdermal devices Staphylococci Otto, 2008; 
Prosthetic joints Staphylococci, Enterococcus 
spp., Propionibacterium acnes, 
Streptococcus spp. 
Deva et al., 2013; Tande 
& Patel, 2014 
Orthopaedic surgery P. aeruginosa, S. aureus, 
Staphylococcus epidermidis 
Veerachamy et al., 2014 
Table 1.2 Biofilm related infections of the human body, and associated with 
medical devices 
 
1.1.2 Development of biofilms – a dynamic series of events 
The development of a microbial biofilm follows a distinct set of stages as 
outlined in Fig. 1.3 and include attachment and adherence, colonisation and 
recruitment, maturation, and dispersal, which are discussed below. 
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The makeup and structure of a biofilm is highly organised and typically 
incorporates open channels presumed to be used for transport of nutrients into 
and around the biofilm (Costerton et al., 1999). The composition of local 
regions within a multi-species biofilm will vary depending on the requirements 
of the individual microorganisms in respect of nutrient and gaseous delivery. It 
is important, for example, that aerobic microorganisms have access to oxygen 
and other nutrients required for metabolism and growth, whereas fastidious or 
anaerobic microorganisms would not survive in the same conditions. Thus, 
biofilm channels provide a means of control in providing the necessary 
microenvironment for different regions in a biofilm (Christensen et al., 1998).  
 
As biofilms are highly organised, 3D structured communities, it is necessary 
for the development to be an ordered and temporal process. Dental plaque is 
one such well-studied example of a polymicrobial biofilm, and serves as a 
perfect model to describe biofilm formation, development and maturation as 
detailed by Marsh & Bradshaw (1995). Figure 1.3 provides a schematic 
representation of biofilm formation and development within this distinct and 
structured process, highlighting the stages of formation; attachment and 
adherence, colonisation and maturation, and then mature biofilm and dispersal 
for secondary colonisation elsewhere.  
 
 
Figure 1.3 Diagrammatic representation of distinct stages of biofilm 
development; attachment and adherence, colonisation and maturation, mature 
biofilm and dispersal for secondary colonisation 
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1.1.2.1 Acquired surface pellicle, and subsequent microbial attachment 
and adherence of primary colonisers to the surface 
Initial attachment and adherence of microorganisms to a surface is essential 
for successful colonisation, growth and maturation of the biofilm. Strictly 
speaking, surfaces in general are rarely ‘naked’, but most often are coated with 
a pellicle, which In the case of the oral cavity is typically saliva (de Paula et al., 
2017). Whole saliva contains different substances including the main 
component, water; electrolytes including sodium, potassium, calcium, and 
phosphates, and host factors including enzymes, proteins, mucins, 
immunoglobulins (Humphrey & Williamson, 2001). The resulting coating film 
contains saliva-derived proteins, glycoproteins, lipids and glycolipids (Marsh & 
Bradshaw, 1995). Furthermore, other host components including cells; 
epithelial cells, immune cells and, of course, the constituents of the resident 
microbiome (Wade, 2013; Nasidze et al., 2009; Yang et al., 2012) are present. 
These components coat the surfaces, whereby proteins and mucins deposit 
onto the surface. This deposition determines the surface characteristics, 
particularly the charge of the surface, which can significantly influence 
microbial attachment. 
 
The primary stage of biofilm development is the initial attachment of the 
microorganism to the surface which is a result of non-specific, reversible 
interactional forces such as van der Waals and electrostatic forces arising from 
charges on the surface and cells (Pascual, 2002). Microorganisms themselves 
have proteins on the surfaces of the cell; teichoic acid, pili, flagella antigens, 
and lipopolysaccharides (Eden & Hansson, 1978; O’Toole et al., 2000; Scott 
& Zahner, 2006), which promote attachment to the surface via these non-
specific forces by increasing surface area of the microorganism, thus 
increasing the relative force by which it can attach, and have also been 
implicated in subsequent biofilm formation (Tomaras et al., 2003). The forces 
are relatively weak, but if external influences do not break these bonds, the 
initial attachment persists and if the conditions are suitable, the 
microorganisms subsequently initiate processes of adherence of the cells to 
the surface. Surfaces are also rarely perfectly smooth, with the presence of 
microscopic ridges and other irregularities or imperfections that can influence 
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the initial attachment of microorganisms. 
 
The subsequent adherence, considered an active process, is driven by specific 
binding arising from ligand-receptor interactions (Cotter & Kavanagh, 2000). 
The action of salivary flow in the oral cavity can remove loosely or non-adhered 
microorganisms from the surfaces, thus adherence to the oral surfaces is 
essential for successful microbial establishment and persistence. Adhesins 
such as Als1p, Als3p, and Hwp1p (Nobile et al., 2006) for Candida species, 
and cell surface polypeptides such as SspA and SspB (Demuth et al., 1996) 
for Streptococcus species and Actinomyces species. Once strongly attached 
to the surface, the microorganism can utilise nutrients on the surface or from 
the immediate environment to support growth.  
 
In the case of dental plaque formation, the primary colonisers are typically 
streptococci and Actinomyces species. S. sanguinis and S. mutans are able 
to bind to terminal sialic acid residues; a component of saliva (McBride & 
Gisslow, 1977; Levine et al., 1978), and S. oralis and S. mitis expresse lectins 
that interact with galactose and trisaccharide structures containing galactose, 
sialic acid and N-acetyl-galactosamine (Murray et al., 1982; Murray et al., 
1986). Actinomyces can bind to proline-rich proteins within the pellicle 
(Gibbons & Hay, 1988; Ruhl et al., 2004) via a -galactoside-sensitive 
mechanism (Stromberg & Boren, 1992). Additionally, streptococci are known 
to bind to such proline rich proteins (Ruhl et al., 2004). 
 
1.1.2.2 Biofilm maturation; arrival of secondary colonisers and 
development of 3D biofilm architecture 
After the initial process of attachment and adherence, microorganisms begin 
to develop into microcolonies. The ability of microorganisms to adhere to one 
another (known as co-aggregation) is beneficial for subsequent biofilm 
development and maturation, thus sustained production of adhesins is 
important. Co-aggregation is an important characteristic of oral 
microorganisms, particularly secondary colonisers to establish a biofilm 
(Marsh & Bradshaw, 1995) and there are a number of mechanisms by which 
11 
 
co-aggregation can occur. Firstly, through ligand-receptor like binding of these 
secondary coloniser cells to primary colonisers on the surface, or secondarily 
as an already co-aggregated collection of cells adhering to a set of receptors. 
Actinomyces species have two functionally distinct fimbriae; type 1 which are 
necessary for the binding to salivary proteins (Gibbons et al., 1988), and type 
2 which are associated with lectin-like interactions for co-aggregation with 
streptococci (Mishra et al., 2010).  
 
Whilst the vast majority of oral microorganisms exhibit co-aggregation 
characteristics to some extent, not all are able to. However, these still form an 
important part of the biofilm community, and are able to do so by the presence 
of so-called bridging bacteria. Fusobacteria are a genera or bacteria that are 
important to facilitate the binding of non-co-aggregating bacteria for 
incorporation into biofilms, and particularly bridging anaerobic with aerobic 
bacteria, an example of a mutualistic microbial relationship (Bradshaw et al., 
1998; Periasamy & Kolenbrander, 2009). F. nucleatum, specifically, bind 
extensively with most other oral bacteria, and facilitate the binding of early- 
and late-colonisers, to establish a more comprehensive community (George & 
Galfkler, 1992). 
 
Whilst in close proximity, microorganisms can communicate, as discussed in 
1.1.3, via secreted molecules as part of a quorum sensing system and are able 
to stimulate expression of virulence factors and other cell density dependent 
genes (Li et al., 2002; Kruppa et al., 2004). This allows the cells to adapt to 
changes in their environment quickly.  
 
As these microcolonies form and develop, through both division and co-
aggregation, the microorganisms produce EPS. Defined microenvironments 
also begin to form, allowing for the existence of diverse habitats and therefore 
supporting a range of microorganisms (Stoodley et al., 2002). During biofilm 
maturation, if there is restriction in the availability of nutrients or gases around 
the biofilm matrix, cells can enter a ‘stationary phase’ where metabolic activity 
is significantly lowered until conditions alter (Fricks-Lima et al., 2011). 
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As microcolonies grow in a structured manner, microenvironments within them 
become more defined in different regions of the biofilm as the penetration of 
nutrients and gases become more restricted. As oxygen availability is 
generally highest at the point of the biofilm furthest away from the attached 
surface, aerobic microorganisms tend to exist in this area, whereas anaerobic 
microorganisms are most likely to be found toward the base of the biofilm 
(Marsh, 2005; Monroe, 2007). Nutrients are supplied via channels (as 
previously described) in order to ensure diffusion within the EPS matrix is 
sufficient to enable sustained growth. Recruitment of additional 
microorganisms also occurs during this growth and maturation phase 
(Costerton et al., 1987), as the presence of EPS provides a dynamic surface 
more likely to encourage adherence and integration of the new 
microorganisms into the biofilm, and this continued addition of microorganisms 
increases the likelihood of co-aggregation via ligand-receptor interaction 
(Hoyer & Cota, 2016). 
 
Once the biofilm has an established structure, consisting of the early 
colonisers, and additional microorganisms recruited as part of the maturation 
phase, late colonisers join the biofilm through co-aggregation mechanisms and 
quickly integrate within the biofilm matrix and community (O’Toole et al., 2000). 
 
1.1.2.3 The mature biofilm, microbial cell dispersal and subsequent 
implications 
The ‘mature biofilm’ typically exists after a number of days of growth and 
maturation, whereby the content of the community becomes more stable in 
physical size, distribution of microorganisms within the biofilm, and relative 
abundance of different genera and species. This is also known as the climax 
community. It is the phase at which the biofilm is in its most developed state, 
stable despite changes in local environmental stresses including dietary 
components, host defences, salivary flow and pH, the continues growth of 
which is most likely restricted by sheer forces imposed by salivary flow within 
the oral cavity (Marsh, 2006). 
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The final stage of biofilm development cycle is cell dispersal. It is thought that 
dispersal of cells occurs not by chance, but as part of a highly-regulated 
system influenced by physiological and environmental signals (Jackson et al., 
2002). It is necessary in order for the microorganisms to colonise and re-
establish a biofilm development cycle at a different location, and is considered 
a major pathogenic factor. Numerous methods of biofilm dispersal have been 
observed such as planktonic cell dispersal via surface or liquid phase, and 
clumped cell dispersal (Hall-Stoodley et al., 2004). Both types of dispersal can 
lead to relocating and establishing new microcolonies, which if the conditions 
are still suitable, have the potential to lead to further biofilm development and 
an increased infection state. Depending on the environment, shear force can 
also cause biofilm cell dispersal such as liquid flow (Rochex et al., 2008; 
Bearon, 2003).  
 
The molecular process of dispersal is not completely clear, but one molecular 
method of biofilm dispersal in E. coli arises from induction of a global regulatory 
gene, csrA. Interestingly, this gene has also been implicated in the microbial 
invasion of host mucosa, and a plant homologue has been identified, which is 
involved in disease and host response (Jackson et al., 2002). In Candida 
species, the production of the yeast wall protein (Ywp1p) has been implicated 
with anti-adherence properties, and linked to dispersal of cells from an 
established biofilm (Heilmann et al., 2011; Granger, 2012).  
 
The advantage of polymicrobial biofilms containing Candida species is that 
Candida has the ability to form hyphae (or pseudohyphae) depending on 
species. These morphologies are distinct and considered a significant 
virulence factor and indicator of pathogenicity (Santana et al., 2013). The 
formation of hyphae is also implicated in tissue invasion, which inevitably 
increases the host immune response. Furthermore, the hyphae provide a 
structural advantage to the biofilm, allowing maturation and development in a 
3D manner to occur (Seneveratne et al., 2008; Williams et al., 2011). 
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1.1.3 Microbial interactions and responses to environmental factors 
Environmental awareness and communication between microorganisms are 
important features of successful mature biofilm development. Mechanisms for 
environmental sensing and inter-cellular communication are commonly known 
as quorum sensing systems or two component quorum sensing systems. 
 
1.1.3.1 Quorum sensing 
Quorum sensing is considered a major communication and environmental 
sensing mechanism of microorganisms. Distinct mechanisms exist for 
individual bacterial and fungal species (Ng & Bassler, 2009), but the overall 
concept of communication is similar. Gram negative bacterial quorum sensing, 
for example, is dependent on the autoinducer molecule N-acyl homoserine 
lactone (AHL), and the LuxI/LuxR system (or homologues to LuxI/LuxR), 
commonly found in bacterial genera including Pseudomonas, Vibrio, 
Burkholderia (Fux et al., 2003; Ng & Basser, 2009; Spoering & Gilmore, 2008; 
Williams et al, 2007). The basic principle behind this mechanism is driven by 
cell density (Swift et al., 1996). Gram negative bacterial cells constitutively 
produce the small molecule, AHL, which is freely diffusible into the surrounding 
environment. This AHL can modulate specific gene expression and at lower 
cell densities, the threshold at which gene transcription occurs (as a result of 
protein binding and activation) is not met. Consequently, the genotypic and 
subsequent phenotypic profile of the bacteria follow a particular route. At 
higher cell densities however, the increased concentration of AHLs in the 
environment leads to increased diffusion into the cell. AHL then binds to LuxR 
and initiates transcription of alternative or additional operons. This results in a 
modified bacterial phenotype through the activation of expression of different 
genes, potentially changing cell behaviour.  
 
This concept is similar through Gram positive, and fungal quorum sensing 
systems. The fungus Candida, utilises the molecule farnesol, which has a 
similar effect and mechanism to the AHLs mentioned above (Hornby et al., 
2001, Ramage et al., 2002). Some characteristics of Candida, including the 
yeast to hyphae transition, are controlled by cell density in their ability to sense 
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the concentration of cells in the local environment, and adapt accordingly. The 
production of farnesol accumulates in the environment as it is actively and 
constitutively secreted, and above a certain threshold, modulates gene 
expression for induction of hyphae (Ramage et al., 2002). 
 
1.1.3.2 Inter-kingdom interactions 
It is beneficial for microorganisms to communicate with each other for the 
overall survival of the community. It is also beneficial for microorganisms of a 
different kingdom to be able to communicate, or at least sense communication 
between other microorganisms. These sensing and communication systems 
are mediated by small, diffusible molecules, including AHLs and autoinducer 
molecules (AIs). It is proposed that autoinducer 2 (AI2) is an inter-species 
communication molecule, which makes it distinct from AHLs, which are 
generally genus specific (Kolenbrander et al., 2002). In addition to this, no 
evidence has been observed of AHL production by oral bacteria, indicating that 
these molecules are not used for microbial sensing or signalling. The 
production of both AHLs and AIs are cell density dependent. These molecules 
are produced in a continuous manner, such that changes in cell density can 
be detected, resulting in the production or up- regulation of virulence factors 
(Williams et al., 2000) via cell-to-cell communication. AI2 has also been 
implicated in mutualistic polymicrobial biofilm development as a cell-density 
dependent molecule (Rickard et al. 2006).  
 
Virulence factor regulation in streptococcal species has been described by 
Heath et al. (1999), resulting from the interruption of a gene encoding the 
response regulator csrR. The csrR gene is implicated in subsequent 
downstream processing events and regulation of other genes involved with 
pyrogenic exotoxin production, speB, and streptolysin production, sagA.  
 
Candida are known to produce the quorum sensing molecule, farnesol, which 
is thought to directly influence or control morphological transition from yeast to 
hyphae (Ramage et al., 2002; Chen et al., 2004). Farnesol has been shown to 
enhance the growth and microcolony formation of S. mutans (Kim et al., 2017), 
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which is implicated in dental caries, but has also been shown to reduce 
formation of single and mixed (Candida and S. mutans) species biofilms 
(Fernandes et al., 2016). Whilst the evidence reports two polar effects of this 
single quorum sensing molecule, it suggests the resultant effects need to be 
considered as part of a wider, multi-component complex, and an overall net 
effect. In addition to farnesol, other sensing and communication molecules 
have been discovered and characterised such as tyrosol (Chen et al., 2004), 
tryptophol and phenethyl alcohol (Lingappa et al., 1968), and farnesoic acid 
(Oh et al., 2001) as reviewed by Kruppa (2009).  
 
1.1.4 Antimicrobials and their decreased efficacy against biofilms 
It is generally accepted that microbial cells within biofilms possess a 
significantly higher tolerance to the effects of antimicrobials (Kumamoto, 
2002). Studies estimate that biofilms can be in the region of 1,000 times more 
resilient to treatment with antimicrobials than their planktonic counterparts 
(Mah & O’Toole, 2001; Prosser et al., 1987). Furthermore, the knowledge that 
microbial cells do not behave in the same manner in planktonic states as they 
do in biofilms may have some influence on the mechanism of resistance or a 
method of developing tolerance towards the compounds (Hall-Stoodley et al., 
2004). 
 
A number of mechanisms are known to play a role in increased resistance to 
antimicrobials, some of which are shown in Fig. 1.4, and detailed below.  
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Figure 1.4 Diagrammatic representation of biofilm mechanisms of 
antimicrobial resistance.  
Mechanisms include reduced penetration into the biofilm as a result of physical 
restriction by EPS; quorum sensing which modulate responses to 
environmental stresses, and can lead to phenotypic and metabolic changes; 
multi drug resistance pumps to actively sequester antimicrobials from within 
the biofilms; reduced nutrient and oxygen concentration, which impacts 
antimicrobial efficacy, and a reduced metabolism can alter efficacy as many 
antimicrobials are growth dependent by inhibiting cell wall production. Image 
used with permission from O’Toole (2001) 
 
1.1.4.1 Physical mechanisms of biofilm protection 
The makeup of biofilms includes EPS, which is a thick matrix of a mixture of 
components, which can physically restrict entry into the deeper segments of 
the biofilm structure, or by diluting the compounds once they have penetrated 
through and into the EPS (Sutherland, 2001). Stewart & Costerton (2001) 
suggested that, by their very nature, cells within biofilms, being embedded in 
a matrix of EPS, have a physical mechanism of protection, which was echoed 
in a review of biofilm resistance to antimicrobials by Mah & O’Toole (2001).  
 
The inability of the antimicrobial to penetrate into the biofilm to a sufficient 
depth to be effective is important. The mechanism by which this occurs is 
complex and multifactorial. It is thought that as a result of opposite charges of 
the EPS and antimicrobial compounds, sequestration of the compounds within 
the EPS can arise. Furthermore, the effect of reduced oxygen availability and 
reduced metabolic activity of the microorganisms toward the centre of the 
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biofilm makes these cells more tolerant of antimicrobial activity (Walters et al., 
2002). 
 
The range of environments within the biofilm, and accumulation of waste 
products or by-products of metabolism can act as antagonists to the 
compounds. Biofilm mediated protection has been observed for C. albicans 
biofilms, where the effective concentration of antimicrobials (minimum 
inhibitory concentration, MIC) were up to 1,000 times higher for cells within a 
biofilm than the planktonic equivalent (Kuhn et al., 2002). This biofilm 
protective effect is also true for host-immune response assault of biofilms. 
Although antibodies may be raised against microorganisms at the biofilm 
periphery, most areas of the biofilm will be unaffected. It is likely that given the 
polymicrobial and localised microbial composition the antigens of some 
species may even be ‘hidden’ from the immune system. This response may 
be somewhat effective in an attempt to clear a small range of microorganisms, 
but the ability of antibodies or recruited immune cells to penetrate into the 
biofilm is severely reduced, as also observed with antimicrobial compounds 
(Fux et al., 2005). 
 
1.1.4.2 Active mechanisms of protection 
Antimicrobial compounds enter into the biofilm in what is an already arduous 
task of penetrating into and within the EPS, and subsequently into the depths 
of the metabolically active biofilm. As the drug reaches the cell, before it can 
have any effect, the cell can employ a number of mechanisms to avoid the 
effects of the compound. One such mechanism is to simply secrete the 
compound back into the environment. This is made possible by the 
employment of efflux pumps, which are membrane pores that control active 
transport of materials across the cellular membrane (Mukherjee et al., 2003). 
Efflux pumps are effective mechanisms of active secretion of antimicrobial 
compounds from cells, particularly within biofilms (Ramage et al., 2002; 
Mukherjee et al., 2003). Ramage et al (2002) showed up-regulation of genes 
known to be involved in formation and function of efflux pumps in C. albicans 
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biofilms, and a subsequent increase in antifungal resistance to fluconazole 
when these biofilms were challenged.  
 
Furthermore, it was hypothesised by Mukherjee et al., (2003) that in addition 
to the involvement of efflux pumps in enhanced resistance, the reduction in 
overall cell membrane permeability also played a role. These factors, along 
with the ability for cells within biofilms to substantially reduce their metabolic 
activity, and thus become quiescent, lead to an enhancement of innate 
tolerance to the efficacy of targeted drugs. The role of quiescence in C. 
albicans biofilm resistance, however, is not clear in the literature, with studies 
suggesting that the majority of cells are metabolically active (LaFleur et al., 
2006), and others suggesting they can exhibit a reduction in metabolic activity 
(Chandra et al., 2001; Lewis, 2005). 
 
Microorganisms also have the ability to actively secrete DNA (extracellular 
DNA; eDNA) into the local biofilm environment (Okshevsky & Meyer, 2014; 
Hirota et al., 2016; Vilain et al., 2009; Jakubvics & Burgess, 2015). This eDNA 
has a structural role, supporting maturation and biofilm integrity, and a 
functional role, where portions of eDNA can then be taken up by surrounding 
microorganisms and integrated into their genome. Some genes in such eDNA 
fragments can code for antimicrobial resistance genes, and can give the new 
host an advantage in what is already a very competitive community. The 
presence of eDNA has also been attributed to inducing morphological 
transition from yeast to hyphae in Candida biofilms (Hirota et al., 2016). 
 
1.1.4.3 Persister cells 
An additional mechanism of antimicrobial resistance, and indeed tolerance to 
other environmental stresses such as extreme changes in local environment; 
temperature, pH, nutrient availability and desiccation, lie with the existence of 
persister cells (Lewis, 2001; Jenkinson, 2011; Percival et al., 2015). The cells 
exist in a state of substantially reduced metabolic activity. As discussed briefly 
above, the existence of cells that are considered dormant, or demonstrate 
reduced metabolic activity, have a significant advantage for these communities 
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at a time where the community is literally fighting for its life. Fig. 1.5 outlines 
the concept of persister cells, and their ability to avoid methods of treatment or 
removal which are important in the maintenance and recovery of biofilms. 
 
 
Figure 1.5 Diagrammatic representation of microbial persister cells, and 
biofilm recovery after ineffective initial antimicrobial treatment. 
A) Polymicrobial biofilm exists on surface, embedded in extracellular polymeric 
substances, and after antimicrobial treatment B) few viable persister cells 
remain, which after antimicrobial treatment or challenge has subsided, re-
establish and recolonise and re-establish the biofilm C), where it returns to its 
polymicrobial, mature state. These persister cells, and thus the biofilm in 
general now have increased tolerance for subsequent treatment or 
antimicrobial challenges. 
 
1.2 The oral cavity 
1.2.1 The anatomy of the oral cavity 
The oral cavity is a portal to the body for the purpose of obtaining nutrients 
through food and drink. There are a number of anatomically distinct sites within 
the cavity, including the tongue, palate, teeth, and gingiva (Fig. 1.6); all with 
bespoke features and functions. There are a range of teeth with the same 
A 
B 
C 
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primary functions, from tearing to crushing different foods to allow digestion. 
This chewing mechanism is facilitated by the production of whole saliva, mixed 
from the ducts of many salivary glands (de Paula et al., 2017), which contain 
a range of enzymes (Fabian et al., 2012), assisting the breakdown of 
substrates in the mouth and oesophagus. These enzymatic constituents of 
saliva, including lysozymes and phosphatases, also have a significant role in 
immunity of the oral cavity from microbial infection. The presence of the 
enzymes can prevent colonisation of surfaces by microorganisms. This, 
together with the presence of immunoglobulins and mucins, serve to maintain 
the inhibition of microbial colonisation and where necessary, establish an 
immune response to the potential infection. They also assist with mediating 
tolerance to commensal microorganisms, so as not to mount an inappropriate 
immune response, and constitutive localised inflammation (de Paula et al., 
2017, Feller et al., 2013, Fabian et al., 2012). 
 
In addition to teeth, other sites provide structural function to the oral cavity. 
The purpose of gingival tissue is to provide support to erupted teeth, and as it 
is comprised of mucosal tissue components, also acts as a barrier to potential 
infection. However, as a result of insufficient oral hygiene, it is common for 
dental plaque biofilms to accumulate above and below the gingival margin 
(supra- and sub-gingival respectively), where localised inflammation occurs, 
and can lead to destruction of the tissue (Marsh, 2005; Marsh & Bradshaw, 
1995). This infection (periodontal disease) is dynamic, and depending on 
severity and length of sustained infection, can lead to severe tissue 
destruction, and ultimately bone destruction and tooth loss (Jenkinson & 
Lamont, 2005; Gendron et al., 2010). 
22 
 
 
Figure 1.6 Schematic representation of sites within the oral cavity. 
Image used with permission from Terese Winslow, For the National Cancer 
Institute © 2012 Terese Winslow LLC, U.S. Govt. has certain rights 
 
The hard palate, a site of specific focus for this PhD, is a complex layered 
tissue (Fig. 1.7) analogous to other epidermal or dermal tissues. The most 
superficial layers of epithelial cells are keratinised, and the layers of cells 
beneath are well differentiated and stratified. These layers, moving from the 
superficial layer into the tissue are as follows: stratum corneum, stratum 
granulosum, stratum spinosum, and stratum basale. Again, as observed with 
skin, palatal mucosa provides a physical barrier to infection, whilst tolerant to 
colonised commensal microorganisms as discussed previously. Beneath the 
epithelial layer exists a final layer, lamina propria: fibrous connective tissue 
(Moharamzadeh et al., 2007) comprised of a fibroblast cell-populated matrix 
of collagen. 
 
23 
 
 
Figure 1.7 Diagrammatic representation of the oral mucosa and similarities in 
structure to skin 
Image used with permission: Glim et al. (2013). Wound Repair and 
Regeneration 
Volume 21, Issue 5, pages 648-660, 8 AUG 2013 DOI: 10.1111/wrr.12072 
 
1.2.2 The oral microbiome 
1.2.2.1 The journey to characterise the oral microbiome 
Each of the surfaces in the oral cavity exhibit a variety of local environmental 
conditions including varying oxygen availability resulting in aerobic and 
anaerobic environments, but also different physical influences such as 
mechanical action caused by movement of the tongue and salivary flow. These 
varied local environments can support a vast array of microorganisms 
including bacteria and fungi. In fact, the oral microflora is second only to the 
colon in terms of microbial diversity in the human body, with over 1000 species 
reported to be present (Dewhirst et al., 2010; Wade, 2013).  
 
Studies of the oral cavity have previously relied upon culture-dependent 
methods to investigate the composition of the oral microbiome and organisms 
implicated in specific diseases (Bowden et al., 1979). The advancement of 
technology and continued development of novel methodology has allowed 
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molecular techniques such as DNA analysis to be employed (Aas et al., 2005; 
Ghannoum et al., 2010; Wade, 2011). The use of molecular analysis has 
revolutionised our understanding of the oral microbiome. It is now known that 
there are far more microorganisms present in the oral cavity than originally 
thought based on culture-dependent methods.  
 
Both culture-dependent and culture-independent analytical methods have 
provided valuable information into the range of microorganisms found in the 
oral cavity, and the creation of a central database (the Human Oral Microbiome 
Database; HOMD) to capture and collate results of characterisation studies 
was launched in 2010 (Chen et al., 2010; http://www.homd.org). This database 
uses data from studies involving 16S rDNA sequencing, which, whilst providing 
information about the bacterial content, does not currently incorporate analysis 
of fungi (such as Candida species), which lack the 16S ribosomal subunit. This 
is significant as Candida species are known to be major causative agents of 
oral infections and diseases. However, all fungi, including Candida, have a 
similar ribosomal subunit, namely the 18S subunit, regions of which are highly 
conserved and can be analysed in the same manner as 16S rDNA for bacterial 
identification. In order to evaluate and compare Candida sequences, 
alternative databases are available, an example of which is the Candida 
Genome Database (Inglis et al., 2012; http://www.candidagenome.org).  
 
1.2.2.2 Characterisation of microbial hierarchy and their relationships 
The most recent advances in this field highlight the issue that a significant 
proportion (as many as 35%) of oral microorganisms are not currently 
cultivable in vitro (Chen et al., 2010). This may be due to the reliance of some 
microorganisms on enzymes, nutrients or cofactors produced by other 
microbes present in the locality. Many examples of symbiotic relationships 
between microorganisms growing as part of a biofilm have been reported. One 
such example of intra-kingdom, inter-species symbiotic relationships is the 
relationship between Streptococcus gordonii and Veillonella atypica. 
S gordonii utilises sugar for growth, the by-product of which is lactic acid, which 
is then used by V. atypica for energy production (Johnson et al., 2009). In this 
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instance, both microorganisms benefit from the presence of each other. 
Without V. atypica the build-up of lactic acid would form part of a negative 
feedback signal transduction system leading to a reduction in S. gordonii sugar 
metabolism. Metabolism of lactic acid by V. atypica prevents this feedback 
occurring, allowing both organisms to benefit. Other relationships are not 
necessarily mutually beneficial, but may benefit just one microorganism, either 
at the expense of others (parasitic), or to no benefit or expense of others 
(commensal/neutral) and are detailed in Table 1.3.  
 
A preliminary study investigated inter-kingdom in vitro relationships of mixed 
species culture, showing the effect of the presence of a range of bacterial 
species when grown in dual-species co-culture with C. albicans (Thein et al., 
2006). The study enumerated the number of viable cells after a period of time, 
and found that when maintaining a standardised inoculum of C. albicans, the 
effect of changing the inoculation rate of bacteria gave varied results. For 
example, S. mutans, a frequently isolated oral commensal microorganism, 
which is also commonly associated with oral infections, had no influence on 
the number of viable C. albicans. However, when Porphyromonas gingivalis 
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Relationship Description Example 
Mutualistic All organisms benefit from 
the relationship in some 
way 
S. mutans and C. albicans sugar utilisation in co-culture: 
C. albicans is inefficient at sucrose breakdown, S. mutans has preference for sucrose. 
Sucrose breakdown results in glucose and fructose, which are utilised by C. albicans, 
producing lactate, further facilitating S. mutans growth (Kim et al., 2017) 
   
Commensal/neutral One (or more) organism(s) 
benefit with no benefit or 
harm to the host or others 
Many gut and oral microorganisms operate a commensal relationship. Nutrients 
extracted from sources in the oral cavity or digestive tract are utilised for sole benefit, 
with no negative implications of surrounding environment or other microorganisms 
   
Parasitic One (or more) organism(s) 
benefit to the detriment of 
the host or others 
Viral and parasite-associated infections are considered parasitic, with no host benefits 
as a result of presence, metabolism or behaviour of the microorganism 
Table 1.3 Categories and descriptions of relationships between organisms 
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was added in co-culture with C. albicans, the number of viable C. albicans 
decreased. This study only investigated dual-species, so the effect of a true 
polymicrobial biofilm on the number of viable cells of both C. albicans and 
bacteria is of great interest. Furthermore, the study investigated biofilms grown 
only over 48 hours, a relatively short time period considering that oral 
infections can contain biofilms that will have grown over a significantly longer 
period than this. This is particularly true for denture wearers with poor general 
oral hygiene where biofilms may exist for many weeks or months. Overall, the 
study highlighted the fact that such mixed species relationships are complex 
with many variables affecting overall outcomes.  
 
Our current understanding of the microbial composition of the healthy oral 
cavity indicates the presence of a vast and broad array of commensal 
microorganisms (Mager et al., 2003; Aas et al., 2005; Bik et al., 2010; Dewhirst 
et al., 2010; Ghannoum & Mukherjee, 2013). These studies found that 
commonly isolated or detected microorganisms in healthy individuals include 
bacteria such as Porphyromonas, Streptococcus and Veillonella, and yeast 
such as Candida. The characterisation of a healthy oral cavity is significant, as 
when we consider studies investigating oral diseases such as periodontitis, 
gingivitis, dental plaque and other oral infections, the same microorganisms 
found in healthy individuals are also identified as causative or supportive 
agents in disease progression. Consequently, it can be challenging to identify 
the aetiological agents within the commensal pool of microorganisms.  
 
The current understanding of the roles of different microorganisms within 
biofilms is more complex than it just being a microbial collective. Each 
microorganism may have a distinct role to play, contributing to the overall 
community in some way. Different types of microbial roles can be classified 
into several types, more than just the typical commensal versus pathogen, as 
detailed in Table 1.4. 
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Microorganism role Description Example 
Commensal Normal microorganisms found in the typical 
microflora, indigenous microbiota 
Streptococci in oral cavity, S. epidermidis on skin 
Accessory pathogen Typically commensal microorganisms, but 
contributes by nutritional/colonisation support to 
enhanced growth and/or virulence of other 
microorganisms, including pathogens  
S. gordonii enhances virulence of P. gingivalis and 
A. actinomycetemcomitans  
 
Keystone pathogen Microorganisms whereby the influence they have 
on the microbial community is disproportionately 
large relative to their absolute abundance (Power 
et al., 1996) 
P. gingivalis within the oral cavity; significant indirect 
contribution to development of gingivitis/periodontitis by 
inducing dysbiosis of the microbial community, thus 
enhancing inflammatory response and tissue damage 
Opportunistic pathogen Typically commensal microorganisms, but have 
the ability to adapt/change and cause infection 
under certain environmental conditions 
C. albicans; commensal within the oral cavity of healthy 
individuals with no adverse effects, but in 
immunocompromised patients, can cause substantial 
localised and systemic infection 
Pathobiont  Microorganisms whose effect, although similar to 
opportunistic pathogens, occurs indirectly via 
stimulation/activation of the host immune system 
P. gingivalis induces systemic inflammation, segmented 
filamentous bacteria potent stimulation of host mucosal 
immune system (Hornef, 2015) 
Table 1.4 Summary table of different roles of microorganisms within polymicrobial communities and hosts 
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1.2.3 Dysbiosis and development or progression of disease 
The normal microbiome exists to maintain a state of health and homeostasis 
between commensal, and potentially pathogenic microorganisms, including 
bacteria, fungi and viruses (Wade, 2013; Zarco et al., 2012; Ghannoum et al., 
2010). Several distinct advantages arise as a result of the presence of a 
distinct and diverse oral microbiome, including assistance with breakdown of 
substrates and nutrients within the oral cavity, and tolerance toward the 
presence of pathogenic microorganisms. 
 
During the continual change in local environmental stimuli and conditions, and 
the stimulation of the immune system by the resident microflora, eventually the 
fine balance of homeostasis is tilted either by a local change or other factors 
such as diet or medication, and dysbiosis can occur. Dysbiosis refers to the 
shift from a homeostatic microbiome to one in favour of pathogenic and 
infection causing microorganisms. Dysbiosis is a serious concern, because not 
only can localised infection and inflammation occur (Zemanick et al., 2015), 
but also development of cancers and autoimmune diseases (Chen et al., 2015, 
Li et al., 2014). 
 
The onset or progression of disease is attributed to the reduction in diversity 
of the local microbiome, which in turn is responsible for maintaining tolerance 
of the immune response, and modulation of the local environment in which the 
microorganisms exist. This in turn requires adaptation of the host cells to 
changes in environmental conditions, and can lead to a change in genetic 
regulation. Interestingly, in the case of Crohn's disease as reported by Li et al 
(2014), the diversity of the gut mycobiome is inversely related to the diversity 
of the bacterial microbiome, and while there is an increase in the diversity of 
fungi, there is a subsequent reduction in the diversity of bacteria in this 
condition, leading to potentially severe inflammation. In this instance, it 
appears the modulation of the immune response is managed by the bacterial 
cells present, rather than the fungi, and thus, when keystone bacterial species 
change either in presence or relative abundance, the modulation of the 
inflammatory response is unregulated, leading to a proinflammatory response.  
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1.2.4 The role of saliva in the oral cavity, and changes with presence 
of oral prostheses 
Salivary flow in the oral cavity is an important factor for normal function of the 
general oral cavity. As discussed previously, whole saliva contains many 
different components; water; electrolytes, host factors including enzymes, 
proteins, mucins, immunoglobulins (Humphrey & Williamson, 2001), epithelial 
cells, immune cells and, of course, the constituents of the resident microbiome 
(Wade, 2013; Nasidze et al., 2009; Yang et al., 2012). Saliva has a unique 
microbiome of its own, distinct from other sites in the oral cavity, with similar 
contributions to the normal function of the oral cavity as the presence of other 
microorganisms. 
 
The primary function of saliva is lubrication and buffering of the environment, 
as well as antimicrobial activity through immunoglobulins, and antimicrobial 
peptides found in the saliva (Humphrey & Williamson, 2001). The functionality 
of saliva is altered with the presence of oral prostheses, such as dentures 
(Niedermeier et al, 2000), and where salivary flow is reduced, patients often 
experience dry mouth, or a burning sensation. The reduction in saliva, 
particularly between the denture-fitting surface, and epithelial cells of the 
palatal mucosa, can lead to an increase in the presence or persistence of 
biofilms on the denture-fitting surface, and indeed, the palate itself, where 
natural sloughing may be affected. This increased presence of biofilms can 
then lead to inflammatory responses, such as those observed in denture-
associated stomatitis. Furthermore, the salivary microbiome can have 
implications for diseases of other sites of the body, particularly the gut 
(Acharya et al., 2017). 
 
1.3 Candida 
1.3.1 Taxonomical classification and characteristics of Candida species 
The name Candida is derived from the Latin toga candida, which refers to the 
white robe (toga) worn by candidates for the Senate of the ancient Roman 
republic (Lynch, 1994), and relates to the white/off-white colour of the Candida 
colonies when cultured both in vivo and in vitro. 
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The fungal genus of Candida includes a diverse array of species, including the 
more clinically relevant species C. albicans, C. tropicalis, C. parapsilosis, 
C. glabrata and C. dubliniensis (Ramage et al., 2006), and C. auris, a multi 
drug resistant species of the Candida genus (Schelenz et al. 2016; Chowdhary 
et al. 2014). Candida species typically grow as waxy white/off-white colonies 
when cultured on Saboraud dextrose agar, and can differentially metabolise 
compounds in CHROMagar Candida to allow for presumptive identification 
of certain species (Williams & Lewis, 2000). 
 
Candida species are generally considered commensal microorganisms, 
resident within the typical microflora in a range of many bodily sites in animals 
and humans, without any adverse implications, and are also associated with 
the natural environment (Skinner & Fletcher, 1960). Certain species, including 
C. albicans, C. glabrata, C. parapsilosis, C. tropicalis and C. auris however, 
are opportunistic pathogens, and can cause disease in immunocompromised 
individuals, under specific environmental conditions or as a result of external 
stimuli (Ramage et al., 2006; Deorukhkar et al., 2014). 
 
1.3.2 Candida virulence factors 
1.3.2.1 Candida polymorphism 
Candida species (with the exception of C. glabrata) possess a unique, and 
very beneficial morphogenic trait. The ability of this polymorphogenic 
microorganism to exist as yeast cells, but also as distinct, elongated hyphae 
(or pseudohyphae) (Fig. 1.8) is considered an important virulence factor, and 
has been extensively studied and reviewed (Sudbery et al., 2004; Oh et al., 
2001; Ramage et al., 2002; Nobile et al., 2006; Santana et al., 2013). 
Numerous factors are known to influence the morphogenic state of this 
microorganism. Factors that induce hyphae production include high 
temperatures, high CO2 level relative to O2 and poor nutrient supply, whereas 
the yeast form of this microorganism is the preferred phenotype when there is 
a more acidic pH in the local environment and lower temperatures (Oh et al., 
2001). Another important factor of morphogenic control is cell density. It has 
been shown that a cell density of >106
 
cells/ml results in the production of 
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budding yeasts, whereas a cell density of <106 cells/ml results in production of 
hyphae (Hornby, et al., 2001). The production of the quorum sensing molecule 
farnesol has also been implicated in morphological transition, the higher 
concentration of which correlates with preference for the yeast form and an 
inhibition of production of hyphae. This is linked with viable cell density as 
farnesol is constitutively secreted as an environmental sensor. 
 
  
Figure 1.8 Fluorescence microscopy image of C. albicans morphological 
states. 
Typical spherical yeast cells; considered the commensal morphology of 
C.  albicans; budding yeast (red arrow), pseudohyphae (green arrow) and 
long, elongated hyphae (white arrow), representing the more virulent 
morphology. 
Image used with permission from Dr Sladjana Malic. 
 
1.3.2.2 Mechanism and regulation of yeast to hyphae morphological 
transition 
The molecular mechanisms by which morphological transition and hyphal 
formation occurs are highly regulated. A number of stimuli can induce a 
signalling cascade leading to enhancement of the genes responsible for 
hyphal formation. Fig. 1.9 demonstrates the signalling pathways of a number 
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of typical stimuli including elevated temperature, pH, concentrations of quorum 
sensing molecules farnesol or homoserine lactones, among others (Sudbery, 
2011).  
 
Figure 1.9 Summary of multiple hypha-inducing stimuli and subsequent 
signalling pathways leading to hyphal formation.  
A number of environmental stimuli including changes in pH, concentration of 
quorum sensing molecules and concentration of CO2 can lead to activation of 
specific signalling pathways including the mitogen-activated protein kinase 
(MAPK) pathway (green), pH sensing pathway (brown), matrix-embedded 
pathway (blue) and cAMP pathway (turquoise), activating a panel of 
transcription factors (orange). The general transcriptional regulator Tup1 
(yellow) is responsible for negative regulation, by targeting the hypha-specific 
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gene promotors including Nrg1 and Rox1p-like regulator of filamentous growth 
(Rfg1). Image used with permission from Sudbery (2011). 
 
Induction of hypha-specific gene expression is performed by a range of 
transcription factors including Efg1 (Stoldt et al., 1997; Lane et al., 2001; 
Kumamoto & Vinces, 2005) which is necessary for the formation of hyphae in 
response to serum, CO2, neutral pH and N-acetyl-D-glucosamine (GlcNAc), 
Cph1 (Liu et al., 1994; Leberer et al., 1996; Kumamoto & Vinces, 2005), Cph2 
(Lane et al., 2001), Tec1 (Lane et al., 2001) and Ndt80 (Sellam et al., 2010). 
The pathways to expression involve cyclic adenosine monophosphate (cAMP) 
and mitogen-activated protein kinase (MAPK) pathways. Induction of the 
pathways lead to activation of an array of hypha-specific genes including 
glycosylphosphatidylinositol (GPI)-anchored cell wall proteins HYR1, IHD1 
and agglutinin-like sequences ALS3/ALS10 which are considered adhesins, 
hyphal wall proteins HWP1, RBT1, and secreted aspartyl proteinases 
SAP4/SAP6 (Nantel et al., 2002; Kadosh & Johnson, 2005). Negative 
regulation of hypha-specific gene expression is provided by the corepressor 
Tup1 along with Nrg1 or Rox1p-like regulator of filamentous growth (Rfg1) 
(Kumamoto & Vinces, 2005; Sudbery, 2011). 
 
1.3.2.3 Biofilm formation and important transcriptional regulators 
The biofilm and cell wall regulator 1 (Bcr1) transcription factor is essential for 
both activation and repression of a number of genes related to biofilm 
formation in C. albicans (Nobile et al., 2011). Knockout studies have confirmed 
the relevance of the protein with regards to biofilm formation in vitro and in 
vivo, where Bcr1 deficient mutants were unable to produce biofilms (Nobile et 
al., 2006a; Dwivedi et al., 2011), and showed altered gene expression of ALS1, 
ALS3, ECE1 and HWP1 in vitro (Nobile & Mitchell, 2005; Nobile et al., 2006a; 
Yano et al., 2016). Furthermore, Bcr1 deficient mutants were more susceptible 
to leukocyte-induced damage when grown in vitro or on mucosal tissues 
(Dwivedi et al., 2011). 
 
Although Bcr1 is not critical for formation of hyphae, it is a positive regulator of 
a number of hypha-specific adhesins including ALS3 and HWP1 (Nobile et al., 
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2006a), where overexpression of these targets partially restores biofilm 
formation in Bcr1 deficient mutants. Presence of a TEF1-BCR1 construct 
restored expression of these genes, confirming the role of Bcr1, but Bcr1 acts 
downstream of the hyphal development activator Tec1, as studies involving 
Tec1 deficient strains also showed restored biofilm formation with the 
presence of the TEF1/BCR1 construct (Nobile et al., 2006a). 
 
Further to this regulator, other transcriptional regulators are known to modulate 
biofilm formation, where deletion of the TEC1, EFG1 (Nobile et al., 2011) or 
indeed other regulators NDT80, ROB1 and BRG1 result in defective biofilm 
formation (Mayer et al., 2013). The transcriptional regulators control 
expression of a range of genes necessary for adhesion and biofilm formation, 
detailed in the following sections. 
 
1.3.2.4 Adhesion 
The first stage of biofilm formation for any microorganism is attachment and 
adherence to a surface. In many cases, this is primarily initiated by non-
specific interactions with the surface by phenomena such as Van der Waals 
forces, or ionic bonding as a result of differences in charge between the cell 
and surface. However, if surface contact is maintained beyond this reversible 
phase, the expression of surface adhesins and the initiation of irreversible 
binding to surface receptors occurs. Adhesins are well documented in many 
microorganisms such as P. aeruginosa, S. aureus and also in C. albicans 
(Foster & Höök, 1998; Calderone & Fonzi, 2001; Verstrepen & Klis, 2006; 
Nobile et al., 2006, Ma et al., 2006; Silverman et al., 2010). 
 
A number of Candida adhesins have been identified (select proteins of which 
are detailed in Table 1.5), including the agglutinin-like sequences family 
(including the proteins Als1-Als7 and Als9), hyphal wall protein 1 (Hwp1), and 
epithelial adhesin 1 (Epa1) (Sundstron, 1999; Zhao et al., 2004; Hoyer et al., 
2008; Liu & Filler, 2011; Halliwell et al., 2012). Many of these, including Als3, 
Hwp1 and Epa1 are also associated with virulence of the fungus. Furthermore, 
it is known that a number of these adhesins are involved with the 
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morphological transition to hyphae, such as Als3 and Hwp1 and have 
additional functions including invasion into host cells (Phan, 2007; Liu & Filler, 
2011) and subsequent pathogenesis of infections (Hoyer et al., 2008). 
However, anti-adhesive properties have also been identified with these 
adhesins, where in knockout studies, the deletion of Als5, Als6 or Als7 resulted 
in increased adhesion of C. albicans to human cells (Zhao et al., 2007). 
 
Als3 is a known multifunctional adhesion, expressed specifically during hyphal 
formation and plays a crucial role in adhesion to biotic and abiotic surfaces, 
and invasion of host cells (Nobile & Mitchell, 2005; Argimon et al., 2006; Liu & 
Filler, 2011; Hoyer & Cota, 2016). It is a GPI-linked protein that localises to the 
surface of the cell wall and is activated by Bcr1 stimulation by the transcription 
factor Tec1. As detailed above, repression of ALS3 gene expression by Tup1, 
Nrg1 and Rfg1, downregulates transcription via two repressor binding regions 
(Argimon et al., 2006; Liu & Filler, 2011), which results in growth in the yeast 
form. Folding of the N-terminal domain of Als proteins is reminiscent of 
bacterial adhesins, such as those observed in Staphylococcus species (Hoyer 
& Cota, 2016), indicating a conserved structure for adhesion to surfaces, 
indicating specific binding preferences despite the relative abundance of 
potential receptors on the surface.  
 
Bcr1 is also necessary for candidal adherence, and the activation of ALS3 
expression contributes to, but is not solely responsible for subsequent biofilm 
formation once adhered to the surface (Nobile et al., 2006a) where Als3 
deficient Candida retain biofilm formation capability., Overexpression of known 
Bcr1-regulated genes including ALS1, ALS3 and HWP1 result in some 
improvement in biofilm formation, highlighting the multi-gene contribution to 
biofilm formation. 
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Virulence 
attribute 
Protein Virulence role(s) References 
Adhesins Als1 Adhesion to surface and colonisation. 
Associated with yeast form of Candida 
Nobile et al., 2006b; 
Williams et al., 2011; 
Hoyer & Cota, 2016 
Als3* Adhesion to surface and biofilm 
formation. Associated with hyphal form 
of Candida, can bind to fibronectin, 
collagen, E-cadherin, N-cadherin 
Nobile et al., 2006b; 
Phan et al., 2007 
Williams et al., 2011; 
Hoyer & Cota, 2016 
Hwp1* Adhesion and formation of hyphae and 
involved in biofilm formation 
Nobile et al., 2006b; 
Hoyer & Cota, 2016 
Epa1 Epithelial cell adhesion. Haynes, 2001; Alves 
et al., 2014 
Hypha 
formation 
Ece1* Epithelial infection; secreted toxin also 
known as Candidalysin, required for 
cell damage 
Nobile et al., 2006b; 
Moyes et al., 2016 
Hydrolytic 
enzymes 
Sap4 Nutrient acquisition, tissue 
invasion/damage, associated with 
hyphae 
Naglik et al., 2003; 
Schaller et al., 2005; 
Williams et al., 2011 
Sap5 Nutrient acquisition, tissue 
invasion/damage, breakdown of E-
cadherin, associated with hyphae 
Naglik et al., 2003; 
Schaller et al., 2005; 
Williams et al., 2011 
Sap6 Nutrient acquisition, tissue 
invasion/damage, associated with 
hyphae 
Naglik et al., 2003; 
Schaller et al., 2005; 
Williams et al., 2011 
Pld1 Invasion during infection Sanglard et al., 1997; 
Naglik et al., 2003; 
Schaller et al., 2005; 
Naglik et al., 2011; 
Hebecker et al., 2014 
Table 1.5 Selected known virulence proteins and their associated roles in 
Candida virulence. 
Adhesins including agglutinin-like sequences (Als1 and Als3), hyphal wall 
protein 1 (Hwp1), epithelial adhesion 1 (Epa1), extent of cell elongation 1 
(Ece1), secreted aspartyl proteinases (Sap4, Sap5, Sap6) and phospholipase 
D1 (Pld1). *Als3, Hwp1 and Ece1 are implicated in both adhesion and 
formation of hyphae.
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Hwp1 is a well-studied hypha-specific GPI-anchored cell surface adhesin 
(Staab et al., 1999; Nobile et al., 2006b; Nobile et al., 2011; Mayer et al., 2013). 
It is involved in the adhesion of Candida to surfaces including a salivary pellicle 
and fibrinogen (Haussler & Parsek, 2010; Nobbs et al., 2010), and formation 
of elongated hyphae (Staab et al., 1999; Hoyer et al., 2008; Williams et al., 
2013). The adhesion of C. albicans cells to buccal epithelial cells and the 
involvement of interactions between C. albicans hyphae and keratinocytes via 
Transglutaminase cross-linkages has been reported (Staab et al., 1999). 
 
1.3.2.5 Hydrolytic enzymes 
Within its armoury, Candida has the ability to produce hydrolytic enzymes, 
including secreted aspartyl proteinase enzymes (Saps), and to a lesser but still 
significant extent, phospholipase enzymes as summarised in Table 1.5 
(Sanglard et al., 1997; Schaller et al., 2000; Naglik et al., 2003; Naglik et al., 
2011; Hebecker et al., 2014). These enzymes are not unique to Candida, or 
indeed fungi in general. They are known to be produced by a range of 
microorganisms including bacteria (Finlay & Falkow, 1997) and protozoa 
(McKerrow et al., 1993), in addition to fungi.  
 
The enzymes are multifunctional: they have been associated with enhancing 
adherence to epithelial cells (Naglik et al., 2011), and active penetration and 
invasion of epithelial cells (Gow & Hube, 2012; Hebecker et al., 2014). This 
suggested increased virulence and pathogenicity of the microorganism. They 
have been observed in multiple Candida species, including C. albicans, 
C. glabrata, C. tropicalis, C. krusei (Haynes, 2001), indicating the conserved 
nature of these proteins and their widespread use. The production of these 
enzymes is typically associated with nutrient acquisition and infection/invasion 
of host tissues (Schaller et al., 2000; Naglik et al., 2003). 
 
Secreted aspartyl proteinases are encoded by a family of 10 SAP genes and 
include two sub-families (Saps1-3, and Saps4-6) (Williams et al., 2013), and 
are considered key virulence traits of C. albicans. Other Candida species 
possess the ability to produce Saps, but which specific Saps are species 
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dependent (Naglik et al, 2003). Saps4-6, for example, result in 
permeabilisation of the lysosome, triggering caspase-1 dependent apoptosis 
(da Silva Dantas et al., 2016) and are linked with hyphal formation and invasion 
into the epithlium, while Sap5 is involves in breakdown of E-cadherin, a protein 
that maintains tight junctions between epithelial cells (Williams et al., 2013). 
Sap2 and Sap6 have been shown to produce inflammatory responses in the 
host (Pietrella et al., 2013; Gabrielli et al., 2015). 
 
The proteinases are produced intracellularly before being packaged into 
secretory vesicles, and transported to the cell membrane and either released 
extracellularly, remains attached to the cell membrane, or anchored via a GPI 
anchor (Sap9 and Sap10) (Naglik et al., 2003).  
 
Aspartyl proteinases have also been a target for treatments of Candida 
infection (Naglik et al., 2003), where aspartyl proteinase inhibitors showed 
good effects on the inhibition of these enzymes, and subsequently, reduce 
virulence in infections. 
 
1.3.2.6 Candidal invasion of epithelium 
In general, cells have a level of tolerance toward the presence and colonisation 
of a range of microorganisms. Candida is no exception to this tolerance, and 
is commonly observed as a commensal microorganism on mucosal surfaces. 
If and when environmental conditions allow it, Candida can activate virulence 
traits, one of which is the ability to invade colonised tissues (Felk et al., 2002; 
Naglik et al., 2003). The benefit in doing so is to seek nutrients in order to 
continue to survive, and potentially avoid factors that could lead to its demise 
such as environmental factors e.g. pH or factors secreted by the host and other 
microorganisms within the local community, or, within the oral cavity, salivary 
flow which could potentially physically remove it from the mucosal surface.  
 
Candida can invade multi-layered tissues either by breakdown of E-cadherin 
to expose the junctions between epithelial cells (Nobile et al., 2006b; Phan et 
al., 2007 Williams et al., 2011; Hoyer & Cota, 2016) , or by physical penetration 
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of and invasion through cells themselves (Felk et al., 2002; Moyes et al., 2016; 
Wilson et al., 2016). The process by which Candida invade tissues is 
organised and relatively complex. Firstly, adherence to the cell surface is 
necessary, as with typical colonisation, which involves the ALS family of 
genes. This is typically followed by hypha formation involving ALS3 and HWP1 
(as discussed above) and interestingly, cells deficient in the transcription factor 
Efg1, which is responsible for the control of hypha formation, do not invade 
tissues, indicating HWP1 and formation of hypha are essential for the invasion 
(Stoldt et al., 1997; Lane et al., 2001; Felk et al., 2002; Kumamoto & Vinces, 
2005). Hyphal invasion then occurs via one of two methods (Fig. 1.10); host-
mediated endocytosis of the yeast/hypha, or hyphae induced inter- or intra-
cellular active penetration (Wilson et al., 2016; Moyes et al., 2016). Inter-
cellular invasion relies on the breakdown of E-cadherin in order for the hypha 
to physically move between the junctions of the cells, and involves the 
production of ALS3 and aspartyl proteinases known for their lytic capability.  
 
During early intra-cellular invasion, as described by Moyes et al. (2016), an 
indwelling membrane pocket is formed by the physical action of penetrating 
hyphae, and the secretion of Ece1 occurs. This leads to cellular signalling as 
a response, calling for a localised immune response by the production of 
proinflammatory cytokines including IL-6, G-CSF, GM-CSF. Continued 
secretion of Ece1 leads to accumulation in the pocket, and the concentration 
reaches a threshold whereby it has a lytic effect. This causes membrane 
damage and allows lactate dehydrogenase to leak out of the cell, and calcium 
influx. Cell signalling pathways are maintained and induction of damage-
associated cytokines occurs including IL-1. 
 
Sustained invasion provides an obvious route through epithelia to endothelia, 
whereby Candida can become disseminated throughout the host via the blood 
stream, known as systemic candidosis. Production of secreted aspartyl 
proteinases have also been linked to invasion of parenchymal organs in in vivo 
experiments (Felk et al., 2002). 
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Figure 1.10 Early- and late-stage intra-cellular invasion of epithelial cells by 
candidal hypha 
Penetration of the candidal hypha creates a pocket, into which (A) Ece1 is 
secreted leading to cellular responses (B, C). Continued secretion of Ece1 
accumulates in the pocket (D), leading to membrane lysis (E, F) and sustained 
immune responses (G, H). Image used with permission from Moyes et al. 
(2016) 
 
1.4 Candidoses 
Candidoses have been recognised for thousands of years, and first known to 
be described by Hippocrates and published in 4th century BC (Lynch, 1994). 
Candida was then subsequently cultured some time later by Lagenbeck in 
1839 (Knoke & Bernhardt, 2006), who described a culture similar to what we 
now consider to be Candida. The association between thrush (candidosis) and 
the microorganism was first reported by Berg in 1846 (Vazquez, 2003). 
 
Opportunistic fungal pathogens of the genus Candida are frequently isolated 
from various sites of the human body and are considered causative agents of 
numerous medical conditions, commonly known as candidoses. Examples of 
infections caused or supported by Candida include vaginal candidosis 
(Heilmann et al., 2011), oral candidosis and urinary catheter infections. 
Candida is more commonly implicated in conditions affecting the young or 
elderly, and those with current illness or immunological suppression (Scully et 
al., 1994). The primary species involved in candidoses are considered to be 
Candida albicans, with other species including C. tropicalis, C. glabrata, 
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C. krusei and C. parapsilosis also implicated, but to a lesser extent (Odds, 
1994).  
 
1.4.1 Candidoses as human infections 
The term candidosis (plural: candidoses) refers to an infection in a living 
organism as a result of infection by the fungus of the genus Candida. Such 
infections are also commonly, although incorrectly, referred to as candidiasis. 
The term candidosis stems from the Latin word Candida, and the suffix –osis 
from the Latin for ‘state of disease’. 
 
An array of distinct candidoses exist in humans, affecting almost every part of 
the human body. These can be categorised as superficial candidosis, which 
includes the most common form of candidoses, namely oral and vulvovaginal 
mucosal candidosis (Scully et al., 1994; Williams & Lewis, 2011; 
Samaranayake et al., 2002); cutaneous candidoses, including candidal 
folliculitis and onychomycosis (Deorukhkar et al., 2014); and systemic 
candidosis (Scully et al., 1994; White et al., 2005). Due to the distinct local 
environments in which the infection occurs, each category of infection has a 
different pathogenesis and prognosis, but similar treatment strategies which 
primarily rely on the use of local or systemic antifungals. Sub-groups within the 
categories exist. The primary subgroup of interest within the scope of this 
research topic was oral candidosis. 
 
1.4.1.1 Localised Candida infections 
Local Candida-associated infections present on almost every surface on the 
human body, ranging from cutaneous infections to mucosal, each with an array 
of sub-infection categories. The severity varies depending on the Candida 
species, the area of infection and health of the patient. Of course, the longer 
an infection is left without treatment, the more severe and more difficult it 
becomes to treat. This is true of any sort of infection, but as candidosis can be 
an invasive infection, with cells penetrating into tissues to establish 
themselves, a stronger and longer treatment regime may be necessary. 
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Localised Candida infections are typically treated with antifungal medication, 
such as azoles. However, systemic antifungal medications may be necessary 
in the scenarios discussed above. 
 
1.4.1.2 Systemic Candida-associated infections 
Compared with localised infections, systemic Candida-associated infections 
are potentially far more serious in terms of mortality. The innate ability to 
migrate and potentially re-establish themselves in any number of vital organs 
within the body, known as disseminated candidosis, is of significant concern 
when it comes to treatment options. A study by Wisplinghoff et al (2004) of 
almost 25,000 hospital patients with bloodstream infections implicated 
Candida species in 9% of cases, with an associated mortality rate of 
approximately 40% (47% of ICU patients, 29% of non-ICU patients). 
 
1.4.2 Oral candidoses 
Within the category of mucosal candidoses, oral candidosis is one of the most 
common forms of infection. Primary oral candidoses, depicted in Fig. 1.11, are 
recognised as the following; pseudomembranous, chronic hyperplastic, and 
acute or chronic erythematous candidosis, each clinical presentation 
accompanied with a distinct diagnosis and prognosis, but also strong 
similarities in factors affecting initiation development of the infection. There are 
numerous pre-disposing factors (Table 1.6) associated with all oral candidoses 
such as the use of broad-spectrum antibiotics or corticosteroids, immune 
system defects such as infection with human immunodeficiency virus (HIV) or 
the subsequent onset of acquired immunodeficiency syndrome (AIDS), 
diabetes, and natural physiological factors such as age and pregnancy (Scully 
et al. 1994; Samaranayake et al., 2002). 
 
1.4.2.1 Chronic hyperplastic candidosis 
Chronic hyperplastic candidosis, (CHC, Fig 1.11a), also known as candidal 
leukoplakia, is one of the less frequent forms of candidosis, and generally 
presents as bilateral candidal lesions of the buccal mucosa, close to the 
commissures of the oral cavity. The hyphae of these lesions penetrate into the 
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surrounding tissue (Webb et al., 1998a; Webb et al., 1998b), thus, the lesions 
cannot be removed by simple mechanical action (Sitheeque & Samanarayake, 
2003). 
 
Diagnosis of CHC involves observation of white plaques on the tissue, after 
which a swab for microbiological analysis or biopsy can be taken for 
histological analysis to confirm the presence of Candida (Williams et al., 1997; 
Sitheeque & Samanarayake, 2003). Treatment for CHC typically involves the 
administration of antifungals, and the recommendation for improvement of 
general oral hygiene. In cases where a more complex diagnosis is present, 
such as in the case of altered immune state, or systemic infections in addition 
to CHC, these are treated systemically. 
 
1.4.2.2 Pseudomembranous candidosis 
Pseudomembranous candidosis (Fig 1.11b), typically known as oral thrush, 
presents as white plaque lesions on the tongue and mucosa, also with 
evidence of erythema in the affected areas. The plaques, however, can be 
removed by physical scraping. This clinical presentation is the most commonly 
observed despite, like many of the candidoses, being influenced by a number 
of predisposing factors (Table 1.4) such as immunocompetence or use of 
medication. The infection can affect any gender, of any age, with similar 
presentation and pathology. Treatment for pseudomembranous candidosis is 
similar to others, with the administration of antifungal medication, both local 
and systemic. 
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Figure 1.11 Clinical presentations of oral candidoses. A) hyperplastic 
candidosis, B) pseudomembranous candidosis, C) acute erythematous 
candidosis, D) chronic erythematous candidosis. Note the white lesions on the 
mucosal surfaces of A and B, the localised inflammation in the centre of the 
tongue in C, and diffuse inflammation of the palatal mucosa in D.  
Image courtesy of Prof. Michael Lewis, School of Dentistry, Cardiff University 
 
Host-associated factors Miscellaneous factors 
General oral/denture hygiene Tobacco/alcohol use 
Ill-fitting denture Nocturnal denture use 
Reduced salivary flow Antibiotic use 
Age Steroid use 
Health status: 
immunodeficiency, 
immunosuppression, diabetes 
mellitus 
 
Table 1.6 Predisposing factors associated with development of oral candidosis 
 
B A 
C D 
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1.4.2.3 Erythematous candidosis 
Erythematous candidosis can either be acute or chronic in its persistence. 
Acute erythematous candidosis (as depicted in Fig. 1.11c) arises as a result 
of broad-spectrum antibiotic treatment. Antibiotics are active against bacteria, 
and will lead to a non-selective reduction of bacterial species within the 
microflora, many of which will be commensal species. Candida is unaffected 
directly by such antibiotic treatment and is then presented with an altered 
environment with less competition from other bacteria, and thrives, leading to 
a state of dysbiosis in that local area. Figure 1.11c shows a typical lesion in 
the centre of the tongue caused by the administration of a broad-spectrum 
antibiotic. This lesion is surrounded by an area of erythema. Upon completion 
of the antibiotic treatment, the homeostasis of the bacterial microflora and thus 
the equilibrium of the microflora will become re-established, and the lesion and 
area of erythema will resolve, as the immune response returns to a normal 
level. This emphasises the necessity of the commensal microorganisms to be 
present and in equilibrium for the health of the host.  
 
Chronic erythematous candidosis (shown in Fig. 1.11d), is also known as 
denture-associated stomatitis (DS), and typically presents as areas of 
inflammation of the mucosa exclusively in contact with a denture-fitting surface 
(Rogers et al. 2013b). DS is discussed in more detail below. It is primarily 
associated with the use of a complete upper acrylic denture (Fig. 1.12), where 
biofilms exist on the surface and in prolonged contact with the palatal mucosa, 
resulting in inflammation of the epithelium. 
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Figure 1.12 Image of complete upper acrylic denture-fitting surface. 
Image courtesy of Dr Helen Rogers, School of Dentistry, Cardiff University 
 
1.4.2.4 Denture-associated stomatitis (DS)  
Denture associated stomatitis (DS) is considered the most prevalent oral 
candidosis, affecting up to 67% of denture wearers (Arendorf & Walker, 1980). 
Candida species were first considered a potential causative agent in DS by 
Cahn in 1936, and both the clinical condition of DS and infecting Candida have 
since been extensively studied. The clinical presentation of DS can be sub-
categorised according to the severity of the irritation based on Newton’s 
classification. The classifications are characterised as the following: Type 0; 
no erythema, Type I; localised, pin-point erythema (slightly red or swollen 
tissue), Type II; diffuse erythema (moderately red or swollen mucosa covering 
part or all of the area of denture contact), and Type III; hyperplastic granular 
inflammation (severely red or swollen hard palate) (Samaranayake et al., 
2002; Coco et al., 2008; Dar-Odeh et al., 2012). Where inflammation is 
present, all three classifications (Type I, II and III) can be observed 
simultaneously in differing locations of the palatal mucosa. Although DS is 
generally asymptomatic, some sufferers experience general discomfort, an 
itching or burning sensation, and occasional bleeding (Rogers et al., 2013b).  
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Predisposing factors to DS include those mentioned for other oral candidoses, 
but also include, among other factors, poor general oral hygiene, poor denture 
hygiene, tobacco use, nocturnal denture wearing, and an ill-fitting denture 
(Shulman et al., 2005; Rogers et al., 2013b). Immune status also plays a 
substantial role, with innate immunity responsible for management of the 
commensal state, and infection by the microorganisms (Feller et al., 2013). 
These predisposing factors lead to, or facilitate, a change in 
microenvironments within the oral cavity, which are also associated with oral 
candidosis. The ideal microenvironment conditions for candidosis include a 
low pH, increased temperature, increased carbohydrate concentration, 
reduction in or suppression of commensal bacterial population, and nitrogen 
and carbon starvation (Figueiral et al., 2007; Tobouti et al., 2015). Candida 
species tend to prefer these conditions, which can be too extreme for bacterial 
populations to survive, thus the equilibrium of the microbiome is shifted toward 
Candida growth leading to infection.  
 
Interestingly, although immune status is a known predisposing factor for the 
development of DS in individuals, studies have observed that whilst the 
immune cells from patients with DS produce a suitable immune response, in 
upregulation of proinflammatory cytokines associated with (T-helper cell 1) 
Th1, Th2 and Th17 responses (Rogers et al., 2013b), a reduction in the 
amount of proinflammatory cytokines was produced in DS patients than those 
without DS, or non denture-wearers (Pinke, et al., 2016). These findings 
indicate that there are specific mechanisms related to immunocompetence 
that are affected during DS, that can lead to DS progression, despite calling 
for an immune response. Rogers et al (2013b) also determined that there 
appeared to be palatal clearance of Candida as a result of the immune 
response, but with no such mechanism possible on a prosthesis, a reservoir 
for subsequent infection persisted unless suitably removed through good 
denture care. 
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1.4.2.5 Microbial content of DS associated biofilms  
Numerous studies have been undertaken involving analysis of the microbial 
content of biofilms implicated in DS (the findings of which are detailed in Table 
1.7, and reviewed by Webb et al. (1998a, 1998b)). Geographical location, and 
subsequently the population analysed, appears to be a factor in differences of 
microbial content, as well as patient-to-patient variability, so it is difficult to 
achieve a consistent characterisation finding between studies. To date, 
subsequent studies arising from findings of these characterisation studies 
have involved single-species, dual-species or polymicrobial biofilms with only 
a few species, that is, dual-species or a limited number of microorganisms 
used at any one time (Jack et al., 2015; Cavalcanti et al., 2016). Whilst this 
provides some information about biofilm development from a physical and 
molecular perspective, it is not a completely true reflection of in vivo biofilms, 
and more complex biofilms need to be evaluated as each microorganism will 
contribute to the overall community.  
 
 
5
0
 
Study Sample/analysis method Summary of findings 
Kulak et al. 
(1997) 
Swab, culture  and 
presumptive identification 
Higher frequency and density of C. albicans in DS patients (6/15 heathy 
patients. 45/45 DS patients) 
Increased density of -haemolytic Streptococcus, Neisseria species in 
DS relative to healthy subjects 
Barbeau et al. 
2003 
Agar imprint of denture, or agar 
culture of swab of denture 
surface 
Significant increase in number of yeast in subgroups of DS; Newton’s 
classification II and III than Newton’s I, but no significant difference in 
carriage between healthy and DS overall (Newton’s I, II and III) 
Campos et al 
2008 
Molecular identification using 
16S rRNA sequencing 
82 bacterial species detected in all samples, 27 common to both healthy 
and DS, 29 exclusive to DS, 26 exclusive to healthy patients. Relative 
abundance of different species not determined, but phylogenetic 
relationships between species/genera determined 
O’Donnell et al 
2015 
Swab and molecular 
identification using 16S rRNA 
sequencing 
72% samples colonised by Candida, bacterial composition determined to 
phyla level 
Significantly fewer OTUs detected on denture surface compared with 
mucosa or teeth 
Predominantly colonised by actinobacteria and bacilli, more similar to 
microbiome of mucosa than teeth 
Table 1.7 Summary of findings in a number of published studies to investigate biofilms associated with denture stomatitis 
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1.4.3 Treatment of candidoses 
Current treatment strategies of candidoses in addition to the primary 
recommendation of improvement of general oral and denture hygiene, include 
the use of local or systemic antifungals, depending on the type and severity of 
infection (Pappas et al., 2016). Common treatments include azoles such as 
imidazoles, triazoles and thiazoles, and echinocandins such as Caspofungin 
(Sheehan et al., 1999), and polyenes such as Amphotericin B and nystatin 
(Baginski & Czub, 2009). 
 
The mechanism of action of the azole group of antifungals is inhibition of the 
enzyme responsible for conversion of lanosterol to ergosterol, thus disrupting 
the fungal membrane structure and inhibition of cell growth. Echinocandins act 
by inhibiting production of -1,3-glucan, which is a major component of the 
fungal cell wall (Sheehan et al., 1999), whereas polyenes bind to sterol 
(primarily ergosterol) in the fungal cell wall, modifying the porosity and causing 
leakage from the membrane (Baginski & Czub, 2009). The different 
compounds have the ability to target different mechanisms of the cell, which is 
useful when selecting treatment, and to limit the inevitable development of 
antifungal resistance of these fungi. Alternative treatment strategies may be of 
use in the future, with the recent advances and understanding of probiotics as 
a potential prophylactic and/or treatment for many microbial related diseases 
including intestinal infection (Isolauri et al., 2002; Resta-Lenert & Barrett, 2003) 
and diarrhoea (Szajewska & Mrukowicz, 2001).
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1.5 Summary 
Chronic erythematous candidosis is the most common denture-associated 
disease, affecting up to 67% of denture wearers. The disease presents as 
areas of inflammation on the palatal mucosa, which is in contact with the 
denture fitting surface. The inflammation is caused by the presence of 
polymicrobial biofilms that exist on the denture-fitting surface, leading to a host 
inflammatory response to attempt to clear the infection. There is no natural 
sloughing that occurs on dentures, thus the continued contact with the palate 
of the biofilms continues to induce an inflammatory response, leading to 
damage to surrounding tissues. Current treatment strategies are targeted 
toward the fungal component of the biofilm, but our knowledge of the role of 
Candida in candidoses is relatively comprehensive, and highlights the 
importance of bacteria within mixed species biofilms in these infections. 
 
Existing knowledge of the role of bacteria in this disease, and the subsequent 
effect on Candida in terms of virulence factor expression, morphogenic 
influence and pathogenicity is poor. In order to address the gaps in our current 
knowledge, this study aims to investigate and further the understanding of 
microbial interactions within denture-associated biofilms, and determine the 
pathogenicity of such biofilms in infection models. 
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1.6 Project aims and objectives 
Current understanding of chronic erythematous candidosis (denture-
associated stomatitis; DS) is related primarily to the fungal component; 
Candida. The presence of bacteria in the oral cavity is well documented, but 
their role infection is unclear, thus this project aimed to further understand the 
role of bacteria with respect to expression of C. albicans virulence factors, and 
subsequent pathogenicity in infections of tissue models. The project has the 
following primary aims: 
 
Chapter 2: To develop an in vitro biofilm model representing DS-associated 
biofilms using denture-acrylic as the substrate. Interactions between Candida 
and a number of oral bacterial strains, and subsequent effects on Candida 
virulence will be evaluated. 
 
Chapter 3: To develop in vitro tissue models that can be used to evaluate 
biofilm-associated pathogenicity, and further our understanding of how 
bacteria affect Candida virulence and pathogenicity in polymicrobial biofilms. 
 
Chapter 4: To evaluate the effects of DS-associated biofilms in an infection 
model using commercially available and in vitro 3D tissue constructs, and to 
investigate host immune cell responses to the presence of bacteria by use of 
LPS, and subsequent challenge with Candida cells. 
 
Chapter 5: To characterise the bacterial microbiome of patients with and 
without DS using next-generation sequencing technologies, in order to 
determine whether differences exist in the bacterial species present that can 
be attributed to DS incidence. 
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Chapter 2 
 
Denture-associated biofilm development and 
microbial interactions 
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2.1 Introduction 
Biofilms are naturally occurring, complex phenomena. The concept of a biofilm 
has been investigated for some time and is currently defined as a polymicrobial 
community existing in distinct regions, that differ in respect of local 
environmental conditions such as oxygen or nutrient availability. Biofilm 
development progresses according to a series of distinct events (as described 
in detail in section 1.1.2). These events include initial attachment and 
adherence to the surface, formation of microcolonies followed by maturation 
of the biofilm and recruitment of additional microorganisms, and production of 
EPS, and finally when necessary, dispersal of microorganisms (Costerton et 
al., 1987; Costerton, 1995).  
 
Our current knowledge of biofilms has been underpinned by the development 
of a range of in vitro biofilm models which have allowed investigations into an 
assortment of experimental concepts. These studies included basic 
investigation into the primary stage of biofilm development including microbial 
attachment and biofilm forming ability, where effects of surface pellicles can 
be evaluated, as in this study, or more detailed molecular analysis such as 
ligand-receptor interactions between microorganism and the surface (Dunne, 
2002; Katsikogianni & Missirlis, 2004; Mandlik et al., 2008). Growth 
characteristics of single- and mixed-microorganism biofilms is an important 
field within biofilm research, with applications ranging from pure biological 
understanding of growth patterns of different species, and their biofilm forming 
capability, to the effects of antimicrobials in, for example, sub-minimum 
inhibitory concentration conditions, and the development of resistance to the 
compounds. Inter-species and inter-kingdom microbial interactions have also 
been shown to be crucial in determining the effects of co-culture, or 
polymicrobial interactions (Sztajer et al., 2014; Montelongo-Jauregui et al., 
2016). The polymicrobial nature of interactions within biofilms is essential to 
consider during in vitro analysis, as generally, biofilms that exist in nature, or 
more importantly for this project, in medicine, are most likely to be a mixture of 
many different types of microorganisms, with even more variety of species.  
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Further complex analyses have also included the sensing and adaptation of 
biofilms to environmental changes or external challenges (Polke et al., 2017), 
and evaluation of antimicrobial efficacy (di Luca et al., 2014). The extent of 
potential analyses is endless, and helps further our understanding of the 
behaviour of cells in biofilms compared with their planktonic counterparts. 
Furthermore, once a biofilm model has been developed, comparisons between 
similar types of biofilms with subtle changes including the use of different 
microorganisms or changing culture conditions can be completed relatively 
easily. Modifications of biofilm models or the microorganisms that are cultured 
can also help with determining those responsible for disease (keystone 
pathogens), or with the use of genetically modified microorganisms like 
knockout variants can facilitate a furthering of the molecular understanding of 
certain genes. 
 
Biofilm models frequently use the bottom of multi-well plates, or glass cover 
slips as the substrate for growth, but the differences in material to clinically 
relevant surfaces like hydroxyapatite or dentine for dental-associated biofilms 
(Guggenheim et al., 2001), or mucosal tissues can substantially influence the 
behaviour of the microorganisms. Therefore, it is essential to develop biofilm 
models using the surface of interest, or at least a material that closely 
represents the surface of interest. 
 
Microorganisms are known to behave differently in different environments, and 
when attached to different surfaces or other microorganisms (Bibel et al., 1982; 
Costerton et al., 1987; Hawser & Douglas, 1994). It is therefore important that 
the biofilms evaluated in vitro are as close as possible to the ones that they 
are meant to represent from in vivo clinical scenarios. Thus, the primary aim 
of this study was to develop an in vitro biofilm model using the most commonly 
used denture material; poly(methyl methacrylate), that represented denture-
associated biofilms as closely as possible. Bacterial species commonly 
associated with colonisation of denture surfaces; Streptococcus sanguinis and 
S. gordonii, and Actinomyces odontolyticus and A. viscosus, along with the 
fungus C. albicans were deemed to be the most clinically representative 
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microorganisms to develop this biofilm model, and evaluate polymicrobial 
biofilm behaviour and interactions. 
 
Interactions between microorganisms, particularly when in close proximity with 
each other, as is the case in biofilms, is essential for survival of biofilm cells. A 
number of environmental sensing mechanisms are known to be used by 
bacteria, and fungi, and even contribute to cross-kingdom interactions. These 
quorum sensing, or two component regulatory systems have been well 
documented in previous studies (Ramage et al., 2002; Parsek & Greenberg, 
2005; Spoering & Gilmore, 2006; Hojo et al., 2009), and are discussed in 
section 1.1.3.1. The primary mechanism of communication and environmental 
sensing is quorum sensing, which exists in bacteria and fungi, but are unique 
to each. Candida species produce the molecule farnesol as their primary 
quorum sensing molecule (QSM). This molecule was determined to be 
produced in relation to controlling the morphological transition between yeast 
and hyphae, in a cell number dependent manner (Albuquerque & Casadevall, 
2012). Furthermore, farnesol is also known to modulate biofilm formation of 
Candida species, by inhibiting genes responsible for hyphae formation, 
including HWP1 (Ramage et al., 2002). Bacterial QSM have also been shown 
to regulate biofilm formation with C. albicans, by disruption of the 
communication mechanism of the bacterium S. gordonii (Jack et al., 2015). 
 
Investigations of direct contact between bacteria and fungi in biofilms have 
also demonstrated modulation of behaviour, observationally and at the 
molecular level (Bamford et al., 2015; Silverman et al., 2010; Cavalcanti et al., 
2016). Studies by Silverman et al (2010) and Cavalcanti et al (2016) have 
demonstrated co-aggregation of bacteria with Candida in planktonic and 
biofilm investigations, indicating the importance of cell-to-cell contact in 
development of biofilms, both directly and indirectly by modulation of factors 
that promote biofilm formation. 
 
Direct cell-to-cell contact is also known to contribute to genotypic and, 
subsequently, phenotypic changes as a result of interactions (Kolenbrander, 
2000; Silverman et al., 2010). Both direct (in the case of cell-to-cell contact) 
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and indirect (in the case of secreted molecules) interactions can have a 
substantial influence on the phenotype of the specific microorganisms 
involved, which, in turn behave differently and can thereafter interact differently 
with additional microorganisms. This chain of events can modulate the 
behaviour of cells in local regions to entire biofilms, and can possibly modulate 
the virulence and pathogenicity of the biofilms. 
 
A secondary aim of this chapter was therefore to evaluate the effect of the 
presence of bacteria in mixed-species biofilms on C. albicans virulence. 
 
Specifically, the research sought to: 
1. Develop single, and mixed-species biofilms on acrylic coupons, 
evaluating the effect of preconditioning the surface with an artificial 
saliva solution on subsequent microbial adherence and subsequent 
mature biofilm development 
2. Evaluate the modulatory effect of bacteria toward C. albicans virulence 
a. Determine relative changes in expression of known putative C. 
albicans virulence genes between C. albicans-only and C. 
albicans plus bacteria (mixed-species) biofilms 
b. Evaluate the production of C. albicans hyphae in single versus 
mixed-species biofilms 
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2.2 Materials and Methods 
2.2.1 Microorganisms and culture conditions 
2.2.1.1 Overview of microorganisms used in this research 
A number of clinically relevant oral microorganisms were used in the studies. 
These are detailed in table 2.1. 
 
Microorganism Reference Source Reference ID 
Candida albicans ATCC 90028 
Streptococcus sanguinis NCTC 7863 
Streptococcus gordonii ATCC 10558T 
Actinomyces viscosus ATCC 1598 
Actinomyces odontolyticus NCTC 9935 
Porphyromonas gingivalis NCTC 11834 
Table 2.1 List of microorganisms used in this research 
ATCC: American Type Culture Collection, NCTC: National Collection of Type 
Cultures 
 
A number of industrial funded research projects have used the strains in Table 
2.1 to develop in vitro biofilms for evaluation of product formulations. C. 
albicans ATCC 90028 is a well-documented, characterised and widely 
published representative C. albicans strain, particularly for investigations into 
oral candidosis (Samaranayake et al., 2006; Thein et al., 2007; Jayatilake et 
al., 2007; Silva et al., 2010; Nithyanand et al., 2014). The bacterial strains 
listed in Table 2.1 have also been used  in published studies, but this particular 
mixture was selected as it represents a range of oral microorganisms 
associated with the oral cavity, particularly denture surfaces. They have been 
used in industrial-sponsor funded studies by this research group for 
investigations into oral-associated biofilms. 
 
2.2.2 Preparation of microorganisms, dental materials and experimental 
reagents 
2.2.2.1 Microbial culture conditions 
Candida albicans ATCC 90028 was cultured on Sabouraud Dextrose Agar 
(SDA, Lab M, Lancashire, UK) and incubated aerobically at 37 °C for 24 h. 
One colony was then aseptically transferred into 10 ml of sterile 1 × Yeast 
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Nitrogen Base (YNB; BD Difco, Oxford, UK) supplemented with 500 mM of 
sucrose (Fisher Scientific) or 100 mM of D-glucose (Fisher Scientific). The 
inoculated YNB was then incubated aerobically in sterile universals with the 
lids slightly loose at 37°C for 24 h with shaking at 180 rev/min. Streptococcus 
species were cultured on Blood Agar (BA; Blood Agar Base, Lab M) 
supplemented with 5% (v/v) defibrinated horse blood (TCS Biosciences, 
Buckingham, UK) and incubated aerobically at 37°C for 24 h. One colony was 
then aseptically transferred to 10 ml of Brain Heart Infusion broth (BHI; Lab M) 
and incubated aerobically at 37°C for 24 h with shaking at 180 rev/min. 
Actinomyces odontolyticus, A. viscosus, and P. gingivalis were cultured on 
Fastidious Anaerobe Agar (FAA; Lab M) supplemented with 5 % (v/v) 
defibrillated blood which was incubated anaerobically at 37°C for 24-48 h. One 
small loopful of an isolated colony was then aseptically transferred to 20 ml of 
BHI supplemented with 50 g/ml of hemin (Sigma), 10 g/ml of vitamin K 
(Sigma), and 5 g/ml of L-cysteine (Sigma) (final in use concentrations), then 
incubated anaerobically at 37°C for a further 48 h. 
 
2.2.2.2 Standardisation of inocula 
Prior to inoculation for each experiment, the cultures were adjusted to a 
standardised inoculum level. Microorganisms were adjusted by optical density 
(OD600nm) measurements using a spectrophotometer (DiluPhotometer, 
Implen, Westlake Village, CA, USA). The equipment was calibrated at 600nm 
to zero (blank) by using sterile uninoculated YNB or BHI medium. Subsequent 
sample readings were performed and diluted as necessary with sterile PBS to 
achieve a final OD600 of 1.00 ( 0.05) for C. albicans (equivalent to 
approximately 1  107 cells/ml), and an OD600 of 0.09 ( 0.01) for bacteria 
(equivalent to approximately 1.5  108 cells/ml (McFarland Standard 0.5)). 
 
2.2.2.3 Denture acrylic (poly(methyl-methacrylate), PMMA) coupon 
preparation 
Disc shaped poly(methyl methacrylate) (PMMA) coupons were prepared 
according to the manufacturer’s instructions. Briefly, self-cure acrylic polymer 
(Bracon Ltd., Etchingham, UK) was added to self-cure acrylic monomer 
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(Bracon Ltd.) at a 2:1 ratio and mixed by hand until homogenous. The mixture 
was then carefully poured into a silicone mould (with pre-cut circular sections 
of approximately 10 mm diameter and 2 mm thickness) and left for 
approximately 15 s, after which, a thick glass cover was placed on top, and a 
500 ml glass bottle containing approximately 250 ml water on top of the glass 
to apply pressure. The mixture was allowed to cure under ambient conditions 
overnight. The coupons were sanded to remove rough edges. The 
experimental surface (smooth upper surface left in contact with the glass 
during curing) was not manipulated or prepared in any way prior to use. The 
coupons were allowed to soak in water for a minimum of 7 d to allow excess 
monomer to leech out, before being sterilised by autoclaving at 121°C for 15 
min. Coupons were stored in sterile distilled water prior to use, and as they are 
intended for single use only, used coupons were discarded after 
experimentation. 
 
2.2.2.4 Preparation of artificial saliva (AS) solution 
Artificial saliva (AS, Cavalcanti et al., 2015) was prepared by thoroughly mixing 
the following in sterile distilled water: 5.0 g/L proteose peptone (Oxoid) 2.5 g/L 
porcine stomach mucin (Oxoid), 2.0 g/L yeast extract (Oxoid), 1.0 g/L lab 
lemco powder (Oxoid), 0.35 g/L sodium chloride (Fisher Scientific), 0.20 g/L 
potassium chloride (Fisher Scientific), 0.20 g/L calcium chloride dihydrate 
(Fisher Scientific). Once homogenous, aliquots were prepared in glass bottles 
then the solution autoclaved at 121°C for 15 min. A 40% (w/v) urea solution 
was prepared in sterile distilled water and filter sterilised, then added to the 
artificial saliva solution at 1.25 ml/L immediately before each AS use. 
 
2.2.2.5 Pre-conditioning PMMA coupons with AS 
Sterile PMMA coupons were randomly selected and preconditioned by 
submersion in sterile artificial saliva solution for 16-20 h, incubated at 37°C. 
Randomly selected non-preconditioned PMMA coupons used as negative 
controls were submersed in sterile water and incubated overnight at 37°C. 
Immediately before transfer of the PMMA to the six-well plates for experimental 
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analysis, the AS preconditioned coupons were held vertically and excess AS 
allowed to aseptically drain to a waste container. 
 
2.2.3 Adherence assay 
To evaluate the effects of AS pellicle formation on adherence of 
microorganisms to the surface of PMMA, adherence assays were performed 
using Streptococcus sanguinis NCTC 7863; a representative species of oral 
bacteria commonly isolated from the oral cavity, and C. albicans ATCC 90028. 
All multi-well plates used in this project were polystyrene material (Starstedt, 
Nümbrecht, Germany). 
 
2.2.3.1 Aseptic transfer and inoculation of microorganisms to PMMA 
Sterile 24-well plates were used as containers for the PMMA coupons in each 
experiment. Aseptically, one preconditioned (PC) or non-conditioned (NC) 
PMMA piece was transferred into each individual well, with the smooth surface 
upwards, the total number of which was determined by the number of variables 
and replicates for each experiment. The lid of the 24-well plate was replaced 
immediately to avoid contamination. 
 
A 100-μl volume of each standardised inoculum (prepared as described in 
section 2.2.2.2) was applied to the surface of the relevant PMMA coupons and 
the culture medium was added to give a 2 ml final volume. The 24-well plates 
were carefully moved to an aerobic incubator at 37°C for up to 90 min to allow 
adherence. 
 
2.2.3.2 Enumeration of adhered microorganisms 
Post-incubation, the PMMA coupons were aseptically removed, rinsed gently 
in PBS to remove any loosely or non-adherent cells, then transferred to a 
sterile plastic bijou container containing 5 ml of sterile PBS. The containers 
were vigorously vortex mixed for 1 min at 2500 rev/min to remove adhered 
cells. The solution was serially decimally diluted to 10-4-fold in sterile PBS 
(100 μl sample to 900 μl PBS in sterile microcentrifuge tubes; Eppendorf). 
Four 10 μl samples of each dilution (including the original vortex mixed sample) 
63 
 
were plated according to the Miles and Misra drop count method (Miles et al., 
1938) on to agar plates appropriate for the target microorganism. Sabouraud 
dextrose agar was used for C. albicans ATCC 90028 and BA for S. sanguinis. 
 
Inoculated agar plates were incubated aerobically at 37°C until colonies had 
grown sufficiently (24-48h) to allow visual counting of individual colonies. The 
average colony count of the four 10 μl drops was determined and extrapolated 
to total recovered cells. The counts were analysed for statistical significance 
using unpaired two tailed T test at 95% confidence. 
 
2.2.3.3 Fluorescence microscopy of adhered microorganisms 
In addition to the enumeration of adhered microorganisms, direct 
determination of adherence was achieved by fluorescence microscopy. PMMA 
coupons were inoculated and microorganisms allowed to adhere as described 
in 2.2.3 Live/Dead BacLight™ Bacterial Viability Kit (Life Technologies) was 
prepared as recommended by the manufacturer, and 20-30 μl of the 
fluorescent dye solution added to the surface of each PMMA coupon. The 
coupon was then overlaid with a glass cover slip for microscopy. The PMMA 
coupons were protected from light until use for microscopy. 
 
Images of the PMMA surface were collected using an Olympus Provis AX 70 
fluorescence microscope, using an Olympus U-MWIB3 filter cube (for 
Live/Dead staining) at 200 and 400 magnifications (10 objective, with 20 
and 40 lenses). Five fields of view were obtained for each microorganism and 
each condition (PC and NC), and representative images selected as visual 
representations.  
 
2.2.4 Biofilm development and analysis 
2.2.4.1 Single- and mixed-species biofilm development on PMMA 
surface 
Microbial cultures were prepared according to sections 2.2.2.1 and 2.2.2.2, 
and PMMA coupons were preconditioned overnight according to section 
2.2.2.3, after which the coupons were aseptically transferred to 24-well plates. 
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A 100 μl volume of each standardised inoculum was added to the PMMA 
coupons and sterile culture medium added to a final volume of 2 ml. The plates 
and coupons were then incubated aerobically or in 5% CO2 at 37°C for the 
microorganisms to adhere. After an initial adherence period of 90 min, the 
medium was removed, and replaced with 2 ml of fresh sterile culture medium. 
The well-plates were returned to the relevant incubator with shaking at 180 
rev/min. After 24 h incubation, the well plates were removed from the 
incubator, the medium aspirated by pipette and replaced with 2 ml of fresh 
culture medium. This process was repeated again at 48 h, and the culture 
continued until 72 h, after which the biofilms were collected for analysis. 
 
2.2.4.2 Culture enumeration of biofilms 
Biofilms were removed from the coupon by vortex mixing in 5 ml PBS at 
2500 rev/min for 1 min. The cell suspension was diluted by serial decimal 
dilution with each dilution plated according to the drop count method onto agar 
relevant for each microorganism. For mixed-species biofilms, BA, FAA and 
SDA were used to selectively culture bacteria or C. albicans. 
 
The agar plates were incubated under conditions necessary for the growth of 
the relevant microorganism (for example, 37°C aerobically for C. albicans and 
Streptococcus species, or 37°C anaerobically for Actinomyces species). Once 
growth of colonies had been observed (sufficient to allow for visual counting), 
the colonies were enumerated, and extrapolated to determine total recovered 
cell numbers. 
 
2.2.4.3 Confocal laser scanning microscopy (CLSM) 
CLSM analysis was completed using an inverted Leica TCS SP5 confocal 
system, controlled by Leica Confocal software. PMMA coupons with biofilms 
were stained using one or more of the fluorescent dyes described in table 2.2. 
The biofilms were inverted onto a glass cover slip by using sterile forceps to 
invert the PMMA coupons and place them on top of the cover slip, and imaged 
at 200, 400 or 630 magnification (10 objective; 20, 40, 63 
magnification lenses). Z-stacks were obtained by imaging at varying depths of 
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the biofilm, creating a ‘pan-biofilm’ image. Emission windows were set 
according to the fluorescent stains used, and were set to at least 30 nm 
distance from the excitation of other lasers to avoid crossover. 
 
2.2.4.4 Quantification of C. albicans hyphae 
For the purpose of determining relative proportion of C. albicans hyphae within 
biofilms, confocal microscopy images were obtained and compressed into a 
single plane. The image was manipulated in order to use an automatic 
counting tool in Image J software (version 2.0.0-rc-64/1.51s), according to the 
following directions (originally developed by Larry Reinking Department of 
Biology, Millersville University Millersville, PA): images were converted into an 
8-bit image, and then converted to a binary image. The ‘analyse particles’ tool 
was then used to identify individual circular yeast cells within the whole image 
area and enumerate them. Hyphae were counted manually. Validation of the 
method was confirmed by manual counts on two random images to ensure 
consistency between manual and automatic counts with good agreement 
between the two methods, thus automatic counting was determined to be 
suitable for this purpose.
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Fluorophore/stain Excitation/Emission (nm) Intended target 
Syto9 
Non-selective DNA specific 
485/498 Live cells 
(active uptake) 
Propidium iodide 
Non-selective, DNA specific 
535/617 Dead cells  
(entry via permeable/compromised membrane only) 
Calcofluor white 
 
355/433 Fungi 
(chitin in candidal cell wall) 
Concanavalin A 
Alexa Fluor® 594 conjugated lectin 
590/617 Candida albicans 
(carbohydrate in candidal cell wall) 
Candida albicans PNA 
FITC conjugate 
490/525 Candida albicans 
Universal bacterial PNA 
Cyanin-5 conjugate 
550/570 16S rRNA gene of bacteria 
Table 2.2 Fluorescent dyes used for confocal microscopy analysis of biofilms 
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2.2.4.5 Scanning electron microscopy (SEM) 
SEM was used to further image polymicrobial biofilms to determine biofilm 
structure and demonstrate C. albicans hyphal presence within the biofilms. 
 
The biofilm samples were removed from multi-well plates, and immersed in 
2.5% glutaraldehyde (diluted in sterile water) overnight. The biofilm coupons 
were washed gently with distilled water 2  10 min. The samples were then 
dehydrated using a gradient of increasing concentrations of ethanol: 30%, 
50%, 70%, then 90%, for 10 min at each concentration, then 100% ethanol for 
2  10 min. The samples were then immersed in hexamethyldisilazane for 10 
min, then allowed to air dry. 
 
Once dehydrated and prepared, the samples were sputter coated with gold, 
and imaged on a Tescan VAGA SEM system, at 5-10kV. 
 
2.2.5 Quantitative PCR (qPCR) for C. albicans virulence genes 
2.2.5.1 Extraction of RNA 
Biofilms were suspended in 1 ml PBS, pelleted by centrifugation at 11,000  g 
for 2 minutes and then resuspended in 200 μl TE buffer containing 10 mg/ml 
of lysozyme (LTE). RNA extraction was performed using 
phenol:chloroform:isoamyl alcohol solution (25:24:1, Sigma) and RNeasy Mini 
Kit (Qiagen) as described below. All centrifugation steps occurred at 
11,000  g unless otherwise stated. 
 
The suspended biofilm cells in LTE were mixed with 350 μl RLT Buffer 
(Qiagen) with 1% (v/v) β-Mercaptoethanol and vortex mixed for 15 s. The 
suspension was transferred to a pathogen lysis tube (Qiagen) which contain 
sterile glass beads of an undisclosed diameter, and 500 μl of 
phenol:chloroform:isoamyl alcohol. The cells were disrupted using a Mini-
BeadBeater-8 (Stratech Scientific Ltd., Suffolk, UK) for 1 min and placed on 
ice immediately, after which the suspension was centrifuged for 5 min. The 
solution separated into three distinct layers; a lower red coloured phenol rich 
layer, an intermediary white layer containing proteins and cell debris, and an 
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upper transparent layer rich in nucleic acids. The upper phase was carefully 
transferred on ice to a 1.5 ml microcentrifuge tube containing 700 μl of 
molecular biology grade 100% ethanol. This mix was stored at -20C for 
15 min to precipitate any proteins. 
 
The lysate (700 μl maximum) was transferred to an RNeasy column (Qiagen) 
which was placed in a collection tube, and centrifuged for 1 min. The flow 
through was discarded and the centrifugation repeated for the remaining 
lysate. The pre-prepared DNase I solution (80 μl; Qiagen) was added to the 
column membrane and the membrane incubated at room temperature for 30 
min. After incubation, 350 μl of RW1 buffer (Qiagen) was added and samples 
incubated at room temperature for a further 5 min, then centrifuged for 1 min. 
The flow through was discarded, then 500 μl RPE buffer (Qiagen) was added 
and the samples centrifuged for 1 min. The flow through was discarded, and a 
further 500 μl of RPE buffer was added and the samples centrifuged for 2 min. 
The flow through was discarded, and the column centrifuged for a further 
2 min. The column was placed into a new collection tube and 30 μl of RNase-
free water was added to the centre of the filter. The RNA was allowed to 
dissolve for 2 min before centrifugation for 2 min. The flow through was added 
onto the membrane and subjected to a second elution. The RNA solutions 
were stored on ice when being processed immediately, otherwise they were 
immediately frozen at -80C until used. 
 
RNA concentration and purity was quantified using a Nano-Vue Plus 
spectrophotometer (GE Healthcare) immediately prior to reverse transcription. 
Samples were diluted when necessary to achieve a standardised 
concentration. 
 
2.2.5.2 Reverse transcription of RNA to cDNA (RT) 
Quantified total RNA was subjected to a two-step reverse transcription to 
cDNA using the Precision nanoScript 2 reverse transcription kit 
(PrimerDesign, Southampton, UK) according to the manufacturer’s 
instructions. Total concentrations used ranged from 500-1000 ng total RNA 
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(due to variability of total extracted RNA from biofilms). Step one involved 
annealing of random nonamer primers to the RNA. This was achieved by 
adding RNA (diluted as necessary in a final volume of 9 μl in RNase/DNase 
free water) to 1 μl of the random nonamer primers. This was then placed into 
a thermocycler at 65°C for 5 min, then immediately transferred to ice. The step 
two master mix was then prepared and comprised (for each reaction) of 5 μl 
nanoScript2 4 Buffer, 1 μl of dNTP mix (10 mM), 3 μl of RNase/DNase free 
water and 1 μl of nanoScript2 enzyme. The mixtures were vortex mixed for 5 
s to homogenise and subjected to thermocycling of 25°C for 5 min, 42°C for 
20 min, and a final heat inactivation step of 75°C for 10 min. The resulting 
cDNA was stored at -20°C until used. 
 
2.2.5.3 qPCR analysis 
Gene expression of samples was analysed by qPCR using a QuantStudio 6 
Flex Real Time PCR system (Applied Biosystems). Each well contained a 20 
μl reaction volume, and included 10 μl of 2× SYBR Green based Precision 
FAST qPCR master mix (PrimerDesign), 1 μl of each reverse and forward 
primer (detailed in Table 2.3), (10 mM), 3 μl of RNase/DNase free water and 
5 μl of cDNA template. 
 
The qPCR program used the following thermal cycling parameters: 95°C for 
20 s, followed by 40 cycles of 95°C for 1 s and 60°C for 20 s. After completion 
of the cycles, a final melt curve stage was completed at 95°C for 15 s, and 
from 60°C for 1 min and final 95°C for 15 s. The cycle threshold for each 
sample was determined automatically by the software at the point of 
logarithmic amplification of the samples. 
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Target gene Sequence (5’  3’) Reference 
ACT1 
Housekeeping Gene 
F – TGCTGAACGTATGCAAAAGG 
R – TGAACAATGGATGGACCAGA 
Alves et al., 2014; Cavalcanti et al., 2015 
ALS1 
Agglutinin-Like Sequence 1 
F – CCCAACTTGGAATGCTGTTT 
R – TTTCAAAGCGTCGTTCACAG 
Alves et al., 2014; Cavalcanti et al., 2015 
ALS3 
Agglutinin-Like Sequence 3 
F – CTGGACCACCAGGAAACACT 
R – GGTGGAGCGGTGACAGTAGT 
Bandara et al., 2012; Alves et al., 2014; 
Cavalcanti et al., 2015 
EPA1 
Epithelial Adhesin 1 
F – ATGTGGCTCTGGGTTTTACG 
R – TGGTCCGTATGGGCTAGGTA 
Alves et al., 2014; Cavalcanti et al., 2015 
HWP1 
Hyphal Wall Protein 1 
F – TCTACTGCTCCAGCCACTGA 
R – CCAGCAGGAATTGTTTCCAT 
Alves et al., 2014; Cavalcanti et al., 2015 
PLD1 
Phospholipase D 1 
F - GCCAAGAGAGCAAGGGTTAGCA 
R – CGGATTCGTCATCCATTTCTCC 
Alves et al., 2014; Cavalcanti et al., 2015 
SAP4 
Secreted Aspartyl Proteinase 4 
F – GTCAATGTCAACGCTGGTGTCC 
R - ATTCCGAAGCAGGAACGGTGTCC 
Alves et al., 2014; Cavalcanti et al., 2015 
SAP6 
Secreted Aspartyl Proteinase 6 
F – AAAATGGCGTGGTGACAGAGGT 
R - CGTTGGCTTGGAAACCAATACC 
Alves et al., 2014; Cavalcanti et al., 2015 
Table 2.3 Forward (F) and reverse (R) primers used for evaluation of C. albicans virulence genes via quantitative polymerase chain 
reaction (qPCR) 
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2.3 Results  
2.3.1 Effect of preconditioning acrylic coupons with artificial saliva on 
microbial attachment and biofilm formation 
The formation of a salivary pellicle on different surfaces has been reported to 
increase the attachment of certain microorganisms. Thus, to develop an 
optimised acrylic biofilm model, an evaluation of the effect of an artificial 
salivary pellicle on microbial attachment to PMMA and subsequent biofilm 
formation was undertaken. 
 
2.3.1.1 Adherence of Candida albicans to PMMA 
Fluorescence microscopy showed an increase in the number of adhered C. 
albicans cells to PMMA preconditioned (PC) with artificial saliva (AS) 
compared with PMMA conditioned in water (NC). Viable cell recovery and 
enumeration also demonstrated a significant (P=0.0075) increase in the 
number of adhered viable cells to the PC PMMA coupons (5.28  0.25 log10 
recovered CFU), compared with NC PMMA coupons (4.49  0.11 log10 
recovered CFU) (Figs. 2.1, 2.2; Table 2.4). 
 
2.3.1.2 Adherence of Streptococcus species to PMMA 
Similar to C. albicans adherence, a significant (P=0.0063) increase was 
observed in the recovery and enumeration of viable S. sanguinis from PMMA 
preconditioned with AS (PC; 5.32  0.28 log10 recovered CFU) compared with 
non-preconditioned PMMA (NC; 4.47  0.04 log10 recovered CFU) was 
observed (Fig. 2.3; Table 2.5). Differences in surface coverage by 
fluorescence microscopy were more subtle (Fig. 2.4) 
 
Adherence of both microorganisms was homogenously distributed across the 
surface of the acrylic coupons, with no distinct clusters or aggregates of cells 
evident, irrespective of preconditioning status. 
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Figure 2.1 Effect of artificial saliva (AS) preconditioning of PMMA coupons on C. albicans adherence. 
Typical fluorescence images of C. albicans adherence to acrylic coupons. Left: no preconditioning, right: artificial saliva pre-
conditioning. Cells were stained with Syto-9. Scale bar represents 50 m
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Figure 2.2 Effect of artificial saliva pre-conditioning of acrylic coupons on C. 
albicans adherence as measured by number of recovered viable C. albicans. 
Data expressed as mean of 3 experimental replicates (experimental n=3, 6 
replicates). Error bars represent SD. NC= Non-preconditioned, PC=AS pre-
conditioned. 
 
Experimental 
replicate 
Mean Log10 total CFU ( SD) 
Non-conditioned Pre-conditioned 
1 4.60 (0.28) 5.57 (0.11) 
2 4.39 (0.32) 5.10 (0.32) 
3 4.50 (0.25) 5.18 (0.24) 
Mean 4.49 5.28 
SD 0.11 0.25 
P value 0.0075 
 
Table 2.4 Effect of artificial saliva pre-conditioning of acrylic coupons on C. 
albicans adherence as measured by number of recovered viable C. albicans. 
 
** 
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Figure 2.3 Effect of artificial saliva (AS) preconditioning of PMMA coupons on subsequent S. sanguinis adherence. 
Typical fluorescence microscope images of S. sanguinis adherence to PMMA. Cells stained with Syto-9. 
Left: Non-preconditioned, right: artificial saliva pre-conditioned. Scale bar represents 10 m 
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Figure 2.4 Effect of artificial saliva pre-conditioning of acrylic coupons on 
S. sanguinis adherence as measured by number of recovered viable 
S. sanguinis. 
Data expressed as mean of 3 experimental replicates (experimental n=3, 6 
replicates). Error bars represent SS. NC= Non-preconditioned, PC=AS pre-
conditioned. 
 
Experimental 
replicate 
Mean Log10 total CFU ( SD) 
Non-conditioned Pre-conditioned 
1 4.43 (0.47) 5.15 (0.35) 
2 4.50 (0.23) 5.18 (0.56) 
3 4.48 (0.76) 5.65 (0.28) 
Mean 4.47 5.32 
SD 0.04 0.28 
P value 0.0063 
 
Table 2.5 Effect of artificial saliva pre-conditioning of acrylic coupons on 
S. sanguinis adherence as measured by number of recovered viable 
S. sanguinis.
**
* 
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2.3.2 Single and mixed-species biofilm formation on PMMA 
Whilst no significant differences were observed in the adherence of 
microorganisms to the surface of PMMA coupons with the presence or 
absence of an AS pellicle, biofilm formation may have been influenced as well 
as potential interactions with microorganisms. Thus, formation of mature 
biofilms were evaluated with and without an AS pellicle. 
 
2.3.2.1 Effect of artificial saliva pre-conditioning of PMMA on C. albicans-
only and bacteria-only 72h biofilms 
Using a batch culture biofilm system with daily medium changes, biofilm 
formation was measured by recovery and enumeration of viable 
microorganisms. The number of recovered viable C. albicans and S. sanguinis 
was not significantly (P>0.05) influenced by the presence of an AS 
preconditioning pellicle (Figure 2.5; Table 2.6). 
 
Figure 2.5 Effect of pre-conditioning acrylic coupons with artificial saliva on 
formation of single-species 72 h biofilms as measured by number of recovered 
viable cells. 
Data expressed as mean of 3 experimental replicates (n=3, 4-5 replicates), 
error bars represent SD. NC= Non-preconditioned, PC=AS pre-conditioned.  
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Experimental 
replicate 
Mean Log10 total CFU ( SD) 
C. albicans S. sanguinis 
Non-
conditioned 
Pre-
conditioned 
Non-
conditioned 
Pre-
conditioned 
1 7.33 (0.10) 7.63 (0.14) 8.68 (0.09) 8.65 (0.17) 
2 8.09 (0.39) 8.50 (0.17) 8.41 (0.08) 7.96 (0.23) 
3 7.67 (0.19) 7.36 (0.10) 7.69 (0.11) 7.49 (0.05) 
Mean 7.70 7.83 8.26 8.03 
SD 0.38 0.60 0.51 0.58 
Table 2.6 Effect of artificial saliva pre-conditioning of acrylic coupons on 
formation of single-species 72h biofilms as measured by number of recovered 
viable cells 
 
The number of recovered viable cells of C. albicans was similar for both PC 
(7.83  0.60 log10 recovered CFU) and NC (7.70  0.38 log10 recovered CFU) 
conditions. Similarly, no significant differences in number of viable 
S. sanguinis was observed following PC (8.26  0.51 log10 recovered CFU) 
and NC (8.03  0.58 log10 recovered CFU) conditions. Furthermore, the extent 
of biofilm formation, as measured by enumeration of recovered viable cells, 
was similar for both C. albicans and S. sanguinis. 
 
Confocal microscopy results of the mature single species biofilms (Figs. 2.6, 
2.7) correlated with the findings presented in Table 2.6, in that no clear 
differences were evident due to AS conditioning. CLSM showed no clear 
visible differences in the observed biomass, coverage, or formation/structure 
of the biofilms irrespective of the presence or absence of an AS pre-
conditioning pellicle. 
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Figure 2.6 Typical confocal microscope images of C. albicans-only 72 h biofilms on acrylic coupons to evaluate the effect of 
artificial saliva pre-conditioning on development of mature biofilms, assessed visually for surface coverage and biofilm 
structure. 
Candida albicans single-inoculum 72h biofilms with non-preconditioned acrylic coupon (left) and artificial saliva pre-
conditioned acrylic coupon (right). Cells were fixed overnight with 10% (v/v) formal saline, then stained with propidium iodide 
(red) and calcofluor white (blue/purple).
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Figure 2.7 Typical confocal microscopy images of S. sanguinis-only 72h biofilms on acrylic coupons to evaluate the effect 
of artificial saliva pre-conditioning on development of mature biofilms, assessed visually for surface coverage and biofilm 
structure. 
Bacteria-only 72 h biofilms with non-preconditioned acrylic coupons (left) and artificial saliva pre-conditioned acrylic coupons 
(right). Cells were stained with Live/Dead BacLight bacterial viability kit (Syto-9, green; propidium iodide, red).
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2.3.2.2 Effect of artificial saliva pre-conditioning on mixed-species 
(C. albicans and bacteria) biofilms 
When mature biofilms were cultured using a mixed species inoculum 
(C. albicans with bacteria (Streptococcus sanguinis, S. gordonii, Actinomyces 
odontolyticus and A. viscosus), no significant (P>0.05) differences in the 
number of recovered viable cells, as a measure of biofilm formation, were 
evident (Fig. 2.8; Table 2.7).  
 
 
Figure 2.8 Effect of artificial saliva pre-conditioning of acrylic coupons in 
mixed-culture 72h biofilms as measured by number of recovered viable cells. 
Total recovered viable cell counts of C. albicans ATCC 90028, and bacteriaA 
from mixed culture 72 h biofilms. Data expressed as average of 10 replicates, 
error bars represent SD. NC= Non-preconditioned, PC=AS pre-conditioned. 
 
Experimental 
replicate 
Ave Log10 total CFU ( SD) 
C. albicans Bacteria 
Non-
conditioned 
Pre-
conditioned 
Non-
conditioned 
Pre-
conditioned 
1 6.93 (0.18) 7.68 (0.11) 6.79 (0.14) 7.75 (0.09) 
2 7.66 (0.05) 7.11 (0.07) 7.63 (0.14) 6.78 (0.08) 
Mean (SD) 7.30 (0.52) 7.40 (0.41) 7.21 (0.60) 7.26 (0.69) 
 
Table 2.7. Effect of artificial saliva pre-conditioning of acrylic coupons in 
mixed-culture 72 h biofilms as measured by number of recovered viable cells 
  
A Mixed culture inocula included S. sanguinis and S. gordonii but enumeration 
data does not distinguish between species; presented as total bacteria 
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Recovery of C. albicans from mixed species biofilms on NC coupons (7.30  
0.52 log10 recovered CFU) was very similar to that of PC (7.40  0.41 log10 
recovered CFU). Furthermore, high similarities were also observed with total 
recovered bacteria (NC=7.21  0.60 log10 recovered CFU, PC=7.26  0.69 
log10 recovered CFU). Interestingly, the overall total number of bacteria in 
mixed-species biofilms was nearly 10-fold lower than that observed for the 
single-species bacteria-only biofilms. 
 
Of note was that C. albicans-only and mixed-species biofilms were typical in 
biofilm structure and formation; characteristic aggregates of cells were evenly 
distributed over the surface where biofilm maturation developed as three-
dimensional clusters. This was particularly evident at lower magnification, 
where a larger surface area was observed (figure 2.9). 
 
2.3.3 Effect of oral bacteria within mixed species biofilms on expression 
of specific C. albicans virulence factors 
Denture stomatitis (DS) is normally associated with polymicrobial biofilms 
including the fungus Candida, on the denture fitting surface. Whilst the 
presence of Candida subsequently leads to chronic palatal irritation and 
inflammation, other factors could impact the development of DS. One of these 
is the associated bacterial microbiome, which varies between individuals, and 
may have capacity to influence behaviour of Candida. 
 
Using the developed acrylic biofilm model described in section 2.2.4, this study 
evaluated the effect of certain oral bacteria in mixed-species biofilms on 
expression of a range of putative virulence factors of C. albicans. These 
included morphological transition from yeast to hyphae, expression of 
virulence genes involved in adherence, biofilm formation, hyphal formation and 
production of hydrolytic enzymes 
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2.3.3.1 Use of a standardised microbial inoculum to develop biofilms for 
in vitro interactions 
A standardised, reproducible microbial inoculum was used for evaluation of 
the influence of oral bacteria on C. albicans virulence as detailed in section 
2.2.2.1. In addition to C. albicans ATCC 90028, the inoculum included the 
commensal oral bacteria S. sanguinis NCTC 7863, S. gordonii ATCC 10558T, 
A. odontolyticus NCTC 9935 and A. viscosus ATCC 1598. Porphyromonas 
gingivalis NCTC 11834 was also used as an additional bacterial species to 
evaluate differential regulation of C. albicans virulence compared with the 
former standardised bacterial inoculum. 
 
2.3.3.2 Morphological transition from yeast to hyphae 
Formation of hyphae is considered an important virulence factor of C. albicans. 
Whilst no significant differences were observed by culture in the quantity of 
viable C. albicans in either C. albicans only biofilms (7.83  0.60 log10 
recovered CFU, Table 2.6) or C. albicans with mixed oral bacteria biofilms 
(7.40  0.41 log10 recovered CFU, Table 2.7), the relative proportion of hyphae 
(when compared with yeast form of the cells) was significantly (P<0.001) 
higher in mixed-culture biofilms compared to C. albicans-only biofilms (Figs. 
2.10, 2.11, 2.12; Table 2.8). Candida albicans hyphae were not completely 
absent in C. albicans-only biofilms, but represented a very small proportion of 
the total cells (0.68%  0.56, expressed as % of the total yeast and hyphae 
cells combined). An increase of more than ten-fold in the average ( SD) 
relative proportion of hyphae compared to yeast cells was evident in mixed-
culture biofilms (8.29%  2.48) compared with C. albicans-only biofilms. 
 
Scanning electron microscopy (Fig. 2.11) demonstrated location of hyphae 
within the biofilm, and these hyphae appeared to provide a ‘scaffold like 
structure’ within the biofilm, with yeast and many bacterial cells attached to 
them, and each other. 
 
Interestingly, when P. gingivalis was included in the mixed-species bacterial 
inoculum, no enhancement of C. albicans hyphae production was observed. 
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The extent of hyphal production was similar to that observed in C. albicans-
only biofilms (2.18%  0.06), where there was no significant (P=0.42) 
difference to that of C. albicans-only biofilms when analysed statistically using 
one-way ANOVA with Tukey’s multiple comparisons test. However, the 
reduction in the relative proportion of hyphae compared with mixed-species 
biofilms was highly significant (P<0.001). 
 
Differential modulation of C. albicans hyphal production in mixed-species 
including P. gingivalis biofilms was evident by confocal microscopy, where 
very few C. albicans hyphae were visible (Fig. 2.13). 
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Figure 2.9 Scanning electron microscopy images of mature acrylic biofilms demonstrating distribution and formation of 
biofilms on the surface. 
C. albicans-only (left) and mixed-species (right) 72 h acrylic biofilms representing typical distribution and clustering as a result 
of the three-dimensional formation of surface biofilms. Scale bar represents 50 m. 
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Figure 2.10 Confocal laser scanning microscopy images of C. albicans-only and mixed-species biofilms to quantify C. 
albicans hyphae. 
Candida albicans hyphal presence in single (left) and mixed-culture (right) biofilms including C. albicans and oral bacteria. 
Arrows indicate hyphae. Cells stained with propidium iodide (red) and calcofluor white (blue/purple).
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Figure 2.11 Typical scanning electron microscopy of C. albicans-only, and C. albicans with oral bacteria (mixed-species) 
biofilms to evaluate hyphal presence and bacterial attachment. 
Typical scanning electron microscopy images of 72 h C. albicans-only biofilm (left) and 72 h mixed-species biofilm (right). 
Bacterial attachment appears to be primarily to the acrylic surface, but bacterial attachment to the C. albicans cells was also 
evident. Red arrows indicate C. albicans hyphae, green arrows indicate bacterial cells. 
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Figure 2.12 Relative proportion of C. albicans hyphae in C. albicans-only, 
mixed-species and mixed-species with P. gingivalis acrylic biofilms. 
Proportion of C albicans hyphae in biofilms relative to total cells including yeast 
and hyphae. A significantly (P<0.001) higher proportion of hyphae was evident 
in mixed species biofilms than C. albicans only biofilms and mixed-culture 
biofilms also including P. gingivalis. No significant difference was observed 
(P=0.42) when comparing C. albicans-only biofilms with mixed-culture plus 
P. gingivalis biofilms. 
Data expressed as mean of 4-5 replicates, error bar represents standard 
deviation.  
 
Sample 
Relative proportion of hyphae (%) 
C. albicans only 
C. albicans plus 
bacteria 
C. albicans 
plus bacteria 
plus 
P. gingivalis 
1 0.82 3.88 2.11 
2 0.00 8.29 2.23 
3 0.21 10.75 2.13 
4 1.62 10.57 2.22 
5 0.74 7.96 - 
Mean (SD) 0.68 (0.56) 8.29 (2.48) 2.18 (0.06) 
 
Table 2.8 Relative proportion of hyphae in C. albicans-only biofilms versus 
biofilms developed using C. albicans plus oral bacteria analysed with Image J.
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Figure 2.13 Typical confocal microscopy images demonstrating reduced C. albicans hyphal production in mixed-culture plus 
P. gingivalis biofilms compared with mixed-species biofilms. 
Candida albicans hyphal presence in mixed-culture biofilms (left) and mixed-culture plus P. gingivalis (right).  White arrows 
indicate presence of hyphae. Cells stained with propidium iodide (red) and calcofluor white (blue/purple). 
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2.3.3.3 Expression of C. albicans virulence genes 
Changes in the relative expression of a number of C. albicans virulence genes 
was evident in mixed-species and mixed-species including P. gingivalis 
biofilms compared with C. albicans-only biofilms. These results are presented 
in Fig. 2.14 and Table 2.9. 
 
Compared with C. albicans-only biofilm controls, mixed-species biofilms 
exhibited significantly increased expression of all the C. albicans virulence 
genes assessed in this study: agglutinin-like sequence (ALS3, P<0.01), 
epithelial adhesin (EPA1, P<0.01); hyphal wall protein 1 (HWP1, P<0.001), 
phospholipase D 1 (PLD1, P<0.001), secreted aspartyl proteinases 4 and 6 
(SAP4, P<0.001; SAP6, P<0.05). 
 
Despite the increases in C. albicans virulence observed with mixed-species 
biofilms, mixed-species plus P. gingivalis biofilms resulted in a different pattern 
of gene expression where, when compared to C. albicans-only biofilms, there 
was a significant down regulation of virulence genes including ALS3 (P<0.01) 
and SAP6 (P<0.001), and no significant (P>0.05) change in expression of 
EPA1, HWP1 or PLD1. Interestingly, despite levels of expression for many 
genes being similar between C. albicans-only biofilms and mixed-species plus 
P. gingivalis, a significant (P<0.01) increase was evident in expression of the 
SAP4 gene, to a level similar to that observed in mixed-species biofilms. 
 
The pattern of increased gene expression, particularly for those genes 
involved in the formation of hyphae (ALS3, ALS3), correlated with observations 
by CLSM (Figs. 2.9, 2.10) of C. albicans-only and mixed-culture biofilms. Also, 
the down regulation of the expression of these same genes in mixed-species 
plus P. gingivalis biofilms correlated with a reduction in the number of hyphae 
when biofilms were analysed by CLSM (Fig. 2.13)).  
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Figure 2.14 Changes in the expression of known putative C. albicans virulence genes, relative to the housekeeping gene 
ACT1, and compared with normalised C. albicans only biofilm controls. 
Fold change in expression of C. albicans adhesin (ALS3, EPA1) genes, hyphal wall protein (HWP1) gene, phospholipase D 
(PLD1) gene and secreted aspartyl proteinase (SAP4, SAP6) genes. Data expressed as mean of 6 replicates, error bars 
represent SD. Analysis performed by Ct method. Representative melt curves shown in Appendix I 
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C. albicans 
virulence 
gene 
Change in expression, relative to C. albicans-only 
biofilms 
Mixed-
species 
Sig. 
Mixed-species 
+ P. gingivalis 
Sig. 
ALS3 Increase P<0.01 Decrease P<0.01 
EPA1 Increase P<0.01 No change P>0.05 
HWP1 Increase P<0.001 No change P>0.05 
PLD1 Increase P<0.05 No change P>0.05 
SAP4 Increase P<0.001 Increase P<0.01 
SAP6 Increase P<0.05 Decrease P<0.001 
 
Table 2.9 Changes in C. albicans gene expression of mixed-species and 
mixed-species plus P. gingivalis biofilms relative to expression from C. 
albicans-only biofilms 
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2.4 Discussion 
This research evaluated the effect of oral bacteria on C. albicans virulence in 
in vitro denture biofilms. Denture stomatitis (DS) is an inflammatory disease 
associated with the presence of Candida. However, whilst C. albicans is 
considered the primary causative agent of DS, the role of bacteria, which are 
normally present in denture biofilms, in this infection remains unclear.  
 
Denture biofilms are complex in their microbial composition and physical 
structure, comprising many different microbial species and a range of 
extracellular polymeric substances (Chandra et al., 2001a). For species to 
survive, the community needs to communicate and respond to changes, and 
the ability of microorganisms to modulate the local environment to their benefit 
is a clear advantage within a biofilm community. Research into interactions 
between bacterial species, and indeed bacteria and fungi (in the case of this 
study), on the behaviour of C. albicans is important to further our knowledge 
of biofilm microbiology and associated infections 
 
Specific oral bacteria were selected for this study and these were selected as 
they are commensal oral microorganisms and also associated with denture 
biofilms (Campos et al., 2008; Dewhirst et al., 2010; Jenkinson, 2011). These 
bacteria included Streptococcus sanguinis and S. gordonii, Actinomyces 
viscosus and A. odontolyticus, facultative anaerobic bacteria commonly 
associated with the oral cavity, and also specifically the denture surface. The 
fungus Candida albicans ATCC 90028 was used as the representative fungal 
component of the in vitro biofilm in these analyses. Candida albicans ATCC 
90028 appears to be a hypovirulent strain that does not demonstrate the same 
extremes of behaviours as other C. albicans strains, including C. albicans 
SC5314, which is commonly used in biofilm studies as a wild-type strain. Lu et 
al., (2006) demonstrated this characteristic difference with a direct comparison 
between both of the aforementioned C. albicans strains, and found that ATCC 
90028 demonstrated fewer hyphae and less invasion into tissue than SC5314 
in an epithelium-only tissue infection model. Therefore, changes in virulence 
demonstrated in this study were testament to the significant influence of 
bacterial modulation of the factors. 
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The study developed an in vitro biofilm model comprising five microbial strains, 
which compared to the biofilms found in vivo is still somewhat simplistic, but 
one that is more representative of denture-associated biofilms than using 
single or dual-species as commonly utilised. The material used in these 
investigations to support biofilms is the most commonly used denture-base 
material namely poly(methyl methacrylate) (PMMA) (Vojdani & Giti, 2015; 
Singh et al., 2011). As saliva is a factor present in the normal oral cavity, and 
oral prostheses such as dentures are continually exposed to the saliva, its 
impact on microbial adherence for subsequent biofilm formation was 
evaluated. The AS formulation used in this study included mucins, proteose 
peptone and a number of salts, which could influence not only the surface 
charge of PMMA, but also the physical surface properties. Mucins are large 
glycoproteins present in normal human saliva (Namavar et al., 1998; Tabak et 
al., 1982; Tabak, 1995; Slomiany et al., 1996), that play a role in immune 
defence and contribute to lubrication of the mucosal surfaces. The presence 
of mucins in the AS formulation makes it more representative of in vivo human 
saliva, but also, from a physical perspective, the mucins can deposit onto the 
PMMA surface. The highly-charged structure is associated with increased 
viscosity and adhesiveness (Tabak, 1995), particularly of whole saliva, but 
mucin deposition onto surfaces has previously been associated with increased 
microbial adherence by Streptococcus mutans, S. sanguinis and by C. 
albicans (Gocke et al., 2002; Stinson et al., 1982).  
 
A significant increase was observed in adherence of C. albicans in the 
presence of an AS pellicle, whereas no significant differences were observed 
with the adherence of S. sanguinis as the representative oral bacteria. An 
increase in adherence could be, in part, attributable to the deposition of 
proteins onto the PMMA surface, where the influence of ligand-receptor 
binding would override the far weaker non-specific bonding forces such as Van 
der Waals forces in the adherence of these microorganisms after the 90-min 
period. Previous studies have also reported varied results for microbial 
adherence, with reports showing increases in adherence (Edgerton et al., 
1993), no differences (Jin et al., 2004), and even decreases in adherence of 
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bacteria (Samaranayake et al., 1980; Satou et al., 1991) to saliva coated 
surfaces.  
 
Despite the differences in the effect of AS on microbial adherence to PMMA, 
the formation of mature biofilms was not influenced by the presence of AS 
preconditioning. Indeed, there were striking similarities between the total 
enumerated viable recovered cells of both total bacteria and C. albicans from 
single and mixed-species biofilms (Figs. 2.5, 2.8). This was likely due to the 
composition and complex physical structure of mature biofilms. As biofilms 
develop in a 3D manner, only the surface-bound cells would be subjected to 
the adherence forces of the preconditioning pellicle. Additional 
microorganisms that make up the biofilm, either as a result of cell division of 
already adhered microorganisms, or by co-aggregation from the planktonic 
phase of the surrounding environment, would not be in direct contact with the 
surface or pellicle, and therefore not influenced or restricted by the pellicle 
constituents. As a result, the majority of the biofilms could develop and grow 
as free entities, reaching a plateau phase of microbial growth and maximum 
support. This end-point of the 72 h culture in this study demonstrated this, with 
similarities between all biofilms in terms of visible growth and enumeration of 
recovered viable microorganisms from the biofilms. 
 
A number of C. albicans virulence factors were investigated in single and 
mixed-species biofilms developed on PMMA. The virulence factors selected 
for analysis were based on previous findings from this research group. These 
factors included genes responsible for adhesins for attachment and 
adherence, and subsequent biofilm initiation and maturation (ALS3 and 
HWP1), epithelial cell adhesin (EPA1), a key factor for adherence of C. 
albicans to epithelial cells, which, in the case of a DS model is essential for the 
infection, and a number of hydrolytic enzymes (PLD1, SAP4 and SAP6). ALS3, 
HWP1, and SAP4 and SAP6 genes are also associated primarily with the 
hyphal morphology of C. albicans. 
 
In this study, mature mixed-species biofilms containing S. sanguinis, 
S. gordonii, A. viscosus and A. odontolyticus resulted in significant 
95 
 
upregulation of C. albicans virulence genes (Fig. 2.14, Table 2.6). An increase 
of between 1.5 to 2.5-fold change was observed for each gene in mixed-
species biofilms, indicating that the presence of bacteria either directly or 
indirectly, stimulated C. albicans to upregulate virulence gene expression.  
 
The induction of hyphae production was also confirmed using confocal 
scanning laser microscopy (Fig. 2.10) and scanning electron microscopy 
(Fig. 2.11). Using these approaches many more hyphae were observed in 
mixed-species biofilms than C. albicans-only biofilms. Over a ten-fold increase 
in the number of hyphae was determined by image analysis that differentiated 
yeast cells from hyphae. The production of hyphae within the biofilms did not 
lead to an increase in the number of viable cells when enumerating by recovery 
of cells from the biofilms. However, hyphae were observed to be integral to the 
biofilm structure of mixed-species biofilms (Fig. 2.11), indicating the overall 
biofilm may be stronger structurally.  
 
Streptococcus gordonii has previously been found to adhere to C. albicans 
hyphae, where expression of the ALS3 gene is known to play a critical role 
(Silverman et al., 2010). ALS3 expression is crucial in the development of C. 
albicans biofilms, and so the increase in its expression in this study correlated 
with this previous finding reported by Silverman et al., 2010. Adhesion of 
bacteria to the hyphae of C. albicans was also observed in this study, but it 
was also evident that the oral bacteria adhered to the PMMA surface, where 
they would be able to colonise and develop microcolonies, with the potential 
for additional biofilms of distinct microbial content. However, bacterial binding 
to hyphae has further implications when, for example, in an environment where 
the biofilm can cause infection to tissues. 
 
Secreted aspartyl proteinases are expressed during Candida hyphal formation 
(Chen et al., 2002), and have also been associated with roles in tissue infection 
and damage (Silva et al., 2011; Alves et al., 2014). During investigations in this 
study, significant upregulation of SAP4 and SAP6 genes was observed in 
mixed-species biofilms (Fig. 2.14), indicating an increase in virulence. When 
extrapolating to an infection scenario, such a change could potentially lead to 
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an increase in pathogenicity. Furthermore, the phospholipase D1 gene was 
upregulated in mixed-species biofilms and this is also associated with yeast to 
hyphal morphological transition and is considered necessary for virulence 
(Dolan et al., 2004; Hube et al., 2001; Baker et al., 2002). Phospholipase D1 
is more closely associated with tissue infection, as the enzyme is responsible 
for hydrolysis of phosphatidylcholine, a substantial component of cellular 
membranes (Baker et al., 2002), thus allowing Candida invasion into tissues, 
and a direct cause of cell damage. Additional phospholipases are also 
attributed to Candida virulence and pathogenicity, and required for invasion 
into tissues, and these include phospholipases B1 and B2, and C1 
(Samaranayake et al., 2006), coded for by the PLB1, PLB2 and PLC1, genes, 
respectively. 
 
The oral bacteria used in this study are considered to be commensal 
microorganisms and thought to be primary (Streptococcus species) and later-
phase (Actinomyces species) colonisers of the oral cavity. These bacteria are 
not typically associated with any specific disease, however, in these in vitro 
investigations, they appeared to modulate the local environment to an extent 
that C. albicans responded at a molecular level, stimulating induction of a 
range of virulence factors as discussed throughout this chapter. The oral cavity 
is diverse, and harbours hundreds of different bacterial species, and so to 
evaluate the differences that other bacteria have on C. albicans virulence, 
another common oral bacterial species was introduced to the mixed-species 
inoculum. This bacterial species, P. gingivalis, and has been implicated in 
periodontal infection, and is a known pathogen within the oral cavity. 
 
Enhancement of C. albicans virulence by the co-existing bacteria in mixed-
species biofilms may be contact-dependent or as a result of secreted 
molecules. The reverse modulation when P. gingivalis was included in the 
biofilms could be attributed to the production of gingipains; proteases secreted 
by P. gingivalis as a virulence trait. The gingipains are multifunctional, 
activating or degrading a range of host proteins and inhibiting the immune 
response to lipopolysaccharide (LPS) (Genco et al., 1999; Potempa et al., 
2003; O’Brien-Simpson et al., 2003; Abe et al., 1998). It is through this 
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mechanism that gingival infection with P. gingivalis can so successfully lead to 
gingivitis and periodontitis, as the biofilms cannot be efficiently cleared by the 
host immune system. Gingipains may be modulating C. albicans virulence 
indirectly by either degradation of proteins related to the other bacteria, or a 
similar mechanism with receptors on the bacterial cell that could induce a 
response in direct contact with C. albicans  
 
Farnesol is a quorum sensing molecule produced by Candida, and is known 
to enhance virulence of oral bacterial species including S. mutans (Kim et al., 
2017). It is possible that the production and accumulation of farnesol is having 
a similar effect on other oral bacteria, particularly other streptococcal species 
included in the mixed-species biofilm model. This may have an antagonistic 
effect, leading to an increase in bacterial responses and an enhancement of 
virulence, subsequently leading to a further increase of C. albicans virulence 
factors. Furthermore, environmental stimuli play an important role in C. 
albicans virulence. Streptococcus sanguinis, S. gordonii, and C. albicans can 
tolerate some extremes such as low pH, which can arise as a result of 
utilisations of sugars. C. albicans has a preference for utilising glucose, 
whereas streptococci prefer sucrose. The initial breakdown of sucrose by C. 
albicans and streptococci creates glucose and fructose, which are then used 
by streptococci, resulting in production of acid (McCourtie & Douglas, 1984; 
Kim et al., 2017). In these environments, the extreme conditions act as stimuli, 
resulting in modified genetic regulation, and the subsequent expression of 
virulence factors as the microorganisms compete for nutrients, and to create 
an environment that suits them for their survival. 
 
2.5 Conclusions 
 
• The presence of an artificial saliva pellicle enhanced microbial 
adherence to the PMMA surface, but did not affect subsequent biofilm 
formation. The presence of the AS pellicle should remain an integral 
part of biofilm investigations, ensuring the surface is more closely 
representative of an in vivo scenario than a naked PMMA surface 
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• The presence of multiple bacterial species in co-culture mixed-species 
biofilms with C. albicans modulated C. albicans virulence; enhancing a 
range of putative virulence factors involved in adhesion, biofilm 
formation, and the production of hydrolytic enzymes, and substantially 
increased the formation of hyphae 
 
• The addition of the opportunistic pathogen P. gingivalis to the mixed-
species biofilm inoculum inhibited the previously observed 
enhancement of virulence, in some cases reducing the expression of 
the factors below the levels observed in C. albicans-only biofilms 
 
99 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
 
In vitro 3D oral mucosal tissue model 
development 
 
3.1 Introduction 
Candida are generally considered the main causative agents of denture 
associated stomatitis (DS). Current clinical treatment strategies where 
intervention in addition to improvement of general oral and denture hygiene is 
necessary, are targeted toward this fungal component of the denture biofilm. 
However, it is becoming increasingly apparent that interactions between 
Candida and bacteria within in vitro biofilms occurs and therefore is an 
important consideration when understanding the infection process (Jack et al., 
2014; Cavalcanti et al., 2015). As demonstrated in Chapter 2, in vitro virulence 
of C. albicans can be modulated by the presence of specific bacterial species 
within mixed-species biofilms, and therefore the role of bacteria in the 
pathogenesis, and thus prognosis and subsequent management of DS 
requires further evaluation.   
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Analysis of pathogenicity would be best represented using in vivo animal or 
human models. These are costly, require substantial ethical consideration, and 
are becoming less favoured, particularly by funders (such as the National 
Centre for the Replacement, Refinement and Reduction of Animals in 
Research (NC3Rs)) who wish to reduce the use of animals for scientific 
analysis unless absolutely necessary.  
 
Oral mucosal tissue models have been used to undertake investigations 
including the pathogenicity of microorganisms and associated host cell 
responses (Silva et al., 2009; Silva et al., 2011; Yadev et al., 2011; Cavalcanti 
et al., 2015). This work is crucial to gaining insight into the complex relationship 
between host and microbes, particularly biofilm infections, but little work has 
been applied to biofilms with the aim of evaluating pathogenicity or host 
responses toward infection, where, in the case of DS, this is essential. 
 
Tissue models are, therefore, valuable tools for a range of in vitro analyses. 
The concept of three-dimensional constructs representing skin were pioneered 
in the 1970s by Rheinwald & Green who began by successfully culturing 
keratinocytes in vitro, and establishing novel protocols in order to maintain 
cellular viability. This was then taken forward by O’Connor et al (1981), Burke 
et al., (1981), and Cuono et al., (1986) who prepared autologous epithelium 
and dermal allografts for grafting onto burns patients, with great success 
during the observational period of approximately 8 months or more. Later work 
included the further development of models to incorporate different cell types, 
particularly fibroblasts, and understand the pivotal role they play in 
revascularisation and repair/remodelling (Dermanchez et al., 1992). From this 
concept, a range of commercial models were developed. Many of these 
models incorporate a scaffold or dressing; either bovine collagen (Integra, 
Apligraf, OrCel, Varkey et al., 2015) or acellular dermal scaffold, and are 
seeded with autologous cells in order graft onto patients with various needs. 
Some models include a mixture of cell types; epithelial cells and fibroblasts 
(Tiscover, Permaderm, denovoSkin, Varkey et al., 2015). 
 
101 
 
Several different types of 3D tissue constructs are commercially available, 
including those representing dermal (as reviewed by Varkey et al., 2015), 
vaginal, lung (Braian et al., 2015), corneal (Yang et al., 2015; Ghezzi et al., 
2017), and of interest in this project, oral tissues. In particular, this study 
focuses on the palatal mucosa, where two different types of tissue models are 
available; a keratinocyte-only tissue model (SkinEthic RHOE, EpiSkin, Lyon, 
France), representing the oral epithelium, and a full-thickness tissue model 
(EpiOral FT, MatTek Corporation, Ashland, MA, USA); more closely 
representing human oral mucosa, comprising a lamina propria overlaid with an 
epithelium. 
 
Commercially available constructs are popular within research, but have some 
limitations. Keratinocyte-only models are comparatively simplistic, containing 
the epithelial layer developed using a cancer-derived cell line; TR146, 
originally isolated from a buccal squamous cell carcinoma, which is cultured at 
the air-liquid interface for 5 days. A 3D structure develops with maturation of 
the TR146 cells and culture in a 3D manner, but full differentiation is typically 
absent with these cells under these conditions (Nor et al., 2016). These tissue 
models have been used in numerous studies of microbial infection, particularly 
for investigations into furthering understanding of virulence and/or 
pathogenesis related to candidosis (Yadev et al., 2011; Alves et al., 2014; Silva 
et al., 2009; Silva et al., 2011; Jayatilake et al., 2005). The responses of these 
tissues may be somewhat limited relative to other tissue models that 
incorporate additional cells such as fibroblasts, as found in full thickness tissue 
models. However, as the first line of defence, the epithelial cells produce a 
wide array of proinflammatory cytokines to attract and engage immune cells 
(Waelti et al., 1992; Jayatilake et al., 2005), which are possible to detect in the 
supernatant of the cell culture. Detection and quantification of the cytokines 
depends on the type and duration of the infection, as it takes some time for the 
cytokines to accumulate in the supernatant to a level that is detectable with 
typical methods of analysis like enzyme linked immunosorbent assays 
(ELISAs). This is particularly important when trying to identify differences 
between infection types. 
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There are also advantages and disadvantages of the full thickness tissue 
model. The full thickness tissues (EpiOral) comprise both a lamina propria; a 
fibroblast populated collagen matrix, and an epithelium. A significant 
advantage of this tissue model is that the presence of both cell types will allow 
for cell-to-cell communication in the form of cytokines and chemokines. This 
crosstalk between the cell types is vital for normal immune responses and 
function, and should therefore ensure the responses of the cells are more 
representative of normal oral mucosa, as a result of the feedback mechanism 
the cytokines play on stimulating other cytokines or chemokines (Galley & 
Webster, 1996; Dinarello, 2000). The primary responses by epithelial cells 
occurs in the form of interleukin-1 (IL-1) IL-1, IL-8 and IL-18, some of which 
are also shared with fibroblast cells, including IL-18 (Dongari-Bagtzoglou & 
Ebersole, 1996) and IL-6. Fibroblast cells, importantly, are substantial 
producers of IL-6, also a proinflammatory cytokine, which occurs in response 
to stimuli including a number of interleukins. This increased production of IL-6 
further stimulates epithelial-associated interleukins in a positive feedback 
mechanism, driving inflammation (Ansel et al., 1990; McKenzie & Sauder, 
1990; Netea et al., 2006). Furthermore, the cells used in the model are normal 
primary oral cells, and so expected to more closely represent normal mucosa 
when cultured than the cancer-derived cell lines. The epithelium is typically 
well structured and layered, and some keratinisation present, further adding to 
the defence of the tissue from potential infection. The primary disadvantage is 
cost of the tissues. For the minimum quantity of tissues (24), the batch cost is 
approximately $4,000, plus transport and import costs. This is a major 
limitation for many research laboratories, where consumable budgets are very 
modest relative to this.  
 
All commercially available tissue models are considered ‘static’, in that no 
modification of the tissue can be performed post-culture. There is scope to 
further develop these tissue models to incorporate additional cell types, such 
as immune cells. There are clear advantages of adding additional cell types, 
primarily in the ability to evaluate the call for an immune response to infections, 
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and the ability to monitor migration of immune cells through the tissue model 
in response to stimuli. Furthermore, the lifespan of these tissue constructs is 
limited to just a few days after receipt, due to cornification of the models, and 
rapid loss of cell viability. It is important, therefore, to be aware of the physical 
limitations of working with a large number of tissue models, where additional 
time for actual use may be necessary, but not available. 
 
The tissue models are reproducible and consistent between batches, but very 
expensive, which can be prohibitive in many cases to the quantity of infections 
that can be evaluated. 
 
In order to overcome the restrictions of the tissue models imposed by the 
financial, and ‘static’ nature of the models, the primary aims of this study were 
to establish and optimise an in vitro alternative to commercially available 
constructs. Specifically: 
- Develop and optimise culture conditions for an alternative to SkinEthic 
RHOE, using TR146 keratinocytes. 
 
- Establish a full-thickness oral mucosal tissue model; 
o develop and optimise a lamina propria, by varying levels of 
collagen and seeding number of cells 
o comparing the use of TR146 cancer-derived cells with normal 
oral-derived cells in the culture of the model, as an alternative to 
EpiOral FT.
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3.2 Materials and methods  
3.2.1 Cell types and culture conditions 
A range of cells were used for this study and the details of each cell type and 
origin are presented in Table 3.1. 
 
Cell name Cell type Source/details 
TR146 Keratinocyte Buccal squamous cell carcinoma (Rupniak 
et al., 1985) 
HCA-2 Fibroblast Neonatal dermal fibroblasts (foreskin) 
(Wyllie et al., 2000) 
3T3 Fibroblast Mouse embryonic (Todaro & Green, 1962) 
FNB6 Keratinocyte hTERT immortalized normal oral 
keratinocytes (McGregor et al., 2002) 
NOF806 Fibroblast Normal oral fibroblasts (Colley et al., 2011) 
Table 3.1 Overview of cell types used in this research 
Details of the cell name, type and source or description of cell origin 
 
Normal oral fibroblasts (NOF806) were kindly provided by Dr Helen Colley, 
University of Sheffield. All tissues were collected with written, informed consent 
(ethical approval was granted by the University of Sheffield Ethics Committee 
ref: 3463) and processed according to Colley et al., (2011). 
 
Normal oral fibroblast cells, hTert immortalised HCA-2 fibroblasts, and FNB6 
and TR146 keratinocyte cells were cultured and maintained in Dulbecco’s 
Modified Eagle Medium (DMEM; Life Technologies, UK) supplemented with 
10% (v/v) foetal bovine serum (FBS), 4.5 g/L glucose, and 2 mM L-glutamine; 
this medium was changed every 2-3 d of incubation. Each cell type was split 
at approximately 85-90% confluence (approximately 4-7 d). To provide 
suitable culture conditions for FNB6 keratinocytes, -irradiated mouse 3T3 
fibroblast cells were also co-seeded at a density of approximately 400,000 
cells per flask as feeder cells, and 3T3 and FNB6 cells were co-cultured as 
described above. The incubation parameters for all cells were 37°C, 5% (v/v) 
CO2 with high humidity. 
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3.2.2 Type I collagen extraction 
Type I collagen extraction from the tails of euthanised rats was performed at 
the University of Sheffield (during a research secondment by the candidate). 
Briefly, rat tails were surgically removed and stored at -20°C until sufficient 
numbers were obtained for batch collagen extraction. The rat tails were broken 
in sections by hand, twisted to break the skin and then gently pulled apart to 
reveal collagen strands. These strands were cut using a scalpel and placed in 
500 ml of sterile PBS. The collagen strands were washed thoroughly by mixing 
the container by hand. The PBS was removed and the collagen was dissolved 
in 1 L of 0.1 M acetic acid. The collagen solution was then mixed at 4°C for 
approximately 2 weeks. Once sufficiently dissolved (where no visible 
aggregates remained), the collagen mixture was freeze dried in 150 ml 
aliquots. The dried collagen was weighed and stored at -20°C prior to 
dissolving in 0.1 M acetic acid at a final concentration of 5 mg/ml for 
approximately 1 week prior to use in tissue models. 
 
3.2.3 Development of an in vitro keratinocyte-only oral mucosal tissue 
model 
The development of an in vitro keratinocyte-only model was performed as 
detailed below and outlined in Fig. 3.1 
 
3.2.3.1 Cell preparation and seeding 
To obtain keratinocyte cells for 3D culture, the culture medium was removed 
from the flasks and adhered cells washed (1) with sterile PBS. The PBS was 
aspirated and 3 ml of 0.25% trypsin-EDTA (Life Technologies) added to detach 
the cells. The flasks were incubated at 37°C for 5 min for enzymatic 
detachment of cells. A 10-ml volume of culture medium was added to the 
detached cells to dilute the enzyme in solution, thus reducing activity to 
negligible levels. The cell suspension was aseptically transferred to a sterile 
universal and the cells were pelleted by centrifugation at 330  g for 5 min 
(Durafuge 200 Precision, Thermo Scientific). The medium was carefully 
removed by decanting to a waste container, and the remaining pelleted cells 
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were agitated gently by flicking the universal to suspend. The cells were 
suspended in 5 ml of Dulbecco’s Modified Eagle Medium supplemented with 
Ham’s F12 medium (DMEM/F12, Life Technologies), then gently mixed to 
ensure homogeneity and a 10 l sample of cells counted using a 
haemocytometer. 
 
The cells were resuspended at twice the required seeding density, ranging 
from 2  105 to 2  106 cells/ml. Free standing cell culture inserts (PIHP01250, 
Merck Millipore) were aseptically placed in a sterile 12-well plate, and 500 l 
of the suspended keratinocyte cells added to the inside of the insert. One ml 
of DMEM/F12 (supplemented with 10% (v/v) of FBS and keratinocyte culture 
supplements (detailed in Table 3.2)) was added to the outside of the inserts, 
and the well plate was incubated for 24 h at 37C in 5% (v/v) CO2.  
 
Component Final in-use 
volume/concentration 
Supplier 
DMEM/F12 450 ml Life Technologies 
FBS 50 ml Life Technologies 
Penicillin 100 U/ml Life Technologies 
Streptomycin 100 U/ml Life Technologies 
Human epidermal 
growth factor 
10 ng/ml R&D Systems 
(Abingdon, UK) 
Cholera toxin 1.8x104 U/ml Sigma 
Insulin 0.5 g/ml Sigma 
Adenine 5 g/ml Sigma 
Table 3.2 Composition of DMEM culture medium with added culture 
supplements for keratinocyte-only tissue model development 
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Figure 3.1 Diagrammatic representation of the stages of in vitro keratinocyte-only tissue model culture 
A) Establishment of monolayer, then B) raised to air-liquid interface. Cultures were maintained through C) maturation and 3D 
culture, resulting in a multi-layered tissue structure. 
A B C 
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3.2.3.2 Establishing air-liquid interface and tissue model maintenance 
Once the cells were established on the insert membrane (after approximately 
24 h), the used culture medium was aspirated from inside the cell culture insert, 
and from the well. Six hundred µl of fresh DMEM/F12 culture medium was 
added to the well, ensuring the surface of the medium was in contact with the 
cell culture insert, but not above the level of the cells. It was important to 
maintain an air-liquid interface (ALI) for the cells, to allow stratification. The 
well plate was returned to the incubator and the culture medium replaced every 
other day, for a total culture period of 5-10 d. 
 
3.2.4 Development of a full thickness in vitro oral mucosal tissue model 
The full thickness oral mucosal tissue model was cultured in three distinct 
stages. Establishment of the lamina propria (fibroblast cell-populated collagen 
matrix), seeding of the keratinocytes, and maintenance of the tissue model 
culture at the ALI. A diagrammatic representation outlining the method is 
shown in Fig. 3.2. 
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Figure 3.2 Diagrammatic representation of the stages of in vitro full-thickness tissue model culture 
A) Fibroblasts in collagen matrix added to cell culture insert, and allowed to set, then B) collagen contracted, after which C) 
keratinocyte cells were added and allowed to establish a monolayer. D) The cultures were brought to air-liquid interface and E) 
maintained to culture into a 3D tissue structure 
A B C 
B 
 
D E 
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3.2.4.1 Establishment of the lamina propria 
A collagen mixture was prepared on ice in a 30 ml falcon tube, and this mixture 
contained the following (sufficient volume for 10 tissue models): 1 ml of 10  
DMEM (D5648, containing 4.5 g/L of glucose, 2 mM of L-glutamine, Sigma), 1 
ml of reconstitution buffer (comprising 0.02 M of HEPES buffer, 0.062 M of 
sodium hydroxide), 0.83 ml of FBS, and 6.73 ml of 5 mg/ml collagen. The 
solution was mixed gently but thoroughly by hand, avoiding the formation of 
bubbles within the mixture. Due to the acidity of the collagen solution, a bright 
yellow colour was formed. The pH was adjusted to pH 7 using 1 M sodium 
hydroxide with gentle mixing by hand between addition. The colour of the 
solution changed to red, and was re-adjusted to approximately pH 7 after 10 
min once the mixture equilibrated. 
 
The fibroblast cells were detached from the T75 flasks as described in section 
3.2.3.1, and resuspended to a final cell seeding density of 6.25  106 cells/ml 
in a volume of 800 μl (equivalent to 2.5  105 cells per 40 μl cell suspension). 
The high cell density was necessary to avoid introducing excess medium into 
the collagen solution, and thus influencing the final pH. 
 
Hanging cell culture inserts (PIHP15R48, Merck Millipore; 0.4 μm pore size, 
PET membrane) were aseptically placed into each well of a 12-well plate using 
sterilised forceps. The suspended fibroblast cells were then added to the 
collagen mixture, and mixed gently by hand. Immediately after mixing, 1 ml of 
collagen/cell mixture was added to each insert. The inserts and collagen were 
transferred to an incubator (parameters as above) for 60 min to allow the 
collagen mixture to solidify. Once suitably solidified, 500μl of DMEM Green’s 
medium (as detailed in table 3.3) was added to the insert, and 2 ml to the well 
outside of the insert. The plates were returned to the incubator and incubated 
for approximately 44 – 48 h. 
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Component Final in-use 
volume/concentration 
Supplier 
DMEM/F12 450 ml Life Technologies 
FBS 50 ml Life Technologies 
Penicillin 100 U/ml Life Technologies 
Streptomycin 100 U/ml Life Technologies 
Adenine 0.025 pg/ml Sigma 
3,3,5-tri-iodothyronine 1.36 ng/ml Sigma 
Apo-transferrin 5 g/ml Sigma 
Human epidermal 
growth factor 
5 ng/ml R&D Systems 
(Abingdon, UK) 
Cholera toxin 8.47 ng/ml Sigma 
Insulin 5 g/ml Sigma 
Table 3.3 Composition of DMEM Green’s culture medium for full thickness 
tissue model development 
 
3.2.4.2 Keratinocyte seeding and establishment of epithelial layer 
FNB6 or TR146 keratinocyte cells were detached from the culture flasks with 
3 ml of 0.25% (w/v) trypsin-EDTA as described in section 3.2.3.1. The cells 
were washed, pelleted and resuspended to 5  105 cells/ml in DMEM Green’s 
medium, and 500 μl of the cell suspension added to each insert. The medium 
on the outside of the well was replaced with 2 ml fresh DMEM Green’s medium. 
The plates were returned to the incubator for a further 48 h, after which, 
significant contraction of the collagen was evident (Fig. 3.2b). 
 
3.2.4.3 Establishing the air-liquid interface to initiate tissue maturation 
in a 3D manner and stratification  
After 48 h culture, the tissue models were removed from the incubator, and the 
liquid medium aspirated from inside the insert and wells. Fresh DMEM Green’s 
medium was added only to the well for the remainder of the tissue model 
culture. The volume used was sufficient to allow feeding of the cells from 
below, but was small enough to allow an air-liquid interface of the keratinocyte 
cells on the outermost section of the tissue model. The tissue model was 
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maintained at the ALI for a further 14 d with culture medium replenished every 
other day 
 
Prior to infection, the final medium change (2 d before use) used culture 
medium devoid of antimicrobial compounds (penicillin or streptomycin). 
 
3.2.5 Tissue processing and preparation for analysis 
Tissues were processed overnight using a Leica ASP300S processor, prior to 
paraffin wax embedding using Leica EG115OH embedding equipment. The 
processing protocol was as follows: dehydration in ethanol (90% (v/v) for 1 h, 
95% (v/v) for 1 h, absolute for 4  1 h), immersion in xylene (3  1 h), and 
embedded in paraffin wax for 1 h, 1.5 h, and 2 h. The tissues were transferred 
to a paraffin wax container in a Leica EG115OH embedder. To section 
transversely, each tissue was orientated on the sectioned edge, then 
submersed in paraffin wax, which was allowed to solidify. The samples were 
trimmed and sectioned at 5 m thickness using a rotary microtome (Thermo 
Shandon Finesse ME +, Thermo Scientific). The sections were attached to 
Thermo Colorfrost Plus microscope slides (Thermo Scientific), and heated at 
60 C for at least 1 h to ensure strong attachment to the slides 
 
3.2.6 Histological staining 
The sections were stained with haematoxylin and eosin using automated 
staining equipment (Thermo GLX Linistainer, Thermo Scientific). Briefly, the 
sections were dewaxed in a series of xylene baths (4, decreasing 
concentrations), dehydrated in alcohol (2, increasing concentrations), then 
rinsed with tap water and stained with haematoxylin (5, VFM Harris 
Haematoxylin (Acidified), CellPath Newtown, UK). The samples were then 
rinsed with tap water, and subjected to acid alcohol rinse (5% (v/v) acetic acid 
in 70% (v/v) ethanol), and rinsed again with tap water. The blue colouration 
(nuclei) was enhanced by rinsing in Scott’s tap water substitution, followed by 
a further rinse using tap water and then counterstained with Shandon aqueous 
eosin (Thermo Scientific). Finally, the sections were dehydrated through a 
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series of alcohol baths (3), then xylene (2) and stored in xylene until they 
were covered with a glass coverslip using DPX (CellPath).. 
 
3.2.7 Observational analysis of tissue models 
Analyses for the tissue models were primarily observational, which includes 
visual analysis by microscopy of sections for the different cultured tissue 
models to evaluate a number of parameters: tissue depth, morphology of cells, 
maturation and establishment of layers of cells, and keratinisation. 
 
3.2.7.1 Keratinocyte-only tissue model analysis 
Sections of keratinocyte-only tissue models were evaluated visually, to 
determine relative tissue depth by number of layered cells in the epithelium, 
and cellular morphology. The morphology TR146 cells in continued culture in 
culture flasks was determined to be the typical cell morphology. This 
morphology was then compared with the morphology of the cells within the 3D 
constructs, to determine whether culture in the 3D manner influenced 
morphology.  
 
The typical morphology for TR146 in flasks was described as polygonal in 
shape, with a distinct large nucleus. 
 
3.2.7.2 Full-thickness tissue model analysis 
As the full-thickness tissues comprised 2 distinct sections, each were 
considered when analysing development of the structures. 
 
The lamina propria contained fibroblasts, which were compared with typical 
fibroblast cells, and their characteristics when cultured in culture flasks. 
Fibroblasts grow as elongated cells, with a central nucleus, and fibrous 
spindle-like characteristics outwards from the centre. 
 
Epithelial cell morphology was also evaluated visually, similar to that described 
in section 3.2.7.1. FNB6 keratinocytes have similar cell morphology to TR146 
when cultured in culture flasks; polygonal shape with large distinct nucleus 
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typically around the centre of the cell. Maturation of cells that behave normally 
when cultured at the ALI should show a transition from ‘block’ like cells at the 
innermost layer, becoming more spherical to the outermost layer, where they 
begin to keratinise. Tissue models were compared to the typical morphology 
of cells in a biopsy of normal palatal mucosa to determine whether cells follow 
the anticipated maturation pathway.
115 
 
3.3 Results 
3.3.1 Commercially available epithelial tissue model  
The SkinEthic RHOE tissue model (EpiSkin, Lyon, France) comprised of 
multi-layered epithelial cells (TR146 cell line; originally isolated from a 
squamous cell carcinoma of the buccal mucosa) cultured in a well plate 
culture insert, which had a porous polycarbonate membrane of 10 mm in 
diameter, with 4 m-sized pores. 
 
A number of models from each batch undergo quality control checks prior 
to dispatch from the manufacturer, which ensures consistency. The 
requirements for the tissues to successfully ‘pass’ quality tests are for the 
tissue depth to be greater than 4 cells, and to exceed a baseline cell viability 
level assessed by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide, MTT assay. The tissue models are also checked for bacterial, 
fungal and viral contamination. Each batch of tissue models received met 
these criteria. 
 
A number of batches of the commercial tissue models were received, and 
varied in tissue depth across the membrane of individual models, with most 
areas thicker than the 4 cells as specified in the quality control 
specifications. There were some areas that were just 4 cells thick and other 
regions that did appear thinner than the specified minimum. Overall, when 
considered as a whole, the tissues did exceed the minimum average cell 
depth as specified by the manufacturer. The structure of the model differed 
slightly from the quality control image provided in terms of cellular 
morphology, as the cell-to-cell junctions were less defined in the slides 
observed after receipt and processing at the University. 
 
No keratinisation of the epithelium was evident microscopically (Fig. 3.4A). 
Furthermore, there was no distinct maturation or stratification of the cells 
throughout the 3D epithelium as would be expected with normal 
keratinocytes. The morphology of the cells through the layers was 
consistent. The lack of differentiation of the cells was anticipated as the cells 
116 
 
were originally derived from a cancer, and these typically do not mature or 
differentiate as normal cells would.  
 
3.3.2 In vitro development of epithelial tissue model 
3.3.2.1 Effect of cell seeding density on tissue model development 
The manufacturer, EpiSkin, states that the SkinEthic™ RHOE tissue model 
is cultured for 5 d at the air-liquid interface (ALI), however further information 
is considered proprietary by the company, and as such, not publically 
available. Therefore, for in vitro tissue model development, a range of initial 
cell seeding densities were evaluated from 1  105, 2  105, 5  105 and 1  
106 cells total. These were seeded into a cell culture insert of similar surface 
area as the SkinEthic™ RHOE tissue model (10 mm2). 
  
At lower cell seeding densities of 1  105 and 2  105 total cells, the 
keratinocytes that attached to the membrane were too few to establish a 
confluent single layer, and subsequently did not develop into a 3D structure 
to be considered a tissue model, despite the culture period of 5-10 d 
(Fig. 3.3). 
 
At higher seeding densities of 5  105 and 1  106 total cells, sufficient 
numbers of cells attached to the membrane, and when cultured at the ALI, 
developed into a 3D structure (Fig. 3.4). There was a clear difference in the 
observed tissue depth (number of layers of cells) (Figs. 3.4a, 3.4c) with the 
higher seeding density of 1  106 cells providing the thickest tissue model 
at the end of the 5-d culture period. The depth of tissue observed appeared 
consistent across the membrane for each model cultured, but did show 
some variation between models. 
 
3.3.2.2 Effect of culture period on tissue model development 
Two culture periods for the in vitro models were evaluated by light 
microscopy. This assessment was based on the number of layers of cells 
of the models, and consistency across the membrane for each model 
evaluated. At the lower seeding density of 5  105 total cells, an increase in 
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the number of cell layers, and tissue model depth occurred between 5 and 
10 days of culture (Figs. 3.4b, 3.4c). This was in contrast to the models 
seeded with 1  106 total cells, where no increase in the number of cell 
layers (and thus, depth of tissue model) was observed between 5-10 d 
culture (Figs. 3.4d, 3.4e).. 
 
 
Figure 3.3 Lower keratinocyte cell seeding densities (2  105 cells) did not 
result in a stratified epithelium, irrespective of culture period 
A) 5d culture, 2  105 cells, B) 10d culture, 2  105 cells. Sections stained 
with haematoxylin and eosin. Scale bar represents 50m. 
 
A 
B 
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Figure 3.4. Effect of initial cell-seeding density and culture periods on final 
3D epithelial tissue model thickness and structure. 
Light microscopy images demonstrating the effect of varying cell seeding 
density and culture periods on epithelial tissue model thickness, cell 
morphology and tissue structure. A) SkinEthic RHOE, B) 5 d culture, 5  
105 cells, C) 10 d culture, 5  105 cells, D) 5 d culture, 1  106 cells, E) 10 d 
culture, 1  106 cells. Stained with haematoxylin and eosin. 
 
3.3.3 Development of full thickness tissue models 
3.3.3.1 MatTek models as ‘gold standard’ 
A range of 3D tissue models are available from MatTek Corporation, 
including the EpiOral models or oral mucosa. These ‘full thickness’ tissue 
models comprise a lamina propria of fibroblasts in a collagen matrix, 
overlaid with a stratified and slightly keratinised epithelium. 
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The fibroblast cells in the lamina propria showed typical morphology with 
‘spindle-like’ cells sparsely populating the collagen matrix (Fig. 3.7). Good 
3D culture and maturation of the epithelial cells was evident, with ‘block’ like 
cells making up the stratum basale, and the outermost cell layers more 
representative of keratinised epithelial cells, but somewhat limited in 
quantity. The maturation process was evident in the layers of keratinocytes 
in the model, with changes in cellular morphology evident from the stratum 
basale to the stratum corneum. 
 
Histologically, the depth of the epithelial layer was relatively consistent 
across the model. Toward the edges of the insert (closest proximity to the 
cell culture insert wall), the depth of both the collagen matrix and the 
epithelial tissue noticeably decreased, to an extent where there were no 
cells or matrix evident. Although, this was not a sudden change, the depth 
tapered off, beginning far  from the centre of the tissue model. 
 
3.3.3.2 Establishment of lamina propria 
A commercially available collagen solution (Bornstein and Traub Type I, 
extracted from rat tails, pepsinised extraction method, Sigma) was initially 
evaluated to develop a method or establishing a lamina propria of fibroblast 
cells contained within a collagen matrix. The concentration of the collagen 
within the solution varied between batches, but was 3.76 mg/ml for these 
experiments. The collagen was dissolved in acetic acid, and thus was 
required to be diluted, and pH adjusted by addition of 1 M sodium hydroxide 
prior to use, to avoid immediately killing the cells. Two final collagen 
concentrations were evaluated; 1.88 mg/ml and 0.94 mg/ml (1:1 and 1:3 
dilution of the collagen solution, respectively). 
 
The concentration of the collagen solution used in this study was not 
suitable for establishing a scaffold in which the fibroblast cells could embed 
for structural support of a 3D tissue model. Figure 3.5 illustrates the effect 
of cell seeding density and culture period on establishment of the fibroblast 
cells in a 3D structure. A clear pattern was evident concerning the cell 
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seeding density with increased cell seeding density resulting in a 
histologically thicker model with an increase in the number of cell layers. 
Furthermore, increasing the culture period from 24 h to 48 h, irrespective of 
the concentration of collagen used, resulted in better establishment of the 
cells in the collagen matrix, which appeared more fibroblast-like in 
morphology, with elongating filaments. 
 
At the lower seeding density of 2  105 cells, few cells were observed on the 
membrane after 24 h culture, whereas more cells were observed after 48 h 
culture, and these exhibited better layering and cell morphology. At the cell 
seeding density of 5  105 cells, a similar pattern was observed, but more 
cell layers were evident after 24 h, and more layers were formed after 48 h 
culture. The highest cell seeding density of 1  106 cells yielded the greatest 
number of cell layers, with little difference between 24 h and 48 h culture. 
Morphologically, the cells after 48 h culture were fibroblast-like, whereas 
after 24 h culture, they were poorly established and did not have a typical 
fibroblast phenotype. 
 
 
1
2
1
 
24h culture 48h culture 
  
  
  
Figure 3.5 Effect of varying cell seeding density and culture period on establishment of a lamina propria layer. 
Light microscopy images of HCA-2 fibroblasts in a collagen matrix (0.88 mg/ml). Cell seeding density A+B) 2  105 total cells, C+D) 
5  105 total cells, E+F) 1  106 total cells. The depth of the layer and cell morphology was dependent upon both culture period and 
cell seeding density. Increased thickness was observed with a higher cell seeding density, but no difference between 24-48 h culture 
periods. 
Sections stained with haematoxylin and eosin. Scale bar represents 20 . 
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Building upon the evaluation of cell seeding density, and using the highest 
cell seeding density of 1  106 cells, the effect of varying the collagen 
concentration was investigated. The purpose of the collagen matrix was to 
provide a scaffold for fibroblasts to establish, on which, keratinocytes could 
be overlaid, and subsequent adherence to the collagen matrix could be 
established. Figure 3.6 demonstrates the effect of doubling the collagen 
concentration from 1.88 mg/ml to 0.94 mg/ml final concentration, which 
resulted in no clear visible differences in terms of lamina propria thickness; 
there was however an apparent effect on cellular morphology and definition 
of the layer. The cells seeded into the higher concentration of 1.88 mg/ml 
collagen appeared histologically more structured, with a more defined outer 
layer at the ALI. There were little differences between 24 h and 48 h culture 
periods for this collagen concentration, but the surface definition persisted 
after 48 h culture. Additionally, no differences in the thickness of the layer 
was evident when comparing the collagen concentrations, and no 
contraction of the collagen layer was evident at any seeding density, nor 
culture period. 
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Figure 3.6 Effect of varying collagen concentration for production of an in vitro lamina propria layer comprising 1  106 fibroblast cells 
Light microscopy images demonstrating the effect of collagen concentration on subsequent lamina propria layer development, 
measured observationally. A+B) 0.94 mg/ml collagen, C+D) 1.88 mg/ml collagen. Tissue depth (number of layers) was not affected 
by collagen concentration. but a more defined border at the higher collagen concentration was evident compared with rugged 
outermost layer in 3.6A and 3.6B (highlighted with red arrows). Sections stained with haematoxylin and eosin. Scale bar represents 
20 m in images 3.6A and 3.6B, 50 m in 3.6C and 3.6D. 
D
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3.3.4 Initial in vitro studies to develop full thickness tissue model 
Initial studies employing the knowledge acquired from the in vitro 
keratinocyte-only tissues were completed to establish a co-culture full-
thickness tissue model. This used a fibroblast populated collagen matrix, 
overlaid with keratinocytes that would stratify into a 3D epithelium. 
 
Fig. 3.7 demonstrates a representational section of MatTek full thickness 
tissue model that more closely represented the target tissue structure. Initial 
studies building on the establishment of an in vitro lamina propria used this 
knowledge and overlaid it with keratinocyte cells to establish the epithelium. 
 
 
 
Figure 3.7 Typical representation of MatTek EpiOral full thickness tissue 
model section by light microscopy 
Representative image of typical MatTek EpiOral full-thickness tissue model. 
Stained with haematoxylin and eosin. Scale bar represents 100 m. 
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Figure 3.8 Initial in vitro full-thickness tissue models developed with 1.88 
mg/ml collagen in conjunction with non-normal oral cell lines 
SE, multi-layered keratinocyte-containing epithelial layer; LP, lamina propria 
comprising fibroblasts in collagen matrix. Cells stained with haematoxylin 
and eosin. Scale bar represents 50m. 
 
A somewhat defined fibroblast-populated lamina propria layer was evident, 
with multi-layered epithelium. However, the definition of cell morphology for 
the lamina propria was poor, with very little depth of the matrix structure, 
and was very densely populated by fibroblast cells. Additionally, the 
epithelial stratification was limited, with no defined differentiation of the 
keratinocyte cells, as was anticipated with the use of this TR146 cell type. 
 
The lamina propria was cultured with HCA-2 fibroblast cells: hTert 
immortalised diploid fibroblasts, and although viable, did not show typical 
fibroblast-like morphology. The cells appeared very densely populated, with 
a myofibroblast-like appearance. 
 
The epithelium showed a number of cell layers, indicating keratinocytes did 
develop into a 3D epithelium, but no maturation of the cells was evident. 
This was also observed in Fig. 3.4, where the same cells were used in the 
keratinocyte-only tissue model. No definition of stratum basale, or other 
anticipated layers were visible, although the viable cell morphology was 
similar to that expected with the TR146 cell line.  
 
3.3.5 Full thickness model culture 
Development of a full thickness tissue model was completed as part of a 
collaboration with Dr Craig Mudroch, and Dr Helen Colley at the School of 
SE 
LP 
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Clinical Dentistry, University of Sheffield. Some time was spent at the 
University of Sheffield to obtain the relevant technical knowledge and skills 
to culture the full thickness tissues at Cardiff University for this research. 
 
Use of normal oral fibroblast cells to establish the lamina propria, which was 
then overlaid with immortalised normal oral keratinocytes, yielded the most 
representative oral mucosa full-thickness tissue of all models in this study, 
as represented in Fig. 3.9A. There was a very thick lamina propria, which in 
some areas was greater than 700 m from the membrane to the stratum 
basale.  
 
The fibroblast cells were spindle-like, with typical normal healthy fibroblast 
morphology, and sparsely populated within the collagen matrix. The higher 
concentration (5 mg/ml) of collagen used in this full thickness model protocol 
provided a much stronger and more stable physical structure in which the 
fibroblasts were able to establish and contract the matrix, but still maintain 
good integrity of the lamina propria. 
 
The overlaid epithelium of immortalised normal oral keratinocytes showed 
excellent stratification, with many cell layers. The number of cell layers was 
greater than both in the in vitro keratinocyte-only and SkinEthic RHOE 
tissue models. The maturation of the in vitro epithelium showed defined 
layers with distinct cell morphologies, and some keratinisation of the 
outermost layers, as evident in normal histological palatal mucosa samples. 
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Figure 3.9 In vitro full-thickness tissues using normal oral fibroblasts and A) immortalised normal oral keratinocytes, and B) TR146 
cancer-derived keratinocytes. 
Typical light microscopy images of in vitro full thickness oral mucosal tissues in a collagen matrix (5 mg/ml) comprising a lamina 
propria (LP), sparsely populated with fibroblasts (red arrows), and layers of epithelial cells (SE). Tissues cultured for 10 d at ALI. Cells 
were stained with haematoxylin and eosin. Scale bar represents 50 m.
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The use of TR146 cancer-derived keratinocytes in place of immortalised 
normal oral keratinocytes (Fig. 3.9B) resulted in some interesting changes 
to the epithelium. The structure of the lamina propria remained similar with 
the TR146 cells as the FNB6 cells, indicating a similar response to 
environmental stimuli by the fibroblasts, and therefore they contracted in the 
normal manner. However, epithelial maturation and stratification were 
significantly affected. Little maturation of the keratinocyte cells was 
observed, despite many cell layers being present within the model. It was 
also noted, however, that the extent of epithelial stratification was less in the 
tissues using TR146 cells, than when using FNB6 cells. 
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3.4 Discussion 
Commercially available tissue models have been widely used for a number of 
different types of investigations, from chemical cytotoxicity, to evaluation of 
candidosis (Jayatilake et al, 2005; Dongari-Bagtzoglou & Kashleva, 2006a; 
Silva et al, 2009; Silva et al, 2011; Yadev et al, 2011; Cavalcanti et al, 2015). 
The tissue models are relatively consistent and reproducible, as are the 
responses to infection between batches. There are, however, substantial 
limitations to each of the commercially available models, primarily associated 
with cost, but also the type of cells used. This study aimed to develop in vitro 
models equivalent to the commercially available constructs, in order to allow a 
higher throughput of analyses in future studies, but substantially reducing 
costs. 
 
The SkinEthic RHOE tissues have been widely used for infection analyses, 
but primarily using planktonic cells, as opposed to biofilms which were of 
primary interest in this project. The SkinEthic RHOE tissue comprised solely 
of keratinocyte cells, in particular, TR146 cells, which were originally derived 
from a squamous cell carcinoma. The very nature of cancer cells, in that they 
are considered ‘non-normal’, can dictate the way they behave and respond to 
different stimuli. The responses to infection, expression of surface receptors 
may be different in cancer cells, compared with their non-cancerous 
equivalent. This study also used TR146 keratinocytes to establish a 
keratinocyte-only epithelial tissue model. The manufacture of the SkinEthic 
RHOE is proprietary; the culture period of commercial RHOE tissue models is 
published as 5 d at the ALI, but it was not known whether this was due to 
limitations of the model in terms of continued culture, part of the optimisation 
process, or due to the commercial nature of the model and wanting to reduce 
culture time to provide a greater number of models more frequently. 
Additionally, the cell seeding density, and specific details of the culture medium 
and supplements are not disclosed.  
 
Previous preliminary, but unpublished work by the research group of Xiaoqing 
Wei at Cardiff University established culture medium supplements that support 
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the culture of keratinocytes and encourage stratification and development in a 
3D manner. The evaluation of cell seeding density resulted in different tissue 
depths, increasing with the number of seeded cells (Fig. 3.1). The effect of 
culture period did not appear to influence tissue depth, with no substantial 
increase in depth despite doubling the culture period from 5 d to 10 d. The 
morphology of the cells within the 3D structure was similar in the in vitro tissues 
to that in the SkinEthic RHOE tissues. Tight, defined cell-to-cell junctions 
were evident in both in vitro and RHOE tissues, with typical TR146 cellular 
morphology. Previous work has been undertaken using TR146 to establish a 
3D tissue, but this cultured for a significantly longer period (23 d), and the 
resulting tissues did not show as much stratification of the epithelial cells 
(Jacobson et al., 1999). 
 
The keratinocyte-only tissue model is limited as it contains only keratinocytes, 
and no other cell types. The typical responses to infection or local 
environmental stresses of tissues is complex and includes many different cell 
types, such as keratinocytes, fibroblasts, Langerhans cells, immune cells, with 
a vast array of cytokine and chemokine signals being produced and sensed. 
Pro- and anti-inflammatory cytokines are critical to mount a suitable immune 
response to infection, and the limitation of cell types present in the model may 
not result in the same responses, as the production of the cytokines are known 
to further stimulate or suppress subsequent responses. Keratinocyte cells 
produce a range of cytokines, including interleukin-18 (IL-18), IL-1, IL-1, IL-
3, IL-6, IL-8, and Tumour necrosis factor alpha (TNF) (Waelti et al., 1992; 
Yadev et al., 2011; Jayatilake et al., 2005). These cytokines can have 
subsequent effects on monocytes and fibroblast cells, which subsequently 
produce cytokines of their own to mount an immune response to the stimulus, 
which in this case would be the infection. Fibroblasts, particularly in co-culture 
with keratinocytes are known to produce IL-6, which in turn further stimulate 
keratinocytes to produce pro-inflammatory cytokines (Ansel et al., 1990; 
McKenzie & Sauder, 1990; Netea et al., 2006). 
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To develop upon the relatively simple keratinocyte-only tissue model, a co-
culture model was established, comprising both epithelial cells and a 
fibroblast-populated collagen matrix. The first stage was to evaluate the effect 
of collagen concentration on establishment of a lamina propria. Two 
concentrations of type I collagen were evaluated in this study; 1.88 mg/ml and 
0.94 mg/ml, and were based on the commercial availability of a rat tail collagen 
solution. The pre-dissolved collagen was selected for use in preliminary 
studies due to the great expense of purchasing collagen in powder form, when 
considering the quantities required for such studies. For example, the lowest 
concentration of collagen used in these studies was 0.88 mg/ml for each tissue 
model, thus while making the cell suspension volume necessary for a batch of 
tissues (12 tissues), this equated to approximately 1 mg/ml. The price for 
collagen powder as a raw material was approximately £4-£9 per mg, which 
equates to a minimum of £12 per single batch. Taking into account that 
multiple batches were cultured at any one time, and the concentration of 
collagen used in the models varied from the equivalent of 1 mg/ml-
approximately 6 mg/ml for each model, the cost very quickly becomes 
significant. For a single batch of full-thickness tissue models for infection 
studies, for example, the collagen cost alone equates to up to £1,296. Despite 
this, the in vitro tissue models are still significantly cheaper than the 
commercially available equivalent models, at approximately $4,000 (US 
dollars) for 24 tissues. 
 
When the collagen solution was mixed with fibroblasts and allowed to set, 
neither produced a structure resembling a typical lamina propria, which is 
typically relatively thick compared to the epithelium, and contains fibroblasts 
that are sparsely populated within the matrix. A number of fibroblast seeding 
densities were also investigated, to determine an optimum seeding density for 
sufficient contraction of the collagen, whilst maintaining structural integrity. A 
slight increase was observed in lamina propria depth with increasing numbers 
of seeded cells. Observationally, there was however, little difference in cellular 
morphology. The cells retained the same spindle-like, elongated phenotype, 
indicating there were no benefits in using a higher number of cells to achieve 
a thicker fibroblast-collagen layer. Increasing the concentration of type I 
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collagen in the mixture also did not significantly affect tissue thickness, or 
structure of the lamina propria. The higher concentration of collagen (1.88 
mg/ml) resulted in a more defined outer layer which was smoother than that 
evident with the lower concentration. The outermost edge of the lower 
concentration of collagen (0.94 mg/ml) was visibly rough, whereas the 
outermost edge when using the higher concentration (1.88 mg/ml) of collagen 
had a more uniform appearance with fewer peaks and troughs. These 
concentrations of collagen were still ultimately lower than were used in the final 
in vitro full-thickness tissue development protocol. 
 
A preliminary in vitro co-culture tissue model was developed with 1.88 mg/ml 
collagen, and the highest seeding density of HCA-2 fibroblasts (1  106 total 
cells), followed by the highest seeding density of TR146 keratinocytes (1  106 
total cells) as deemed optimal in this study. The resulting culture at the ALI 
showed a 3D culture of the lamina propria and epithelium, but no true 
stratification. The epithelial depth was similar to that observed in in vitro 
keratinocyte-only tissues, and was consistent across the membrane. The 
depth was similar between batches, indicating there may be a maximum 
thickness that can be supported by both the HCA-2 and TR146 cells in these 
models. The TR146 cells are limited in the potential extent of maturation and 
stratification of the resulting epithelium, as previously observed, which in turn 
may influence the cellular responses to infection. 
 
In addition to the substantial contribution made to the development of in vitro 
replacements for grafts by researchers including Rheinwald & Green (1975, 
1977), O’Conner et al., (1981), Gallico et al., (1984), continued development 
and optimisation of a co-culture mucosal tissue model protocol has been 
completed at the University of Sheffield by the group of Dr Craig Murdoch. Dr 
Helen Colley and Dr Craig Murdoch kindly shared their expertise which 
allowed substantial progress for this project for infection analyses. The 
protocol used by the University of Sheffield was adopted for this project, where 
the use of normal oral fibroblasts and immortalised normal oral keratinocytes 
yielded a very histologically different tissue model to those developed when 
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using cancer-derived cells. Fig. 3.7A demonstrates the resultant tissues when 
using normal oral cells, compared with TR146 keratinocytes in Fig. 3.7B. There 
was considerable difference between the two cell types when cultured in the 
full-thickness tissue model. The primary difference is the maturation of cells, 
where, TR146 cells do not show any maturation within the epithelial layer. The 
same cellular morphology was evident throughout the epithelium, with no 
distinct ‘block’-like stratum basale, through to keratinised outer epithelium as 
would be anticipated. However, distinct cell morphologies were evident in the 
model containing normal oral keratinocytes; a dark stratum basale, after which, 
the cells matured and differentiated, to the outermost layer which some  
keratinisation. 
 
There were some observed differences between the in vitro full thickness 
tissues, and EpiOral full thickness tissues. The extent of keratinisation was 
slightly higher in the EpiOral tissues, and such keratinisation may serve as a 
physical barrier to damage or infection. The cellular morphology of the 
fibroblasts was very similar, as were the keratinocytes in the epithelium. 
Distinct cell morphologies were visible for both models, indicating the 
similarities in culture, despite using cells from different sources. Upon 
consultation with Dr Adam Jones (Oral Pathologist, Cardiff Dental Hospital), 
who has expertise in histopathology, it was observed that some of the MatTek 
full thickness tissue models had a dysplastic-like appearance. It is not known 
whether this was a true representation of the cells, or an artefact during culture 
of the models, or indeed during the processing of the samples prior to 
sectioning. 
 
Furthermore, this study did not evaluate the expression of cell markers such 
as those known to be expressed on keratinocytes of different stages of 
maturation and differentiation, nor did the study evaluate additional collagen 
types produced by fibroblasts in the full-thickness model. These would be 
interesting factors to evaluate in future work, but the limitations of time within 
the development and use of the models in this study were prohibitive to this 
undertaking. Expression of cell markers has previously been confirmed for the 
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in vitro full-thickness tissue model used in this study by Yadev et al (2011), as 
part of the development of the model at the University of Sheffield. 
 
3.5 Conclusions 
 
• An in vitro keratinocyte-only tissue model was developed, using TR146 
cells, and optimised to achieve tissue depth equivalent to that of the 
SkinEthic RHOE tissue model. Cellular morphology was similar 
between the two tissue models, as was tissue depth and overall 
appearance. 
 
• An in vitro full thickness tissue model was developed with normal oral 
fibroblasts and immortalised normal oral keratinocyte cells. The in vitro 
tissue model was considered superior to the MatTek EpiOral full 
thickness tissues, which were dysplastic in appearance when evaluated 
histologically. 
  
• The use of cancer-derived keratinocyte cells resulted in a non-normal 
appearance epithelium respectively, whereas a normal phenotype with 
typical maturation and differentiation characteristics were observed with 
immortalised normal cells. 
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Chapter 4 
 
Biofilm infection of oral mucosal tissue 
models and host immune responses 
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4.1 Introduction 
In vitro interactions between microorganisms, either in planktonic culture, or 
as biofilms can be evaluated in several ways, but these analyses represent 
only part of the story, particularly when studies also have clinical implication. 
In Chapter 2, the development of single- and mixed-species biofilms was 
reported, and interactions between Candida albicans and a range of oral 
bacteria associated with denture stomatitis (DS) were studied. The presence 
of bacteria within these mixed-species biofilms increased the expression of a 
range of C. albicans virulence factors, and whilst this indicates increased 
pathogenic potential as a result, the actual pathogenicity (amount of damage 
caused) by these biofilms in an infection situation is not known. 
 
To better understand the pathogenicity of mixed species biofilms in vivo, we 
need to further our basic understanding of events and interactions taking place 
in in vitro infection models. In addition to providing insight into the behaviour 
and prognosis of the infection, these models will allow better understanding of 
associated host responses. Previously simple interactions between cell 
monolayers and micro-organisms have been used to evaluate the responses 
of cells to stimuli, but more recent development of in vitro 3D tissue models 
provide an opportunity to build upon that, with more complex, but much more 
representative models of tissues and the host responses to infection. 
 
The surfaces provided by the human body for colonisation or infection by 
micro-organisms vary histologically. For example, areas such as the skin or 
palatal mucosa include keratinised epithelial cells, primarily comprised of 
keratins (McLean & Irvine, 2007), which can resist microbial invasion, effects 
of chemicals, and harsh environments (Bibel et al., 1982; McLean & Irvine, 
2007). However, non-keratinised epithelium lacks this robustness of the initial 
physical barrier for the other layers of stratified epithelial cells.  
 
A number of 3D tissue models are commercially available including those that 
represent mucosal, epidermal, and vaginal tissues, and these have been used 
in a number of published studies (Schaller, 2002; Silva et al., 2009; Williams 
et al., 2013; Cavalcanti et al., 2015). In addition to evaluating cytotoxicity of 
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chemicals or formulated products, these tissue models are a good system for 
evaluating microbial infections, particularly, in the case of this PhD, infections 
using denture-associated biofilms. The use of 3D tissue models can provide 
benefits over monolayer cell studies including being more histologically 
representative of in vivo tissues for infection studies. This is important, 
because, the 3D structure compared with monolayers results in a reduction of 
effective local concentration of the compounds due to reduced penetration of 
the compounds to the inner-most cells, reducing their efficacy (Sun et al., 
2006). This is also the case with biofilm infection studies; physical damage 
occurs initially on the outermost epithelial cells through direct-contact 
mediated pathogenicity factors, and secreted components such as hydrolytic 
enzymes. This damage then leads to lysis of the cells, allowing access to the 
next layer of cells, whereby the process repeats. Cells within tissues tend to 
have tight cell-to-cell junctions, thus permeability of solutions or secreted 
factors into the tissue is typically limited. Microbial invasion into tissues and 
secretion of compounds including hydrolytic enzymes are important virulence 
factors of many biofilms, and provide an opportunity for pathogens to cause 
substantial damage in order to obtain nutrients to continue to thrive and obtain 
nutrients critical for their survival including iron (Weinberg, 1975). 
 
Whilst pathogenicity in tissue models is of great interest, previous studies 
investigating infections of these models have typically used planktonic cells as 
the inocula, whereas, in the case of DS, the infection originates from biofilms. 
Existence of microorganisms in a biofilm is known to change the behaviour of 
the cells compared with their planktonic counterparts (O’Toole et al., 2000). It 
is likely that researchers will continue to use planktonic inocula, because of the 
ease of preparation, and more precise standardisation between experimental 
replicates, where biofilms may vary slightly more. Additionally, the design of 
previous and likely future investigations follows a similar pattern of outcomes; 
analysis of microorganism-induced cell damage and histological analyses as 
part of an infection and host response (Silva et al., 2009; Yadev et al., 2011). 
There are substantial costs involved in the use of commercially available tissue 
models in large scale infection studies, hence the development and evaluation 
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of in vitro models that may be used in place of the commercially available 
constructs. 
 
Previous in vitro studies of candidosis have relied upon the evaluation of the 
causative agent Candida alone (Yadev et al., 2011; Silva et al., 2009), but have 
not considered the contribution of other microorganisms that are also present 
in such conditions, such as the many different types of bacteria also present 
in denture biofilms. Whilst Candida species are indeed the causative agents 
of candidosis, bacteria are inevitably present and as this thesis has shown in 
Chapter 2, the presence of bacteria can influence the virulence of Candida in 
biofilms. The careful selection of bacterial species to use, along with the overall 
presence of both bacteria and Candida may influence subsequent 
pathogenicity and therefore influence mechanisms by which actions occur. 
 
Host responses to infection are the most important factors in clearing infections 
in vivo. The initial call for an immune response through production of cytokines 
and chemokines that trigger infiltration of immune cells to the site of infection, 
and the sustained proinflammatory responses by epithelial cells, fibroblasts 
and dendritic cells. Cellular recognition of microorganisms occurs by detection 
of one of several conserved molecular patterns; lipopolysaccharide (LPS) from 
the cell walls of Gram-negative bacteria, or peptidoglycan (PG) present in cell 
walls of Gram-positive bacteria (Philpott et al., 2001), and -glucans in the cell 
wall of fungi (Gow et al., 2007). These are collectively known as pathogen 
associated molecular patterns (PAMPs), and the detection of these results in 
production of an array of inflammatory cytokines, which depends on the cell 
producing them, but can include IL-8, IL-1, IL-18, IL-6 and TNF. These 
cytokines then induce leukocyte recruitment to clear the microorganisms. 
 
As discussed in Chapter 3, the different types of tissue models have different 
abilities to produce cytokines, influenced by the type of cells used; cancer-
derived cell lines, or normal cells, and determined by the type of tissue model 
used. Full thickness tissues, which comprise both epithelium and lamina 
propria, in theory could produce a full range of cytokines, and may be more 
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representative of an in vivo response as a result of cytokine-induced feedback 
mechanisms, controlling cytokine production by other cells. 
 
It was therefore necessary for this PhD project to evaluate the pathogenicity 
of denture-associated biofilm infections toward commercially available and in 
vitro tissue models; to determine the effects of biofilms with differing microbial 
composition on the biofilm induced damage and invasion into the tissues. 
Interleukin-18 is a representative proinflammatory cytokine produced by 
keratinocyte cells in response to microbial infection, and the expression of the 
gene responsible for its production was selected for evaluation in this analysis, 
as the production of the cytokine to a detectable level may not be sufficient for 
the analysis methods employed. Furthermore, monocyte cells were selected 
to represent the immune cell responses to infection, as would be the case in 
vivo. These cells were primed and challenged with LPS and heat killed C. 
albicans cells, in order to determine the responses from both a bacterial cell 
wall component, as would be the case in vivo, and whole C. albicans cells. A 
number of studies have evaluated specific proinflammatory cytokines with 
stimulation solely with LPS, including a comparison between THP-1 cells and 
whole blood or peripheral blood monocytes (Schildberger et al., 2013), and 
LPS with additional compounds (Harrison et al., 2005; Chanput et al., 2010). 
 
It is known that in order for immune cells to control fungi and any fungal-related 
infection, dectin-1 expression on the cell surface is an essential receptor for 
recognition of -glucan (Brown et al., 2003). Taylor et al., (2007) demonstrated 
that monocytes deficient in dectin-1 rendered mice susceptible to fungal 
infection, highlighting the necessity for the receptor in recognition to restrict 
infection occurring. It is known that members of the IL-12 family are involved 
in proinflammatory responses to infection (Wei et al., 2011), particularly with 
fungi, thus the production of IL-23, a monocyte-associated pro-inflammatory 
cytokine was selected for evaluation to this priming and challenge. In order to 
evaluate immune responses with a perspective of DS, where both bacterial 
cells and Candida are implicated, investigations related to both LPS 
(representative of bacteria) and heat killed C. albicans need consideration. 
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The aims of this study were to evaluate the pathogenicity of single and mixed-
species biofilms developed in Chapter 2 within in vitro 3D tissue models. 
Specifically, this research involved: 
1. Evaluating biofilm-induced tissue model infection: 
a. Determining the extent of biofilm-induced damage of 3D tissue 
models, using a lactate dehydrogenase assay to quantify relative 
damage caused by different single- and mixed-species biofilms 
formed on acrylic surfaces. 
b. Histological analysis of tissues to observe physical damage to 
the epithelial layers, and invasion of C. albicans and bacteria 
within the layers of epithelial cells. 
c. Assessment of host tissue pro-inflammatory (IL-18) responses.  
d. Assessment of C. albicans virulence gene expression. 
 
Evaluating immune cell responses as a result of stimulation with bacterial 
lipopolysaccharide (LPS) and/or heat killed C. albicans cells (HKC)
141 
 
4.2 Materials and Methods 
4.2.1 Commercially available tissue models and culture conditions 
Commercially available three-dimensional tissue models were used to 
evaluate in vitro pathogenicity of polymicrobial biofilms on acrylic surfaces. 
These tissue models were cultured by the manufacturer and transported to the 
School of Dentistry, Cardiff University for use in this study. Upon receipt, the 
tissue models were prepared as detailed below. 
 
4.2.1.1 EpiSkin SkinEthic Reconstituted Human Oral Epithelium (RHOE) 
Keratinocyte only (TR146 cells originally isolated from a squamous cell buccal 
carcinoma) based oral mucosal tissue models (EpiSkin, Lyon, France) were 
cultured in cell-culture inserts on polycarbonate membranes with 0.4 m 
diameter pores to allow free circulation of nutrients to the cells. The models 
were cultured at the air-liquid interface (ALI) for 5 d by the manufacturer prior 
to shipping. For shipping, the medium was replaced with an agar-based cell 
culture maintenance medium (of proprietary formulation) to restrict movement 
of the inserts during transport but provide nutrients to the cells. 
 
Upon receipt, the models were moved to a new well plate and 2 ml of fresh 
sterile cell culture maintenance medium devoid of the phenol-red indicator 
(proprietary formulation) added. The volume of medium added ensured the 
tissues were maintained at the ALI during this period. The tissues were 
incubated at 37C, 5% (v/v) CO2, 95% air in a humidified incubator until use 
(minimum of 4 h after receipt). 
 
4.2.1.2 MatTek EpiOral tissue model 
The EpiOral tissue models were cultured for an undisclosed period using a 
proprietary protocol at the MatTek laboratories (Ashland, MA, USA). Similar to 
the EpiSkin transportation method, the EpiOral full thickness tissue models 
were shipped in an ‘agar-like’ medium. Upon receipt, tissue models were 
carefully removed from the agar and each model placed into a new tissue plate 
well with a sterile aluminium ring to elevate the model from the base of the 
well. Five ml of fresh cell culture maintenance (phenol-red free) medium was 
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added to each well, and the models incubated at 37C, 5% (v/v) CO2, 95% air 
in a humidified incubator until use (minimum 4h after receipt). 
 
4.2.2 Tissue model preparation for biofilm infection 
Immediately prior to infection, tissue models were transferred to new well 
plates containing 1 ml of cell maintenance culture medium and returned to the 
incubator momentarily to avoid potential adverse effects of a fully aerobic 
environment. 
 
The tissue model infection was performed as depicted in Fig. 4.1. Biofilms 
(developed as described in section 2.2.4) were carefully lifted with sterile 
forceps, then inverted so the biofilm was on the underside of the coupon. The 
biofilm surface was carefully placed in contact with the tissue models. It was 
important to minimise inducing physical damage to the tissue from addition of 
the biofilm coupons, or by touching the tissue models with the forceps. The 
infected tissue models were returned to the humidified incubator (37C, 5% 
(v/v) CO2, 95% air) for 12-14h.  
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Figure 4.1 Diagrammatic representation of protocol for biofilm infection of 
tissue models 
Biofilms developed on PMMA are placed in contact with tissues and incubated 
overnight. Tissues are removed, bisected and processed (total RNA 
extraction, and histology), and supernatant collected for cell damage analysis. 
 
4.2.3 Post-infection processing of tissue models 
After 12-14 h incubation, tissue models were removed (one well plate at a time 
to reduce the atmospheric exposure during removal and processing) from the 
incubator for processing. 
 
4.2.3.1 Tissue model removal and preparation for analysis 
The PMMA coupon supporting the biofilm, was carefully removed from the 
tissue using forceps, and the membrane/tissue model was carefully cut from 
the cell culture insert with a scalpel. The tissue was bisected with a clean 
scalpel, and half was placed in a sterile pathogen lysis tube (Qiagen) 
containing glass beads (undisclosed diameter), 350 L RLT buffer (Qiagen) 
with 1% (v/v) -mercaptoethanol, 500 L of phenol:chloroform:isoamyl alcohol 
(25:24:1) and 200 L TE buffer containing lysozyme (10 mg/ml) for RNA 
extraction and purification as described in section 2.5.1. The remaining half of 
the tissue was carefully wrapped in Surgipath Bio-Wrap to maintain model 
integrity during processing, and securely placed into a pathology cassette. The 
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cassettes were immersed and stored at room temperature in neutral buffered 
formalin overnight prior to being processed for analysis by microscopy (as 
described in section 3.2.7). 
 
The used cell culture supernatant was transferred to a centrifuge tube and 
placed on ice prior to analysis of lactate dehydrogenase (LDH) activity. The 
remaining portion was stored at -20C until necessary for further analyses. 
 
4.2.3.2 Histological preparation, analysis and fluorescence in situ 
hybridisation (FISH) analysis via confocal microscopy 
Preparation and histological analysis was completed as described in sections 
3.2.5 and 3.2.6. 
 
Sections of the SkinEthic RHOE tissues were used as the preliminary tissue 
model for infection analysis, and were also stained for fluorescence 
microscopy for publication.  
 
Wax embedded tissue sections were cut at 20 m thickness and dewaxed with 
xylene, then dehydrated with 70% then 100% (v/v) ethanol. The tissues were 
rehydrated with distilled water immediately prior to processing. A 50-100 l 
volume of lysozyme (10 mg/ml) was added to each section, and incubated at 
37C for 30 min in a humidified container. After incubation, the slides were 
washed twice with PBS. A 50-100 l volume of 1 × citrate buffer (Sigma) was 
added to the sections, and the slides incubated in a humidified container at 
55C for 30 min. The sections were then washed twice with PBS. 
 
Pan cytokeratin (C11) antibody (SC8018, Santa Cruz Biotechnology, 
Heidelerg, Germany) was added at 20 g/ml, followed by an Alexa Fluor 488-
conjugated goat anti-mouse IgG secondary antibody (Life Technologies) at 
5 g/ml. The sections were protected from light and incubated at 55C for 60 
min. The sections were then washed with pre-warmed (55C) fluorescence in 
situ hybridisation (FISH) washing solution and incubated at 55C for 15 min. 
The cell nuclei were stained with Hoechst 33342 solution (Life Technologies) 
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at 1 g/ml. Additionally, Yeast Traffic Light kit (AdvanDX, Vedbaek, Denmark), 
and a universal bacterial Cy3 labelled peptide nucleic acid (PNA) probe (Bac-
Uni1CY3; 300 nM; probe sequence: CTGCCTCCCGTAGGA) specific for 
bacterial 16S rRNA (Malic et al., 2009) were mixed at a 1:1 ratio, and 30 l of 
the solution added to the sections. Finally, 20 l of Alexa-594 conjugated 
concanavalin A lectin (0.025% w/v in PBS) solution was added to the sections 
at room temperature, and the sections washed again with 200 l FISH washing 
solution. The slides were then mounted with 20 l Vectashield (H1100), and 
analysis performed by confocal microscopy 
 
Despite two targets using Alexa-594 conjugates, they were to stain different 
components. Both bacterial cells and the cell wall of C. albicans cells are 
stained and visualised using the 594 nm wavelength excitation (red). The 
distinct cellular morphology (size and shape) of the bacterial and C. albicans 
cells, along with the inclusion of a co-stain for C. albicans with the Yeast Traffic 
Light kit (green). The co-stain for C. albicans allows differentiation between 
yeast and hyphae when evaluating tissue invasion. 
 
Prior CLSM work was performed with 3D tissue models to ensure suitable 
conditions and protocol for FISH staining, and whilst no blocking solution was 
used, use of primary or secondary-antibody only resulted in no fluorescence 
staining, indicating the specificity of binding to the targets within the tissue 
model sections. 
 
4.2.3.3 Biofilm-induced tissue model damage 
Measuring LDH activity can provide an indirect quantitative measurement of 
cell damage, as the enzyme is released when cells lyse. In the case of biofilm 
infections of 3D tissue models, the released enzyme collects in the 
supernatant, which can be used in a colorimetric LDH activity assay to 
determine relative quantities. 
 
The Pierce LDH activity assay kit (Thermo Fisher Scientific) was used 
according to the manufacturer’s instructions. Briefly, the assay buffer and 
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substrate mix were combined to prepare the reaction mixture, after which 50 
l of the tissue model supernatant was added in triplicate to wells of a 96-well 
plate. A 50-l volume of the reaction mixture was then added to all of the wells 
and mixed gently. The plate was incubated at room temperature for 30 min, 
then 50 l of the stop solution was added. As the colour change of the solution 
was clear to red, the absorbance of the wells was analysed at 490 nm 
(background absorbance) and 680 nm (target absorbance) wavelengths. The 
background absorbance values were subtracted from the target absorbance 
values, and differences in colour intensity relative to the uninfected PMMA only 
infection control were calculated. 
 
4.2.4 Expression of human genes 
4.2.4.1 Nucleic acid extraction and purification 
RNA was extracted and purified, and reverse transcribed to cDNA as 
described in sections 2.5.1 and 2.5.2. 
 
4.2.4.2 Quantitative PCR 
Quantitative PCR was used to measure relative level of expression of genes 
associated with the proinflammatory cytokine IL-18, and monocyte cell 
receptors; Dectin-1, and Toll Like Receptors 2 and 4 (TLR2, TLR4) as host 
responses to infection. Keratinocytes (as used in the tissue models tested in 
this chapter) are major producers of interleukin-18; a proinflammatory 
cytokine, which can mediate subsequent T cell responses. Dectin-1 is a cell 
surface receptor for –glucans as found in the C. albicans cell wall, and 
TLR2/TLR4 are pattern recognition receptors involved in candidal cell 
clearance.  
 
Target genes are detailed in table 4.1, along with the forward and reverse 
primer sequences. 
 
Each qPCR reaction contained reagents as described in 2.2.5.3, and the 
following thermal cycling parameters: 95°C for 20 s, followed by 40 cycles of 
95°C for 1 s and 70°C for 20 s. After completion of the 40 cycles, a final melt 
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curve stage was completed at 95°C for 15 s, and from 60°C for 1 min then 
95°C for 15 s. The cycle threshold for each sample was determined 
automatically by the QuantStudio Real Time PCR software (version 1.2, 
Thermo Fisher Scientific) at the point of logarithmic amplification of the 
samples. 
 
Calculation of fold change was completed according to the Ct method 
described by Levak & Schmittgen (2001). Statistical analysis was performed 
using the Ct values, using students T-test or one-way ANOVA.. 
 
 
 
1
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Target gene Sequence (5’  3’) 
β-actin  
Housekeeping gene 
F – GAGCACAGAGCCTCGCCTTTGCCGAT 
R – ATCCTTCTGACCCATGCCCACCATCACG 
IL-18 
Interleukin 18 (pro-inflammatory cytokine) 
F – CCTTCCAGATCGCTTCCTCTCGCAACAA 
R – CAAGCTTGCCAAAGTAATCTGATTCCAGGT 
Dectin-1 
Cellular membrane receptor 
F – ACAGCAATGAGGCGCCAAGGAGGAGATG 
R – GGAGCAGAAAGAAAAGAGCTCCCAAATGCT 
Toll Like Receptor 2 
Cellular membrane receptor 
F –  GGAGCATCCGAATTGCATCACCGGTCAGA 
R – GGCCATCACACACCCCAGAAGCATCACA 
Toll Like Receptor 4 
Cellular membrane receptor 
F – GGCACTGTTCTTCTCCTGCCTGACACCA 
R – AGGGACTTTGCTGAGTTTCTGATCCATGC 
 
Table 4.1 Human gene primer sequences for qPCR analysis of tissue model infection and host cell response
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4.2.5 Monocyte cell responses to challenge with Candida 
4.2.5.1 Monocyte cell culture conditions and preparation 
THP-1 monocytes were cultured in RPMI 1640 medium (Life Technologies, 
UK), supplemented with 10% (v/v) FBS and 2 mM L-glutamine. The culture 
medium was changed every 2-3 d and cells were split when cultured to a cell 
density of no greater than 1  106 cells/ml. 
 
The cells were collected by aspirating the suspended cells into a sterile 
universal container, then subjecting them to centrifugation (Durafuge 200 
precision, Thermo Fisher Scientific) at 330  g for 5 min to pellet the cells. The 
culture medium was removed and the cells enumerated using a 
haemocytometer, and resuspended to a density of 1  106 cells/ml. 
 
4.2.5.2 Preparation of bacterial lipopolysaccharide (LPS) and heat killed 
Candida albicans (HKC) 
Bacterial LPS (isolated from Escherichia coli, Sigma) was prepared at a stock 
concentration of 1 mg/ml in PBS, and diluted in RPMI 1640 culture medium 
(supplemented with 10% (v/v) FBS, 2 mM L-glutamine) immediately prior to 
use.  
 
Candida albicans ATCC 90028 was cultured in Yeast Nitrogen Base (BD 
Difco) supplemented with 100 mM glucose (as previously described in section 
2.2.2.1). The cells were centrifuged at 2879  g (Thermo IEC CL10, Thermo 
Fisher Scientific) for 5 min to pellet and washed in PBS, then resuspended in 
PBS at a density of 1  109 CFU/ml. The suspended cells were heated in a 
water bath at 95C for 10 min. Heat killing efficacy was assessed by adding 
100 μl of the suspended cells to a Sabouraud Dextrose Agar plate in triplicate 
and incubating for 48 h. The heat killed Candida (HKC) cells were then 
retained at 4C for short term storage, or -20C for longer term storage. 
 
4.2.5.3 Monocyte priming and challenge with Candida 
THP-1 monocyte cells were seeded at a density of 2  105 cells/ml in 6-well 
plates. LPS was added to each of the wells at the necessary concentration, 
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and the plates were incubated overnight (37C, 5% (v/v) CO2). Dilutions of 
HKC were prepared at various densities (ranging from 1  105 to 1  108 
cells/ml), and 100 μl of each concentration was added to the respective wells 
(1  104 to 1  107 cells/ml final density of HKC). 
 
The plates were incubated for 24 h, after which the cells were suspended by 
repeat pipetting, and the suspension transferred to a 1.5 ml microcentrifuge 
tube. The tubes were centrifuged (Durafuge 200 precision) at 330  g for 5 min 
to pellet the cells, after which, the supernatant was aspirated and transferred 
to a new microcentrifuge tube for cytokine analysis. The cells were 
resuspended in 1 ml PBS and stored at -20C for flow cytometry. 
 
4.2.5.4 Interleukin-23 cytokine ELISA 
IL-23 cytokine quantification was performed using a sandwich enzyme linked 
immunosorbent assay (ELISA), with the Human IL-23 Ready-SET-Go kit 
(eBioscience, Thermo Fisher Scientific), according to the manufacturer’s 
instructions. All reagents were provided (except those stated) in the assay kit 
and diluted to a 1 concentration when initially provided in a concentrated 
form. 
 
Each well of a 96-well plate was coated with 100 μl of capture antibody (pre 
standardised by the manufacturer but of undisclosed concentration, prepared 
in diluted coating buffer), and mixed on a shaking plate for 30 s to ensure 
homogeneous coating of the base of the wells. The plate was sealed with an 
adhesive seal, and incubated at 4C overnight to ensure optimal coating of the 
antibody to the well.  
 
After incubation, the antibody solution was removed and the wells washed (5) 
with Wash Buffer (0.05% tween 20 in PBS). The plate was then washed (5) 
with wash buffer, and 200 μl Assay Diluent added to all of the wells for 2 h at 
37C to block remaining non-specific binding sites. The protein standard was 
prepared in Assay Diluent at a concentration of 1 ng/ml, and added to the wells 
in triplicate. Two-fold dilutions of the protein standard in triplicate were 
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performed to a final concentration of 15.625 pg/ml. Triplicate wells containing 
Assay Diluent-only (to establish baseline absorbance) were included. Samples 
were added to wells in triplicate (100 μl volume) and the plate incubated 
overnight at 4C to allow binding of any target protein to the capture antibody.  
 
The plate was washed (5) with Wash Buffer and biotin-conjugated detection 
antibody was then added. The plate was incubated at room temperature for 2 
h and then washed (5) with Wash Buffer. Fifty μl of diluted HRP-conjugated 
StreptAvidin (1:1000 dilution) was added to each well, and the plate incubated 
for 1.5 h at 37C, after which it was washed (6) with Wash Buffer. Fifty μl of 
tetramethylbenzidine (TMB) solution was added to each well and the plate was 
stored for 15-30 min at room temperature in the dark to allow colour 
development. The reaction was stopped with 50 μl Stop Solution (0.16M 
sulphuric acid) and the absorbance (at 450 nm wavelength) of the wells 
determined. 
 
4.2.6 Flow cytometry for monocyte Dectin-1 cell surface receptors 
Collected monocyte cells (all cells from each well independently) were 
resuspended in 50 μl of ice cold flow cytometry buffer (5% (v/v) FBS, 0.05% 
(w/v) sodium azide in PBS), and 1 μl of anti-human PE conjugated Dectin-1 
antibody (20 μg/ml), then the solution incubated on ice for 30 min. The cells 
were pelleted by centrifugation (Durafuge 200 precision) at 330  g for 5 min 
and washed (3) with wash buffer (0.05% (w/v) sodium azide in PBS). The 
cells were finally resuspended in 200 μl flow cytometry buffer (2% (v/v) FBS, 
0.05% (w/v) sodium azide in PBS) for flow cytometry. 
 
Samples were analysed in a BD FACSCanto II (BD Biosciences, Oxford, UK) 
flow cytometer using the following parameters: FSC voltage, 250V; SSC 
voltage, 435V; PE voltage, 250V, with medium flow rate, and counting a 
minimum of 10,000 events.
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4.3 Results  
4.3.1 Effect of bacteria in mixed-species biofilms on subsequent 
pathogenicity and tissue damage in tissue model infections 
Using tissue models constructed solely with keratinocytes, the effect of 
infecting with biofilms on acrylic surfaces was assessed. The biofilms analysed 
included C. albicans-only biofilms, oral bacteria-only biofilms and C. albicans 
plus oral bacteria species biofilms (mixed-species). Controls of sterile 
uninfected PMMA acrylic coupons were included with all experiments. Analysis 
of tissue infections and pathogen responses include measurement of lactate 
dehydrogenase (LDH) activity, expression of genes for human IL-18 and 
dectin-1, and C. albicans virulence genes (as previously analysed in in vitro 
biofilms in section 2.3.3.3), and histological examination of the infected tissue. 
 
4.3.2 Epithelial tissue model infection 
Epithelium- only tissue infections were evaluated using two 3D tissue models. 
These tissues were a SkinEthic Reconstituted Human Oral Epithelium 
(RHOE; EpiSkin, Lyon, France), and an in vitro keratinocyte-only tissue model 
which has previously been described (section 3.3.2). 
 
4.3.2.1 Infection of SkinEthic Reconstituted Human Oral Epithelium 
LDH activity to measure cell damage was expressed as fold-change relative 
to tissues overlaid with acrylic coupons devoid of biofilms. Infection of the 
RHOE (Figure 4.1A) with bacteria-only biofilms resulted in a small, increase in 
tissue damage which was however not significantly different to the control. 
However, a significant (P<0.05) increase in tissue damage was observed with 
C. albicans-only biofilms, and a further significant (P<0.01) enhancement in 
tissue damage occurred using mixed-species biofilms. 
 
Host inflammatory responses (Figure 4.2B) to infection were evaluated by 
expression of the IL18 gene relative to the response of tissues to uninfected 
acrylic coupons. A slight increase in expression of the IL18 gene was observed 
in tissues previously infected by bacteria-only biofilms. A further increase in 
the expression of the IL18 gene was found with tissues infected by C. albicans-
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only biofilms. These increases were however determined not to be significantly 
increased compared to controls, whereas in the case of tissues infected with 
mixed-species biofilms, a significant (P<0.01) increase in expression of the 
IL18 gene was evident compared with controls. 
 
Histological analysis was used to assess structural damage to the epithelium 
and the location of microorganisms during the infection. Fig. 4.3 shows a post-
infection cross-sectional representation of each of the biofilm infections by 
confocal microscopy.  
 
Fig. 4.3A shows a tissue that had been overlaid with an acrylic coupon devoid 
of a biofilm where, for this tissue, good cellular structure that was typical of 
TR146 cells was evident with no observable damage to the cells.  
 
Fig. 4.3B shows tissue previously overlaid with an acrylic coupon supporting a 
bacteria-only biofilm. For this tissue, a bacterial biofilm was evident on the 
surface of the epithelium with the bacteria seen as clustered aggregates. 
Some damage to the tissue was evident, as seen by lesions in the epithelium, 
and there was atypical morphology of the cells.  
 
Similarly, Fig. 4.3C shows a tissue previously overlaid with an acrylic coupon 
supporting a C. albicans-only biofilm. For this tissue, the biofilm could be 
detected on the surface of the epithelium, although little visible damage was 
evident. Interestingly, the C. albicans were primarily in the yeast form.  
 
Mixed-species biofilm infection of tissues (Fig. 4.3D) illustrate the substantial 
differences between the biofilms during infection. Extensive biofilm invasion of 
all layers of the epithelium was observed and significant tissue damage was 
evident, although in this representative image, it did visually appear somewhat 
less than bacteria-only (Fig 4.3B). Furthermore, C. albicans hyphae were 
clearly seen to invade through to the lower layers of the epithelium, and this 
was seemingly both between and penetrating through cells. The bacterial cells 
within the biofilm appeared to adhere to the hyphae, and therefore were also 
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found within the epithelium itself. Lesions occurred in the tissue and an atypical 
morphology of the keratinocyte cells was also apparent. 
 
 
1
5
5
 
 
    
Figure 4.2. Acrylic biofilm-induced damage of SkinEthic RHOE tissue models as measured by lactate dehydrogenase (LDH) 
activity and IL-18 gene expression. 
A) Fold change of biofilm-induced cell damage measured by LDH in collected supernatant post-infection relative to a 
normalised uninfected acrylic-only control. A significant increase in cell damage was caused by C. albicans-only biofilm, and 
this was further increased in tissues infected with mixed-species biofilms. B) Host pro-inflammatory interleukin-18 (IL-18) 
cytokine gene expression as a result of infection. Mixed-species biofilms led to a significantly increase expression of the IL-
18 gene. Data expressed as mean of 6 replicate experiments. Error bars represent standard deviation. *P<0.05, **P<0.01. 
Representative melt curves are provided in Appendix 1.
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Figure 4.3 Fluorescence in situ hybridisation images of sections taken from 
3D tissue models post-biofilm infection. 
Fluorescently stained tissue model sections of A) uninfected acrylic only, 
B) oral bacterial biofilm infection, C) C. albicans-only biofilm infection and 
D) mixed-species biofilm post-infection. 
Epithelial cells were stained with Hoechst 33342 dye (nuclei, blue) and a 
fluorescently labelled pan-cytokeratin antibody (cytoplasm, green). Bacteria 
were stained with a universal-bacterial peptide nucleic acid (PNA) probe (red), 
and C. albicans was stained using a Yeast Traffic Light PNA probe (AdvanDX, 
bright green). Light arrows indicate bacteria, bold arrows indicate invading C. 
albicans hyphae.Scale bar represents 20 m. 
 
4.3.2.2 Infection of in vitro keratinocyte models 
A similar pattern of tissue damage (LDH release) to that of the RHOE was 
observed when biofilm infection was assessed in the ‘in-house’ developed in 
vitro keratinocyte model (Fig. 4.4A). Compared with the uninfected acrylic 
coupons, only a very slight increase in biofilm-induced tissue damage was 
observed with bacteria-only biofilms, although a significant (P<0.01) increase 
was apparent using C. albicans-only biofilms and this was further enhanced 
(P<0.001) when tissues were infected with mixed-species biofilms. It was also 
observed that the relative extent of damage for the in vitro epithelial tissue 
models was lower than previously encountered for the commercial epithelial 
tissue models, but this may be due the quantity of tissue present rather than 
the relative effect of the biofilms on the respective tissues. 
 
The induction of an inflammatory response (IL18 gene expression) of the in 
vitro keratinocyte-only tissues followed a very similar pattern to the SkinEthic 
RHOE tissues (Fig 4.4B). 
 
Light microscopy images demonstrated a similar visual progression of the 
infection as previously observed with the SkinEthic RHOE tissue infections 
(Fig. 4.5); an intact epithelium when using PMMA coupons only with no 
infection (Fig. 4.5A), some visible damage with bacteria-only biofilms 
(Fig. 4.5B), and similar with C. albicans biofilms (Fig. 4.4C), but C. albicans 
remain on the outer surface, whereas substantial tissue damage was observed 
with mixed-species biofilms (Fig. 4.5D).
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Figure 4.4 Acrylic biofilm-induced damage of in vitro keratinocyte-only tissue models as measured by lactate dehydrogenase (LDH) 
activity, and IL18 gene expression. 
A) Fold change of biofilm-induced cell damage measured by lactate dehydrogenase (LDH) in collected supernatant post-infection 
relative to a normalised uninfected acrylic-only control. Slight increase in damage caused by C. albicans-only biofilms, and significant 
increase in cell damage caused by mixed-species biofilms B) Host pro-inflammatory interleukin-18 (IL18) cytokine gene expression 
as a result of infection. Mixed-species biofilms induce significant increase of IL18 gene expression. Data expressed as mean of 6 
replicates. Error bars represent standard deviation. *P<0.05, **P<0.01 
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Figure 4.5 Light microscopy images of histological sections of in vitro 
keratinocyte-only tissue infections with different biofilms 
A) uninfected acrylic only, B) oral bacterial biofilm infection, C) C. albicans-
only biofilm infection and D) mixed-species biofilm infection. 
Stained with periodic acid Schiff. Scale bar represents 50m 
 
4.3.3 Full-thickness tissue model infections 
Biofilm infections of full-thickness tissue models included a commercially 
available full-thickness oral mucosal tissue model (EpiOral), purchased from 
MatTek Corporation, and a full-thickness tissue model cultured at Cardiff 
University as described in section 3.3.5. 
 
4.3.3.1 Infection of MatTek full-thickness tissue models 
Biofilm infection of commercial full-thickness (FT) tissues (MatTek) (EpiOral, 
MatTek Corporation) resulted in a similar pattern of damage (Fig. 4.6A) as 
observed with the previously described keratinocyte-only tissue models, but 
not to the same extent. This was despite significant histological differences 
between the two model types and the cells used to develop them. The MatTek 
tissues comprised a lamina propria, as well as layered epithelial cells 
(Fig. 4.7A).. 
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Tissue damage was measured by LDH activity assay (Fig. 4.6A), and the 
extent of damage caused specifically by biofilm infections were expressed as 
fold change relative to the uninfected acrylic coupons. When compared with 
tissues overlaid with uninfected acrylic coupons, tissue damage was observed 
with C. albicans-only and mixed-species biofilms. There was, however, no 
difference in LDH activity caused by uninfected control coupons and bacteria-
only biofilms. However, despite evident increases in damage, none of the 
differences were statistically significant. 
 
The observed differences in biofilm-induced MatTek tissue damage (Fig. 4.6A) 
were not obvious histologically (Fig. 4.7). The morphology of the cells after the 
12h duration of biofilm infection (Figs. 4.7B, 4.7C, 4.7D) were similar to that of 
tissues exposed to uninfected control acrylics (Fig. 4.7A). Histology revealed 
keratinised epithelial layers with normal cell morphology and anticipated 
stratification with few indications of substantial epithelial damage caused by 
the biofilms. Additionally, biofilms were evident on the tissue surface after 
overlaying with C. albicans-only and bacteria-only biofilms, and, in the case of 
mixed-species biofilms, areas of invasion into the tissue were evident 
(Fig. 4.7D), but not to the same extent as seen in the mixed-species biofilm 
infection of SkinEthic RHOE tissues (Fig. 4.3D. 
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Figure 4.6 Biofilm-induced tissue damage as measured by lactate dehydrogenase (LDH) activity assay 
A) Relative to an uninfected acrylic control, biofilm infections of MatTek EpiOral tissues resulted in slight increases in damage 
caused by mixed-species biofilms, and a greater increase caused by C. albicans-only biofilms, but no increase in damage by 
bacteria only biofilms. However, no observed increase was significant. B) Biofilm infections of In vitro full-thickness tissues 
resulted in a significant increase in damage caused by C. albicans-only biofilms, and a similar increase again by mixed-
species biofilms, however as observed with MatTek tissue infections, no difference in damage caused by bacteria-only 
biofilms was observed. Data expressed as mean of 9 replicates, error bars represent standard deviation. *P<0.05, **P<0.01
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Figure 4. 7 Histological sections of biofilm-infected MatTek EpiOral tissues 
Typical light microscopy images of histological sections of A) Uninfected 
acrylic coupons, B) bacteria-only biofilms, C) C. albicans-only biofilms and 
D) mixed-species biofilms, and E) mixed-species biofilms showing hyphal 
invasion.  
Sections stained with haematoxylin and eosin. Arrows indicate biofilms. Scale 
bar represents 50m
E 
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4.3.3.2 Infection of in vitro full-thickness (FT) tissue models 
Biofilm-induced tissue damage of in vitro full thickness tissues, as measured 
by LDH activity (Fig. 4.6B), followed the same pattern as previously observed 
(section 4.3.3.1); a significant (P<0.05) increase in tissue damage was caused 
by C. albicans-only biofilms, and this was further significantly (P<0.01) 
enhanced in tissue infections by mixed-species biofilms relative to the 
uninfected acrylic coupon controls. The overall levels of tissue damage were 
smaller than that previously observed with infection of either keratinocyte-only 
or MatTek tissues. 
 
Despite the smaller differences observed by LDH, substantial damage was 
observed visually by histological analysis of the tissues (Fig. 4.8). The tissues 
exposed to uninfected acrylic coupons did not show any signs of damage 
(Fig. 4.8A); no disruption to the keratinised epithelium, nor any clear signs of 
damage to the cells deeper within the epithelium. Bacteria-only biofilm infected 
tissues (Fig. 4.8B) showed some extent of cell damage to the keratinised outer 
layer, with evidence of biofilms existing on the outer surface. A large extent of 
damage was evident in C. albicans-only biofilms (Fig. 4.8C), with some 
invasion within the layers of the epithelial section, and considerable destruction 
of the epithelial cells. It is also evident that the C. albicans cells were primarily 
in the yeast form, as previously observed. Furthermore, tissue infection with 
the mixed-species biofilms resulted in extensive destruction of the epithelium, 
and a large extent of invasion of the microorganisms into the tissue. 
Interestingly however, no infection of commercial or in vitro tissue models 
showed any damage to the lamina propria layer. It is not known whether the 
viability of these cells was affected by the production of hydrolytic enzymes, 
but there appeared to be maintained structural integrity and normal cellular 
morphology. 
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Figure 4.8 Histological sections of biofilm-infected in vitro full-thickness tissues 
stained with haematoxylin and eosin 
Typical replicated (left and right) light microscopy images of histological 
sections of A) Uninfected acrylic coupons, B) bacteria-only biofilms, C) 
C. albicans-only biofilms and D) mixed-species biofilms, stained with 
haematoxylin and eosin. Arrows indicate biofilms. Scale bar represents 50m 
A 
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Infected tissue model type Mean LDH absorbance raw values (blank adjusted 490nm wavelength) ( SD) 
Uninfected acrylic Bacteria-only C. albicans-only Mixed-species 
SkinEthic RHOE 0.218 (0.040) 0.339 (0.087) 0.488 (0.149) 0.832 (0.179) 
In vitro keratinocyte only 0.233 (0.032) 0.222 (0.014) 0.269 (0.015) 0.444 (0.034) 
MatTek EpiOral FT 0.295 (0.004) 0.305 (0.006) 0.338 (0.011) 0.386 (0.017) 
In vitro full thickness 0.430 (0.013) 0.448 (0.035) 0.476 (0.029) 0.485 (0.014) 
Table 4.2 Raw absorbance values for tissue model post-biofilm infection lactate dehydrogenase assay  
Raw data (mean of 6-9 replicates) of adjusted absorbance values (490 nm wavelength) for each infection type with each tissue model 
type. Data shown as mean of test conditions minus negative/blank samples (culture medium only). SD=standard deviation.
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4.3.4 C. albicans virulence gene expression during tissue model 
infection 
Figures 4.9 and 4.10 detail the expression of a range of C. albicans virulence 
genes across the infected tissue models, expressed as a fold change in gene 
expression of mixed-species biofilm infections relative to a C. albicans-only 
control.  
 
An increase was observed in the expression of ALS3, EPA1, SAP4, SAP6 and 
PLD1, although no increase in the expression of HWP1 was evident. The 
expression of HWP1 has previously shown to be upregulated in mixed-species 
biofilms (Chapter 2), and despite there being no upregulation shown here, it is 
considered that the expression was not consistently up regulated once hyphae 
formation ceased, e.g. in the case where sufficient hyphae are formed within 
the environmental conditions. Results in Chapter 2 and in Fig. 4.8 show 
substantial hyphae within the biofilms and infected tissues. There was 
consistency in the extent of gene expression between the infections of different 
tissue models, and the expression profile was also similar to that observed in 
in vitro biofilms (section 2.3.3.3), but interestingly, the increase in relative 
expression of the epithelial adhesin EPA1 was considerably greater in this 
study than was observed in in vitro biofilms. 
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Figure 4.9 C. albicans virulence gene expression of mixed-species biofilm infections of tissue models.  
Candidal adhesin (ALS1, ALS3, EPA1) genes, hyphal wall protein (HWP1) gene, phospholipase D (PLD1) gene and secreted 
aspartyl proteinase (SAP4, SAP6) genes. Gene expression relative to C. albicans-only infection control  
Data expressed as mean of 6 replicate experiments; error bars represent SD. Analysis performed by Ct method. Orange 
dashed line represents normalised C. albicans-only biofilm infection control.
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Figure 4.10 C. albicans virulence gene expression of mixed-species biofilm infections of tissue models.  
Candidal adhesin (ALS1, ALS3, EPA1) genes, hyphal wall protein (HWP1) gene, phospholipase D (PLD1) gene and secreted 
aspartyl proteinase (SAP4, SAP6) genes. Gene expression relative to C. albicans-only infection control  
Data expressed as mean of 6 replicate experiments; error bars represent SD. Analysis performed by Ct method. Orange 
dashed line represents normalised C. albicans-only biofilm infection control. 
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4.3.5 Immune cell responses to bacterial LPS and C. albicans 
THP-1 monocyte cells were used to evaluate host immune responses to 
bacterial lipopolysaccharide (LPS), Short-term (0-24h) monocyte cell 
responses in the form of expression of the genes responsible for the two 
subunits of the interleukin-23 cytokine; IL12p40 and IL23p19, and dectin-1, 
and sustained responses (>24h) by measurement of released IL-23 protein in 
the culture supernatant were evaluated 
 
4.3.5.1 THP-1 monocyte cell gene expression when stimulated with LPS 
Previous work by our group has shown that secretion of the IL-12 family of 
cytokines is up regulated during monocyte challenge, therefore IL-23 was 
selected as a representative proinflammatory cytokine within this family. The 
expression of genes responsible for the production of the two IL-23 subunits 
(IL12p40 and IL23p19) when stimulated with 100 ng/ml LPS (Fig. 4.11) 
showed some increases after 24h stimulation relative to the unstimulated 
control cells for both subunits, but these were not statistically significant.  
 
LPS stimulation of THP-1 cells resulted in an immediate decrease in dectin-1 
gene expression (Fig. 4.12) relative to unstimulated cells immediately after 
LPS stimulation and at 4h, whereas following continued stimulation at 24h, a 
significant (P<0.05) increase was then observed. There was some variation in 
the gene expression of samples at 2h, and although it showed a trend toward 
a repression of expression, the difference was not statistically significan.  
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Figure 4.11 Gene expression of monocyte cells in response to stimulation with 
lipopolysaccharide (LPS) 
Expression of the genes coding for the two subunits of IL-23 (IL23p19 and 
IL12p40) significantly increased over 24h when stimulated with 100 ng/ml LPS 
 
 
Figure 4.12 Monocyte cell expression of dectin-1 gene in response to 
lipopolysaccharide (LPS) stimulation 
Expression of the dectin-1 gene decreased immediately after stimulation, but 
then increased over time, and showed a significant increase at 24 h compared 
with 0h cells. *P<0.05 
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Furthermore, flow cytometry analysis to determine the quantity of dectin-1 
surface receptor positive cells resulted in no observed differences between the 
number of unstimulated and LPS-stimulated cells showing no detection of 
dectin-1 on the cell surface, irrespective of LPS concentration (Fig. 4.13). 
 
 
Figure 4.13 Flow cytometry of THP-1 monocyte cells staining for dectin-1 
surface receptor expression 
THP-1 monocyte cells were analysed for expression of the C. albicans surface 
receptor dectin-1. Flow cytometry analysis showed no differences in the 
intensity of fluorescence, and thus the quantity of cells showing expression of 
the receptor between unstimulated and LPS-stimulated cells, irrespective of 
the overnight (12-14h) LPS stimulation concentration. 
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The genes responsible for toll like receptors 2 and 4 (TLR2, TLR4) showed 
little change of expression in LPS stimulated cells over the 24h stimulation 
period (Fig. 4.14). A slight, but not significant, increase in expression was 
evident at 24h stimulation for TLR4, but the overall relative expression returned 
to a similar level as unstimulated cells thereafter.  
 
4.3.5.2 IL-23 production when stimulated with LPS and heat killed C. 
albicans 
The production of IL-23 in response to LPS followed a dose dependent pattern. 
Figure 4.15 demonstrates the responses of monocyte cells to stimulation with 
LPS and HKC. No IL-23 was detected in unstimulated cells, but in the 
presence of heat killed C. albicans (HKC), a low level was detected (6.31 pg/ml 
 0.82). When the cells were stimulated with 10 ng/ml LPS, a significant 
(P<0.001) increase in the production of IL-23 was observed (124.98 pg/ml  
3.13), and increasing the concentration of LPS to 100 ng/ml resulted in a five-
fold increase of the detected IL-23 in the supernatant (689.98 pg/ml  3.09) 
which was also statistically significant (P<0.001). 
 
Co-stimulation of the monocyte cells with 10 ng/ml LPS and HKC resulted in 
slight fluctuations in the level of detected IL-23 similar to that of the cells 
stimulated with LPS alone, but no clear pattern with increasing numbers of 
HKC. However, co-stimulation of cells with 100 ng/ml LPS and HKC resulted 
in an increase with increasing numbers of HKC, and statistical significance 
(P<0.001) when comparing 100 ng/ml LPS alone, and LPS with 107 HKC cells. 
The biological significance is likely to be limited, as the increase between 10 
and 100 ng/ml LPS is far more substantial, whereas the difference of 100 pg/ml 
of IL-23 is likely to have less of an effect. 
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Figure 4.14 Expression of toll like receptors 2 and 4 (TLR2, TLR4) genes by monocyte cells in response to lipopolysaccharide 
(LPS) stimulation. 
A) Toll-like receptor 2 gene expression of LPS stimulated cells remained constant relative to an unstimulated control for the 
24h period with no significant differences over time. B) Toll-like receptor 4 gene expression remained constant up to 4h, but 
then showed an increase after 24h. 
Data expressed as mean of 4 replicates, error bars represent standard deviation. 
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Figure 4.15 Interleukin-23 (IL-23) cytokine release as a result of stimulation of monocyte cells, protein quantification measured 
by enzyme linked immunosorbent assay (ELISA).  
Release of IL-23 cytokine increased in a dose dependent manner with stimulation using LPS, relative to the basal level 
expression of IL-23 cytokine in unstimulated cells. Stimulation with the higher LPS concentration resulted in a further small 
increase with increasing numbers of heat killed C. albicans (HKC). 
Data expressed as mean of 3 replicates, error bars represent standard deviation. ***P<0.001 
*** 
*** 
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4.4 Discussion 
The use of in vitro biofilms is essential to investigate microbial behaviour and 
interactions, the findings of which can provide many benefits to our basic 
understanding. The results obtained in Chapter 2 demonstrated that mixed-
species biofilms including C. albicans and several oral bacterial species can 
enhance the in vitro virulence of C. albicans, as suggested by an increase in 
the proportion of hyphae and an increase in the expression of a number of 
virulence genes. As denture stomatitis (DS) arises as a result of polymicrobial 
biofilms on the denture-fitting surface in contact with the palatal mucosa, it was 
necessary to evaluate these in vitro biofilms during infection of tissues, to 
ascertain whether the observed effects during in vitro biofilm interactions, and 
the upregulation of a range of virulence factors translates to a more destructive 
and more inflammatory infection. Experiments using monolayers of cells would 
have been useful, but not as clinically representative as a 3D tissue model, 
that more closely represents the oral mucosa. 
 
There are a number of tissue models commercially available that could be 
used for such infection analyses, and have been used extensively by others 
(Schaller, 2002; Samaranayake et al., 2006; Silva et al., 2009; Silva et al., 
2011; Williams et al., 2013; Yadev et al., 2011) for the investigation of many 
infections including candidosis. The work in this chapter evaluated infections 
of 3D tissue models using the in vitro biofilms developed in Chapter 2, and 
certain associated host responses. 
 
The infection of tissue models using biofilms developed in vitro the most 
simplistic representation of the oral mucosa; SkinEthic RHOE showed an 
interesting pattern of results. Relative to the tissues infected with acrylic 
coupons only (no biofilm), slight tissue damage was induced with bacteria-only 
biofilms, a further increase in damage, which was statistically significant, 
caused by C. albicans-only biofilms, and a further increase in damage, which 
was also statistically significant caused by mixed-species biofilms. This pattern 
of biofilm-related pathogenesis correlated with the expression of C. albicans 
virulence factors in in vitro biofilm analyses (Chapter 2). The strong correlation 
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between virulence and pathogenicity was highlighted by microscopic analysis 
of histological sections of the infected tissues, where the uninfected tissue 
model showed no signs of damage, but each of the infections showed some 
damage, the extent of which is determined by the biofilm used. 
 
Both C. albicans-only and bacteria-only biofilm infections induced some 
damage, and this was evident in the tissue model sections, but the residual 
biofilms after removal of the acrylic coupon were clustered on the surface of 
the tissues. The mixed-species biofilms showed substantial damage and 
extensive invasion through the epithelium. The increase in C. albicans hyphae 
observed in in vitro biofilm studies, was also evident in the tissue infections, 
where the hyphae appear to be responsible for penetration through the cells. 
It was interesting, however, that there was no upregulation of the HWP1 gene 
when evaluating the C. albicans virulence genes used throughout this PhD. 
Hyphae were evident in all mixed-species infections, which correlated with the 
upregulation of genes involved with hyphae formation, but HWP1 was not 
upregulated during these infections. It is known that a number of genes are 
collectively involved with the regulation of hyphal formation, including ALS3, 
HWP1 and HYR1 (Bailey et al., 1996), EFG1 (Sohn et al., 2003), the 
transcriptional regulator UME6 (Banerjee et al., 2008), UME6 and HGC1 
(Zheng et al., 2004; Lu et al., 2015). The expression of HWP1 is not exclusively 
responsible for the development of hyphae (Sundstrom, 2006), and therefore, 
although the expression was not elevated at the time of sampling in this study, 
and the presence of hyphae was clearly demonstrated in microscopy images, 
the relative level of expression may have been influenced by other factors in 
this case. The aim of this study was to compare relative levels of expression 
of virulence genes between infections of commercial and in vitro tissue models 
of the same type, and there were no significant differences observed with this 
perspective. Relative abundance of gene expression is important to consider 
when interpreting qPCR data. Small fold changes in genes with low relative 
abundance can lead to more substantial phenotypic changes than small 
changes in genes that are typically highly expressed. The Ct values between 
qPCR runs can vary due to the differences in starting RNA concentration, but 
relative values are the same as RNA concentration is standardised within each 
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reverse transcription. With respect to gene expression of mixed-species biofilm 
infection of SkinEthic RHOE tissues, EPA1 (Ct=28.739  0.343) and HWP1 
(Ct=28.738  0.540) mean Ct were very similar to that of the housekeeping 
gene ACT1 (Ct=28.907  0.658). Other virulence genes including ALS3 
(Ct=24.055  0.255), and PLD1 (Ct=26.157  0.413) had Ct values much lower 
than ACT1, whereas SAP6 (Ct=23.535  0.263) was substantially lower again 
indicating an increase in abundance of the gene relative to the ACT1 gene. 
The abundance of the SAP4 gene, however, (Ct=30.274  0.413) was higher 
than ACT1 indicating the expression was not what would be considered high 
in relative abundance. 
 
Adhesion of bacteria to C. albicans hyphae, which has been reported 
previously (Bamford et al., 2014; Silverman et al., 2010) was evident in in vitro 
biofilms, and is also evident in the tissue models. In the tissue models, the 
bacteria appear to be invading the tissue along with the C. albicans hyphae, in 
close proximity, suggesting they remain adhered through the invasion process. 
It is not known which of the bacterial species are adhered, but the sustained 
adherence could be continually inducing contact-dependent responses and a 
possible increase in C. albicans virulence. This increased virulence may be 
similar to that observed in Chapter 2, an increase in hydrolytic enzymes, and 
responsible for the observed tissue damage, or it may be a cooperative effort 
between bacteria and C. albicans and their respective secreted factors 
 
This pattern of biofilm-infection related tissue damage was also evident when 
using an in vitro keratinocyte-only tissue model, where an increase in damage 
caused by bacteria-only and C. albicans-only biofilms, but a further increase 
in mixed-species biofilms was observed. The correlation between the in vitro 
keratinocyte-only tissue model, and the SkinEthic RHOE, show strong 
similarities between the tissue models in their behaviour during biofilm 
infection. This was further confirmed with evaluation of the expression of the 
gene responsible for the pro-inflammatory cytokine IL-18, known to be 
produced by keratinocytes (Dinarello, 1999). In the case of both SkinEthic 
RHOE, and the in vitro keratinocyte tissues, infection with mixed-species 
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biofilms stimulated an increase in gene expression of the IL18 gene, more so 
than was observed with C. albicans-only or bacteria-only biofilms. 
Full thickness mucosal tissue models included both the epithelium and lamina 
propria. Not only is the physical structure more representative of human oral 
mucosa in vivo, which is more complex than just an epithelium, both the 
EpiOral FT and in vitro full-thickness tissues were cultured using normal 
human cells, that lack the limitations of cancer-derived cells as used in the 
epithelial model. However, despite the improvement of the epithelium-only 
models, these models still do not take into account many other factors present 
in vivo. Langerhans or other immune-associated cells, nerves, endothelial 
cells all contribute to the structure and normal function of mucosa, but are 
absent in these tissue models. Subsequent infection responses, while still of 
academic interest, may not necessarily be entirely representative of an in vivo 
response. 
 
This study evaluated MatTek EpiOral full thickness tissue models, as a 
representative commercially available full thickness tissue model. Additionally, 
an in vitro full thickness tissue model, established in the School of Clinical 
Dentistry, University of Sheffield was adopted for use in biofilm infection 
studies at Cardiff University through collaboration with Dr Craig Murdoch. The 
same biofilm model was used for the full thickness infections as with 
keratinocyte-only tissues, and the results follow a remarkably similar pattern. 
The C. albicans-only and bacteria-only biofilms resulted in some tissue 
damage as evidenced by LDH release, but an increase in damage caused by 
mixed-species biofilms was evident when compared to these. The 
characteristic profile of tissue damage was consistent across all tissue models, 
with invasion only occurring in mixed-species biofilm infections, indicating the 
increased C. albicans virulence did indeed directly lead to increased 
pathogenicity, irrespective of the infection model used. Similarly, this indicates 
good comparability between all the tissue models used in this study, within the 
scope of the analyses completed.  
 
Histological sections of the biofilm-infected full thickness tissues also followed 
a similar pattern of epithelial damage when analysed by microscopy, but there 
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was some variation between the in vitro and MatTek EpiOral full thickness 
models. There was significantly more visible damage to the tissues in the in 
vitro full thickness tissues than was observed with the MatTek tissues. The 
MatTek tissues had been transported for 3 d prior to receipt, which can 
adversely affect the integrity and viability of the cells within the tissues. MatTek 
recommend using the tissues immediately, although they suggest tissue 
viability up to 5 days after shipping, but there is a substantial risk of 
cornification of the tissues (Eckhart et al., 2013), increasing with time. This is 
one possibility for this batch of tissues, as there was less visible damage, and 
less microbial penetration in the mixed-species biofilms than observed in the 
in vitro full thickness tissues, despite there being no initially obvious signs of 
cornification. 
 
The development of the tissue models, as discussed in Chapter 3, was 
primarily to overcome the substantial financial costs involved with the use of 
the commercially available models, to allow a higher throughput of infection 
analyses. There were similarities between the models in terms of physical 
structure, progression of infection and associated host responses, but the in 
vitro model appeared more normal in its appearance, where the MatTek 
EpiOral model had more of a dysplastic appearance.. 
 
Microbial penetration and subsequent invasion into tissue models has also 
been observed by other groups investigating candidosis. Samaranayake et al 
(2006) showed that C. albicans can induce damage of SkinEthic RHOE 
tissues, but very little invasion into the tissues was observed in this study, 
which was also observed in a similar study but using an alternative strain; 
C. parapsilosis completed by Silva et al., (2009). Yadev et al. (2010) also 
evaluated RHOE, and MatTek and in vitro full thickness tissue models, but not 
with biofilms as the inoculum. This study found that the hyphae of C. albicans 
SC5314 (which forms hyphae more readily than ATCC 90028, which was used 
throughout this project) could invade into the tissues, and cause damage. 
Candida albicans was the sole inoculum in this study, and appeared not to 
invade into the SkinEthic RHOE tissues, and although the RHOE showed 
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responses by production of TNF, they did not show a significant increase in 
the production of IL-1 or CXCL8, both of which are also pro-inflammatory, as 
observed with the other full thickness tissue models. These observations 
confirmed that the type of tissue model that should be used in any study is 
dependent upon the anticipated analysis, and driven by the experimental 
question. In this project, initially, the restricted analysis of tissue damage, 
microscopic analysis and mRNA analysis for gene expression are sufficient, 
but in the future, it would be useful to be able to characterise the responses of 
tissues to different types of biofilm infection. The development of these in vitro 
models therefore allow more analyses to be completed in a more cost effective 
manner, and these additional parameters can be evaluated. 
 
The responses of full-thickness tissue models, should, in theory, be more 
representative of normal oral mucosa than keratinocyte-only tissues. The 
presence of both an epithelium and fibroblast cells would allow for cell-to-cell 
communication as a result of stimulation by the microorganisms, and the 
distinct cytokines the different cells produce are known to regulate the 
production of subsequent cytokines as part of a rounded inflammatory 
response. 
 
This study did not evaluate additional cytokines known to play a role in 
inflammatory responses to microbial infection, such as IL-6, IL-10, IL-12, IL-
1, CXCL8, TNF (Yadev et al., 2011; Wei et al., 2011; Akira et al., 2006; 
Waelti et al., 1992), but it would be of great interest to characterise the cytokine 
profile of tissue model responses, particularly with a view to using different 
biofilm inocula. The work in Chapter 2 also showed that presence of different 
microorganisms in addition to the mixed-species inoculum can differentially 
modulate the virulence of C. albicans. This bacterial modulation directly 
influences C. albicans, but it is not known whether it can also modulate the 
host responses. The work in this chapter also showed that immune cells can 
respond to components of the bacterial cell wall to induce gene expression for 
cell surface receptors intended to recognise C. albicans, so microbial 
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modulation of host responses would be a beneficial trait for promoting 
clearance of other organisms, leaving opportunity for some to thrive. 
 
In vitro tissue models used in this study did not contain immune cells, which of 
course, play a crucial role in clearing infections, and without them, humans 
would not survive. However, the development of in vitro tissue models has not 
yet reached a point at which they can be viably included in such a model 
system. It would be very beneficial for these cells to be incorporated into such 
a system, as their response to cytokines or direct stimuli can be monitored 
alongside the parameters measured here. Currently, methods of analysis 
using immune cells are limited to adhered or suspended cells in multi-well 
plates. This method still has advantages, as the immune cells can be directly 
stimulated in isolation and their responses evaluated, but in a more complex 
tissue model, these responses may differ. 
 
This study evaluated host immune responses using suspension cells in multi-
well plates described above. The study examined the effects of 
lipopolysaccharide (LPS, a common component of the cell wall of Gram 
negative bacteria, of which contribute to denture-associated biofilms within the 
oral cavity) on the responses of THP-1 monocyte cells. These cells were then 
also subsequently challenged with heat killed Candida albicans (HKC) to 
evaluate production of a common proinflammatory cytokine, IL-23. An 
increase in the expression of the genes responsible for both subunits of IL-23 
(IL23p19 and IL12p40) were observed (Fig. 4.11) at 24h post-stimulation with 
LPS, but these were not statistically significant. This increase in gene 
expression was also observed in the quantification of IL-23 protein when 
stimulated with the same concentration of LPS. Rogers et al. (2013) showed 
that stimulating monocyte cells with LPS primed them for recognition of 
Candida. A basal level of IL-23 was established with HKC challenge only 
relative to the normalised unstimulated cells. Significant increases were 
evident with stimulation with LPS at increasing concentrations, and a further 
significant increase again was observed at the higher LPS concentration, 
between LPS alone and 10^7 HKC cells. Interestingly, despite the recognition 
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of Candida, and the increase in the production of IL-23 protein, no differences 
were evident when evaluating Dectin-1 surface receptor.  
 
Dectin-1 is a c-type lectin membrane-bound receptor for recognition of 
Candida. The receptor recognises -glucans, which make up approximately 
40% of the Candida cell wall (Gow et al., 2007; Netea et al., 2008) and 
mannans (Shibata et al., 2007) which are also targeted by the immune system 
through receptors such as toll-like receptors 2 and 4 (TL2 and TLR4). The 
expression of the genes responsible for the dectin-1, TLR2 and TLR4 
receptors in monocyte cells was also evaluated. Following stimulation with 
LPS, statistically significant increases in the expression of genes responsible 
for dectin-1 and TLR4 were observed after 24 h. Interestingly, no significant 
increase was evident in the expression of TLR2. Furthermore, despite an 
increase in the expression of the gene responsible for dectin-1, no differences 
were observed in the presence of the specific surface receptor on the cells, 
irrespective of stimulation with varying concentrations of LPS. This suggests 
the cells did not respond to LPS in the expected way. LPS is a very common 
molecule, and may have contaminated the cells at some point in the past, 
which may also explain the limited increase in upregulation of the gene 
observed in the study, although the cell still responds in an anticipated manner 
with respect to production of cytokines. 
 
There were a number of interesting findings from this study, primarily the 
differential infection profile of the bacteria-only and C. albicans-only versus 
mixed-species biofilms, and the resultant damage and invasion into the 
tissues. There are clear directions of future work that have arisen: as 
discussed in Chapter 2, it is not known which single/dual-species of bacteria 
result in the increased expression of C. albicans virulence factors, and it was 
shown in this chapter that the mixed-species biofilms, where C. albicans 
virulence factors are enhanced, result in greater tissue damage and invasion 
into the tissue. Therefore, it is of interest to evaluate not only the monospecies 
versus mixed-species biofilms in terms of their inter-microbial interations, but 
also in the tissue infection model. The development of the model in Chapter 3, 
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and subsequent evaluation of the tissues compared with commercially 
available models in this chapter, has confirmed the suitability of the tissues, 
and thus will allow a higher throughput of investigations related to the single-
species influence and infection prognosis. Chapter 2 also showed that 
inclusion of an additional bacterium Porphyromonas gingivalis resulted in 
inhibition of enhancement of the C. albicans virulence factors observed with 
use of the other bacterial species. P. gingivalis is a known keystone pathogen, 
and results in tissue damage in its own right in the case of gingivitis and 
periodontitis. It would therefore be very interesting to evaluate these biofilms 
in the tissue infection to see whether the biofilms still had the same level of 
pathogenicity relative to the mixed-species, or monospecies, and whether the 
gene expression profile of C. albicans virulence factors was the same as in 
vitro biofilms.  
 
Further to this, cytokine and receptor responses are of major interest in order 
to fully understand the host response to the infection. I would like to follow this 
up more comprehensively from the perspective of the mixed-species biofilms 
used in this chapter, that is, to use a screening tool to evaluated an array of 
cytokines produced by the tissues. This would include other pro and indeed 
anti-inflammatory cytokines to profile the responses to the different infections. 
Additionally, inclusion of P. gingivalis would also be interesting to establish 
whether the host responses are further enhanced due to the known 
pathogenicitiy of P. gingivalis, or whether the host response is more toward C. 
albicans in the biofilms, and as such, as the C. albicans virulence factors were 
not upregulated when including P. gingivalis in biofilms, the host response 
would be limited. 
 
Use of THP-1 monocyte cells did not appear to yield much of an insight into 
whether the cells respond to C. albicans and/or LPS in this chapter, but other 
cell lines are known to respond to stimulation by C. albicans and/or LPS, and 
could be of use in future studies. U937 is another monocytic cell line that has 
been used to evaluate C. albicans infections (Heidenreich et al., 1996; Lopez 
et al., 2014), but it would of course be more representative to use primary 
human monocytic cells as investigated by Lopes et al., 2015). As a screening 
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tool, however, cell lines are good representations of cells that can be used as 
the primary investigative tool. Further development of the in vitro tissue models 
described in Chapter 3 could incorporate such monocyte cells, and thus, 
infection with monospecies and mixed-species biofilms could then be used to 
investigate a more comprehensive range of host responses and tissue 
infection. 
 
4.5 Conclusions 
• Mixed-species biofilms that demonstrated enhanced C. albicans 
virulence also demonstrate increased pathogenicity in oral mucosal 
tissue model infections 
o Increases in damage, and substantial tissue invasion were 
observed in mixed species biofilms compared with C. albicans-
only or bacteria-only biofilms 
 
• The type of tissue model used for infections did not influence C. 
albicans virulence gene expression 
 
• Monocyte stimulation with LPS resulted in increased production of the 
pro-inflammatory cytokine IL-23, and also when challenged with heat 
killed Candida, but showed little increase in dectin-1 gene expression 
or expression of the dectin-1 surface receptor when analysed by 
fluorescent antibody immuncytochemistry 
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Chapter 5 
 
Metataxonomic analyses of bacterial 
communities at sites within the oral cavity of 
denture-wearing patients, presenting with 
and without denture-associated stomatitis 
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5.1 Introduction 
There is ever increasing interest in the understanding of the microbiomes of 
various higher organisms, particularly humans, and identifying the changes 
within the microbiome that leads to the onset of disease or infection. This 
interest is, in part, fuelled by the view that whilst communities of 
microorganisms exist naturally at sites in the human body without any negative 
impact on the host, subtle or substantial changes in the composition of the 
microbiome can lead to development of infection (Jenkinson et al., 2005; Avila 
et al., 2009; Zarco et al., 2012; Wade, 2013).  
 
There has been significant recent interest in the influence of the microbiome 
in maintaining normal bodily function and overall health, particularly 
concerning the gut or intestinal microbiome (Turnbaugh et al., 2009; 
Turnbaugh & Gordon, 2009; O’Brien et al., 2013). Radical treatments have 
also been offered to ‘replenish’ the microbiome of sites of interest such as 
these, including faecal transplantation whereby the colon is cleaned, and 
processed faecal matter is introduced from a ‘normal’ or ‘healthy’ individual 
with the aim to re-establish a ‘normal’ microbiome (Turnbaugh & Gordon, 
2009; Turnbaugh et al., 2009). The efficacy of these treatments appears to be 
beneficial in the short period that has elapsed since they were introduced, but 
induced changes of this magnitude of the resident microbiome and the 
subsequent longer-term effects need to be considered with caution, with little 
evidence supporting any benefit in the longer-term as yet. Additional human 
microbiome studies investigating other key sites such as the skin and oral 
cavity have been completed as part of the Human Microbiome Project (Methé 
et al., 2012). 
 
The oral cavity is an area of extensive interest with respect to the microbiome 
in health and disease. Various distinct environments and surfaces within the 
oral cavity can harbour a large array of microorganisms, with each site 
potentially accommodating a unique microbiome of bacteria, fungi and viruses 
(Dewhirst et al., 2010; Wade, 2013). Several benefits to the host associated 
with the presence of microorganisms are known, related to modulation of the 
local environment which has a subsequent indirect inhibition of the 
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development of disease including caries (Burne & Marquis, 2000). 
Additionally, the competition within biofilms that exist at the various locations 
within the oral cavity help maintain a stationary level of potentially pathogenic 
microorganisms (Wade, 2013; Kilian et al., 2016). Additionally, direct inhibition 
of pathogenic species has been demonstrated in the intestine (Buffie & Pamer, 
2013), where despite distinct microbiomes, the concept of direct microbial self-
modulation could also be a factor in play in the oral cavity. The distinct 
composition of the microbiomes at each oral site shows the adaptability of 
microorganisms to different surfaces and environmental conditions. Different 
sites within the oral cavity share common microbial species, but overall have 
distinct characteristic microbiomes, when compared with other sites of the 
human body (Costello et al., 2009; Bik et al., 2010). 
 
The development of Sanger sequencing and related technological advances 
has allowed microbiome analyses that can identify the composition of microbial 
communities to species level. Studies indicate that more than 1000 bacterial 
species have been detected using molecular methods from samples of the oral 
cavity; including on the surfaces of teeth, oral mucosa, and within saliva 
(Palmer, 2014; Wade, 2013; Acharya et al., 2017), and a database established 
known as the Human Oral Microbiome Database (HOMD; Dewhirst et al., 
2010) to facilitate analysis of the substantial data sets. The higher detection of 
species by molecular methods compared with culture-dependent methods, 
partly relates to the latter’s reliance on specific suitable culture media, specific 
culture conditions, and the potential requirement for the presence of additional 
microorganisms to facilitate growth. Furthermore, dying or non-replicating 
microorganisms may not grow in vitro thus limiting their detection by culture. 
Identification by molecular methods, and indeed using other recent 
technological advances including proteomics and pyrosequencing (Jenkins, 
2011), bypass the requirement of culture, and the microorganisms present 
even at relatively low proportions can be detected and identified.  
 
Several oral diseases have been attributed to specific microorganisms 
including Candida (causative agent of candidosis), Streptococcus mutans (a 
causative agent of dental caries) and Porphyromonas gingivalis (a species 
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associated with onset of periodontal disease) (Axelsson & Lindhe, 1981). 
Detection of these keystone pathogens has focussed treatment strategies 
toward the pathogenic component, rather than pursuing a broad-spectrum 
treatment, avoiding potentially untargeted and unnecessary manipulation of 
the resident microflora. 
 
In addition to our understanding of the importance of the resident microflora in 
maintaining a state of symbiosis and health in the host, it has been 
hypothesised that a shift in the prevalence of certain bacterial species within 
the microbiome of a particular site can contribute to disease progression, as in 
the case of periodontal disease (Marsh & Bradshaw, 1995). This change of 
state from symbiosis to dysbiosis can lead to an inflammatory response, 
subsequently changing environmental conditions in which many other 
microorganisms can flourish, or conversely, undergo a stress response. These 
responses and changes in the conditions further exacerbate the disease and 
can lead to a substantial inflammatory scenario. Tissue damage can occur, 
and if allowed to persist, can lead to significant tissue destruction and a great 
burden on the host. Furthermore, the oral microbiome has also been 
implicated in non-oral diseases (Scannapieco, 1999; Wade, 2013). It is 
possible for oral microorganisms to bypass typical mucosal membranes and 
enter the bloodstream through, for example, local trauma to the gingiva or 
other mucosal site, and serious subsequent infections can occur. Examples of 
such serious infections include endocarditis (Mylonakis & Calderwood, 2001), 
and respiratory infections (Sands et al., 2017). 
 
Most oral microbiome studies have been focused on the bacterial species of 
the different sites within the oral cavity, and justifiably so as many oral 
conditions are attributed to bacteria; periodontitis and caries associated with P 
gingivalis and S. mutans respectively (Axelsson & Lindhe, 1981). Fungal and 
viral infections of the oral cavity are also important, especially in the case of 
the many clinical presentations of candidosis. In candidoses, the causative 
agent Candida are attributed to the disease, and there are multiple additional 
factors that also contribute, but the fungal composition of the oral cavity often 
takes a backseat in in vitro and in vivo studies. This was the case with the 
189 
 
creation of the oral microbiome database, where bacterial species were solely 
included in the draft database, and subsequently added to through the years 
that followed its creation. Some studies have investigated the fungal 
component of the oral cavity (Ghannoum et al., 2010; Ghannoum et al., 2013; 
Mukherjee et al., 2014; Dupuy et al., 2014), but very few specifically of 
candidosis-associated dentures (O’Donnell et al., 2015; Shi et al., 2016). The 
overall microbiome, including both bacteria and fungi, is necessary for it to be 
a true representation of the ‘microbiome’, which strictly speaking should 
additionally include other microorganisms such as viruses and protozoa. The 
role of the presence of bacteria in ecological niches such as dentures is an 
important factor to consider alongside other predisposing factors like diabetes 
or immune status. As certain bacteria are known to contribute to C. albicans 
virulence as demonstrated in this thesis, it highlights the need to understand 
the mycobiome and microbiome of dentures as equals. 
 
To further understand the role of the bacterial microbiome in the case of 
denture-associated stomatitis (DS), was the aim of this study. The approach 
employed molecular analysis by next generation sequencing of appropriate 
oral samples.  Such samples were obtained from patients with and without 
clinical presentation of DS and therefore comparisons in the relative 
microbiomes between these patient cohorts could be made.  
 
The specific aims of the study were: 
1. To obtain microbiological samples from patients with and without DS, 
and use next generation sequencing technologies to characterise the 
bacterial microbiome of microbiological samples of the tongue, palatal 
mucosa and denture-fitting surface (in contact with the palate). 
 
2. To determine whether differences in the bacterial microbiome of 
patients with and without clinical presentation of DS occurred and was 
assessed by: 
a. Determining whether differences exist in number of unique 
bacterial species present in patients of each disease grouping. 
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b. Evaluating richness and evenness of the distribution of bacterial 
species in patients of each disease grouping. 
c. Identifying any species that undergo substantial changes in the 
relative abundance of each disease grouping that could be 
attributed to causation of the disease. 
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5.2 Materials and Methods 
Informed consent and recruitment of patients to the clinical study was 
completed by certified clinicians Dr Helen Rogers and Dr Jeff Wilson. 
Processing of the obtained samples was completed by Daniel Morse with 
assistance from Ms Lucy Marsh (Research Technician, Cardiff University). 
This included microbiological culture analysis on agar plates and extraction of 
fungal/bacterial DNA from samples. 
Next generation sequencing analysis; sample preparation and sequencing 
according to the two step protocol detailed in Section 5.2.7 was completed by 
Research and Testing Laboratories, (RTL, Texas, USA). The sequence data 
was processed by Dr Ann Smith (Postdoctoral Research Associate, Cardiff 
University), and data analysed by Dr Smith and Daniel Morse together and 
independently. 
 
5.2.1 Ethical approval and patient recruitment 
5.2.1.1 Research ethics approval 
Research ethics committee approval was sought prior to the collection of 
clinical samples for analysis in this study. Ethical approval was obtained on the 
12th February 2014 with the following reference information: Study title: 
Denture acrylic biofilms: microbial composition, interactions and prevention; 
REC reference: 14/WA/0023; Protocol number: SPON 1265-13; IRAS project 
ID: 137108 (Appendix II). 
 
Training courses for the Human Tissue Act, and Principles of Good Clinical 
Practice were attended prior to the start of clinical sample collection. 
 
5.2.2 Patient recruitment and sample collection 
Patients attending the Oral Medicine clinic at the Dental Hospital, Cardiff and 
Vale NHS Trust, for normal, routine treatment were recruited following 
informed consent, according to the inclusion/exclusion criteria detailed in 
Table 5.1. Patient details were recorded and stored along with the signed and 
dated consent form, and each individual patient assigned a unique identifier, 
which remained anonymous to the researcher throughout the study. A limited 
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amount of clinical information was recorded about each patient, and included: 
gender, age, smoking status, and the presence and the extent of denture 
stomatitis according to Newton’s classification. The clinician then performed a 
clinical assessment of the palate, and if denture stomatitis was evident, then 
collected clinical samples for processing in the laboratory. Clinicians who 
contributed to this aspect of the study included Dr Helen Rogers and Mr Jeff 
Wilson. 
 
Inclusion Criteria Exclusion criteria 
Period prior 
to study 
18 years of age Antibiotic use 30 days 
Able and willing to  
consent Steroids (systemic, inhaler) 30 days 
Complete upper acrylic  Immunosuppressant drugs 30 days 
denture Receipt of investigational drug 30 days 
 Participation in other clinical 
study 30 days 
Table 5.1 Selection criteria for patient recruitment  
 
5.2.3 Clinical sampling  
Following recruitment, and before any clinical intervention, swabs and imprint 
cultures of the patient’s tongue, palate and denture fitting surface were 
obtained by qualified clinicians as detailed above. Sterile Transwab® Amies 
Charcoal swabs (Medical Wire and Equipment (MWE), Wiltshire, UK) were 
used to recover microorganisms for DNA extraction, and for isolation of 
microorganisms for future studies. The swabs were rubbed across the denture 
fitting surface, tongue and hard palate for 15 s, placed into a sterile container, 
sealed and transported to the microbiology laboratory for microbial DNA 
extraction as detailed in the clinical protocol in Appendix I. 
 
For microbial culture, sterile square foam pieces (imprint cultures; measuring 
approximately 2 cm × 2 cm) were pre-soaked in PBS, then pressed against 
the denture fitting surface, tongue and hard palate for approximately 30 s, then 
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overlaid on to SDA and transported to the microbiology laboratory where it was 
processed immediately upon receipt according to section 5.2.4 and 5.2.5. 
 
Laboratory processing of samples was performed with occasional practical 
assistance from Ms Lucy Marsh. 
 
5.2.4 Laboratory processing of swab samples 
The tip of the swab was carefully separated from the stem (the latter was then 
discarded), and placed into a sterile bijou container containing 1 mL PBS. The 
bijou was vortex mixed at 2,500 rev/min for 1 min. The supernatant was 
collected by pipette, thoroughly mixed and transferred into a sterile centrifuge 
tube and centrifuged for 2 min at 13,000 × g to form a pellet. The supernatant 
was discarded and 300 μl of sterile PBS was added, and the suspension 
homogenised by pipetting. The suspension was aliquoted in three sterile 
microcentrifuge tubes. DNA was extracted from one aliquot as described in 
section 5.2.4.1, to another was added 20 μl glycerol. All samples were stored 
at −80°C according to HTA regulations until required for use. 
 
5.2.4.1 Total microbial DNA extraction from clinical swab samples 
Bacterial genomic DNA was extracted using a Gentra PureGene Bact/Yeast 
DNA extraction kit (Qiagen, USA) according to the manufacturer’s instructions, 
and using the Gram-positive bacteria extraction protocol. In brief, the samples 
were centrifuged for 5 s at 16,000 × g. The pellets were re-suspended in 
300 μL of Cell Suspension Solution and homogenised by repeat pipetting. 
Once homogenous, 1.5 μL of Lytic Enzyme Solution was added and the 
mixture inverted (×25). The tubes were then incubated at 37°C for 30 min. After 
incubation, the tubes were centrifuged at 16,000 × g for 1 min to pellet the 
cells. The supernatant was carefully removed, then 300 μL of Cell Lysis 
Solution and 1.5 μL of RNase A Solution added. The solutions were thoroughly 
mixed to lyse the cells and 100 μL Protein Precipitation Solution was added. 
The tubes were vortex mixed at 2,500 rev/min for 20 s and then centrifuged 
for 3 min at 16,000 × g. The supernatant was then aspirated into a clean 1.5 
mL microcentrifuge tube containing 300 μL of isopropanol. The tubes were 
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mixed by inverting (×50) and the mixtures then centrifuged for 1 min at 
16,000 × g. The supernatant was discarded and the tubes drained on to an 
absorbent paper. A 300-μL volume of 70% (v/v) ethanol was added to each 
tube to wash the DNA. The tubes were then centrifuged again for 1 min at 
16,000 × g, the supernatant discarded and the tubes drained again on 
absorbent paper, before allowing to air dry for 5 min. Once suitably dry, 100 μL 
of DNA Hydration Solution was added and the tubes were vortex mixed for 5 s 
at 1,000 rev/min. The tubes were then incubated at 37°C for 1 h, after which 
the tubes were transferred to a water bath set to 65°C to dissolve the DNA. 
The tubes were then placed on an orbital shaker overnight at room 
temperature (15-25°C), and stored at -20°C prior to subsequent next 
generation sequencing (NGS). Immediately prior to shipment for NGS, the 
samples were moved from -20°C and placed into an appropriate transport 
container on dry ice. 
 
In addition to culture based methods, the presence or absence of Candida was 
evaluated by molecular analysis. The remaining portion of the swab sample 
for DNA analysis, was used for extraction of yeast DNA for PCR using the 
Gentra PureGene Bacteria/Yeast DNA extraction kit. The DNA was extracted 
using the according to the yeast/fungi extraction protocol, which was similar to 
that of the Gram-positive bacterial extraction protocol, except that the RNase 
A solution was added after the DNA Hydration Solution as opposed to 
immediately after Cell Lysis Solution in the Gram-positive bacterial DNA 
extraction protocol. 
 
5.2.5 Laboratory processing of imprint cultures 
The foam imprints were received already placed on the surface of SDA, and 
were then gently pressed on the agar for 30 s to ensure optimal contact of the 
foam with the agar. The foam square was then aseptically transferred with 
sterile tweezers to a blood agar plate and pressed for 30 s and then aseptically 
transferred to fastidious anaerobe agar. After contact with the FAA surface the 
imprint was then discarded.  
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The SDA and BA plates were incubated aerobically at 37°C, and FAA 
incubated anaerobically at 37 °C until sufficient growth was achieved to isolate 
and presumptively identify individual colonies by colour and appearance. For 
samples that were deemed culture positive for Candida, representative 
colonies were further sub-cultured on to CHROMagar® Candida medium for 
presumptive identification of Candida albicans. 
 
5.2.6 Identification of microorganisms from clinical samples by 
molecular methods 
The methods described below were performed with the assistance of Ms 
Raquel Posso under the supervision of Dr Lewis White (Department of Medical 
Microbiology and PHLS, University Hospital of Wales, Cardiff). 
 
5.2.6.1 Pre-amplification of pan-fungal DNA 
Extracted fungal DNA was pre-amplified in a general nested PCR using the 
RenDX Fungiplex Amplification Kit (Renishaw Diagnostics Ltd, Glasgow, UK) 
with a final reaction volume of 50 L. The kit targets a region on the fungal 18S 
rRNA gene. Each reaction mix contained 5 L of 10  PCR buffer, 1 L MgCl2 
(7.5 mM), 4 L dNTPs (10 mM each nucleotide), 10 L primer mix (10 mM), 
19.5 L molecular grade water, 0.5 L Taq polymerase enzyme (5 U/L) and 
10 L of the extracted DNA template. Target DNA was amplified using the 
following thermal cycling protocol: 95 C for 15 min, followed by 45 cycles of 
94C for 30 s, 58C for 30 s and 72C for 30 s. A final elongation step of 72C 
for 7 min was also performed. The samples were held at 4C until required for 
the next stage of amplification. 
 
5.2.6.2 Real-time PCR of pre-amplified DNA 
Amplified samples were subjected to a second round of probe-based real-time 
PCR to amplify regions of the internal transcribed spacer (ITS) region (located 
between 18S and 5.8S rRNA genes) that were specific to C. albicans, C. krusei 
and C. glabrata. The primers are detailed in table 5.2. 
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Primer/probe 
name (target) 
Sequence (5’  3’) 
Melting 
temp. (C) 
L18R GCC-TGC-TTT-GAA-CAC-TCT 54.0 
L18F CTC-GTA-GTT-GAA-CCT-TGG 54.0 
Pan-Candida ATC-TTT-TTG-ATG-CGT-ACT-GGA-CCC-TG 52.9 
C. glabrata GGC-TAA-CCC-CAA-GTC-CTT-GTG-GCT-T 55.9 
C. krusei TAC-CTA-TGG-TAA-GCA-CTG-TTG-CGG-C 54.2 
Table 5.2 Primer sequences for Candida detection of clinical samples by 
nested-PCR 
Primers L18R and L18F, and probes pan-Candida, C. glabrata-specific and 
C. krusei-specific 
 
DNA samples were amplified using LightCycler FastStart DNA Master 
HybProbe (Roche Diagnostics, Sussex, UK), and contained 2.5 L of 
hybridisation mix, 3 L MgCl2, 15 L nuclease free, molecular grade water, 
2.5 L primer/probe mix and 2 L template DNA. The preparations were 
homogenised by brief vortex mixing. The DNA was amplified using the 
following thermal cycling protocol: 95C for 15 min, followed by 30 cycles of 
95C for 15 s, then 58C for 30 s. Amplicons were detected using the following 
fluorescence probes FAM (green), JOE (yellow) and ROX (orange) for 
detection of pan-Candida species, C. glabrata and C. krusei, respectively. 
 
5.2.7 Metataxonomic profiling of bacterial microbiome of clinical swab 
samples using the Illumina MiSeq two stage amplification protocol 
Bacterial DNA samples were transported on dry ice to Research and Testing 
Laboratories (RTL, Texas, USA) for NGS, and upon receipt, were processed 
according to a standard operating procedure used by RTL. The method was 
based on an Illumina 2-step protocol as outlined below by trained staff 
members at RTL. The resulting sequence data was provided in fasta file 
format, and analysed in conjunction with Dr Ann Smith (Postdoctoral Research 
Associate in bioinformatics, School of Biosciences, Cardiff University). 
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5.2.7.1 Primary stage amplification 
The forward primer was constructed with (5’-3’) the Illumina i5 sequencing 
primer (TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG) and the 28F 
primer (GAGTTTGATCNTGGCTCAG), and the reverse primer was 
constructed with (5’-3’) the Illumina i7 sequencing primer 
(GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG) and the 388R primer 
(TGCTGCCTCCCGTAGGAGT). Reactions were performed using ABI Veriti 
thermocyclers (Applied Biosystems, California, USA) in a 25 L final volume 
comprising 22 L Qiagen HotStar Taq master mix (Qiagen Inc. California, 
USA), 1 L of each primer (5 M) and 1 L DNA template. The thermal cycling 
protocol was: 95C for 5 min, then 25 cycles of 94C for 30 s, 54C for 40 s, 
72C for 1 min, followed by one final cycle of 72C for 10 min, then the products 
were held at 4C. This primary amplification generated multiple 250 bp 
sequences, which overlap at the V4 region of the 16S rRNA gene. 
 
5.2.7.2 Second stage amplification 
Products from the first stage amplification were added to a second PCR, based 
on qualitatively determined concentrations. Primers for the second PCR were 
designed based on the Illumina Nextera PCR primers and were as follows: 
Forward - 
AATGATACGGCGACCACCGAGATCTACAC[i5index]TCGTCGGCAGCGTC 
and Reverse - 
CAAGCAGAAGACGGCATACGAGAT[i7index]GTCTCGTGGGCTCGG. The 
thermal cycling protocol for this second stage amplification was the same as 
the first, but involved 10 cycles. 
 
5.2.7.3 Standardisation of PCR products for next-generation sequencing 
Amplification products were initially visualised with eGels (Life Technologies, 
New York, USA). Products were then pooled at equimolar concentrations and 
each pool was size selected in two rounds using Agencourt AMPure XP 
(BeckmanCoulter, Indiana, USA) in a 0.7 ratio for both rounds. Size selected 
pools were then quantified using the Quibit 2.0 fluorimeter (Life Technologies) 
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and loaded on an Illumina MiSeq (Illumina, Inc., California, USA) 2 × 300 flow 
cell at 10 pM. 
 
5.2.7.4 Preparation of sequence library 
The sequencing data was obtained in FASTA file format, and processed 
according to the MOTHUR pipeline (Schloss et al., 2009). Briefly, the forward 
and reverse sequences for each unique sample were aligned, made into 
contigs and enumerated; then ambiguous sequences were removed. The 
remaining sequences were re-aligned and counted again, then aligned to a 
reference database. The sequences were then trimmed to remove ambiguous 
base calls, chimeras or sequences outside of the required base pair length. 
The undesirable sequences (those that were not specific for bacteria) were 
then filtered to identify, and removed. Sequences were clustered into 
operational taxonomic units (OTUs). Using the USEARCH algorithm and the 
Ribosomal Database Project (RDP) database (Edgar, 2010), the resulting 
taxonomy was determined to 97% similarity at species level. Those OTUs with 
less than 97% sequence similarity to a bacterial species in the database were 
classified only to genus level 
 
5.2.7.5 Data analysis 
Once the data was taxonomically assigned, a number of analyses were 
completed using a range of statistical programs. Firstly, the shared OTU file 
was used to determine the frequency at which each OTU was observed in the 
samples, and thus the occurrence of each bacterial species. The analyses 
included the Shannon and Chao indices using R (version 3.3.1, R 
Development Core Team, 2008), where samples were compared according to 
diversity, species abundance and similarities. Bray-Curtis distance measure 
(measurement of dissimilarity) using the STAMP program script (Parks & 
Beiko, 2010) was also used to create dendograms of phylogenetic trees. 
Weighted Unifrac distance matrices were analysed in R using non-metric 
multidimensional scaling (NMDS) plots, where OTUs were grouped by 
similarity, and clustered to determine whether there is a distinction between 
the different patient groupings. 
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5.2.7.6 Community analysis of individual bacterial species 
After phylotypic assignment to bacterial species, the absolute occurrence 
(number of sequence reads) of the OTUs was transformed into relative 
occurrence for comparison with other samples. 
 
Relative proportions of specific bacterial species expressed as a percentage 
of the overall community were compared within each sample site, to determine 
whether changes in the abundance of specific bacterial species could be 
attributed to the incidence of DS. 
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5.3 Results 
5.3.1 Patient demographics 
Tables 55.3 and 5.4 summarise the demographics and recorded clinical 
information of the 19 patients recruited to the study. More females (n=11, 
57.9%) were recruited to the study than males (n=8, 42.1%), and similar 
average ages 69.64 yrs (13.84) and 64.88 yrs (7.14) were evident for 
females and males, respectively. Of the recruited patients, eight (42.1%) were 
current smokers. 
 
Eight (42.1%) patients showed clinical presentation of DS to varying extent, of 
which six were female (75%, 31.58% of total) and two were male (25%, 
10.53% of total). Eleven (57.9%) individuals had no signs of DS (Female n=5, 
45.5%, 26.32% of total; Male n=6, 54.5%, 31.58% of total). 
 
Samples from each patient were assigned an anonymised reference number 
(S001-S019) upon sampling, to which each patient is referred herein. 
 
5.3.2 Detection of Candida species in samples 
Both swab and imprint culture methods for determining Candida in clinical 
samples resulted in varied detection of Candida species as shown in table 5.5. 
The agar culture method from foam imprints resulted in positive detection of 
Candida species in 9 (47.37%) individuals, whereas the molecular method of 
nested real-time PCR resulted in detection of Candida species in 11 (57.89%) 
individuals. Samples of the tongue, palate and denture surface from 3 
individuals of the overall cohort were not tested using the molecular method. 
Samples of the palate from patients 9, 11 and 12, and the denture surface of 
patients 10 and 14 were also not tested by this method due to the requirement 
of additional samples for next generation sequencing. 
 
Interestingly, several samples that did not yield Candida growth by agar 
culture, did ultimately result in positive detection using nested real-time PCR. 
These samples were S003D, S006P and S006D, S007T and S007D, S008T, 
S008P and S008D, S0013D, S0014P and S0015D (where T refers to tongue 
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sample site, P is palatal mucosa sample site, and D is denture surface). 
Additionally, although sample S0014T was positive for Candida by agar 
culture, it was not detected using the nested real-time PCR method. 
 
 
2
0
2
 
 Total n Female Male 
Mean age Candida 
presence 
Smoker 
Female Male 
DS 
8 
(42.11%) 
6 
(75%) 
(31.58% of total) 
2 
(25%) 
(10.53% of total) 
67.00 
(17.57) 
70.00 
(7.07) 
6 
(75%) 
5 
(62.5%) 
NS 
11 
(57.89%) 
5 
(45.45%) 
(26.32% of total) 
6 
(54.54%) 
(31.58% of total) 
72.80 
(8.38) 
63.17 
(6.88) 
8 
(72.72%) 
3 
(27.27%) 
Total 19 11 8 
69.64 
(13.84) 
64.88 
(7.14) 
14 8 
Table 5.3 Demographics and key outcome measures of recruited individuals.  
Total number of patients recruited n=19 (Female n=11, Male n=8) 
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Patient 
ID 
Gender 
Age 
(yrs) 
Tobacco 
smoker 
Denture stomatitis 
Present 
Newton’s 
Classification 
S001 Female 59 Yes No 0 
S002 Female 66 No Yes 1 
S003 Male 66 No No 0 
S004 Male 66 No No 0 
S005 Male 52 Yes No 0 
S006 Male 64 No No 0 
S007 Female 67 No Yes 1 
S008 Female 75 No No 0 
S009 Male 72 Yes No 0 
S010 Female 74 Yes Yes 2 
S011 Female 36 Yes Yes 1 
S012 Female 81 No No 0 
S013 Male 75 Yes Yes 3 
S014 Male 65 Yes Yes 2 
S015 Female 72 No No 0 
S016 Female 90 No Yes 2 
S017 Male 59 No No 0 
S018 Female 77 No No 0 
S019 Female 69 Yes Yes 2 
Table 5.4 Patient specific clinical information recorded during recruitment 
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Patient ID 
Candida presence Presumptive Candida 
species identification 
(CHROMagar/RT-PCR) 
Tongue 
(Culture/PCR) 
Palate 
(Culture/PCR) 
Denture 
(Culture/PCR) 
S001 + / NT + / NT + / NT C. albicans 
S002 - / NT - / NT - / NT - 
S003 - / - - / - - / + C. albicans 
S004 + / + + / + - / + C. albicans 
S005 + / + + / + - / - C. albicans 
S006 - / - - / + - / + C. albicans 
S007 - / + - / - - / + C. albicans 
S008 - / + - / + - / + C. albicans 
S009 - / + + / NT - / + C. albicans 
S010 - / + - / + + / NT C. albicans 
S011 + / + + / NT + / + C. albicans 
S012 + / + + / NT + / + C. albicans 
S013 - / - - / - - / + C. albicans 
S014 + / - - / + + / NT C. albicans 
S015 - / - - / - - / + C. albicans 
S016 - / - - / - - / - - 
S017 - / - - / - - / - - 
S018 - / - - / - - / - - 
S019 + / NT + / NT + / NT C. albicans 
 
Table 5.5 Evaluation of Candida presence and presumptive identification by 
culture and PCR 
Candida presence (+) or absence (-) determined by positive agar culture and 
real-time PCR identification. Samples not tested by real-time PCR are denoted 
by NT. Samples that were positive by culture were further subcultured onto 
CHROMagar® Candida for presumptive identification of Candida species 
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Those samples that were positive for Candida species either by culture and/or 
nested real-time PCR (n=14) were subsequently used for analyses by next 
generation sequencing. It is accepted that for the infection to be considered 
candidosis, that Candida species will be present, as opposed to other causes 
of palatal inflammation. 
 
5.3.3 Identification of detected Candida species 
From each sample type (e.g. tongue, palate or denture) on Sabouraud 
dextrose agar, several typical colonies were subcultured on to CHROMagar® 
Candida agar as described in section 5.2.5. The agars were incubated for 48 
h, after which, a turquoise/green colour was observed for each subculture 
streak, indicating the presumptive presence of Candida albicans within 
samples. No other colour was observed for any streak cultured on this agar. 
 
The molecular method of nested real-time PCR also used primers to amplify 
the ITS regions of the 18S rRNA considered to be conserved within species, 
and thus identify Candida in samples to species level. Amplicons were 
observed in the pan-Candida channel for numerous samples, but no detection 
was evident in the C. glabrata or C. krusei probe channels, thus eliminating 
the presence of these species. These results, in addition to those of culture, 
indicated the presence of C. albicans within all Candida positive samples. 
 
5.3.4 Metataxonomic profiling of bacterial species present in swab 
samples 
The raw data obtained from the next generation sequencing analysis, post-
processing and phylotypic assignment can be found in Appendix III. 
 
5.3.4.1 Primary analysis of sequence reads 
From the 57 samples from 19 patients, 2 were not analysed by sequencing 
(these samples were pooled together in the laboratory and thus not available 
for NGS), and 5 failed to yield amplicons at the primary step. A total of 
2,194,967 sequence reads were obtained from the remaining 50 samples prior 
to quality control of the FASTA file data. 
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Quality control steps resulted in the removal of some sequence reads, and the 
total number of final reads was 1,864,575. The number of reads for each 
sample ranged from 133,846 (S003_D) to 10,995 (S019_P), and to normalise 
the data between samples and to avoid sample size bias, the operational 
taxonomic units (OTUs) were sub-sampled to the lowest read count (S019_P) 
of 10,995 reads.  
 
Once normalised, patients were grouped based on the presence or absence 
of DS (groupings named DS and NoDS, respectively) and analysed. In total, 
2,411 OTUs were identified, 353 of which had more than ten sequence reads. 
Bacterial species with a minimum of ten sequence reads were included in the 
analysis, as the OTUs with read counts below this were not considered truly 
representative of bacterial species content. Some OTUs when phylotypically 
assigned were determined to be the same bacterial species, but resulted due 
to intra-strain sequence variation. Thus,  
for analysis of the composition of communities to species-level, such multiple 
OTUs representing the same bacterial species were consolidated into a single 
species unit, so the number of bacterial species present in the samples was 
lower than that of the number of OTUs detected. 
 
5.3.4.2 Analysis of OTUs between sample sites 
Each distinct OTU was considered specific to a single bacterial species for the 
purpose of this analysis. However, multiple OTUs can be assigned to a single 
bacterial species (different strains of the same species can generate different 
sequences), therefore the analysis was separated into OTU-wide (Shannon 
and Chao indices, section 5.2.8.5) analysis and post-consolidation species-
specific analysis (section 5.2.8.6). 
 
The Chao index is an indicator of ecological diversity within a sample and 
compares the number of unique OTUs present between sample groups; the 
Shannon diversity index characterises the community diversity by taking into 
account the abundance and the evenness of spread of the OTUs. The values 
associated with the Shannon diversity index are an indication of the 
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commonality of, in this case, OTUs. Thus, the more unequal the abundances 
of the OTUs in the samples, the larger the weighed value, and so the resultant 
Shannon index value is smaller. For example, if the vast majority of samples 
were associated with one OTU, with very few others, irrespective of total 
number of the other OTUs, the Shannon index would be close to zero, whereas 
in cases where there was a more even distribution of frequency of OTUs, the 
Shannon index would be higher. 
 
Non-metric multidimensional scaling (NMDS), a method for determining 
differences between the microbial communities of individual samples was also 
performed for the OTUs using the UniFrac weighted matrix (a measure of 
phylogenetic community distances). The data was presented as a scatter plot, 
and grouped by denture, palate, and tongue site. Additionally, phylogenetic 
heat maps of the microbiome to species level were compiled to further assess 
community distances in each sample within the groups. 
 
5.3.4.3 Diversity of bacteria detected at each sample site 
A large number of unique OTUs were detected for all sample sites, but it was 
also noted that there was a large range variation between samples and sample 
sites. The number of unique OTUs in denture samples ranged from 145 to 382 
(DS: 145-359, NoDS: 156-382), whereas a much larger range was observed 
in the palate (overall: 88-549; DS: 88-207, NoDS: 181-549) and the tongue 
(overall: 89-448; DS: 89-311, NoDS: 136-448). Interestingly, despite only 
having a small cohort of DS samples from the denture (n=5), three of these 
showed a very similar number of unique species (203, 216, 223), with the 
remaining two showing a much higher (359) or lower (146) number of OTUs. 
However, this was not evident in the palatal NoDS samples (also n=5), which 
showed a more even spread of values between the highest and lowest. It 
appeared as though the DS samples of each site not only showed a narrower 
range of the number of unique OTUs, but also a lower overall number of OTUs 
than the NoDS samples. 
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Figures 5.1A, 5.2A and 5.3A show the Chao indices for the denture, palate 
and tongue respectively. Comparing DS samples with NoDS samples, T-tests 
(at 95% confidence) showed no significant differences in either the denture 
(P=0.806) or palatal (P=0.104) samples, whereas the tongue did show a 
significantly (P=0.007) larger overall number of unique OTUs in the NoDS 
samples compared with the DS samples. 
 
Additionally, when evaluating differences in the bacterial microbiome profiles 
within patient groups with STAMP software using Fisher’s exact test with 
Benjamini-Hochber corrections, no significant differences were observed for 
any sample site.  
 
5.3.4.4 Bacterial diversity by abundance and evenness of spread – 
Shannon index 
Analysis with the Shannon index resulted in no significant differences when 
comparing DS with NoDS samples and for all sites (denture P=623, palate 
P=0.318, tongue P= 0.222). NoDS samples, in general, appeared to show an 
overall Shannon index value higher than that of DS samples, indicating the 
frequency of OTUs were more evenly distributed across the whole population, 
thus less clustering of higher relative abundance associated with a smaller 
group of bacterial species. 
 
 
 
2
1
0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Box and whisker plot comparing the number of unique bacterial species (Chao index) and diversity (Shannon 
index) detected in samples of the denture-fitting surface between DS and NoDS patients 
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Figure 5.2 Box and whisker plot comparing the number of unique bacterial species (Chao index) and diversity (Shannon 
index) detected in samples of the palatal mucosa surface between DS and NoDS patients 
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Figure 5.3 Box and whisker plot comparing the number of unique bacterial species (Chao index) and diversity (Shannon 
index) detected in samples of the tongue between DS and NoDS patients. 
P=0.007 P=0.222 
A B 
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5.3.4.5 Similarity of patient groups by grouping using non-metric 
multidimensional scaling (NMDS) plots 
The NMDS scatter plots provided an indication of the cluster groupings of the 
sample within groups, to determine whether they were distinct from each other. 
Fig. 5.4 shows the DS and NoDS groups overlap to a large extent with respect 
to samples of every sample site, suggesting that they were not dissimilar in 
diversity.  
 
It also appeared as though there is less general bacterial diversity for DS 
samples than NoDS for when considering all OTU analyses performed. 
 
5.3.4.6 Phylotypic distancing analysis demonstrated with Bray’s 
heatmap dendograms to determine group similarities 
Similarity or distinctness of the bacterial microbiomes for each specific sample 
site was determined with the use of dendograms. The tree-like structure 
indicated similarities by grouping those phylotypically most closely related to 
each other (Figs. 5.5, 5.6, 5.7). 
 
The overall finding with all sample sites was that there were no distinct 
groupings of samples from patients with or without DS. This suggested that 
the microbiomes were not that distinct from each other, although there were 
more defined clusters of samples in samples of the tongue (Fig. 5.7). 
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Figure 5.4 Nonmetric multidimensional scaling (NMDS) comparison of the bacterial microbiomes of denture surfaces for 
patients with (DS) and without (NoDS) 
Scatter graph showing differences of samples by patient groups. Overlapping clusters indicated strong similarities between 
DS and NoDS samples when considered as a group.
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Figure 5.5 Heat map and dendrogram according to the relative abundance 
and overlap of OTUs in samples of the denture-fitting surface 
Relative abundance ranges from low abundance (pale blue) to high 
abundance (dark blue). 
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Figure 5.6 Heat map and dendrogram according to the relative abundance 
and overlap of OTUs in samples of the palatal mucosa surface 
Relative abundance ranges from low abundance (pale blue) to high 
abundance (dark blue). 
216 
 
 
Figure 5.7 Heat map and dendrogram according to the relative abundance 
and overlap of OTUs in samples of the tongue  
Relative abundance ranges from low abundance (pale blue) to high 
abundance (dark blue). 
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5.3.5 Presence and differences in relative abundance of bacterial 
species detected at each sample site 
The top 25 bacterial species present at each sample site (i.e. denture, palate, 
and tongue) were compared for DS and NoDS (Tables 5.6, 5.7, 5.8) to 
determine whether occurrence of DS was associated not only with Candida 
but also the presence or absence, or abundance of certain bacterial species. 
Differences were evident in the top 25 bacterial species for all sample sites. 
Additionally, the top ten common species (which, for some samples in the 
groups included bacterial species outside of the top 25) also varied in 
abundance. 
 
5.3.5.1 Bacterial species on the denture surface 
In total, 338 bacterial species were identified from all samples obtained from 
the palate; 166 in DS samples, of which 60 (36.1%) were unique to the DS 
group, and 172 in NoDS samples, of which 64 (37.2%) were unique to the 
NoDS group. As detailed in table 5.6, the top 25 bacterial species by average 
abundance (%) represented approximately 92% (DS) and 85% (NoDS) of all 
bacterial species identified within the samples. The highest average 
abundance of individual bacterial species was similar between DS 
(Streptococcus species, 14.24%) and NoDS (Serratia liquefaciens, 13.59%), 
and there were five bacterial species unique to the DS group, compared with 
two unique species to the NoDS group. 
 
Of the top 25 bacterial species in each DS and NoDS groups, 10 common 
species were detected in both groups (Fig. 5.8), but differences in the relative 
abundance of each species was evident. Acinetobacter johnsonii, 
Streptococcus mitis and Actinomyces odontolyticus were greater in 
abundance in the NoDS group compared with DS, and slight increases in 
abundance of Veillonella parvula and S. oralis were also observed in the NoDS 
group. However, Pseudomonas putida, Acinetobacter lwolffii, Lactobacillus 
salivarius and Actinomyces lingnae had higher abundance in the DS than 
NoDS samples.  
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Interestingly, the bacterial species with the highest average abundance; 
S. salivarius, was present at very similar levels in each group of denture 
samples (DS, 6.79%; NoDS, 6.83%), and was detected at the highest average 
abundance in tongue samples, and also exhibited similar average abundance 
between DS and NoDS. 
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DS NoDS 
Bacterial species 
Average 
abundance 
(%) 
Bacterial species 
Average 
abundance 
(%) 
Streptococcus unclassified 14.238 Serratia liquefaciens 13.591 
Myroides unclassified 8.518 Acinetobacter johnsonii 10.645 
Pseudomonas fluorescens 7.209 Streptococcus mitis 10.143 
Streptococcus salivarius 6.786 Actinomyces odontolyticus 9.590 
Brevundimonas terrae 6.477 Streptococcus salivarius 6.831 
Pseudomonas putida 6.180 Lactobacillus fermentum 6.185 
Agrobacterium tumefaciens 4.545 Brevundimonas vesicularis 4.637 
Acinetobacter lwoffii 3.933 Pseudomonas putida 3.731 
Acinetobacter johnsonii 3.733 Microbacterium testaceum 3.481 
Streptococcus mitis 3.490 Veillonella parvula 3.397 
Chryseobacterium unclassified 2.470 Streptococcus oralis 2.680 
Veillonella parvula 2.411 Pseudomonas aeruginosa 2.620 
Lactobacillus salivarius 2.158 Acinetobacter lwoffii 1.915 
Actinomyces lingnae 1.671 Haemophilus parainfluenzae 1.716 
Massilia varians 1.621 Prevotella histicola 1.649 
Actinomyces odontolyticus 1.505 Propionibacterium acnes 1.457 
Streptococcus oralis 1.490 Streptococcus anginosus 1.297 
Lactobacillus rhamnosus 1.333 Actinomyces lingnae 0.986 
Streptococcus sobrinus 1.264 Streptococcus sanguinis 0.796 
Devosia unclassified 1.222 Prevotella melaninogenica 0.790 
Lactobacillus paracasei 1.186 Granulicatella adiacens 0.775 
Stenotrophomonas nitritireducens 1.006 Leptotrichia unclassified 0.668 
Acinetobacter junii 0.953 Lactobacillus salivarius 0.658 
Delftia tsuruhatensis 0.947 Actinomyces graevenitzii 0.630 
Empedobacter brevis 0.734 Lactobacillus unclassified 0.623 
Total 91.929 Total 84.884 
Table 5.6 Top 25 bacterial species in samples of denture-fitting surfaces of 
patients with (DS) and without (NoDS) grouped by disease status. 
Red text indicates unique bacterial species in the top 25 detected bacterial 
species of either group, blue indicates common bacterial species within the top 
25, and species in black text may or may not be present in both sample sets 
but are outside the top 25 detected species.
 
 
2
2
1
 
 
Figure 5.8 Mean relative abundance of the top 10 common bacterial species of patients with (DS) and without (NoDS) of the 
denture-fitting surfaces 
Comparison of mean relative abundance for the top 10 common bacterial species detected in samples from the denture-fitting 
surface of DS (blue columns) and NoDS (red columns) patients as determined by NGS. 
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5.3.5.2 Bacterial species on the palatal mucosa 
In total, 352 bacterial species were identified from all samples obtained from 
the palate; 131 in DS samples, of which 54 (41.2%) were unique to the DS 
group, and 129 in NoDS samples, of which 52 (40.3%) were unique to the 
NoDS group.  
 
The top 25 bacterial species (table 5.7) of the palate represented a more 
significant proportion of the total number of bacterial species than that found 
in the denture fitting surface samples, totalling approximately 98% (DS) and 
95.5% (NoDS). Eleven bacterial species detected were unique to the DS 
samples, compared with 7 unique to NoDS, and 8 bacterial species in the top 
25 common to both groups. 
 
Pseudomonas fluorescens was the bacterial species common to both DS and 
NoDS groups (Fig. 5.9) with the highest representation in DS samples, and 
was also common in the NoDS samples. The difference in the mean relative 
abundance was also the highest of any bacterial species between the two 
sample groups, with 19.99% relative abundance in DS samples, compared 
with just 2.34% in NoDS samples. Furthermore, the other most common 
bacterial species in both groups; S. oralis, A. johnsonii, Brevundimonas terrae, 
and Chryseobacterium (unknown species) were higher in abundance in DS 
samples than NoDS. The abundance of Brevundimonas vesicularis was 
greater in NoDS than DS, whereas only small differences in abundance 
between groups were observed for the remainder of the top ten common 
bacterial species. 
 
Fifteen of the top 25 bacterial species detected in DS samples from the denture 
fitting surface were also found in DS samples of the palatal mucosa site. 
However, 22 of the top 25 bacterial species of NoDS samples from the palate 
were also detected in NoDS denture samples. A higher level of similarity 
between sample sites in NoDS than DS groups. 
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DS NoDS 
Bacterial species 
Average 
abundance 
(%) 
Bacterial species 
Average 
abundance 
(%) 
Pseudomonas fluorescens 19.992 Serratia liquefaciens 16.698 
Massilia aurea 15.572 Pseudomonas putida 16.583 
Streptococcus unclassified 15.338 Lactobacillus paracasei 13.869 
Enterococcus faecalis 12.754 Brevundimonas vesicularis 6.516 
Dermacoccus 
nishinomiyaensis 
6.297 Stenotrophomonas nitritireducens 4.532 
Strept coccus oralis 4.016 Moraxella osloensis 4.477 
Acinetobacter johnsonii 3.839 Agrobacterium tumefaciens 3.611 
Chryseobacterium unclassified 3.819 Stenotrophomonas unclassified 3.366 
Massilia varians 3.334 Acinetobacter johnsonii 3.182 
Brevundimonas terrae 2.646 Streptococcus salivarius 2.794 
beta proteobacterium 2.252 Phormidium species 2.781 
Sphingomonas species 1.576 Streptococcus mitis 2.759 
Devosia unclassified 1.541 Streptococcus oralis 2.562 
Brevundimonas vesicularis 1.016 Pseudomonas fluorescens 2.344 
Massilia unclassified 0.732 Chryseobacterium scophthalmum 2.014 
Rhizobium unclassified 0.712 Propionibacterium acnes 1.914 
Acidovorax unclassified 0.664 Luteimonas cucumeris 1.411 
Propionibacterium acnes 0.393 Stenotrophomonas maltophilia 0.836 
Veillonella parvula 0.232 Streptococcus sanguinis 0.639 
Delftia tsuruhatensis 0.229 Chryseobacterium unclassified 0.551 
Streptococcus sanguinis 0.223 Brevundimonas terrae 0.498 
Brevundimonas unclassified 0.201 Rhizobium unclassified 0.443 
Rhizobium mesosinicum 0.198 Streptococcus infantis 0.420 
Massilia alkalitolerans 0.198 Pseudoxanthomonas mexicana 0.413 
Methylobacterium unclassified 0.186 Acinetobacter lwoffii 0.322 
Total 97.959 Total 95.531 
Table 5.7 Top 25 bacterial species in samples of palatal mucosa of patients 
with (DS) and without (NoDS) grouped by disease status. 
Red text indicates unique bacterial species in the top 25 detected bacterial 
species of either group, blue indicates common bacterial species within the top 
25, and species in black text may or may not be present in both sample sets 
but are outside the top 25 detected species.
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Figure 5.9 Mean relative abundance of the top 10 common bacterial species of patients with (DS) and without (NoDS) of the 
palatal mucosa surfaces 
Comparison of mean relative abundance for the top 10 common bacterial species detected in samples from the denture-fitting 
surface of DS (blue columns) and NoDS (red columns) patients as determined by NGS. 
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5.3.5.3 Bacterial species on the tongue 
In total, 352 bacterial species were identified from all samples obtained from 
the tongue, which was a similar finding to the other sample sites in this study; 
157 in DS samples, of which 35 (22.2%) were unique to the DS group, and 
195 in NoDS samples, of which 73 (37.4%) were unique to the NoDS group. 
Interestingly, a higher number of unique bacterial species were present in the 
NoDS samples than were observed in DS samples. 
 
Also, similar to the denture samples, table 5.8 shows the top 25 bacterial 
species of NoDS samples represented less of the overall bacterial presence 
than that of DS samples (NoDS 88.153%; DS 95.656%). This was also 
observed in the Shannon index values of the samples, which indicated a more 
even distribution of abundance, rather than being high relative abundance 
being clustered to a smaller group of bacterial species. However, the top 25 
species still make up a very significant proportion of the overall bacterial 
microbiome of the sample site in both patient groups, common in all sample 
sites. 
 
Interestingly, of the top 10 bacterial species common to both DS and NoDS, 4 
species of Streptococcus were present (Fig. 5.10), all of which are frequently 
isolated from the oral cavity, and are considered commensal bacteria. The 
species with highest abundance in both patient groups was S. salivarius, with 
only small differences in relative abundance between DS (18.412%) and NoDS 
(15.372%) samples. 
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DS NoDS 
Bacterial species 
Average 
abundance 
(%) 
Bacterial species 
Average 
abundance 
(%) 
Streptococcus salivarius 18.412 Streptococcus salivarius 15.372 
Pseudomonas fluorescens 12.481 Serratia liquefaciens 11.432 
Enterococcus faecalis 11.527 Streptococcus mitis 11.185 
Streptococcus unclassified 8.806 Pseudomonas putida 5.940 
Streptococcus oralis 6.500 Microbacterium maritypicum 5.205 
Streptococcus mitis 6.091 Streptococcus oralis 4.725 
Brevundimonas terrae 4.958 Actinomyces odontolyticus 4.017 
Granulicatella adiacens 4.199 Acidovorax unclassified 3.828 
Chryseobacterium unclassified 3.814 Stenotrophomonas nitritireducens 3.311 
Lactobacillus rhamnosus 3.709 Lactobacillus paracasei 2.978 
Methylophilus methylotrophus 2.873 Pseudomonas aeruginosa 2.315 
Brevundimonas vesicularis 2.224 Haemophilus parainfluenzae 2.167 
Acinetobacter johnsonii 2.017 Pseudomonas fluorescens 2.060 
Rothia mucilaginosa 1.688 Brevundimonas vesicularis 2.033 
Prevotella tannerae 0.853 Propionibacterium acnes 1.637 
Streptococcus sanguinis 0.754 Citrobacter freundii 1.635 
Devosia unclassified 0.730 Granulicatella adiacens 1.605 
Propionibacterium acnes 0.635 Chryseobacterium scophthalmum 1.464 
Pseudoxanthomonas mexicana 0.634 Veillonella parvula 0.843 
Haemophilus parainfluenzae 0.575 Afipia broomeae 0.796 
Lactobacillus plantarum 0.515 Microbacterium testaceum 0.782 
Prevotella oris 0.509 Actinomyces lingnae 0.753 
Dermacoccus nishinomiyaensis 0.405 Acinetobacter johnsonii 0.729 
Streptococcus sobrinus 0.379 Rothia mucilaginosa 0.705 
Veillonella parvula 0.370 Prevotella melaninogenica 0.637 
Total 95.656 Total 88.153 
Table 5.8 Top 25 bacterial species in samples of the tongue of patients with 
(DS) and without (NoDS) grouped by disease status. 
Red text indicates unique bacterial species in the top 25 detected bacterial 
species of either group, blue indicates common bacterial species within the top 
25, and species in black text may or may not be present in both sample sets 
but are outside the top 25 detected species.
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Figure 5.10 Mean relative abundance of the top 10 common bacterial species of patients with (DS) and without (NoDS) of 
the tongue 
Comparison of mean relative abundance for the top 10 common bacterial species detected in samples from the denture-fitting 
surface of DS (blue columns) and NoDS (red columns) patients as determined by NGS.
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5.3.6 Sample size power calculation 
Based on the data obtained within this chapter, a power size calculation was 
performed by Dr Damian Farnell (Lecturer in Statistics, School of Dentistry, 
Cardiff University) to determine sample size necessary to provide confidence 
in the differences determined in these results. As analysed above, the sample 
groups were DS versus Non-DS for each sample site. Power was set at 0.8 
for the purpose of these calculations.  
 
 
Figure 5.11 Sample size power calculation plot showing required n for 
samples of denture-fitting surface 
The number of samples required to achieve a power of 0.8 was calculated to 
be approximately 1500 recruited patients. 
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Figure 5.12 Sample size power calculation plot showing required n for 
samples of palatal mucosa 
The number of samples required to achieve a power of 0.8 was calculated to 
be 22 recruited patients. 
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Figure 5.13 Sample size power calculation plot showing required n for 
samples of tongue 
The number of samples required to achieve a power of 0.8 was calculated to 
be approximately 14 recruited patients. 
 
The threshold for true reflection of results using the samples of the tongue was 
met within this study, thus observed differences are statistically robust and a 
true reflection of the differences within these samples 
 
5.3.7 Effect of smoking status on bacterial microbiome 
Microbiological samples taken and analysed by NGS in this study showed 
some differences in the bacterial microbiome of patients when grouped by 
smoking status.  
 
No significant differences (P>0.05) were observed in the number of unique 
bacterial species of the denture-fitting surface, irrespective of smoking or DS 
status (Fig. 5.14), where the number of bacterial species in the samples were 
very similar between groups. This was also the case with samples of the 
palate, but a decrease, although not statistically significant, was evident for 
smokers with DS compared with each of the other groups.  
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Significant differences were observed between groupings from samples of the 
tongue (Fig. 5.15). A significant increase in the number of unique bacterial 
species was evident for each group compared with the smokers with DS 
(smokers NoDS=P<0.01, non-smokers DS=P<0.05, non-smokers 
NoDS=P<0.05). Interestingly, no significant differences were evident when 
comparing within each of the other three groups (P>0.05). 
 
The pattern of results of the tongue and palatal mucosa were very similar; a 
lower number of unique bacterial species present in smokers with DS, 
compared with each other group, but the extent of differences was more 
pronounced in the results from the tongue samples. 
 
 
 
2
3
2
 
      
Figure 5.14 Effect of smoking status on the bacterial microbiome of DS and NoDS patients as measured by Chao index 
Comparison between the number of unique bacterial species detected in samples from the denture-fitting surface and palatal 
mucosa of patients grouped by smoking and DS status. No significant differences in the number of unique bacterial species 
were observed between any of the groups. 
Denture: smoker DS n=4, smoker noDS n=2, no smoker DS n=3, no smoker noDS n=8 
Palate: smoker DS n=4, smoker noDS n=1, no smoker DS n43, no smoker noDS n=6
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Figure 5.15 Comparison of effect of smoking status on bacterial microbiome 
of the tongue 
Comparison between the number of unique bacterial species detected in 
samples from the tongue of patients grouped by smoking and DS status.  
*P<0.05, **P<0.01 
Smoker DS n=5, smoker noDS n=3, no smoker DS n=3, no smoker noDS n=8 
* * 
** 
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5.4 Discussion 
This research represents the first study to use next generation sequencing to 
characterise denture-associated biofilms from patients with and without clinical 
presentation of DS, with a specific view to characterise the bacterial 
microbiome to species level. The aim was to investigate whether relationships 
existed between the bacterial composition of denture-associated biofilms, and 
DS disease progression. Previous studies in this area have used molecular 
biology methods, but these have typically identified bacteria to genus level 
(O’Donnell et al., 2015; Shi et al., 2016). The study of microbial diversity and 
its association with health status in many niches, including the oral cavity is an 
increasing area of research (Paster et al., 2001; Cho et al., 2014). 
 
Interestingly, Campos et al (2008) performed a similar study to the one 
reported here, but used pooled swab samples of DS versus non-DS patient 
groups. Additionally, when reporting the data, they only described differences 
of detected bacteria between DS and non-DS groups at genus level. 
Furthermore, no statistical analysis was done, making it difficult to evaluate the 
significance of the detected differences in the bacterial composition. The data 
reported in this chapter is based at species level, where substantial differences 
can exist, even within the same genus.  
 
Different bacteria species (even of the same genus) will likely also behave 
differently at a particular site and whilst relative abundance of a genus may be 
an interesting factor in a study, the influence of a particular species may have 
a significant impact on the infection status, which may be missed in cases 
where genus level results are reported. For example, there are many species 
of Streptococcus including S salivarius and S. mutans, which are distinct, 
particularly in their disease-causing ability. Streptococcus salivarius is a 
commensal microorganism, and not associated with oral infection, whereas S. 
mutans is a known pathogen, associated with development of dental caries. 
Interestingly, S. mutans has also been associated with an increase in virulence 
when co-cultured with C. albicans (Kim et al., 2017), where the production of 
the candidal quorum sensing molecule, farnesol, leads to increased S. mutans 
microcolony formation. As an acidogenic microorganism, increased 
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colonisation subsequently results in increased sugar utilisation and thus acid 
production, which is destructive to enamel. 
 
This study considered each patient’s bacterial microbiome individually, 
grouping them according to disease status only after characterisation of the 
bacterial microbiome, and then analysing the differences, after which, results 
were reported as differences at species level.  
 
This study included a number of strict patient recruitment criteria. In order to 
be deemed suitable for inclusion in the study, patients were not to have taken 
antibiotics or used steroids, or administered any immunosuppressive drugs 
investigational drugs in the previous 30 days to recruitment for the study. 
These factors have the ability potentially influence the composition of the 
microbiome, either directly as in the case of antibiotics, or indirectly in the case 
of steroids as a modulator of inflammation, and thus the normal immune 
response to the presence of microorganisms, particularly on the palatal 
surface. To standardise recruitment of patients, it was deemed necessary to 
employ these strict criteria. However, the modulating capacity of each of these 
factors, would be an interesting area for future study.  
 
Use of antibiotics is obviously commonplace in medicine and whilst often 
necessary, their over prescription has led to increased antimicrobial 
resistance. This occurs when common microorganisms that were previously 
controllable with the use of antibiotics develop tolerance or resistance to the 
mechanism of action of the drugs, rendering them far less effective. This in 
turn leads to a requirement for the use of alternative agents, that may also 
have different side effects. Importantly, cases of antibiotic resistance against 
last resort drugs e.g. carbapenems, are increasingly reported. Antibiotic use 
has previously been correlated with onset of acute erythematous candidosis, 
and is thought to arise because of the reduction of the resident bacterial 
microflora (Williams & Lewis, 2011). This in turn, provided an environment 
where Candida has less competition, and thus can grow to a level that 
provokes an immune response and causes local tissue damage. The 
modulatory effect of steroids on the immune response may also play a role in 
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Candida-associated disease progression, as studies have also shown a 
relationship between immune status and Candida colonisation in DS (Rogers 
et al., 2013). As antibiotics and steroids have an influence on the bacterial 
microflora, either directly or indirectly, it would be interesting to assess use of 
these agents in future studies. Use of antibiotics would inevitably reduce 
bacterial load, and possibly modify the overall composition of bacterial species 
present, the changes of which could lead to progression of DS. However, this 
may not necessarily have been the case, as the modulatory capacity of specific 
bacteria for C. albicans virulence may have been left in-tact with the remaining 
bacteria, and subsequent progression to DS may not have occurred. This 
would potentially have allowed the identification of bacterial species that could 
be attributed to progression of DS. Alternatively, the lowered competition 
caused by antibiotics could have a greater effect than the inter-species 
modulatory factors, thus including this as an exclusion criteria does provide a 
more representative environment in which these modulatory factors could be 
determined. Furthermore, a longer-term study would also be of interest to 
monitor the bacterial microflora of DS patients, and a follow-up post-treatment 
analysis of the microbiome would provide additional evidence into species-
specific contributions to DS.  
 
The patient exclusion criteria employed in this study had a negative impact on 
the number of patients recruited. As patients attending the Cardiff School of 
Dentistry are generally referred for treatment from local dental clinics, they 
likely had already received some form of intervention treatment prior to 
attending. An additional criterion for recruitment was use of a full upper acrylic 
dental prosthesis. These are becoming increasingly less common, not only 
with the improvement in dental health for the general public, but also due to 
the introduction of alternative materials to produce the prostheses such as 
cobalt chromium, but also, the somewhat recent introduction of dental implants 
to replace missing teeth. Furthermore, the inclusion of partial dentures would 
have also created an additional level of complexity, as there would be 
remaining teeth that are known to harbour a distinct bacterial microbiome of 
their own. This may have further clouded the results obtained, making the 
subtle differences that were observed, even less so. 
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Whilst the medical history and lifestyle history of the patients recruited to this 
study was limited, the incidence of HIV/AIDS, diabetes or nutritional factors on 
bacterial microbiome and incidence of DS would have been interesting to 
determine. The only ‘lifestyle factor’ recorded in this study was tobacco 
smoking, which has been attributed to changes in the microbiome of a number 
of sites in the human body, including the oral cavity (Kenney et al., 1975), and 
lungs, and some associations with development of microbial-related diseases 
have been made. DS is one such disease, the prognosis of which has 
correlations with smoking status. 
 
Whilst smoking is a key risk factor in oral candidosis (Shulman et al., 2005; 
Williams & Lewis, 2011) and other oral infections, no significant difference in 
the bacterial microbiome of denture surfaces of patients with or without DS, 
irrespective of smoking status was observed for denture and palatal mucosa 
samples. However, a significant (P=0.005) increase in the number of unique 
OTUs (i.e. bacterial species) was observed in tongue samples of Non-DS 
patients compared with DS patients (Fig. 5.15), which although a distinct 
surface, and within the oral cavity, it is separate from the denture and palatal 
mucosa surfaces. Normally, in the absence of a dental prosthesis, the 
influence of the tongue may be more significant, as the two surfaces can 
contact directly, but the physical material of the denture renders this not 
possible (unless dentures are removed). The tongue is also considered a 
reservoir for microorganisms, and although the presence of anaerobes is much 
higher on the tongue (Seerangaiyan et al., 2017), it can also act as a provider 
for other oral sites. 
 
Although only 19 patients were recruited to this study, the distribution of 
disease status between patients DS and non-DS was similar (DS n=8, NoDS 
n=11). Despite the lower than anticipated number of recruited patients, the 
sequence data generated was of excellent quality. The next generation 
sequencing data was sub-sampled at 10,995 reads, which allowed for bacterial 
species at the lower detection to be represented, even with a relatively small 
sample volume used for the NGS process. Some samples did contain a much 
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higher quantity of reads (e.g. S003_D with 133,846 reads). Sub sampling, 
although necessary to normalise samples for inter-sample comparisons of 
relative abundance of species, does render a portion unusable. In this case, 
approximately 12% of the data was used for analysis, leaving 88% unusable.  
 
Interestingly, relatively large differences were observed by culture between 
sample site and between patients. Images of the cultured agar plates were not 
collected for all samples analysed, and thus were not used to compare relative 
colonisation as an indicator of DS status or bacterial load.  
 
Some differences between culture and molecular detection of Candida was 
observed. Each foam imprint was placed onto a section of a Sabouraud’s 
dextrose agar (SDA) plate, and cultured in the laboratory. Where yeast-like 
colonies developed on SDA, the sample was considered Candida-positive. 
Random selections were further cultured on chromogenic agar 
(CHROMagar Candida) (Williams & Lewis, 2000; Perry & Freydière, 2007) 
for presumptive identification of Candida species. There are a number of 
limitations with this method for identification. Firstly, SDA does not discriminate 
between species of Candida. Secondly, not all colonies cultured on SDA were 
subcultured on CHROMagar Candida, thus depending on the number of 
Candida-like colonies that were cultured from the original foam imprint sample, 
there are several opportunities for missed colonies, as of those with many 
colonies, only a small portion were subcultured. Additionally, it was not always 
possible to differentiate between different colonies on the original SDA plate 
due to the close proximity in which they grew, and eventually merged together. 
The CHROMagar Candida claim to clearly differentiate different species by 
colony colour is true to a certain extent, but different species can, and do grow 
as the same colour. This is true for C. albicans and C. dubliensis, both of which 
grow as green-coloured colonies. As a result of these numerous limitations, 
the use of molecular methods was therefore employed to alleviate this 
uncertainty.  
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Further detection of Candida species was performed using a nested PCR, 
which, briefly, involved DNA extraction, pre-amplification with a fungal-specific 
PCR reaction, then using species-specific primers to further amplify the 
samples to detect the presence or absence of different Candida species. The 
results of the nested PCR showed presence of Candida based on a primer set 
that was not species-specific. However, no presence of C. glabrata or C. krusei 
was detected using primers specific for these species. As C. albicans is the 
most frequent cause of Candida-related infection, the absence of the detection 
of C. glabrata or C. krusei species is as important as the positive identification 
and confirmation of C. albicans. For this purpose, it was determined that the 
positive indication of C. albicans-like colonies by CHROMagar Candida and 
the absence of other common Candida species by nested PCR, implied that 
the samples had C. albicans. These samples were included in the NGS 
analysis, as presence of C. albicans was regarded as a pre-requisite for 
classification of DS, rather than an associated issue such as ill-fitting denture 
caused palatal irritation.  
 
Although sensitivity or limit of detection for these sample types was not 
performed, it appeared as though the molecular method of nested PCR was 
more sensitive than the culture method, even with the use of chromogenic 
agar. White et al (2003) determined the limit of detection for Candida species 
in blood samples using the same PCR method as used here was 5 CFU/ml. 
Although in theory, the culture sensitivity only requires one CFU per area 
measured (2cm2 in this case) the foam imprint culture method relies on good 
contact firstly between the foam imprint and the sample-site, and sufficient 
collection of the microorganisms. It also relies on good contact between the 
foam imprint and the agar surface, to efficiently transfer cells to the agar. This 
is then followed by culture of the microorganisms. The foam imprints do have 
the advantage of being porous, thus allowing surface fluids to be drawn into 
the foam, and for microorganisms to be drawn into the imprint along with it, but 
depends on the user and method of imprint sample collection. The use of a 
swab, which is less porous and in closer overall contact when streaked across 
the sample surface, may result in a higher yield of microorganisms collected 
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overall. This again depends on the collection of the sample, and the 
assumption that the area size for the samples were the same between the 
2cm2 area of the imprint, and the swab streaks. Variation in microbial load on 
each of these surfaces was evidenced by the differences in read numbers from 
the NGS data, and such differences were also observed in a similar study 
performed by Rogers et al., (2013b) where although differences were 
observed between sample sites, generally, patients with DS showed a higher 
Candida load on the denture-fitting surface and tongue, but lower on the 
palatal mucosa compared with NoDS patients.  
 
The order in which the samples were taken, which is important, was not 
specified in the sampling protocol. If the imprint and swab samples were taken 
from the same area of the sample site, and the swab was taken first, the 
resulting collection of viable and representative microorganisms for DNA 
extraction would inevitably have been higher than the foam imprint sample, as 
many microorganisms will already have been removed, and vice versa. This 
can affect subsequent culture or molecular analysis, depending on the order 
of sampling. 
 
The NGS data did not show any significant overall differences (P>0.05) in the 
bacterial microbiome between patients with or without DS for the denture-fitting 
surfaces or palatal mucosa. In fact, high similarities of DS and NoDS results 
for both number of unique bacterial species detected (Chao index), and the 
richness and evenness of spread of these species (Shannon index) was 
evident in samples of the denture-fitting surface. A slight trend toward a higher 
number of unique bacterial species was evident in NoDS patients than DS for 
samples of the palatal mucosa. A similar trend was also observed in the 
Shannon index of samples of the palatal mucosa, and of the tongue, where 
the distribution and abundance of bacterial species was more even (as 
demonstrated by the higher Shannon index values for NoDS patients 
compared with DS for each group). A significant increase in the number of 
unique bacterial species was observed in samples of the tongue from patients 
without DS compared with those with DS. This difference in bacterial diversity 
is in line with previous reports that suggest that when a community becomes 
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less diverse, or there is a trend toward dysbiosis, community-modulation of the 
environment is no longer maintained (Marsh, 2005). Microorganisms that can 
exist in more extreme environments subsequently thrive, and can cause 
damage to their local environment, such as the host (Takahashi, 2005; 
Matsubara et al., 2016). Similarity between DS and NoDS samples was also 
observed with other analyses including non-metric multidimensional scaling, 
in which, samples were weighted by relationship and distances assigned, but 
showed no distinct clusters of either DS or NoDs groups. The substantial 
overlap indicated high similarity between the groups. Furthermore, heatmaps 
and dendrograms assigned by phylogenetic distances of bacterial species 
between samples showed few correlations between individual samples, and 
only loose groupings by disease state, further indicating no strong distinctions 
by disease for abundance of particular bacterial species in samples. 
 
There were some striking differences when considering the abundance of 
individual bacterial species within sample groups. For example, when 
considering samples of the denture-fitting surface, a bacterial species within 
the genus myroides (species unknown) was found exclusively in the DS 
sample group, at approximately 8.5% relative abundance. Myroides 
(specifically the species odoratimimus) have been implicated in soft tissue 
infections of immunocompetent patients (Maraki et al., 2012), and linked with 
cases of bacteremia in those suffering with diabetes (Endicott-Yazdani et al., 
2015). It is therefore possible that the presence of this microorganism in the 
DS group is contributing to the palatal inflammation observed when recruiting 
the patients. Alternatively, the presence of the bacteria is contributing to the 
local microbial community (biofilms) residing on the denture surface, and 
modulating Candida virulence, thus resulting in the observed palatal 
inflammation.  
 
P. fluorescens was also detected exclusively in the DS group of denture 
samples with an abundance of approximately 7%, but also detected in both 
DS and non-DS samples of the palate and tongue, indicating its presence is 
not necessarily by chance, but it has successfully colonised each of these 
sites. There were quite significant differences in the abundance of 
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P. fluorescens between DS and non-DS of the palate (DS = 20%, non-DS = 
2.3%) and tongue (DS = 12.5%, non-DS = 2%). This indicates that at both 
biotic sites (palate and tongue), there is a basal level of presence of 
approximately 2% of the overall bacterial microbiome. There are a number of 
possibilities as to why this relative abundance then shifts, but it is not clear 
whether the shift is due to changes in the local environment, saliva, diet, 
immunocompetence, or whether it is indeed due to inflammatory conditions in 
the local area, or whether other factors within the biofilm due to accessory 
pathogens or other species that contribute different by-products can result in 
a better environment for P. fluorescens, which encourages its enhanced 
growth. It is also not clear whether the change in the abundance is due to the 
DS state of infection, or if the increased level of P. fluorescens, and indeed 
other bacterial species either unique to or increased in the microbiome of DS 
patients results in the disease. It is a very complex environment, with many 
influencing factors, with likely no single factor contributing solely to the 
incidence or development of the disease. 
 
Interestingly, when the patients were sub-grouped by smoking status (an 
important predisposing factor of DS incidence (Williams & Lewis, 2011)) there 
was a significant decrease in the number of unique bacterial species on the 
tongue detected in DS patients who smoked compared to DS patients that did 
not smoke, and non-smokers irrespective of DS status. A similar trend was 
observed in analysis of samples of the palate, but these were not statistically 
significant. Both biotic surfaces in this study, although distinct in location and 
histology show the same pattern of results, whereas on the denture-fitting 
surface, the number of unique bacterial species was similar between all sub-
groupings irrespective of disease or smoking status. The abiotic surface is in 
contact with the palate for a significant portion of the day (and not infrequently, 
also during the night), and this contact with the palate does not appear to allow 
for immunological management of the microbial content of biofilms. The 
relatively unchallenged biofilms may be present in similar quantities, and are 
similar in characterisation and profiling as observed in this study, whereas the 
palate and tongue are biotic, and subject to natural sloughing and other 
immunological management. The use of tobacco has long been attributed to 
242 
 
disease progression, including infections (Kinane & Chestnutt, 2000; Arcavi & 
Benowitz, 2004; Bagaitkar et al., 2008; Mehta et al., 2008), cancers (Blot et 
al., 1988; Winn, 2001; Johnson, 2001) and general but substantial 
immunosuppression (Sopori, 2002).  
 
5.5 Conclusions 
 
• Although species-level differences of the relative abundance of 
common bacterial species were evident, no significant differences were 
observed in the bacterial microbiome of the denture-fitting surface or 
the palatal mucosa between patients with or without DS,  
 
• Phylogenetic distance analysis showed overlapping groupings, 
correlating with the primary analysis in that the DS and NoDS groupings 
showed little distinction between bacterial microbiomes. 
 
• A significant increase in the number of unique bacterial species, and 
thus bacterial diversity was evident in the tongue microbiome of patients 
without DS, further suggesting a reduction in diversity results in a loss 
of microbial homeostasis, and possible onset of disease. 
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6. General discussion 
Biofilms are defined as multi-layered aggregates of microbial cells, attached to 
a surface and/or each other, with the cells often embedded in a matrix 
comprised of self-produced polymeric substances. Biofilms are ubiquitous in 
their distribution, occurring in natural and man-made environments (Häussler 
& Parsek, 2010). Of particular interest and relevance to this research is the 
presence of biofilms in the human body, where they can cause important 
clinical infection. To highlight this, an estimated 65% of hospital-acquired 
infections are thought to have a biofilm origin (Costerton et al., 1999; Joo & 
Otto, 2012).  
 
Microorganisms present in biofilms can be up to 1000-fold more tolerant to 
antimicrobials than their planktonic counterparts. The mechanism(s) of this 
increased tolerance is likely multifactorial. The biofilm community itself is 
typically embedded in a matrix of extracellular polymeric substances (EPS) 
(Flemming et al., 2007), which serves to reduce the cidal effects that would 
otherwise be caused by desiccation of the biofilm matrix. The EPS also 
provides a physical barrier to movement of antimicrobial compounds through 
the biofilm, and mitigates the impact of changing environmental variables such 
as temperature and pH (Flemming & Wingender, 2010). Furthermore, the 
polymicrobial nature of most biofilms provides many benefits for the resident 
microorganisms. The close proximity of the microorganisms and the 
constitutive use of quorum sensing molecules can stimulate stress responses 
from others around them, inducing virulence factors and increasing tolerance 
to extremes of conditions or external challenges. Many microorganisms, 
including bacteria and fungi actively secrete DNA to their surrounding 
environment and this provides a structural function to the biofilm (Mann et al., 
2009; Hall-Stoodley et al., 2008; Jakubovics et al., 2013; Martins et al., 2010). 
Furthermore, certain nucleic acid sequences may be taken up by other 
microorganisms, which is a potential method of acquiring additional genetic 
information.  
 
The biofilm matrix is complex, containing channels for nutrient transport 
(Costerton et al., 1999), and providing a range of different conditions in the 
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biofilm. This means that a diverse array of species may inhabit the biofilm but 
not all at the same location. For example, in a location exposed to air, 
anaerobic bacteria would be able to survive in an area of the biofilm where 
oxygen levels are lowest; potentially deep in the biofilm or near the attachment 
surface. Resistance to toxic chemicals including some antimicrobials can be 
mediated in the biofilm by the action of microbial efflux pumps (Costa et al., 
2014; Ramage et al., 2002; Mukherjee et al., 2003; Lewis, 2007), which 
actively remove antimicrobial compounds once they have been taken up by 
the cells.  While efflux pumps are not unique to biofilm cells, they are up 
regulated during antimicrobial challenge to increase resistance (Costa et al., 
2014; Webber & Piddock, 2003). The biofilm matrix itself can sequester 
antimicrobials through hydrophobic or electrostatic interactions, and indeed 
physical cell wall components which can then impede a diffusion gradient 
through the biofilm (Fux et al., 2005; Van Acker et al., 2014; Mah et al., 2003). 
A reduced growth rate and metabolic activity of biofilm embedded cells can 
also contribute to this increased resistance (Fux et al., 2005). Similarly, 
persister cells within a biofilm are viable cells that remain after antimicrobial 
treatment has eradicated the majority of other microorganisms. These 
persister cells can then re-establish the biofilm following completion of the 
treatment regime (Lewis et al., 2001; Seneviratne et al., 2008; Monroe, 2007. 
 
Biofilms are very common in clinical environments. Some of the most frequent 
and widely cited examples of biofilms occur in the lungs of cystic fibrosis 
patients (Stewart & Costerton, 2001; Lewis, 2001; Donlan & Costerton, 2002) 
and in this respect, Pseudomonas aeruginosa and Burkholderia cepacia are 
often implicated bacteria. Within the oral cavity, the most obvious example of 
a biofilm is dental plaque (Marsh & Bradshaw, 1995; Marsh, 2004; Marsh, 
2005; Rosan & Lamont, 2000). Dental plaque biofilms occur on the tooth 
surface and are comprised of hundreds of different bacterial species. Plaque 
colonised with Streptococcus mutans are associated with dental caries (Kim 
et al., 2017), whilst subgingival dental plaque containing proteolytic anaerobic 
bacteria such as Porphyromonas gingivalis are linked to periodontal disease 
(Marsh et al., 2011). 
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Members of the fungal genus Candida, are also frequently associated with 
human infection, and often these occur in biofilms in the oral cavity. Infections 
caused by Candida are termed candidoses, with four primary clinical 
presentations of oral candidosis described (Scully et al., 1994). These include 
pseudomembranous candidosis, chronic hyperplastic candidosis, and acute 
and chronic erythematous candidosis. Chronic erythematous candidosis (also 
referred to as denture-associated stomatitis, DS) was the focus of research in 
this PhD. DS is seen as areas of inflammation of the palatal mucosa in close 
proximity to the denture-fitting surface, on which, biofilms are present (Williams 
et al., 2011). The sustained contact of the denture-associated biofilms with the 
palate can lead to an inflammatory response from the host. Importantly, as the 
abiotic denture surface is not subject to natural renewal, and is not readily 
accessible to the reach of immune cells, the inflammation is chronically 
sustained, leading to subsequent tissue damage. 
 
Current treatments of DS target either improving general oral and denture 
hygiene, or treating the fungal component of the infection, with little 
consideration for the bacterial component of the biofilms. Several studies have 
shown that hundreds of different bacterial species are present in the oral 
cavity, including the denture-fitting surface, each of which could have a 
substantial influence toward the incidence or progression of the infection, as 
they exist in co-culture with other species and Candida.  
 
The overarching aim of this PhD was to investigate the relationship between 
the bacteria within denture biofilms and Candida albicans. Specifically, an 
evaluation of the impact of microbial interactions on Candida virulence was 
investigated. Initially, the research sought to develop an in vitro polymicrobial 
biofilm model using poly(methyl methacrylate) (PMMA) as the biofilm 
supporting surface, as this is the most commonly used material for complete 
dentures. The biofilm model incorporated several species as an inoculum. 
These species included representative oral bacterial species namely the 
facultative anaerobic early colonisers of Streptococcus sanguinis and S. 
gordonii, and the anaerobic secondary colonisers Actinomyces odontolyticus 
and A. viscosus. In addition, Porphyromonas gingivalis, which is an oral 
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bacterial species primarily associated with gingivitis and periodontitis was also 
utilised.  
 
Initial studies involved optimising biofilm model development, through the 
evaluation of the effects of pre-conditioning the PMMA surface with artificial 
saliva (AS) on subsequent adherence and biofilm formation. The AS 
formulation comprised of a range of chloride salts, in addition to proteose 
peptone, yeast extract, and most importantly, mucins. Despite the numerous 
compounds included in the formulation, the AS was still relatively simplistic 
compared with whole saliva which contains additional compounds including 
host cells, enzymes and peptides (Wade, 2013; Nasidze et al., 2009; Yang et 
al., 2012; Fabian et al., 2012; Humphrey & Williamson, 2001). This pre-
conditioning did not appear to influence overall microbial adherence nor biofilm 
formation by single- or mixed-species. This was interesting because the 
presence of saliva in such studies has shown a wide range of results, from an 
increase in adherence (Edgerton et al., 1993) to a decrease in adherence 
(Samaranaye et al., 1980; Satou et al., 1991).  
 
Saliva is a key component of the oral cavity, and also contains mucins and 
other proteins that may influence adherence in vivo, particularly as there is a 
constant flow of saliva in the oral cavity, whereas in the in vitro experiments, 
the pellicle is formed prior to addition of microorganisms. This flow was 
represented in vitro through agitation of the specimens during adherence of 
the microorganisms. Interestingly, this shear flow has also been linked with an 
increase in adherence in vitro (Thomas et al., 2002), but this was not observed 
in this study. It is thought that the deposition of mucins onto the surface modify 
the charge and adhesiveness, and this has previously been associated with 
an increase in adherence of oral bacteria to surfaces (Tabak, 1995; Gocke et 
al., 2002; Stinson et al., 1982). In the present study, biofilm was evident as 
multi-layered structures sporadically growing across the surface which was not 
uniformly covered and this pattern of biofilm growth was not affected by pre-
conditioning with AS. 
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It has been hypothesised that candidosis may occur due to elevated numbers 
of C. albicans, and in this study, the effect that bacterial presence had on the 
numbers of Candida and virulence factor expression was studied. Bacteria in 
mixed-species biofilms increased several putative C. albicans virulence factors 
including expression of genes involved in surface adhesion, biofilm initiation 
and maturation (ALS3, HWP1), and genes encoding hydrolytic enzymes 
involved in tissue invasion and damage (secreted aspartyl proteinases 4 and 
6 (SAP4, SAP6) and phospholipase D (PLD)). These genes, some of which 
are involved in morphological transition of C. albicans from yeast to hyphae 
state were up-regulated. This was also reflected by microscopic analysis of C. 
albicans-only and mixed-species biofilms. In these studies, in excess of 10-
fold increase in the number of C. albicans hyphae was evident in mixed-
species biofilms compared with C. albicans-only biofilms. The observed 
enhancement of putative C. albicans virulence genes, and the increase in the 
presence of C. albicans hyphae could not be attributed specifically to direct-
contact with a specific bacterial species, or to specific secreted molecules. 
There were no significant difference in the number of viable C. albicans in C. 
albicans-only biofilms and mixed-species (bacteria plus C. albicans), 
confirming that the increase in gene expression and formation of hyphae were 
due to the genotypic/phenotypic changes, rather than associated with more C. 
albicans cells.  
 
When mixed-species biofilms were developed incorporating P. gingivalis, most 
of the C. albicans virulence factors were no longer up-regulated. A significant 
decrease in genes involved in production of adhesins and hyphae was 
observed in mixed-species biofilms with P. gingivalis biofilms, and at a level 
similar to or lower than C. albicans-only biofilms. The differences in virulence 
factor expression highlighted the complexity of the microbial interactions, 
either through direct contact or by secreted molecules. Both mechanisms have 
previously been shown to affect virulence. Direct-cell contact has been 
demonstrated in oral bacteria, including S. gordonii and P. gingivalis 
(Kuboniwa & Lamont, 2010), and between S. gordonii and C. albicans 
(Bamford et al., 2015), but modulation of Candida phenotype is also 
associated with quorum sensing molecules including its own, farnesol, but also 
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those produced by bacteria including a homoserine lactone molecule 
produced by P. aeruginosa (Hogan et al., 2004). Although P. aeruginosa is not 
normally associated with colonisation of the oral cavity, the fact that a 
homoserine lactone molecule has been shown to modulate Candida 
morphology, indicates that other similar molecules, produced by other 
bacterial species may have comparable effects. 
 
Studies have shown that streptococci can bind to C. albicans hyphae 
(Silverman et al., 2010), and subsequently induce virulence factor expression. 
Direct binding of cocci-shaped bacteria to C. albicans was also detected by 
SEM of in vitro mixed-species biofilms in this PhD. This co-adhesion was more 
evident on hyphae, in comparison to yeast cells, indicating that direct cell-to-
cell contact may be playing a role in inducing responses that lead to an 
enhancement of Candida virulence. At the time of writing, this was the first 
study that had evaluated the effects of oral bacteria on the modulation of C. 
albicans virulence in in vitro biofilms. It is of great interest to determine the 
mechanism behind the modulation of virulence, as this may provide insight into 
possible targets for prophylactic strategies for individuals at increased 
susceptibility for DS, or management of established infection. 
 
The in vitro biofilm model developed in this project provided valuable insight 
into the modulatory capacity of what are considered commensal bacteria on 
C. albicans virulence factor expression. However, as DS is an infection of the 
palatal mucosa, it was important to also develop a tissue infection model. A 
number of commercially available 3D tissue models exist, but these all have a 
number of limitations, not least of which is their high cost. Furthermore, there 
is an inability to further modify these tissue models to incorporate additional 
cell types, thus somewhat limiting the models as clinically and histologically 
representatives of normal mucosa.  
 
The two main types of tissue models are epithelial-only (comprised of stratified 
keratinocyte cells), and full-thickness (which includes both the epithelium and 
a lamina propria). In an effort to overcome some of the limitations outlined 
above, Chapter 3 of this thesis describes the development of two types of in 
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vitro tissue models as alternatives to those commercially available, thus 
allowing a greater number of analyses to be completed in a cost-effective 
manner. The research involved creating both an alternative tissue model to the 
SkinEthic RHOE (EpiSkin), and a full thickness tissue model similar to 
EpiOral full thickness tissues (MatTek). The in vitro and commercially available 
tissues were also used in biofilm-infection studies in Chapter 4 to investigate 
the pathogenicity of the different types of in vitro biofilms. 
 
SkinEthic RHOE used TR146 keratinocytes, which were originally isolated 
from a buccal squamous cell carcinoma. These cancer-derived cells are not 
normal in their genotype, and as such, may not behave as normal oral 
keratinocytes should. This was evident in both the SkinEthic RHOE and in 
vitro keratinocyte-only tissues, where TR146 cells were used. Although 3D 
culture was evident in both the commercially available and in vitro tissues, to 
a similar extent in each model, no differentiation or stratification of the 
keratinocytes was evident. Normal mucosal epithelium typically has several 
distinct cell morphologies. These include block-like basement epithelial cells 
which then differentiate as they stratify toward the outer layer, where they 
keratinise as longer spindle-like, keratin rich cells. The differences between 
the model and in vivo tissues highlight the limitations of the in vitro tissue 
models. Furthermore, there is no possibility of fully representing immune 
responses, due to the lack of lamina propria and immune cells. On the other 
hand, the relatively short culture period of 5 d, and the relative ease of culture 
in the laboratory facilitates the high throughput of analyses that can be 
completed in a relatively short period, with very little associated costs. 
 
Previously, keratinocyte-only tissues have been used to study in vitro C. 
albicans infection using planktonic inocula (Schaller, 2002; Samanarayake et 
al., 2006; Silva et al., 2009; Silva et al., 2011; Williams et al., 2013; Yadev et 
al., 2011). No studies had evaluated the use of biofilms as the starting 
inoculum, and specifically, the effect of a mixed oral bacterial species 
inoculum. The biofilms developed in this research, whilst simplistic in 
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composition were deemed to be appropriate to evaluate effects on virulence 
and pathogenicity of C. albicans.  
 
Full thickness tissue models, which are considerably more expensive than the 
keratinocyte-only tissues, are more (histologically) representative of oral 
mucosa. This was demonstrated by the presence of both an epithelium and 
lamina propria, with the advantage of being able to evaluate a more complex 
tssue response, as a result of cell-to-cell communication between the epithelial 
cells and fibroblasts. These cells produce distinct cytokine profiles to modulate 
immune responses to infection, and these self-produced cytokines are known 
to have a regulatory function for further production or inhibition of cellular 
production of other cytokines. Due to the substantial costs of the EpiOral full 
thickness tissues, another aim of this research was to develop an alternative 
full thickness tissue. As previously discussed, this model could be used to 
perform a greater number of infection analyses in a cost-effective manner. In 
addition, the model could facilitate the incorporation of additional cells, 
including immune cells such as dendritic cells, monocytes and Langerhans 
cells, making the model even more representative of in vivo oral mucosa. 
 
The successful culture of a full-thickness tissue was achieved using normal 
oral fibroblasts in a collagen matrix, overlaid with immortalised normal oral 
keratinocytes. The histological analysis of the tissues showed excellent 
structure of the tissues. The lamina propria showed a sparsely populated 
matrix, which had contracted during culture, and a thick stratified epithelium, 
with good differentiation of the cells, and some keratinisation. Interestingly, 
when TR146 cells were used in place of immortalised normal oral 
keratinocytes, this differentiation was lost, and despite the better stratification 
in the full thickness tissues than in the keratinocyte only tissues, no maturation 
or keratinisation of the cells was observed. This finding confirms the abnormal 
behaviour and culture of the cancer cells, and highlights the importance of 
using normal, or immortalised normal cells to represent normal tissues.  
 
To culture the immortalised normal oral keratinocytes in vitro, a feeder layer of 
fibroblast cells was required. The by-products of fibroblast metabolism allows 
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the keratinocytes to grow. Without the feeder layer, keratinocytes will initially 
adhere to the flask, but then grow very slowly, where the rate of cell death is 
quicker than the new cell growth, and ultimately no viable cells remain. For this 
reason, the use of immortalised normal oral keratinocytes were not used for 
the keratinocyte-only tissue model. It is possible that the fibroblast feeder cells 
could be seeded into the well of a plate, and keratinocytes seeded into an 
insert, thus providing an opportunity for free movement of by-products in the 
culture medium. In this way the cells could maintain viability, and when 
cultured at the air-liquid interface, could stratify into a 3D tissue structure. Many  
published research articles for candidosis-associated infections use the 
SkinEthic RHOE keratinocyte only models, but the advantages of using 
normal cells over the cancer-derived TR146 do warrant further investigation 
into this possibility of 3D tissue development. This would potentially reduce the 
necessary culture time for the tissue models, and could provide the same 
tissue structure as the RHOE, but with normal cells. In this instance, as the 
RHOE is a widely accepted tissue model for in vitro analyses, the new 
keratinocyte-only model could be adopted as the new standardised, and more 
representative model. 
 
The in vitro biofilm models developed in Chapter 3 were used for infection 
analyses in both the simplistic keratinocyte-only tissues, and full thickness 
tissues, using commercially available constructs and in vitro equivalents. In all 
cases, a similar pattern of biofilm-induced damage was observed, but the 
extent did differ between models. Slight damage was caused by C. albicans-
only and bacteria-only biofilms, whereas the mixed-species biofilms induced a 
greater amount of damage to the tissues. Additionally, the expression of the 
SAP4, SAP6, PLD1, and ALS3 genes was up-regulated, also correlating with 
previously observed results. The upregulation of SAP4, SAP6 and PLD1 could 
indicate production of hydrolytic enzymes, the effects of which were clear when 
analysing the sections by microscopy. Mixed-species biofilms showed 
substantial damage to the tissues, and extensive invasion of C. albicans 
hyphae and bacteria. Previous studies have also implicated the production of 
253 
 
SAPs and PLs with tissue damage and invasion into epithelial layers of tissues 
(Villar et al., 2007; Schaller et al., 2005; Naglik et al., 2003).  
 
In some studies that investigated candidosis using tissue models, C. albicans 
was inoculated as planktonic cells. Interestingly, even when the wild-type C. 
albicans strain (CAF2-1) was used, the damage induced by this planktonic 
inoculum was not visibly as apparent as when using mixed-species biofilms in 
this study. Yadev et al (2011) observed the vast majority of the C. albicans 
cells remained on the surface of the tissues, with relatively few invading into 
the tissues. Although no quantification of damage was reported, it appears as 
though there was relatively little visible damage to the tissues, as the integrity 
of the tissues appeared similar to that observed with tissue infections using C. 
albicans-only biofilms in this study. The observed differences between the 
CAF2-1 strain, and ATCC 90028 could indicate substantial strain variability, 
but the differences in method inoculum also elude to differences in culture 
state, between planktonic and biofilm forms. Moreover, throughout this PhD, a 
strain was used that produced virulence factors less readily, including 
formation of hyphae (Lu et al., 2006). Thus, the induction of C. albicans 
virulence factors within biofilms indicated the strong extent of bacterial 
modulation of C. albicans virulence. 
 
A component of this PhD project was to characterise the bacterial microbiomes 
of specific sites in the oral cavity of patients with and without clinical 
presentations of DS (Chapter 5). The research recruited denture wearing 
patients attending the Cardiff University School of Dentistry for routine 
treatment or appointments. Strict recruitment criteria were imposed to ensure 
a specific group of patients were recruited and to allow for the anticipated 
subtle differences to be observed where evident. However, this also resulted 
in fewer patients being recruited than was desirable.  
 
Analysis of the bacterial content of samples from the tongue, palate and 
denture-fitting surface yielded interesting results. The only significant 
difference in the number of unique bacterial species, as analysed by the Chao 
index of the next generation sequencing data, was the microbiomes of DS and 
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NoDS patients in samples of the tongue. However, using STAMP analysis to 
determine microbiome profiles between patient groupings, there were no 
significant differences at any sampling site.  
 
Analysis of the microbiome data at species level demonstrated some 
substantial differences of particular bacterial species between DS and NoDS. 
For example, the presence of Pseudomonas fluorescens was detected 
exclusively in samples of the denture-fitting surface of DS patients and at 
nearly 6 and 10 times the level in DS patients compared with non-DS patients 
in samples of the tongue and palate respectively. Furthermore, Acinetobacter 
johnsonii was increased approximately 3-fold in patients with DS compared 
with patients with no DS. This was similar to the findings for S. mitis. 
Acinetobacter johnsonii was also present on the palates of both DS and NoDS 
patients, but at similar levels between the disease groupings, and a similar 
level to the denture samples. Thus, the only increase in presence of this 
bacterial species was in the denture samples of DS patients. Furthermore, the 
presence of S. mitis was also increased approximately 2-fold, in samples from 
the tongue. The presence of Actinomyces odontolyticus was also higher in DS 
patients, more than 6-fold, and was one of the selected oral bacteria used in 
the mixed species biofilms experiments in this PhD. Both S. mitis and A. 
johnsonii are opportunistic pathogens (Mitchell, 2011; Shelburne et al., 2014) 
and common residents of the oral cavity. Actinomyces odontolyticus has also 
been deemed an opportunistic pathogen, although it is only rarely associated 
with bacteraemia (Cone et al., 2003). The differences in the presence of 
particular bacterial species, and their apparent correlation with DS warrants 
further in vitro analyses to investigate the effects of these particular bacterial 
strains. Furthermore, it would be useful to evaluate a clinically relevant mixed-
species biofilm, by incorporating not only the specific species, but also the 
relative proportions at which they were detected, and evaluate subsequent 
modulation of C. albicans virulence in biofilms. The difficulty in doing this, is 
that other bacteria that may not necessarily be present at substantial 
quantities, but still contribute to the overall community. Ultimately the whole 
biofilm will adjust to a balance according to the environment in which it is 
cultured. This factor is not easily controlled, but the starting inocula is the 
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easiest factor to control. Whether the resulting biofilm is then relatable to an in 
vivo scenario warrants further investigations. 
 
The presence of Candida is a pre-requisite for DS, but the mere presence of 
Candida does not necessarily lead to onset of DS. The bacteria and their 
effects on Candida virulence were the primary interests in this PhD, but further 
work using clinical strains of C. albicans isolated from patients with and without 
DS to varying extents (according to Newton’s classification of DS), is of great 
interest. Studies have demonstrated that there is significant intra-strain 
phenotype variation, and this may well be another mitigating factor in the 
incidence or severity of DS. In addition to the multiple predisposing factors 
already attributed to DS incidence, if a strain of Candida is present that is 
particularly virulent, or avirulent, it may determine the prognosis of the 
modulation, and thus the subsequent infection by the denture-associated 
biofilms. Furthermore, the absolute numbers of different bacterial species 
present, or microbial load may not be as influential to the microbial community 
or modulation of virulence as the actual species themselves. This project has 
shown that certain bacterial species can differentially modulate C. albicans 
virulence factors in vitro, and it is likely that this will continue in vivo, with more 
comprehensive modulation with a greater diversity of mciroorganisms. 
 
At the time of writing, there was only one published article detailing an 
investigation of the oral bacterial microbiome between patients with and 
without DS, published late into the duration of this project (Shi et al., 2016). 
The findings were very similar to this project, in that no significant differences 
in the overall bacterial microbiome were observed between patients with and 
without DS. No other studies have specifically looked at the bacterial 
component of these biofilms in this context. The study within this PhD however, 
analysed the bacterial content to species level, and found some substantial 
differences in presence of individual specific bacterial species, that may be 
attributed to the incidence of DS. Further studies are warranted, particularly 
with the limited patient numbers achieved in this study, to increase confidence 
in the associations of particular bacterial species with incidence.  
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The similarities of the overall bacterial communities determined in individuals 
with and without DS demonstrate that subtle changes in the composition down 
to specific bacterial species may have an influence on the incidence of DS. A 
larger cohort of patients would be necessary to further evaluate the bacterial 
microbiome, and to identify these subtle changes with more certainty. 
 
This research confirmed the inherent complexity of microbial interactions, 
particularly in mixed-culture biofilms. Although many infections are associated 
with a limited number of ‘keystone’ pathogens, the inevitable co-existence of 
additional microorganisms may, as demonstrated in this research, contribute 
to overall modulation of virulence of these pathogens, or indeed, local 
opportunistic pathogens.  
 
Subtle differences were observed in the clinical study, but these differences 
may be substantial when considering the modulatory capacity of bacteria on 
C. albicans virulence shown in the in vitro research. Small variations in the 
bacterial composition of biofilms may heavily influence the pathogenicity of the 
biofilms, and subsequent inflammatory response in vivo.  
 
These findings have implications for most, if not all polymicrobial biofilm-
associated infections. The modulatory influence that each microorganism has 
in the overall community needs to be considered carefully, and although there 
may be specific pathogens associated with disease or infection, attention 
should be given not necessarily to eradicating the pathogen, but potentially 
managing them. This could be by use of alternative antimicrobial compounds, 
or even the application or introduction of probiotics into the environment.  
 
The observational studies in this project have indicated a number of future 
opportunities and interests that could further our understandings of microbial 
interactions, and microbial modulation within biofilms. These include the 
following: 
 
- Determining the bacterial strain(s) responsible for up-regulation of the 
C. albicans virulence factors 
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- Continue to develop in vitro biofilm models that are more representative 
of denture-associated biofilms using the results of the clinical study. The 
use of clinically relevant species, and inclusion at a level that 
corresponds with the relative proportions detected in patients with and 
without DS to strengthen understanding of in vitro interactions and 
modulation of C. albicans virulence 
 
- Understanding the mechanisms underpinning the enhancement of C. 
albicans virulence in mixed-species biofilms, and the reasons behind 
the reversal of virulence after the inclusion of the keystone pathogen 
P. gingivalis within the mixed-species biofilms 
 
- Building upon the foundations of the in vitro 3D tissue models, to 
develop a normal oral keratinocyte-only tissue model, and incorporate 
additional cells to make the models more closely representative of 
normal oral mucosa. This is necessary to more comprehensively 
understand the host responses to infection when considering cell-to-cell 
communications and responses of epithelial cells to the potential 
varying virulence of the strains. 
 
- Evaluating the in vitro virulence profiles of the C. albicans isolates from 
patients with and without DS, to determine whether intra-strain 
variability of virulence can be associated with the susceptibility to 
candidosis infection. This can be achieved by incorporating the clinical 
isolates in the in vitro biofilm model, and evaluating the virulence genes 
used in this study. The mature biofilms can also be used to infect in vitro 
and/or commercial tissue models to profile the infection progression and 
host responses to the different C. albicans strains. 
 
- Investigating efficacy of antimicrobial compounds and commercial 
denture-cleansing products against denture-associated biofilms 
 
Research Conclusions 
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An in vitro polymicrobial biofilm model was developed to evaluate interactions 
between bacteria and the causative microorganism of DS; C. albicans. The 
biofilm model was used to determine the effects of a mixture of oral bacterial 
species on the production of a range of C. albicans virulence factors, including 
the morphological transition from yeast to hyphae, and the expression of a 
number of putative virulence-associated genes. An up-regulation of the 
expression of the virulence genes involved in adhesion, biofilm formation, 
formation of hyphae and production of hydrolytic enzymes was observed, and 
a visual increase in the proportion of hyphae compared with yeast cells in 
mixed-species biofilms. When the biofilm inoculum was modified to include an 
additional strain of oral bacteria; P. gingivalis, a reverse of the enhancement 
of C. albicans virulence was observed, highlighting the intricacy and 
complexity of polymicrobial interactions and modulation of virulence. 
 
The research also developed two in vitro 3D mucosal tissue models for the 
purpose of evaluating the biofilm-associated pathogenicity in an infection 
model. A keratinocyte-only tissue and a full-thickness tissue were developed 
as alternatives for commercially available constructs of equivalent types. 
Biofilm infections of the in vitro tissue models were compared with infections 
of commercially available models, evaluating biofilm-induced damage, and 
behaviour of the biofilms, with similarities between the in vitro and 
commercially available constructs of both types. 
 
A clinical study was completed to characterise bacterial microbiomes at 
various sites within the oral cavity of patients with and without denture-
associated stomatitis (DS). Some differences in the relative abundance of 
bacterial species were detected between patients with and without DS, but the 
overall microbiomes for each sample site were not significantly different. The 
identification of several bacterial species that may be associated with DS 
incidence is of great interest, but further studies would be required to increase 
confidence in these subtle differences. 
 
The key findings and outcomes of this study are: 
- Certain oral bacterial species when co-cultured in acrylic biofilms 
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significantly increased the expression of C. albicans virulence factors, 
and subsequently, enhanced tissue damage in model systems.  
 
- Enhancement of C. albicans virulence was reversed with the inclusion 
of an additional oral bacterial species, P. gingivalis. This highlights the 
complexity in predicting how bacterial communities as a whole might 
modulate C. albicans virulence.  
 
- Candida was detected in clinical samples of 14 patients (DS n=6, non-
DS n=8). Metataxonomic analyses revealed differences in relative 
abundance of bacterial species, but no significant differences in the 
bacterial microbiomes of the denture-fitting surface and palate between 
DS and non-DS patients were evident. Importantly, however, a 
significant increase in the number of bacterial species was evident for 
the tongue microbiome of non-DS patients. 
 
- The in vitro modulating capacity of bacteria toward Candida virulence, 
and the observed species-level differences in bacteria between DS and 
non-DS patients highlight the need for consideration of the bacterial 
composition of oral biofilms in the pathogenesis of DS 
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School of Dentistry, 
Cardiff University, Heath Park,  
Cardiff, CF14 4XY, UK 
Tel : 029 20742541 
. 
 
Participant Information Sheet and Consent Form  Page 1 of 8 
Clinical Protocol Denture Biofilms 
Version 3 – 17
th
 March 2016 
Protocol: Denture acrylic biofilms: microbial composition, interactions and prevention 
 
PhD Studentship Proposal:-Supervisors Dr David W Williams, Dr Melanie Wilson, Dr Xiao-
Qing Wei and Prof Michael AO Lewis.  School of Dentistry, College of Biomedical and Life 
Sciences, Cardiff University, Heath Park, Cardiff, CF14 4XY. 
 
Background: Biofilms are defined as communities of microorganisms, that are generally 
attached to a surface and embedded inside an extracellular polysaccharide matrix generated 
by the microorganisms. Such a biofilm state appears to be the preferred mode of growth of 
microorganisms in natural environments, and recent estimates associate biofilms with over 
65% of hospital-acquired infections.   
Within the oral cavity, biofilms are present on the hard non-shedding surfaces of teeth in the 
form of dental plaque. Dental plaque is the archetypal biofilm and associated with two of the 
most prevalent infections in humans, namely dental caries and perodontal disease.  
Furthermore, oral biofilms can also occur on the surfaces of soft tissues, as well as 
prosthodontic and orthodontic devices located in the mouth.  
Biofilm development on acrylic denture surfaces is promoted by poor oral hygiene, the failure 
to remove the denture whilst sleeping, and poor denture cleansing. The abiotic surface of the 
denture also means that removal of adherent microbes through ‘self-renewal’ of surface 
layers does not occur as encountered with living mucosa.  In addition, the lack of salivary flow 
over the fitting surface of the denture limits mechanical removal of microorganisms.  The 
significance of biofilms on dentures is that they are associated with the infection, denture 
stomatitis.  The key microrganisms involved in denture stomatitis are believed to be fungi of 
the genus Candida, although bacterial species will also be present.   
Whilst there are numerous studies investigating the microbiology of denture stomatitis, the 
majority are limited to the fungal component of the biofilm. By furthering awareness of the 
microbiology of denture biofilms insight will be gained on the involvement of bacterial species 
in denture stomatitis and this will lead to clinical benefit in terms of management of the 
condition.     
Aims: This work will provide the basis of a PhD EPSRC-CASE award studentship to start in 
October 2013.  The primary aim of this proposed research is to thoroughly characterise the 
microbial composition of denture biofilms, using not only cultural methods, but also, new next 
generation sequencing methodology (Work Package; WP1).  Having identified the key 
microbial components, in vitro biofilms will be generated on acrylic surfaces and the 
distrubution of microbial species will be spatially charaterised by confocal laser scanning 
microscopy (CLSM) and species-specific molecular probes.  This work will form the basis of 
WP2.  In addition, the effect of these biofilms on oral epithelial cells and resident 
macrophages (cell damage and cytokine release) will be assessed.  The test cell lines and 
oral epithelium will be from commercially available sources.  Tissue macrophages are 
heterogeneous cell populations and macrophage responses and phenotypic differentiation will 
be dependent on the tissue environment adjacent to the denture biofilms.  Given the 
inevitable close proximity of microorganisms within biofilms, it is highly likely that synergistic 
or antagonistic effects on virulence gene expression and host responses will occur depending 
on the microbial community members present.  In the case of the effects on host immunity, in 
vitro studies performed in Cardiff have already demonstrated that lipopolysaccharide from 
Gram-negative bacteria enhances inflammatory cytokine release to subsequent Candida 
challenge.  The proposed study will also examine the responses of inflammatory macrophage 
(M1) and anti-inflammatory macrophage (M2) against biofilm microbial challenges for cytokine 
production particular for IL-12 family cytokines.   
In WP3, the effect of different bacterial components on the expression of specific Candida 
virulence factors (e.g. those associated with adherence, as well as hydrolytic enzymes) and 
the cytokine release by the oral epithelial cells interfacing with the developed biofilm will be 
investigated.   
A key management strategy in the treatment of denture stomatitis is appropriate cleansing of 
the denture using antimicobial agents.  Having established our in vitro biofilm model in WP2 
and measured the associated effects this has on tissues in WP3, we aim to assess the 
efficacy of several denture cleansing agents in WP4.  WP4 will involve exposure of preformed 
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biofilms on acrylic surfaces to denture cleansers and assessing their ability to both remove 
the biofilm and have cidal activity on the biofilm cells.  Post-treatment the subsequent effect of 
the ‘inhibited biofilms’ on host tissue will be measured.  A summary of the respective work 
packages is outlined below, each WP providing the basis of the respective Chapters within 
the PhD. 
 
WP1: Analysis of microbial communities involved in denture stomatitis 
This research will involve analysis of the microbial populations recovered from the fitting 
surfaces of dentures, tongue and palate of patients with and without denture stomatitis.  
Given that extensive studies have been undertaken on the Candida species component of the 
denture biofilm involved in denture stomatitis, the aim of WP1 will be to supplement standard 
microbiology culture (to provide quantitative estimation and identification of both Candida and 
bacteria), with next generation sequence (NGS) analysis.  As this has not previously been 
undertaken on these types of samples, and given the extensive amount of data generated by 
high-throughput sequencing, this work will essentially take the form of a pilot study and will 
involve the sampling of 20 patients with pre-existing denture stomatitis and 20 patients 
without denture stomatitis.  These patients will all be attending the School of Dentistry as part 
of their normal oral healthcare. The patients will be identified initially by the clinician in charge 
of their care prior to arrangements being made for informed consent to be taken. The 
essential criteria for subject inclusion will be that individuals will be aged >18 years and have 
a full upper conventional denture.  Exclusion criteria will include those patients who have used 
an antibiotic or antifungal within the previous 30 days, patients who undertake daily use of a 
steroid inhaler, systemic steroids or immunosuppressant drugs, those who have had 
participation in another clinical study or receipt of an investigational drug within 30 days of the 
screening visit.  Palatal inflammation in the subjects will be assessed by the clinician and 
scored according to Newton’s Classfication.  The clinician involved in taking consent and 
sampling these patients will be Dr Joshua Twigg. Dr Twigg has previouis experience in taking 
consent from patients and has received appropriate GCP training.  Appendix I provides the 
information sheet and consent form that will be provided to the patient. 
Imprint cultures will be obtained from the denture surface in contact with the palate, the palate 
itself and also the tongue.  These imprints will be used to inoculate blood agar to provide a 
total quantification of microorganisms, as well as CHROmagar for detection of Candida 
species.  In addition, a swab from both the denture and palate will also be collected and will 
serve as a source of microbial DNA for NGS.  These samples, whilst collected by the 
clinician, will subsequently be processed by the student undertaking the PhD.  Including the 
time taken to acquire informed consent and clinical sampling, it is anticipated that no more 
than an additional 30 min of clinician time will be required for each patient. The service 
support costs for this work will be covered from within the funds available for the PhD. 
In the case NGS, bacterial DNA will be extracted from the imprint culture using a commercial 
DNA extraction kit.  PCR amplicon libraries will be generated using a variety of primers 
including covering the V1-V5 hypervariable regions of the bacterial 16S rRNA gene.  
Identification of the microorganisms will be conducted using the MOTHUR suite of 
programmes (Schloss et al., 2009). Taxonomic composition and relative abundance of phyla, 
genera and species within the microbial communities will be analysed using appropriate 
software.  
 
WP2: Development of a clinically relevant in vitro model of a denture biofilm 
In vitro studies will develop biofilms on acrylic surfaces.  The inoculum for seeding these 
biofilms will be based on identified microbial species collected from WP1.  A common strain of 
C. albicans will be included in all biofilms, but the bacterial component will be modified 
between experiments. Biofilms on acrylic surfaces will be overlaid on to a commercially 
available oral mucosa or one derived from commercially available cell lines. Human 
macrophages previously derived from human peripheral blood monocytes by culture in either 
M1 conditional medium or M2 conditional medium will be incorporated into this in vitro model. 
Epithelial cell damage and Candida tissue invasion will be investigated based on previous 
methodology developed by our research group.  
 
WP3: Microbial interaction and associated effects on host cells 
Using mixed Candida and bacterial species biofilms on acrylic surfaces and RNA extracted 
from infected tissues (from WP2), real-time PCR will be used to quantify expression the 
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putative Candida virulence factors.  These factors will include agglutin-like sequence (ALS) 
proteins, phospholiases, and secreted aspartyl proteinases.  As expression of these factors is 
likely to be affected by the composition of the microbial communities, the presence of 
particular bacterial species may then be correlated with enhanced virulence of C. albicans. 
Human cytokines will be examined using a cytokine array for the inflammatory set IL-1β, IL-8, 
IL-17, IFN-γ, TNFα, TGFβ and IL-10.   
 
WP4. Antimicrobial efficacy in inhibiting denture based biofilms 
Following successful construction of mixed species biofilm models and associated research 
into their effects on host tissue, efforts will be made to inhibit these biofilms through exposure 
to specific antimicrobial denture cleanser agents and mouth washes (i.e.. Polident, sodium 
hypochlorite or chlorhexidine gluconate). The efficacy of these agents on the established 
biofilm will be determined using total viable counts, as well as live/dead staining coupled with 
CLSM.  In addition, biofilms treated with these agents will be introduced into our developed 
tissue model and the clinical benefits measured, based on tissue damage and inflammatory 
responses. 
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Appendix I 
 
 
RESEARCH PARTICIPANT INFORMATION SHEET 
 
Denture acrylic biofilms: microorganisms involved in inflammation of the gums 
 
Clinical Protocol  
 
You are being invited to take part in a research study.  Before you decide, it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully and discuss it with others if you wish.   
• Part 1 tells you the purpose of the study and what will happen to you if you take part.   
• Part 2 gives you more detailed information about the conduct of the study.   
Ask us if there is anything that is not clear or if you would like more information.  Take time to 
decide whether or not you wish to take part.  Thank you for your interest in this research 
study. 
 
PART 1 
 
What is the purpose of the study? 
 
The primary aim of this study is to investigate what microorganisms are involved in colonising 
dentures and causing stomatitis (inflammation of the mucous lining of the mouth). 
 
Why have I been chosen? 
You have been chosen because you meet the study entry criteria of having a full upper 
conventional denture and are at least 18 years of age.  You may also be experiencing clinical 
signs of stomatitis. 
Altogether, a maximum of 40 subjects will take part in this study (approximately half of whom 
will have clinical signs of stomatitis and approximately half of whom will not have stomatitis).  
 
Do I have to take part in this study? 
No.  You are entirely free to choose whether or not to take part.  If you do decide to take part, 
you will be asked to sign a consent form, of which you will be given a copy along with this 
information sheet to keep.  You are still free to withdraw at any time without giving a reason.  
 
Whether you decide to take part or not will have no influence on the subsequent treatment 
that you will receive in the Dental Hospital and School.  
 
What will happen to me if I take part in this study? 
If you agree to participate in this study, you must read this Research Participant Information 
Sheet and then sign and date the Informed Consent Form before any study procedures begin. 
Your involvement will be to permit microbiological samples to be collected from your denture, 
palate and tongue on one occasion.     
 
The activities to be performed if you agree to participate will be as detailed below: 
 
1. Visit 1 
Upon arriving at the clinic, you will be given sufficient time to read through this information 
sheet and ask the clinic staff in private about any questions you may have regarding the 
study, before deciding whether or not to participate in the study.  After you have provided your 
written informed consent to participate in this study, your date of birth, gender, race and 
smoking status will be recorded in your study booklet.  The study dentist will also ask you 
about your medical and dental history, (including the age of your denture) and whether or not 
you use denture adhesive and record this in your study booklet, along with any medications 
you may be taking.  Assuming you meet the study eligibility criteria, the study dentist will then 
carry out an examination of your mouth. 
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You may not participate in this study if you have been on another clinical study in the 30 days 
(1 month) before being sampled or if you have been in receipt of an antibiotic or antifungal 
within the previous 30 days. Similarly, patients who undertake daily use of a steroid inhaler, 
systemic steroids or immunosuppressant drugs, are not able to participate in this study. 
2. Visit 2 – Sampling - up to 30 min 
If this visit is on a separate day to visit 1, you will be asked about any medications you have 
taken/are taking and the study dentist will check that you are still eligible to continue in the 
study by asking you a few questions.  Assuming you continue to meet the study eligibility 
criteria, the study dentist will then carry out a full examination of your mouth and ask you 
about any non-treatment emergent events you may have experienced.  The study dentist will 
then remove your upper denture to determine whether or not you have clinical signs of 
stomatitis (as it is very unlikely that you will know whether or not you have it), and if you do 
have it, how much you have. 
 
You will then undergo the following procedures/assessments: 
 
Procedure 
No. 
Procedure/assessment 
name 
Why is the procedure / 
assessment being 
performed? 
What will 
procedure/ 
assessment 
involve? 
1 Inflammation index To measure and score 
the inflammation in the 
upper oral soft tissue 
inside your mouth 
The study dentist 
looking inside your 
mouth 
2 Imprint culture To assess microbial 
colonisation (yeast and 
bacteria) from cultures 
of your palate, tongue 
and fit surface of the 
denture. 
The study dentist 
will place two 
separate sterile 
2cm
2
 foam squares 
(moistened in saline) 
on each of the fit 
surface of your 
denture, palate and 
tongue for 30  
seconds 
3 Swab To assess the microbial 
population based on the 
presence of the DNA of 
these microbes. 
The study dentist 
will gently swab the 
fit surface of your 
denture, palate and 
tongue. 
 
 
What do I have to do? 
 
• Attend Visit 2 (if separate from visit 1) at the allocated time, this second visit will be an 
already scheduled visit. 
• Complete all study assessments as directed. 
• You must not use denture adhesive on the day you attend the clinic. 
• It is important that you get back in touch should you have any concerns.  The contact 
numbers are at the end of this information sheet. 
• Inform one of the study staff if you are taking part in another clinical study at present. 
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What are the possible disadvantages and risks of taking part? 
The procedures and assessments that you will undergo are similar to those you would 
experience during a routine dental check-up.   
 
The main disadvantage of taking part in the study is the inconvenience of attending for visit 2 
(if required). 
 
Are there any side effects? 
There should be no side effects associated with this study. 
 
Are there any benefits in taking part? 
A possible benefit from participating in this study is that the microbial content of your denture, 
tongue and gums will be analysed very thoroughly and as a result you have the opportunity to 
contribute to a scientific investigation that may benefit others.  There is also the possibility that 
you may not benefit from your participation in this study. There are unlikely to be any direct 
benefits to you as a result of taking part in this study.  However, your participation will help us 
to understand more about the microorganisms that live on dentures and will help in the 
development of treatments to reduce denture related inflammation in the future.. 
 
What will happen to any samples I give? 
The imprint culture samples taken will be transferred to a laboratory where they will be used 
to grow the microorganisms on agar media. Once cultured the microbes will be identified and 
used to try and replicate infection in laboratory models where they will be grown on acrylic 
surfaces and used to infect commercially available cells, grown in the laboratory. We can 
identify the bacteria and yeast recovered from your denturers present based on their genetics.  
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible harm 
you might suffer will be addressed.  The detailed information on this is given in Part 2. 
 
Will my taking part in the study be kept confidential? 
Yes.  All the information about your participation in this study will be kept confidential.  These 
details are included in Part 2. 
 
Contact details 
If you have any further questions concerning the study, or in case of any difficulty during the 
study please contact: 
 
Dr Joshua Twigg  Tel: 02920 746464 (office hours only) 
    Tel: 07874 727549 (mobile – out of office hours) 
Mrs Rita Walker   Tel: 02920 742439 (office hours only) 
 
School of Dentistry, Cardiff University, Heath Park, Cardiff, CF14 4XY, UK. 
 
This completes Part 1 of the Information Sheet. 
 
If the information in Part 1 has interested you and you are considering participation, 
please continue to read the additional information in Part 2 before making a decision. 
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PART 2 
 
 
What will happen if I don’t want to carry on with the study? 
You can withdraw from the study at any time without your medical/dental care or legal rights 
being affected.  If you withdraw from the study we will use the data collected up to your 
withdrawal.  
 
What happens if something goes wrong? 
If you are harmed due to someone’s negligence, then you may have grounds for a legal 
action but you may have to pay for it.  Regardless of this, if you wish to complain, or have any 
concerns about any aspect of the way you have been approached or treated during the 
course of this study, the normal National Health Service complaints mechanisms should be 
available to you. 
 
 
Will my taking part in this study be kept confidential? 
The results will be analysed by laboratory staff, and in due course may be reviewed by the 
regulatory and claims approval authorities.  This may involve inspection of all study-related 
information, but your identity will always remain strictly confidential.  Your name or initials will 
not appear on any information collected.   
 
Your data will be made available (within and outside the European Union) to the sponsor’s 
employees, investigators, members of the ethics committee and/or employees of the 
competent supervisory authorities exclusively in anonymised form for the purposes of 
examining data.  Your participation in the study will be treated as confidential, that is, any 
personally identifiable information will be held and processed under secure conditions Data 
will be kept on file for 15 years.  You will not be referred to by name in any report or 
publication (in a scientific journal) of the study.  Your identity will not be disclosed to any 
person, except in the event of a medical emergency or if required by law.  You are entitled 
under law to access your personal data and to have any justifiable corrections made.  If you 
wish to do so, you should request this from the investigator conducting the study. 
 
Your anonymised data will be processed electronically to determine the outcome of this study, 
and to provide it to health authorities/drug regulatory agencies.  Your data, which is 
anonymised, will not be used for any other research.  If you consent to take part in this study 
we will notify your general practitioner (GP) of your participation. 
 
Who is organising and funding the research? 
The sponsor organising and funding this study is Cardiff University/GSK 
 
What will happen to the results of the research study? 
It is possible that the results of the study will be made available in the public domain through 
scientific publications and/or presentations as appropriate.  Should this be the case any 
information about you will be anonymised as detailed in ‘Confidentiality’ above.   
 
Who has reviewed the study? 
This study has been reviewed and given favourable ethical approval by a Research Ethics 
Committee.   
 
Intellectual property statement: 
The information and any materials or items that you are given about or during the study - the 
type of study being performed - should be considered the confidential business information of 
the study sponsor.  You are of course, free to discuss with your friends and family while 
considering whether to participate in this study or at any time when discussing your present or 
future healthcare. 
 
 
Thank you for your help. 
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Screening Number: S     
 
INFORMED CONSENT FORM 
 
Denture acrylic biofilms: microorganisms involved in inflammation of the gums 
 
Sponsor: Cardiff University  
 
Please initial box 
1. I confirm that I have read and understood the information sheet Version 
3, 17th March 2016.  I have had the opportunity to consider the 
information, ask questions and have had these questions answered 
satisfactorily. 
 
 
  
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical/ 
dental care or legal rights being affected. 
 
 
  
3. I understand that relevant sections of any of my medical/dental notes 
and data collected during the study may be looked at by responsible 
individuals from regulatory authorities or from the NHS Trust, where it is 
relevant to my taking part in this research.  I give permission for these 
individuals to have access to my records. 
 
 
  
  
 
  
4. I agree to take part in the above study.  
 
______________________________  ____________________________ 
Name of Subject (print)     Signature 
 
Date (dd/mmm/yyyy):__________________ 
 
 
______________________________  ____________________________ 
Name of Person taking consent (print)  Signature 
 
Date (dd/mmm/yyyy):__________________ 
 
 
 
 
For office use only (tick appropriate box): 
Subject Copy  Study Site File Copy    
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GP Letter:
 
  
 
 
 
Cardiff	University	 	 	 	 	 University	Dental	Hospital	
Heath	Park	 	 	 	 	 	 Heath	Park	
Cardiff		 	 	 	 	 	 Cardiff	
CF14	4XY	 	 	 	 	 	 CF14	4XY	
Tel	02920742439	 	 	 	 	 Tel	02920746499	
	 	 	 	 	 	 	 	
 
 
Dear Doctor, 
 
RE: Patient Name. Clinical Study: Protocol: Denture acrylic biofilms: microbial composition, 
interactions and prevention 
 
The above patient who is registered at your practice has given informed consent to take part 
in a clinical study. They have been selected since they either wear a denture and/or present 
with some denture stomatitis (which will be managed by routine methods here in the Dental 
School). A sample of oral plaque from the surface of their denture has been collected during 
the routine examination. There is no intervention planned as part of this study and the 
microbiological results of the plaque analysis will not affect the individual patient's subsequent 
management.  
 
Please get in touch if you require further information.  
 
Kind regards, 
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Appendix III 
Supporting documentation 
Clinical study data analysis 
 
- Raw count data of phylotypically assigned bacterial species, grouped 
by sample 
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1
6
 
Species_97 score Group S001_D S001_P S001_T S002_D S002_P S002_T S003_D S003_P S003_T S004_D S004_P S004_T S005_T S006_D S006_T S007_D S007_P S007_T S008_D S008_P S008_T S009_D
Streptococcus_salivarius 97.9 Otu00002 1685 27 125 128 9 259 2 25 95 8 284 1161 2569 672 2552 7 4 63 846 1103 3 783
Serratia_liquefaciens 97.3 Otu00001 0 2 2830 1 0 0 10391 9154 8437 0 2 3 1 1 0 0 0 2 0 0 0 0
Streptococcus_oralis 97.3 Otu00003 266 7 231 6703 3440 293 1 130 0 98 211 69 152 79 149 4 0 4 482 869 898 646
Pseudomonas_fluorescens 97.2 Otu00011 0 59 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_mitis 97.6 Otu00005 1833 10 99 215 50 384 0 22 446 0 543 827 1658 1531 1567 5 4 165 1043 192 186 2464
Acinetobacter_johnsonii 97.2 Otu00004 0 36 1 1 5654 2366 0 0 0 8174 1689 684 2 0 0 2423 2096 1313 0 0 29 0
Streptococcus_unclassified * Otu00008 0 0 0 18 14 123 4 28 74 0 0 0 0 0 4 0 3 25 0 0 0 1
Pseudomonas_putida 97.5 Otu00006 0 681 84 0 0 0 5 0 0 43 6757 4890 1 1 0 0 0 0 9 57 1 0
Stenotrophomonas_maltophilia 97 Otu00007 1 124 4 0 0 0 0 0 2 0 0 10 0 2 0 30 0 0 0 0 0 1
Actinomyces_odontolyticus 97.3 Otu00010 49 0 83 112 51 296 4 0 2 0 1 0 165 5766 771 2 0 24 85 0 84 687
Flavobacterium_lindanitolerans 98.1 Otu00013 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 56
Enterococcus_faecalis 97.1 Otu00015 0 0 12 3 0 0 40 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1
Brevundimonas_terrae Otu00009 0 0 1 0 0 0 0 0 0 0 1 5 0 0 0 3502 1438 3232 0 0 148 0
Brevundimonas_vesicularis Otu00014 1 3558 1 0 0 0 0 0 0 0 0 1995 0 0 1 2 555 1447 3558 1 0 0
Lactobacillus_paracasei 97.7 Otu00017 59 0 0 0 0 0 0 0 1 1 0 0 781 0 0 1 0 0 19 7602 2105 0
Massilia_aurea Otu00012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Veillonella_parvula 97.7 Otu00022 1369 0 238 290 58 324 39 0 0 0 0 5 22 144 96 5 0 4 6 20 175 779
Haemophilus_parainfluenzae 97.6 Otu00018 0 0 62 331 89 837 147 9 185 0 0 2 1 820 1519 0 22 79 149 38 132 168
Granulicatella_adiacens Otu00020 31 0 54 84 6 95 4 14 58 0 56 275 291 156 399 0 0 7 155 73 0 194
Rhizobium_unclassified Otu00021 0 110 43 0 0 0 0 0 0 0 0 0 0 0 0 198 387 88 0 0 1 0
Stenotrophomonas_nitritireducens 97.3 Otu00025 0 0 0 0 0 0 0 0 0 1 1 0 2 0 0 0 0 0 0 1 0 0
Chryseobacterium_unclassified * Otu00016 0 0 4 0 0 0 3 0 0 0 0 0 0 0 0 1572 2086 2486 0 0 1 1
Prevotella_melaninogenica 97.3 Otu00026 1 1 0 249 61 470 0 0 0 0 0 0 1 513 232 3 0 0 0 0 0 0
Microbacterium_maritypicum 97.2 Otu00032 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 5125 0
Agrobacterium_tumefaciens 97.3 Otu00034 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
Streptococcus_oralis 97.6 Otu00024 0 8 2 53 0 64 5 10 411 0 128 256 1332 129 1101 0 3 80 230 12 0 0
Myroides_unclassified * Otu00028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Propionibacterium_acnes 97.7 Otu00033 2 820 1119 20 66 1 116 2 1 754 143 116 36 0 14 4 62 0 64 47 317 182
Lactobacillus_fermentum 97.2 Otu00030 3968 8 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 0 0 0 91 0
Pseudomonas_aeruginosa 97.8 Otu00039 2 70 2243 47 0 118 15 4 5 0 0 24 2 22 0 2 24 0 102 0 0 1867
Acinetobacter_lwoffii 97.5 Otu00027 0 9 39 0 1 0 0 0 0 1470 145 31 0 0 0 1 0 10 0 0 0 0
Acidovorax_unclassified Otu00023 0 0 1 0 0 0 0 7 0 2 0 0 3763 0 0 132 363 8 0 0 1 0
Actinomyces_lingnae 97 Otu00035 184 0 26 22 6 71 5 0 21 0 0 0 0 51 69 0 0 36 0 0 0 404
Lactobacillus_rhamnosus 97.2 Otu00031 2 0 351 0 0 0 6 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Neisseria_flavascens 97.3 Otu00036 2 0 45 414 186 2303 0 0 0 0 0 0 0 19 52 0 0 0 20 151 68 0
Haemophilus_parahaemolyticus 97.6 Otu00037 0 0 0 717 523 10 0 0 0 0 53 55 5 0 0 0 0 0 0 0 0 0
Microbacterium_testaceum Otu00038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2672 0 770 0
Dermacoccus_nishinomiyaensis Otu00044 0 0 98 0 0 0 1 0 0 0 0 0 0 30 0 0 0 0 0 0 0 0
Streptococcus_infantis 97.6 Otu00040 0 0 0 96 70 288 0 3 1 0 0 0 0 33 381 0 0 6 271 223 56 0
Massilia_varians 98.6 Otu00019 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 1062 1822 116 0 0 1 2
Chryseobacterium_scophthalmum Otu00041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella_histicola 97.3 Otu00045 121 0 0 12 0 84 0 0 2 0 0 0 4 0 0 0 0 0 0 0 0 899
Moraxella_osloensis 99 Otu00050 0 2449 24 21 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Fusobacterium_periodonticum Otu00049 1 0 0 119 41 1045 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0
Rothia_mucilaginosa 97.3 Otu00042 44 0 34 3 5 45 4 3 345 0 26 9 32 30 201 0 0 17 71 0 0 42
Lactobacillus_salivarius 97.4 Otu00043 502 6 207 0 5 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Devosia_unclassified Otu00029 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 801 842 476 0 0 0 0
Methylophilus_methylotrophus 97.5 Otu00061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Citrobacter_freundii 100 Otu00046 1 25 0 0 0 0 3 0 5 0 0 0 0 0 1261 0 0 1 2 0 0 0
Stenotrophomonas_unclassified Otu00058 0 1841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_sanguinis 98.5 Otu00056 13 0 16 8 0 8 0 0 0 0 0 0 0 0 0 9 0 6 570 335 125 0
Gemella_haemolysans 97 Otu00051 0 0 0 204 76 8 0 3 4 82 12 18 2 0 0 0 0 0 0 0 52 0
Phormidium_sp. 97.7 Otu00048 0 0 0 0 0 1 0 1525 0 0 0 0 0 0 0 0 2 0 0 0 0 0
Leptotrichia_unclassified * Otu00057 2 0 0 66 17 44 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Streptococcus_mitis Otu00053 0 0 0 53 5 0 0 0 0 41 695 447 0 0 0 0 0 0 0 0 0 0
Pseudoxanthomonas_mexicana 97.3 Otu00055 0 226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 413 0 0 0 0
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Species_97 score Group S001_D S001_P S001_T S002_D S002_P S002_T S003_D S003_P S003_T S004_D S004_P S004_T S005_T S006_D S006_T S007_D S007_P S007_T S008_D S008_P S008_T S009_D
Prevotella_pallens 97 Otu00064 0 0 0 85 94 339 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0
Streptococcus_anginosus Otu00059 0 102 1 0 0 0 0 0 0 0 0 0 9 0 0 9 0 0 0 0 121 0
Pseudorhodoferax_soli 97.8 Otu00063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
beta_proteobacterium 97.5 Otu00047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_sp. 97 Otu00066 0 0 0 5 4 9 0 0 0 0 0 0 0 2 4 0 0 0 0 0 0 0
Porphyromonas_catoniae 98.5 Otu00069 0 1 0 140 117 128 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 0
Streptococcus_sobrinus 97.4 Otu00062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Luteimonas_cucumeris 97.6 Otu00071 0 31 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_unclassified Otu00067 440 0 29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 65 0
Acinetobacter_junii 97.2 Otu00073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0
Haemophilus_influenzae 97.3 Otu00081 2 13 441 22 0 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Delftia_tsuruhatensis 97.5 Otu00060 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 418 125 101 0 0 0 0
Sphingomonas_sp. 97.3 Otu00052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Afipia_broomeae 97.3 Otu00065 0 0 0 0 0 0 0 0 786 27 0 0 0 0 0 0 0 0 0 0 0 63
Roseburia_unclassified Otu00068 0 0 0 2 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella_salivae 97.3 Otu00074 0 0 0 17 11 21 0 0 0 0 0 0 0 43 4 1 0 1 9 0 0 0
Streptococcus_unclassified * Otu00070 0 0 0 0 0 0 0 0 65 0 0 1 0 2 16 0 0 0 0 0 0 0
Zoogloea_ramigera 97.3 Otu00076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11 14 3 0 0 0 0
Gemella_sanguinis 97.1 Otu00072 0 0 0 70 6 48 0 0 0 0 0 0 0 38 274 0 0 9 43 0 0 0
Pseudomonas_unclassified Otu00077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella_tannerae Otu00085 0 0 59 0 0 0 0 0 0 0 0 0 0 0 0 0 33 17 0 0 0 0
Sphingobacterium_multivorum 97.6 Otu00082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Chryseobacterium_unclassified Otu00083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Lachnoanaerobaculum_orale 97.4 Otu00075 0 0 0 10 0 25 0 0 0 0 0 0 0 348 16 1 0 0 0 0 0 0
Massilia_unclassified * Otu00054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 160 373 36 0 0 1 1
Streptococcus_parasanguinis 98.8 Otu00080 0 0 0 1 0 1 0 0 0 0 0 0 0 131 43 0 0 0 62 0 0 0
Lactobacillus_fermentum 97.8 Otu00078 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 24 0
Sphingomonas_ursincola 97.3 Otu00079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Myroides_unclassified * Otu00087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Empedobacter_brevis 98.5 Otu00086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Comamonas_testosteroni 98.1 Otu00091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_unclassified Otu00096 0 0 23 6 0 25 0 0 0 0 0 0 0 9 1 0 0 3 0 0 0 0
Staphylococcus_aureus 97.3 Otu00107 2 9 365 5 0 0 12 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0
Streptococcus_gordonii 97.4 Otu00094 3 0 39 29 13 20 0 0 0 0 0 0 1 40 1 0 0 0 56 63 60 0
Parvimonas_micra 98.2 Otu00123 0 0 375 0 0 0 2 0 0 0 0 0 3 0 0 0 0 6 0 0 0 0
Prevotella_oris 97.3 Otu00111 0 0 37 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
Prevotella_nanceiensis 97.3 Otu00090 0 0 0 108 36 188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mycoplasma_salivarium 98.1 Otu00135 0 0 367 0 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_graevenitzii 98.5 Otu00100 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 351
Granulicatella_unclassified Otu00098 0 0 0 57 38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Flavobacterium_lindanitolerans 97.5 Otu00097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
  
3
1
8
 
Species_97 score Group S001_D S001_P S001_T S002_D S002_P S002_T S003_D S003_P S003_T S004_D S004_P S004_T S005_T S006_D S006_T S007_D S007_P S007_T S008_D S008_P S008_T S009_D
Serratia_marcescens 97.6 Otu00099 0 0 0 0 0 0 0 0 2 0 0 0 0 0 13 0 0 0 0 0 0 0
Micrococcus_luteus 99 Otu00108 2 6 72 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 85 173
Lactobacillus_plantarum 97.2 Otu00093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
Propionibacterium_acidifaciens 97.8 Otu00088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 41 0 0 0 0 0 0
Megasphaera_micronuciformis 97.3 Otu00101 4 0 0 0 0 0 0 0 0 0 0 0 0 39 0 0 0 0 0 0 0 235
Ralstonia_sp. 97.6 Otu00114 0 0 1 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Bradyrhizobium_sp. 97.5 Otu00116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dermacoccus_nishinomiyaensis 97.2 Otu00118 0 0 5 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0
Atopobium_parvulum 97.5 Otu00110 1 0 0 4 0 6 0 0 0 1 0 0 0 27 0 2 0 1 0 0 0 57
Campylobacter_concisus 97.9 Otu00102 0 0 0 36 4 40 0 0 1 0 0 0 0 3 1 0 0 0 0 0 0 0
Staphylococcus_warneri 100 Otu00112 0 24 0 0 0 0 0 0 0 36 0 0 0 0 0 0 0 0 0 6 80 120
Lactobacillus_vaginalis 98.6 Otu00109 240 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Yersinia_pekkanenii 99.7 Otu00129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Flavobacterium_unclassified Otu00133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Neisseria_sicca 97.9 Otu00122 0 0 0 3 3 39 0 0 0 0 0 0 0 0 0 0 0 0 31 89 20 0
Aeromonas_hydrophila 97 Otu00119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Bosea_unclassified Otu00095 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 54 47 96 0 0 0 0
Actinomyces_graevenitzii 98.1 Otu00106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 14 0 0 0 4
Diplorickettsia_unclassified * Otu00127 0 0 9 0 3 0 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Solobacterium_moorei Otu00115 0 0 0 13 0 14 0 0 0 0 0 0 0 31 15 0 0 0 0 0 0 0
Leptotrichia_unclassified * Otu00126 0 35 0 21 2 41 0 0 0 0 0 0 1 8 0 0 0 0 0 0 0 0
Streptococcus_dysgalactiae 97.6 Otu00132 0 0 0 0 0 0 0 0 0 197 0 3 0 8 0 0 0 0 0 4 0 0
Streptococcus_mitis Otu00103 0 1 0 156 25 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Staphylococcus_hominis 97.3 Otu00113 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella_oralis 97.9 Otu00179 0 0 199 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Variovorax_ginsengisoli 98.1 Otu00145 0 4 40 0 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 0 0
Corynebacterium_imitans * Otu00131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 190
Shinella_kummerowiae 97.4 Otu00104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 116 0 69 0 0 0 0
Rhizobium_mesosinicum 97.1 Otu00084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 47 108 24 0 0 0 0
Chryseobacterium_formosense Otu00120 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Lactobacillus_kalixensis 98.5 Otu00134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Massilia_alkalitolerans 98.8 Otu00089 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 56 108 4 0 0 0 0
Pseudocitrobacter_anthropi 98.4 Otu00128 0 5 13 0 0 0 0 0 0 0 0 0 0 0 1 0 12 0 59 0 0 73
Prevotella_buccae 97.3 Otu00164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Bacteroides_unclassified * Otu00147 0 0 0 4 12 16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella_unclassified * Otu00125 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
Ensifer_adhaerens 97.9 Otu00105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14 48 9 0 0 0 0
Streptococcus_mutans 98.3 Otu00148 0 0 26 1 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 61
Actinomyces_oris 97.1 Otu00165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stomatobaculum_longum 99.6 Otu00124 1 0 0 4 0 1 0 0 0 0 0 0 0 51 0 0 0 0 0 0 0 0
Acinetobacter_bereziniae 97.2 Otu00136 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Fusobacterium_nucleatum 97.6 Otu00155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_unclassified Otu00137 0 0 0 0 0 26 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0
Actinomyces_viscosus 97 Otu00161 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sphingomonas_unclassified Otu00121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_oligofermentans 98.1 Otu00149 61 0 46 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0
Alloprevotella_unclassified * Otu00175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Leptotrichia_shahii 97.2 Otu00130 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 148 0 0 0
Comamonas_aquatica 98.4 Otu00142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 1 0
Rhizobium_unclassified Otu00151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Methylobacterium_extorquens 99 Otu00150 0 3 1 0 0 0 8 15 0 0 0 0 0 0 0 0 4 5 0 0 0 0
Actinomyces_odontolyticus 98.4 Otu00153 1 0 0 0 0 1 0 0 0 0 0 0 0 7 1 0 0 0 0 0 0 2
Odoribacter_unclassified * Otu00184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Selenomonas_artemidis Otu00168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 39
Actinomyces_slackii 97.2 Otu00152 0 0 0 0 0 0 0 0 0 0 0 0 4 34 0 3 0 1 1 58 17 0
Sphingopyxis_granuli 97.6 Otu00144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0
Sediminibacterium_unclassified * Otu00154 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 0 72 0 0 48
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Nocardioides_aestuarii 98.4 Otu00192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Abiotrophia_defectiva Otu00174 0 0 0 0 0 13 0 0 0 0 0 0 0 0 0 0 0 0 13 0 0 0
Dermacoccus_nishinomiyaensis 98.8 Otu00177 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Methylobacterium_gregans 98 Otu00217 0 0 122 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_segmentosum 98.5 Otu00146 0 0 33 0 0 2 0 0 0 34 0 0 0 0 0 0 0 0 0 0 0 0
Ochrobactrum_sp. 99.7 Otu00171 0 117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_graevenitzii 98.5 Otu00180 0 0 0 0 0 9 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 45
Lysobacter_unclassified Otu00176 0 115 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_sp. 97.2 Otu00158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Brevundimonas_unclassified Otu00092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 110 1 0 0 0 0
Prevotella_unclassified * Otu00162 0 0 0 22 12 71 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Bryobacter_unclassified * Otu00204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_unclassified * Otu00183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Methylobacterium_unclassified * Otu00182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_rudis 98.2 Otu00172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Oribacterium_unclassified * Otu00159 0 0 1 3 0 8 0 0 0 0 0 0 0 0 54 0 0 0 0 0 0 0
Methylobacterium_goesingense 98.3 Otu00143 0 0 11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Massilia_timonae 98.8 Otu00243 0 1 85 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_unclassified * Otu00219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Devosia_riboflavina 97.9 Otu00140 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 88 0 0 1 0
Achromobacter_mucicolens 97.2 Otu00157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Rhizobium_sp. 98.6 Otu00141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 47 8 16 0 0 0 0
Parvimonas_micra * Otu00203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Leptotrichia_unclassified * Otu00169 0 0 0 19 0 21 0 0 0 0 0 0 0 3 1 0 0 0 0 0 0 0
Streptococcus_pseudopneumoniae 98.1 Otu00163 0 0 1 4 20 0 0 1 0 1 2 1 0 0 0 0 0 0 0 0 0 1
Streptococcus_tigurinus 97.9 Otu00181 0 0 0 0 17 46 0 0 0 0 0 2 13 0 0 0 0 3 0 0 0 0
Tomitella_biformata 98.4 Otu00218 0 0 1 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0
[Eubacterium]_nodatum_group_unclassified Otu00193 0 0 0 2 7 23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_unclassified * Otu00160 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 67 0 0 0 0 0 0
Capnocytophaga_gingivalis 97.8 Otu00199 0 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 2 5 0 28 0
Prevotella_nigrescens 98.5 Otu00200 0 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 32
Terrisporobacter_unclassified Otu00188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 77
Pedobacter_unclassified * Otu00228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Oribacterium_sinus 97.7 Otu00195 0 0 0 0 0 12 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 35
Fusobacterium_nucleatum Otu00244 0 0 63 0 0 0 1 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0
Pseudomonas_putida 97.5 Otu00170 0 0 0 0 0 0 0 0 0 0 72 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_agarici 97.8 Otu00187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sediminibacterium_salmoneum * Otu00210 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 0 0 0 0 0 1 15
Lactobacillus_ultunensis 97.9 Otu00242 0 0 62 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Propionicimonas_paludicola 98.4 Otu00198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 71
Chryseobacterium_hominis 98.4 Otu00178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Ralstonia_unclassified * Otu00186 0 0 0 4 1 1 0 0 0 0 0 0 0 38 0 0 0 0 0 0 0 0
Aeromonas_unclassified * Otu00201 0 0 0 2 0 2 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0
Dermacoccus_nishinomiyaensis 98.4 Otu00208 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
Lactobacillus_crispatus 97.4 Otu00212 0 61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Ornithinimicrobium_kibberense 97.5 Otu00167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 36 0 0 0 0
Bacillus_cereus 97.6 Otu00156 0 0 0 0 0 0 0 0 10 0 8 6 0 0 0 0 15 4 0 0 22 0
Sphingobium_herbicidovorans 99.3 Otu00230 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Hydrogenophaga_defluvii 97.8 Otu00117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 64 0 0 0 0 0
Microbacterium_lacticum 100 Otu00205 0 12 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0
Alcaligenes_aquatilis 98.2 Otu00206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Rhizobium_unclassified 97 Otu00229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Devosia_sp. 97 Otu00139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15 32 15 0 0 0 0
Capnocytophaga_gingivalis * Otu00196 0 0 0 23 0 23 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0
Halomonas_unclassified * Otu00275 0 0 62 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella_unclassified * Otu00191 0 0 0 0 0 0 0 0 0 0 0 0 0 11 0 0 0 0 0 0 0 0
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Streptococcus_sanguinis Otu00209 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 28 14 3 0
Herminiimonas_arsenicoxydans 97.2 Otu00232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_putida Otu00227 0 50 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_graevenitzii 99.4 Otu00238 0 0 0 0 0 9 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0
Ehrlichia_unclassified * Otu00248 0 0 0 0 7 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Enterococcus_faecium 98.3 Otu00283 0 0 54 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Aminobacter_anthyllidis 98.3 Otu00166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 41 0 15 0 0 0 0
Streptococcus_parasanguinis 98.4 Otu00221 0 0 0 0 0 1 0 0 0 0 0 1 4 1 1 0 0 0 0 0 1 0
Propionibacterium_unclassified Otu00262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Anaeroglobus_geminatus 98.9 Otu00299 1 0 52 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_oris 99.1 Otu00197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 2 0 0 0 0
Maricurvus_unclassified * Otu00202 0 0 0 1 1 6 0 0 0 0 0 0 0 26 9 0 0 0 0 0 0 0
Catonella_morbi * Otu00211 0 0 0 21 17 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_matruchotii 97.9 Otu00271 0 0 18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8
Streptococcus_unclassified Otu00190 0 0 0 0 0 0 0 0 1 0 0 0 39 1 2 0 0 0 1 0 0 0
Exiguobacterium_mexicanum 98 Otu00236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50
Pannonibacter_phragmitetus 99 Otu00263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_israelii * Otu00220 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Lactococcus_lactis 99.7 Otu00246 0 44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Finegoldia_magna 98.5 Otu00189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 33 0 0 0 0 0 0 0
Bavariicoccus_seileri 98.1 Otu00247 0 0 0 0 1 12 0 0 0 0 0 0 0 13 4 0 0 0 0 0 0 0
[Eubacterium]_nodatum_group_unclassified * Otu00256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Leptotrichia_unclassified * Otu00250 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sphingobacterium_faecium Otu00213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Bergeyella_unclassified * Otu00224 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_saponiphila 98.5 Otu00234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0
Lactobacillus_unclassified Otu00216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Microbacterium_hydrocarbonoxydans Otu00173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 24 15 0 0 0 0
Prevotella_shahii 97.6 Otu00237 0 0 0 5 0 12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Saccharophagus_unclassified * Otu00245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 38 4 0 0
Treponema_socranskii 97.8 Otu00255 0 42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Shinella_unclassified * Otu00269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Aggregatibacter_segnis 98.1 Otu00276 0 0 32 3 0 0 1 0 0 0 0 0 0 0 0 1 0 4 0 0 0 0
Sphingomonas_paucimobilis 98.7 Otu00226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_odontolyticus 97.5 Otu00231 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1
Capnocytophaga_leadbetteri 98.1 Otu00240 0 0 0 10 0 11 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0
Pseudomonas_oryzihabitans 97.5 Otu00249 0 39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Vibrio_brasiliensis 99.1 Otu00225 0 0 0 0 0 0 0 0 0 0 38 0 0 0 0 0 0 0 0 0 0 0
Sphingobacterium_caeni 100 Otu00260 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Bifidobacterium_animalis 98 Otu00257 0 0 0 3 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
Bacillus_wakoensis 98.3 Otu00235 0 0 2 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella_pallens 97.9 Otu00281 0 0 0 0 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stenotrophomonas_maltophilia 97.9 Otu00254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Alloprevotella_rava Otu00261 0 0 0 5 0 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Rhodococcus_globerulus 97.2 Otu00138 0 0 8 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dyadobacter_unclassified * Otu00194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 34 0 0 0 0
Ideonella_sp. 97.5 Otu00264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 32
[Eubacterium]_nodatum_group_unclassified * Otu00282 0 33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dermacoccus_nishinomiyaensis 98.8 Otu00301 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
Sphingobium_limneticum 98.7 Otu00308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sphingobacterium_anhuiense 97.4 Otu00259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pelomonas_saccharophila 100 Otu00300 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0
Sphingomonas_desiccabilis 98.3 Otu00280 0 28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Brevundimonas_unclassified * Otu00284 0 28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Leucobacter_aridicollis 98.2 Otu00223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 27 0 0 0 0 0 0 0
Prevotella_unclassified * Otu00251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
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Massilia_unclassified Otu00252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Porphyromonas_unclassified * Otu00312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sneathia_unclassified * Otu00214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 19 0 0 0 0
Selenomonas_sputigena Otu00328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Ochrobactrum_anthropi 100 Otu00316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Phenylobacterium_falsum 97 Otu00241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0
Peptostreptococcus_stomatis 97.2 Otu00268 0 0 0 0 0 17 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0
Leptotrichia_hongkongensis 97.3 Otu00273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0
Fusobacterium_nucleatum Otu00298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23 0
Fusobacterium_canifelinum 97.6 Otu00326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_chelonae 99.1 Otu00270 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0
Pseudomonas_sp. 99 Otu00272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mycobacterium_neworleansense 98.4 Otu00289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Morganella_morganii 99.4 Otu00305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_slackii 98.6 Otu00370 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Schwartzia_unclassified * Otu00207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0
Algoriphagus_unclassified * Otu00233 0 0 5 0 0 0 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Selenomonas_unclassified * Otu00307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pseudanabaena_sp. 100 Otu00185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20 0 0 0 0 0
Acinetobacter_guillouiae Otu00294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Rhizobium_sp. 97.9 Otu00239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19 0 0 0 0
Caldicellulosiruptor_actoaceticus Otu00266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19 0 0 0 0 0 0 0
Actinobacillus_porcitonsillarum Otu00279 0 0 0 9 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Raoultella_planticola 98.8 Otu00309 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Campylobacter_concisus * Otu00346 0 0 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Lautropia_mirabilis 100 Otu00292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18 0 0 0
Paracoccus_yeei 98.7 Otu00303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Rhodobacter_veldkampii Otu00313 0 0 0 0 0 0 0 0 0 0 18 0 0 0 0 0 0 0 0 0 0 0
Comamonas_terrigena 98.8 Otu00325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Corynebacterium_marinum 99.4 Otu00378 0 0 18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_cardiffensis 100 Otu00380 0 0 16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0
Brevundimonas_diminuta 97.2 Otu00274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 12 0 0 0 0
Rhodococcus_fascians 99.1 Otu00278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17 0 0 0 0 0 0 0
Veillonella_unclassified Otu00290 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Methylobacterium_adhaesivum 97.3 Otu00302 0 13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Leptotrichia_buccalis 98.1 Otu00339 0 16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Ferrimicrobium_unclassified * Otu00355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17 0
Paludibacter_unclassified * Otu00286 0 0 1 0 0 0 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_xanthomarina 98.1 Otu00287 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Enterococcus_faecalis 99.2 Otu00311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Alcaligenes_faecalis 98.5 Otu00330 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_australis Otu00332 0 0 0 0 0 0 0 0 1 0 0 0 4 0 0 0 0 0 0 0 0 0
Aeromonas_bestiarum 100 Otu00358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Kingella_denitrificans 98.8 Otu00362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Massilia_haematophila 97.1 Otu00253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 8 1 0 0 0 0
Ornithinimicrobium_kibberense 98.4 Otu00331 0 0 0 0 0 0 0 0 0 0 0 15 0 0 0 0 0 0 0 0 0 0
Providencia_rettgeri 99.4 Otu00342 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Kocuria_rhizophila 98.5 Otu00277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Acinetobacter_sp. 99.6 Otu00293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Arthrobacter_defluvii 99.7 Otu00296 0 0 0 0 0 0 0 0 0 0 0 14 0 0 0 0 0 0 0 0 0 0
Lactobacillus_zeae 97.8 Otu00318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Brochothrix_thermosphacta 98.1 Otu00320 0 0 0 0 0 0 0 0 0 0 0 14 0 0 0 0 0 0 0 0 0 0
Acinetobacter_johnsonii 97.2 Otu00336 0 0 0 0 12 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_asplenii 97.5 Otu00347 0 0 0 0 0 0 0 0 0 0 0 9 0 0 0 0 0 0 0 0 0 0
Leptotrichia_unclassified * Otu00353 0 0 0 1 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella_unclassified Otu00360 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
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Species_97 score Group S001_D S001_P S001_T S002_D S002_P S002_T S003_D S003_P S003_T S004_D S004_P S004_T S005_T S006_D S006_T S007_D S007_P S007_T S008_D S008_P S008_T S009_D
Stenotrophomonas_maltophilia. 98.5 Otu00373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Acinetobacter_lwoffii 97.2 Otu00415 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Bradyrhizobium_elkanii 98.3 Otu00291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13 0 0 0 0
Shewanella_putrefaciens 99.1 Otu00315 0 0 0 0 0 0 0 0 0 0 12 0 0 0 0 0 0 0 0 0 0 0
Granulicatella_unclassified * Otu00323 0 0 1 0 0 0 0 0 1 0 0 2 1 0 0 0 0 0 0 0 0 0
Paracoccus_marinus 99.3 Otu00338 0 0 0 0 0 0 0 3 0 0 10 0 0 0 0 0 0 0 0 0 0 0
Prevotella_unclassified * Otu00359 0 0 0 0 0 11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pseudomonas_putida Otu00363 0 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pseudochrobactrum_kiredjianiae 100 Otu00377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sphingomonas_yanoikuyae. 98 Otu00222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12 0 0 0 0 0
Aureibacter_unclassified * Otu00258 0 0 5 0 0 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_vestibularis Otu00306 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0
Devosia_limi 97 Otu00314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 6 4 0 0 0 0
Intestinibacter_unclassified Otu00324 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Aridibacter_unclassified * Otu00285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Uruburuella_suis 98.1 Otu00329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Brevundimonas_unclassified * Otu00337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Prevotella_micans 97.6 Otu00344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Centipeda_periodontii * Otu00354 0 0 0 1 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dermacoccus_nishinomiyaensis 98.8 Otu00413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Smithella_unclassified * Otu00265 0 0 4 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Phenylobacterium_kunshanense * Otu00288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10 0 0 0 0 0
Prevotella_oulorum 99.4 Otu00348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Capnocytophaga_sputigena 97.2 Otu00364 0 0 0 0 3 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Actinomyces_graevenitzii 97.5 Otu00366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Burkholderia_contaminans 99.1 Otu00371 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 0 0 0 0 0
Corynebacterium_aquatimens 98.4 Otu00395 0 0 0 0 0 0 0 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Novosphingobium_resinovorum 98.7 Otu00399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_infantis Otu00418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Streptococcus_unclassified Otu00426 0 0 0 1 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0
Marinomonas_arenicola 98.5 Otu00430 0 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
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Species_97 score Group S009_T S010_P S010_T S011_D S011_T S012_D S012_T S013_D S013_P S013_T S014_D S014_P S014_T S015_D S015_P S015_T S016_D S016_P S016_T S017_D S017_P S017_T S018_D S018_P S018_T S019_D S019_P S019_T Sum
Streptococcus_salivarius 97.9 Otu00002 6041 16 215 2762 3270 1230 2465 0 0 1 2 2 6668 967 91 112 35 59 278 70 50 107 65 71 89 711 2 1884 39673
Serratia_liquefaciens 97.3 Otu00001 0 1 0 0 0 0 0 1 0 0 15 0 3 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 30846
Streptococcus_oralis 97.3 Otu00003 3 125 39 25 1559 89 40 70 2070 1067 2 3 463 46 28 5 3040 67 21 0 24 8 1218 4785 354 822 0 10 30715
Pseudomonas_fluorescens 97.2 Otu00011 1 0 0 0 0 0 0 0 0 0 144 1 0 129 1222 2020 0 61 2546 31 8 0 0 30 0 4462 10972 8208 29894
Streptococcus_mitis 97.6 Otu00005 3491 0 7 904 544 855 2158 1 29 651 5 0 1908 449 44 126 58 189 112 118 57 165 37 18 283 926 1 727 27107
Acinetobacter_johnsonii 97.2 Otu00004 0 0 0 0 1 0 0 1 1 0 18 1 1 1 12 3 0 696 30 62 37 42 0 1 0 3 0 0 25378
Streptococcus_unclassified * Otu00008 8 0 0 0 62 8 34 9342 8407 5214 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23371
Pseudomonas_putida 97.5 Otu00006 1 8 0 1 15 2787 2 0 0 1 3398 0 0 634 1422 872 211 102 369 1 429 222 0 0 0 0 0 0 23004
Stenotrophomonas_maltophilia 97 Otu00007 0 1 0 0 129 0 0 19 22 0 7 10 4 104 320 439 6773 8366 5284 213 33 2 31 41 0 0 0 0 21972
Actinomyces_odontolyticus 97.3 Otu00010 285 5 0 0 54 730 2464 0 1 0 0 0 0 152 53 78 26 116 36 44 15 22 4137 53 763 792 0 3 18011
Flavobacterium_lindanitolerans 98.1 Otu00013 0 5 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1958 6356 6925 9 0 0 0 0 0 15312
Enterococcus_faecalis 97.1 Otu00015 0 6976 7549 0 13 8 0 2 1 0 0 0 0 4 0 0 0 5 0 0 0 0 0 0 0 0 0 0 14615
Brevundimonas_terrae Otu00009 0 0 0 0 0 1 0 1 0 0 15 8 0 728 271 269 0 0 0 2182 816 1323 0 0 0 0 0 0 13941
Brevundimonas_vesicularis Otu00014 0 0 1 0 1 0 0 0 0 0 0 0 1 234 5 7 0 44 318 26 477 364 0 0 0 0 0 0 12597
Lactobacillus_paracasei 97.7 Otu00017 0 0 29 776 0 155 44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11573
Massilia_aurea Otu00012 0 0 0 0 12 0 0 0 0 0 0 8497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8509
Veillonella_parvula 97.7 Otu00022 189 0 0 0 48 262 91 0 125 159 0 2 0 35 5 13 1 0 4 6 19 32 191 142 1189 1544 0 32 7663
Haemophilus_parainfluenzae 97.6 Otu00018 1 0 0 0 0 30 43 1 0 291 0 0 7 3 4 188 6 30 163 4 17 29 181 415 1259 0 0 0 7262
Granulicatella_adiacens Otu00020 215 0 6 0 4 54 258 2 7 2664 0 0 74 42 0 29 29 1 100 38 8 22 233 232 984 2 0 3 6959
Rhizobium_unclassified Otu00021 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 4667 913 526 0 0 0 0 0 1 6940
Stenotrophomonas_nitritireducens 97.3 Otu00025 0 0 0 0 0 0 0 0 0 0 0 0 0 661 2475 3246 0 0 0 0 0 0 0 0 1 0 0 0 6388
Chryseobacterium_unclassified * Otu00016 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6155
Prevotella_melaninogenica 97.3 Otu00026 0 0 0 0 0 90 330 184 0 0 0 0 0 0 1 63 0 0 4 0 3 2 1176 405 2164 0 0 0 5953
Microbacterium_maritypicum 97.2 Otu00032 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 174 0 0 84 5 0 0 0 0 0 0 5391
Agrobacterium_tumefaciens 97.3 Otu00034 0 0 0 0 0 4 0 0 0 0 0 0 0 2985 1974 343 0 0 0 0 0 1 0 0 0 0 0 0 5308
Streptococcus_oralis 97.6 Otu00024 1 0 0 10 160 29 2 0 1 2 0 0 886 0 0 0 22 72 19 0 3 14 0 0 65 0 0 0 5110
Myroides_unclassified * Otu00028 0 0 0 0 0 0 0 0 0 0 5065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5065
Propionibacterium_acnes 97.7 Otu00033 1 88 1 7 407 0 6 0 61 0 4 3 1 3 35 0 0 2 0 81 1 2 3 70 0 0 1 8 4671
Lactobacillus_fermentum 97.2 Otu00030 0 2 0 102 3 451 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 6 0 0 4640
Pseudomonas_aeruginosa 97.8 Otu00039 0 0 0 0 0 2 2 0 0 0 13 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 4586
Acinetobacter_lwoffii 97.5 Otu00027 0 0 0 2406 0 1 0 0 0 0 16 0 0 152 22 8 0 0 0 0 1 0 0 0 0 0 0 0 4312
Acidovorax_unclassified Otu00023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4277
Actinomyces_lingnae 97 Otu00035 244 1 0 0 0 111 205 1 0 0 0 0 0 4 1 175 9 28 70 6 1 11 954 21 41 1093 0 21 3892
Lactobacillus_rhamnosus 97.2 Otu00031 0 0 2433 873 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3667
Neisseria_flavascens 97.3 Otu00036 0 0 0 0 0 0 7 0 0 0 0 0 0 0 2 1 3 0 1 0 4 3 122 53 146 0 0 0 3602
Haemophilus_parahaemolyticus 97.6 Otu00037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 202 1976 12 0 0 0 3554
Microbacterium_testaceum Otu00038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 3446
Dermacoccus_nishinomiyaensis Otu00044 0 2958 219 0 7 2 0 1 0 0 0 0 0 2 0 0 0 5 0 0 0 0 0 0 0 0 0 0 3323
Streptococcus_infantis 97.6 Otu00040 2 0 0 0 0 6 31 3 1 111 0 0 4 94 4 41 108 234 502 0 0 0 134 25 458 0 0 0 3186
Massilia_varians 98.6 Otu00019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 3029
Chryseobacterium_scophthalmum Otu00041 0 0 0 0 0 0 1 0 0 0 0 0 0 235 1101 1435 0 0 0 0 0 0 2 0 0 0 0 0 2774
Prevotella_histicola 97.3 Otu00045 13 2 0 0 0 243 444 0 0 0 0 0 0 0 0 30 0 46 0 0 0 1 52 182 490 36 0 10 2671
Moraxella_osloensis 99 Otu00050 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2497
Fusobacterium_periodonticum Otu00049 0 0 11 7 0 0 0 0 52 0 0 0 0 0 0 0 0 113 0 2 0 3 228 152 541 0 0 0 2320
Rothia_mucilaginosa 97.3 Otu00042 36 0 2 0 12 23 36 0 27 655 0 0 389 57 0 2 1 0 22 4 8 21 0 4 58 2 0 34 2304
Lactobacillus_salivarius 97.4 Otu00043 0 0 0 1196 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 218 0 0 2137
Devosia_unclassified Otu00029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2120
Methylophilus_methylotrophus 97.5 Otu00061 0 3 0 0 1887 2 0 0 0 0 0 13 0 99 0 0 0 1 0 0 1 1 0 0 0 0 0 0 2007
Citrobacter_freundii 100 Otu00046 328 0 0 0 0 0 0 12 0 0 108 0 0 8 59 15 0 0 0 5 2 28 0 0 0 0 0 0 1863
Stenotrophomonas_unclassified Otu00058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1841
Streptococcus_sanguinis 98.5 Otu00056 0 2 0 0 481 0 0 0 111 1 0 0 7 0 1 0 0 43 0 0 0 0 12 2 4 0 0 0 1754
Gemella_haemolysans 97 Otu00051 0 0 0 0 2 1 3 2 0 0 0 0 10 0 3 0 359 0 0 2 0 0 30 845 8 0 0 0 1726
Phormidium_sp. 97.7 Otu00048 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1529
Leptotrichia_unclassified * Otu00057 0 0 0 0 2 490 550 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 181 31 7 0 0 0 1392
Streptococcus_mitis Otu00053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14 42 4 0 17 0 17 11 15 0 0 0 1361
Pseudoxanthomonas_mexicana 97.3 Otu00055 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 600 101 0 0 0 0 0 0 1350
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Species_97 score Group S009_T S010_P S010_T S011_D S011_T S012_D S012_T S013_D S013_P S013_T S014_D S014_P S014_T S015_D S015_P S015_T S016_D S016_P S016_T S017_D S017_P S017_T S018_D S018_P S018_T S019_D S019_P S019_T Sum
Prevotella_pallens 97 Otu00064 0 0 0 0 0 17 29 0 0 0 0 0 0 0 0 13 0 0 0 0 0 0 68 125 549 0 0 0 1323
Streptococcus_anginosus Otu00059 0 3 0 0 2 989 1 0 7 10 0 0 0 0 0 0 0 0 0 1 0 0 13 7 0 0 0 0 1275
Pseudorhodoferax_soli 97.8 Otu00063 0 0 0 0 0 0 0 0 0 0 0 0 0 29 36 1 0 0 0 1092 106 3 0 0 0 0 0 0 1267
beta_proteobacterium 97.5 Otu00047 0 0 0 0 2 0 0 0 0 0 0 1229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1231
Streptococcus_sp. 97 Otu00066 1 0 0 0 0 0 0 0 2 0 0 0 0 18 0 24 66 68 786 16 8 14 37 21 58 1 0 0 1144
Porphyromonas_catoniae 98.5 Otu00069 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 1 95 302 337 0 0 0 1127
Streptococcus_sobrinus 97.4 Otu00062 0 0 0 828 249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1077
Luteimonas_cucumeris 97.6 Otu00071 0 0 0 0 0 0 0 0 0 0 0 0 0 186 740 77 0 0 0 0 0 0 0 0 0 0 0 0 1034
Lactobacillus_unclassified Otu00067 0 0 0 363 0 36 0 0 0 0 0 0 12 0 0 0 0 0 0 0 0 0 0 0 0 44 0 0 989
Acinetobacter_junii 97.2 Otu00073 0 0 0 0 0 1 0 0 0 0 25 0 0 601 48 2 82 31 12 158 6 13 0 0 0 0 0 0 981
Haemophilus_influenzae 97.3 Otu00081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 79 381 24 0 0 0 967
Delftia_tsuruhatensis 97.5 Otu00060 0 0 0 0 0 0 0 0 0 0 24 0 1 179 21 85 0 0 0 0 0 0 0 0 0 0 0 0 954
Sphingomonas_sp. 97.3 Otu00052 0 0 0 0 2 0 0 0 0 0 0 860 0 0 0 0 0 0 0 24 0 3 0 0 0 28 0 0 917
Afipia_broomeae 97.3 Otu00065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 876
Roseburia_unclassified Otu00068 0 0 0 0 5 413 418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 841
Prevotella_salivae 97.3 Otu00074 0 1 0 0 0 237 161 218 0 0 0 0 0 0 0 32 0 0 1 0 0 0 13 18 26 0 0 0 814
Streptococcus_unclassified * Otu00070 28 0 0 0 0 7 52 0 0 0 0 0 468 26 0 5 0 0 0 2 10 2 9 25 60 0 0 0 778
Zoogloea_ramigera 97.3 Otu00076 0 0 0 0 0 0 0 0 0 0 0 1 0 307 0 50 0 0 0 0 65 296 0 0 0 0 0 0 747
Gemella_sanguinis 97.1 Otu00072 0 0 0 0 0 6 9 0 0 83 0 0 0 0 4 0 0 0 12 0 6 10 15 19 53 0 0 0 705
Pseudomonas_unclassified Otu00077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 507 182 0 0 0 0 0 0 689
Prevotella_tannerae Otu00085 0 0 0 4 542 0 2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 658
Sphingobacterium_multivorum 97.6 Otu00082 0 0 0 0 0 1 0 0 0 0 0 1 0 329 150 169 0 0 0 0 0 0 0 0 0 0 0 0 650
Chryseobacterium_unclassified Otu00083 0 0 0 0 0 0 0 0 0 0 0 0 0 46 301 259 0 0 0 0 0 0 0 0 0 0 0 0 606
Lachnoanaerobaculum_orale 97.4 Otu00075 1 0 0 0 5 25 104 0 0 0 0 0 0 0 0 2 0 0 10 0 4 0 7 4 23 0 0 0 585
Massilia_unclassified * Otu00054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 0 0 578
Streptococcus_parasanguinis 98.8 Otu00080 1 0 0 0 2 2 298 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 22 0 0 1 0 0 566
Lactobacillus_fermentum 97.8 Otu00078 0 0 0 168 1 296 2 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 526
Sphingomonas_ursincola 97.3 Otu00079 0 1 0 196 1 297 0 0 0 0 0 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 510
Myroides_unclassified * Otu00087 0 0 0 0 0 0 0 0 0 0 492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 492
Empedobacter_brevis 98.5 Otu00086 0 0 0 0 0 0 0 0 0 0 479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 479
Comamonas_testosteroni 98.1 Otu00091 0 0 0 0 0 0 0 0 0 0 332 0 0 82 26 22 0 0 0 0 0 0 0 0 0 0 0 0 462
Streptococcus_unclassified Otu00096 0 0 0 0 0 19 136 0 0 1 0 0 0 0 0 1 0 0 1 0 0 0 45 15 173 0 0 0 458
Staphylococcus_aureus 97.3 Otu00107 0 0 0 0 61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 456
Streptococcus_gordonii 97.4 Otu00094 0 0 0 1 0 32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 43 30 12 0 0 0 443
Parvimonas_micra 98.2 Otu00123 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 387
Prevotella_oris 97.3 Otu00111 0 0 0 1 334 2 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 376
Prevotella_nanceiensis 97.3 Otu00090 0 0 0 0 0 0 0 0 0 0 0 0 0 6 0 2 0 0 0 0 0 0 0 7 27 0 0 0 374
Mycoplasma_salivarium 98.1 Otu00135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 372
Actinomyces_graevenitzii 98.5 Otu00100 3 0 0 0 0 3 3 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 4 0 0 0 371
Granulicatella_unclassified Otu00098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 103 164 5 0 0 0 367
Flavobacterium_lindanitolerans 97.5 Otu00097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 72 136 141 0 0 0 0 0 0 349
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Species_97 score Group S009_T S010_P S010_T S011_D S011_T S012_D S012_T S013_D S013_P S013_T S014_D S014_P S014_T S015_D S015_P S015_T S016_D S016_P S016_T S017_D S017_P S017_T S018_D S018_P S018_T S019_D S019_P S019_T Sum
Serratia_marcescens 97.6 Otu00099 0 0 0 0 0 0 0 0 0 0 46 0 0 1 168 81 0 0 0 0 7 27 0 0 1 0 0 0 346
Micrococcus_luteus 99 Otu00108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 341
Lactobacillus_plantarum 97.2 Otu00093 0 0 338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 339
Propionibacterium_acidifaciens 97.8 Otu00088 0 0 0 211 0 83 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 336
Megasphaera_micronuciformis 97.3 Otu00101 5 0 0 0 0 13 13 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 4 13 7 0 0 0 334
Ralstonia_sp. 97.6 Otu00114 0 19 0 0 0 1 0 282 7 0 0 0 0 0 0 0 4 0 0 3 5 0 0 0 0 0 0 0 324
Bradyrhizobium_sp. 97.5 Otu00116 0 0 0 0 0 0 0 0 0 0 0 0 1 321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 322
Dermacoccus_nishinomiyaensis 97.2 Otu00118 0 276 28 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 312
Atopobium_parvulum 97.5 Otu00110 0 0 0 0 0 1 3 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 180 0 10 4 0 0 300
Campylobacter_concisus 97.9 Otu00102 0 0 0 0 0 60 43 0 0 0 0 0 0 0 2 21 0 0 15 0 0 6 6 5 53 0 0 0 296
Staphylococcus_warneri 100 Otu00112 0 0 0 0 0 0 1 0 0 0 2 19 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 289
Lactobacillus_vaginalis 98.6 Otu00109 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 28 0 2 274
Yersinia_pekkanenii 99.7 Otu00129 0 0 0 0 0 0 0 0 0 0 16 0 0 249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 265
Flavobacterium_unclassified Otu00133 0 0 0 0 0 0 0 0 0 0 0 0 0 216 0 26 0 0 0 0 0 0 0 0 0 0 0 0 242
Neisseria_sicca 97.9 Otu00122 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 13 12 24 0 0 0 236
Aeromonas_hydrophila 97 Otu00119 0 0 0 0 0 0 0 0 0 0 74 0 0 15 5 13 0 3 106 7 1 0 0 0 0 0 0 0 224
Bosea_unclassified Otu00095 0 0 0 0 0 0 0 0 0 0 0 8 0 7 0 2 0 0 4 0 0 2 0 0 0 0 0 0 221
Actinomyces_graevenitzii 98.1 Otu00106 0 0 0 0 0 76 123 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 221
Diplorickettsia_unclassified * Otu00127 0 20 0 0 5 0 0 169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 220
Solobacterium_moorei Otu00115 0 1 0 0 46 9 20 0 0 2 0 0 0 0 1 5 0 0 3 0 0 0 43 0 16 0 0 0 219
Leptotrichia_unclassified * Otu00126 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 43 8 52 0 0 0 215
Streptococcus_dysgalactiae 97.6 Otu00132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 212
Streptococcus_mitis Otu00103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12 1 0 0 0 209
Staphylococcus_hominis 97.3 Otu00113 0 0 0 0 168 0 0 0 0 0 0 35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 207
Prevotella_oralis 97.9 Otu00179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 200
Variovorax_ginsengisoli 98.1 Otu00145 0 0 0 0 0 1 0 0 0 0 0 0 0 79 43 18 0 0 0 0 0 1 0 0 0 0 0 0 193
Corynebacterium_imitans * Otu00131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 190
Shinella_kummerowiae 97.4 Otu00104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 185
Rhizobium_mesosinicum 97.1 Otu00084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 183
Chryseobacterium_formosense Otu00120 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 183 0 0 0 0 0 0 183
Lactobacillus_kalixensis 98.5 Otu00134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 183 0 0 183
Massilia_alkalitolerans 98.8 Otu00089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 169
Pseudocitrobacter_anthropi 98.4 Otu00128 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 169
Prevotella_buccae 97.3 Otu00164 0 0 0 0 166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 166
Bacteroides_unclassified * Otu00147 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 9 10 113 0 0 0 165
Prevotella_unclassified * Otu00125 0 0 0 0 1 87 71 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 163
Ensifer_adhaerens 97.9 Otu00105 0 1 0 0 0 0 0 0 0 0 0 0 0 19 39 32 0 0 0 0 0 0 0 0 0 0 0 0 162
Streptococcus_mutans 98.3 Otu00148 0 0 0 14 31 22 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 162
Actinomyces_oris 97.1 Otu00165 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 158 0 1 0 0 0 162
Stomatobaculum_longum 99.6 Otu00124 2 0 0 0 1 39 49 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 2 2 4 0 0 0 160
Acinetobacter_bereziniae 97.2 Otu00136 0 0 0 0 0 0 0 0 0 0 39 0 0 0 8 103 0 0 0 0 0 0 0 0 0 0 0 0 158
Fusobacterium_nucleatum 97.6 Otu00155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 146 10 1 0 0 0 157
Acinetobacter_unclassified Otu00137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 95 3 27 0 0 0 0 0 0 0 0 155
Actinomyces_viscosus 97 Otu00161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 145 1 0 0 0 0 155
Sphingomonas_unclassified Otu00121 0 1 0 0 1 150 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 153
Streptococcus_oligofermentans 98.1 Otu00149 0 0 0 0 0 41 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 151
Alloprevotella_unclassified * Otu00175 0 0 0 0 0 0 0 149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 149
Leptotrichia_shahii 97.2 Otu00130 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 148
Comamonas_aquatica 98.4 Otu00142 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 0 0 114 23 0 0 0 0 0 0 0 0 0 147
Rhizobium_unclassified Otu00151 0 0 0 0 0 0 0 0 0 0 0 0 0 1 132 13 0 0 0 0 0 0 0 0 0 0 0 0 146
Methylobacterium_extorquens 99 Otu00150 0 0 0 0 106 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 144
Actinomyces_odontolyticus 98.4 Otu00153 6 0 0 0 0 2 9 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 84 0 0 28 0 0 144
Odoribacter_unclassified * Otu00184 0 0 0 0 0 0 0 136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 136
Selenomonas_artemidis Otu00168 0 0 0 0 95 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 134
Actinomyces_slackii 97.2 Otu00152 0 0 0 0 0 8 4 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 132
Sphingopyxis_granuli 97.6 Otu00144 0 0 0 0 0 0 0 0 0 0 0 13 0 0 18 12 0 0 0 0 75 10 0 0 0 0 0 0 131
Sediminibacterium_unclassified * Otu00154 0 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 131
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Nocardioides_aestuarii 98.4 Otu00192 0 0 0 0 0 0 0 129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 129
Abiotrophia_defectiva Otu00174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 39 31 29 0 0 0 127
Dermacoccus_nishinomiyaensis 98.8 Otu00177 0 112 7 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 124
Methylobacterium_gregans 98 Otu00217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 123
Corynebacterium_segmentosum 98.5 Otu00146 0 0 0 0 1 2 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 122
Ochrobactrum_sp. 99.7 Otu00171 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 120
Actinomyces_graevenitzii 98.5 Otu00180 2 0 0 0 0 3 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16 12 29 0 0 0 118
Lysobacter_unclassified Otu00176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 116
Acinetobacter_sp. 97.2 Otu00158 0 0 0 0 0 0 0 0 0 0 115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 115
Brevundimonas_unclassified Otu00092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 113
Prevotella_unclassified * Otu00162 0 0 0 0 0 4 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 111
Bryobacter_unclassified * Otu00204 0 0 0 0 0 0 0 106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 106
Actinomyces_unclassified * Otu00183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 96 8 0 0 0 0 105
Methylobacterium_unclassified * Otu00182 0 102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 103
Acinetobacter_rudis 98.2 Otu00172 0 0 0 0 0 0 0 0 0 0 102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 102
Oribacterium_unclassified * Otu00159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 27 7 0 0 0 100
Methylobacterium_goesingense 98.3 Otu00143 0 0 0 0 0 0 0 0 0 0 0 87 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 98
Massilia_timonae 98.8 Otu00243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 91
Corynebacterium_unclassified * Otu00219 0 0 0 0 0 0 0 90 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 90
Devosia_riboflavina 97.9 Otu00140 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 89
Achromobacter_mucicolens 97.2 Otu00157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 89 0 0 0 0 0 0 0 0 0 0 0 0 89
Rhizobium_sp. 98.6 Otu00141 0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 10 0 0 0 0 0 0 0 0 0 0 1 0 88
Parvimonas_micra * Otu00203 0 0 0 0 86 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 87
Leptotrichia_unclassified * Otu00169 0 0 0 0 0 0 23 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 10 0 5 0 0 0 86
Streptococcus_pseudopneumoniae 98.1 Otu00163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 41 3 0 0 0 0 0 9 0 0 0 0 85
Streptococcus_tigurinus 97.9 Otu00181 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 85
Tomitella_biformata 98.4 Otu00218 0 78 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 84
[Eubacterium]_nodatum_group_unclassified Otu00193 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0 8 2 31 0 0 0 82
Actinomyces_unclassified * Otu00160 0 0 0 0 0 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 81
Capnocytophaga_gingivalis 97.8 Otu00199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 12 26 0 0 0 80
Prevotella_nigrescens 98.5 Otu00200 0 0 0 1 38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 78
Terrisporobacter_unclassified Otu00188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 77
Pedobacter_unclassified * Otu00228 0 0 0 0 0 0 0 0 0 0 0 0 0 76 0 0 0 0 0 0 0 0 0 0 0 0 0 0 76
Oribacterium_sinus 97.7 Otu00195 0 0 0 0 0 7 4 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 4 4 0 0 0 74
Fusobacterium_nucleatum Otu00244 0 0 5 0 0 0 2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 74
Pseudomonas_putida 97.5 Otu00170 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 72
Pseudomonas_agarici 97.8 Otu00187 0 0 0 0 0 0 0 0 0 0 72 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 72
Sediminibacterium_salmoneum * Otu00210 0 1 0 0 49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 72
Lactobacillus_ultunensis 97.9 Otu00242 0 0 0 0 0 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 72
Propionicimonas_paludicola 98.4 Otu00198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 71
Chryseobacterium_hominis 98.4 Otu00178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 63 0 7 0 0 0 0 0 0 0 0 0 70
Ralstonia_unclassified * Otu00186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 8 1 14 0 0 0 70
Aeromonas_unclassified * Otu00201 0 0 0 0 0 4 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 37 0 14 0 0 0 70
Dermacoccus_nishinomiyaensis 98.4 Otu00208 0 65 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 70
Lactobacillus_crispatus 97.4 Otu00212 0 0 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 70
Ornithinimicrobium_kibberense 97.5 Otu00167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 25 5 0 0 0 0 0 0 68
Bacillus_cereus 97.6 Otu00156 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 67
Sphingobium_herbicidovorans 99.3 Otu00230 0 0 0 0 0 0 0 0 0 0 0 0 0 64 0 3 0 0 0 0 0 0 0 0 0 0 0 0 67
Hydrogenophaga_defluvii 97.8 Otu00117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 64
Microbacterium_lacticum 100 Otu00205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 44 0 0 0 1 0 0 0 0 0 1 63
Alcaligenes_aquatilis 98.2 Otu00206 0 0 0 0 0 0 0 0 0 0 63 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 63
Rhizobium_unclassified 97 Otu00229 0 0 0 0 0 0 0 0 0 0 0 0 0 42 0 21 0 0 0 0 0 0 0 0 0 0 0 0 63
Devosia_sp. 97 Otu00139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 62
Capnocytophaga_gingivalis * Otu00196 0 0 0 0 0 4 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 62
Halomonas_unclassified * Otu00275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 62
Prevotella_unclassified * Otu00191 0 0 0 0 0 21 16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13 0 0 0 61
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Massilia_unclassified Otu00252 0 0 0 0 0 0 0 0 0 0 0 27 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 27
Porphyromonas_unclassified * Otu00312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16 11 0 0 0 27
Sneathia_unclassified * Otu00214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 25
Selenomonas_sputigena Otu00328 0 0 0 0 25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 25
Ochrobactrum_anthropi 100 Otu00316 0 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 24
Phenylobacterium_falsum 97 Otu00241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23
Peptostreptococcus_stomatis 97.2 Otu00268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 23
Leptotrichia_hongkongensis 97.3 Otu00273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 23
Fusobacterium_nucleatum Otu00298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23
Fusobacterium_canifelinum 97.6 Otu00326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11 10 2 0 0 0 23
Mycobacterium_chelonae 99.1 Otu00270 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22
Pseudomonas_sp. 99 Otu00272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14 8 0 0 0 0 0 0 0 22
Mycobacterium_neworleansense 98.4 Otu00289 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22
Morganella_morganii 99.4 Otu00305 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22
Actinomyces_slackii 98.6 Otu00370 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22
Schwartzia_unclassified * Otu00207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21
Algoriphagus_unclassified * Otu00233 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21
Selenomonas_unclassified * Otu00307 0 0 0 4 0 17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21
Pseudanabaena_sp. 100 Otu00185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20
Acinetobacter_guillouiae Otu00294 0 0 0 0 0 0 0 0 0 0 20 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20
Rhizobium_sp. 97.9 Otu00239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19
Caldicellulosiruptor_actoaceticus Otu00266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19
Actinobacillus_porcitonsillarum Otu00279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19
Raoultella_planticola 98.8 Otu00309 0 0 0 0 0 0 0 0 0 0 16 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 19
Campylobacter_concisus * Otu00346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10 0 1 0 0 0 19
Lautropia_mirabilis 100 Otu00292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18
Paracoccus_yeei 98.7 Otu00303 0 0 17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18
Rhodobacter_veldkampii Otu00313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18
Comamonas_terrigena 98.8 Otu00325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 11 0 0 0 0 0 0 0 0 0 0 0 0 18
Corynebacterium_marinum 99.4 Otu00378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18
Actinomyces_cardiffensis 100 Otu00380 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18
Brevundimonas_diminuta 97.2 Otu00274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17
Rhodococcus_fascians 99.1 Otu00278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17
Veillonella_unclassified Otu00290 10 0 0 0 0 1 5 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 17
Methylobacterium_adhaesivum 97.3 Otu00302 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17
Leptotrichia_buccalis 98.1 Otu00339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 17
Ferrimicrobium_unclassified * Otu00355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17
Paludibacter_unclassified * Otu00286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16
Pseudomonas_xanthomarina 98.1 Otu00287 0 0 0 0 0 13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 16
Enterococcus_faecalis 99.2 Otu00311 0 12 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16
Alcaligenes_faecalis 98.5 Otu00330 0 0 0 0 0 0 0 0 0 0 16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16
Streptococcus_australis Otu00332 9 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16
Aeromonas_bestiarum 100 Otu00358 0 0 0 0 0 0 0 0 0 0 9 0 0 0 0 7 0 0 0 0 0 0 0 0 0 0 0 0 16
Kingella_denitrificans 98.8 Otu00362 0 0 0 0 16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16
Massilia_haematophila 97.1 Otu00253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15
Ornithinimicrobium_kibberense 98.4 Otu00331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15
Providencia_rettgeri 99.4 Otu00342 0 0 0 0 0 0 0 0 0 0 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15
Kocuria_rhizophila 98.5 Otu00277 0 0 0 0 0 0 0 0 11 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14
Acinetobacter_sp. 99.6 Otu00293 0 0 0 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14
Arthrobacter_defluvii 99.7 Otu00296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14
Lactobacillus_zeae 97.8 Otu00318 0 0 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14
Brochothrix_thermosphacta 98.1 Otu00320 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14
Acinetobacter_johnsonii 97.2 Otu00336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14
Pseudomonas_asplenii 97.5 Otu00347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 14
Leptotrichia_unclassified * Otu00353 0 0 0 0 0 6 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14
Prevotella_unclassified Otu00360 0 0 0 0 13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14
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Streptococcus_sanguinis Otu00209 0 0 0 0 0 0 0 0 9 0 0 0 0 0 0 0 0 5 0 0 0 0 1 0 0 0 0 0 61
Herminiimonas_arsenicoxydans 97.2 Otu00232 0 0 0 0 0 0 0 0 0 0 0 0 0 61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 61
Pseudomonas_putida Otu00227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 58
Actinomyces_graevenitzii 99.4 Otu00238 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 16 0 0 8 0 19 0 0 0 57
Ehrlichia_unclassified * Otu00248 0 0 0 0 9 0 0 35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 57
Enterococcus_faecium 98.3 Otu00283 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 57
Aminobacter_anthyllidis 98.3 Otu00166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 56
Streptococcus_parasanguinis 98.4 Otu00221 0 0 0 0 0 0 3 0 0 6 0 0 1 35 0 0 0 1 1 0 0 0 0 0 0 0 0 0 56
Propionibacterium_unclassified Otu00262 0 0 0 0 55 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 55
Anaeroglobus_geminatus 98.9 Otu00299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 54
Actinomyces_oris 99.1 Otu00197 0 0 0 0 1 43 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 53
Maricurvus_unclassified * Otu00202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 2 2 0 0 0 53
Catonella_morbi * Otu00211 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 53
Corynebacterium_matruchotii 97.9 Otu00271 0 26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 52
Streptococcus_unclassified Otu00190 3 0 0 0 1 0 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 51
Exiguobacterium_mexicanum 98 Otu00236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50
Pannonibacter_phragmitetus 99 Otu00263 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50
Actinomyces_israelii * Otu00220 0 0 0 0 0 49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 49
Lactococcus_lactis 99.7 Otu00246 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 48
Finegoldia_magna 98.5 Otu00189 0 0 0 0 0 0 0 0 0 0 0 10 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 47
Bavariicoccus_seileri 98.1 Otu00247 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 14 0 0 0 47
[Eubacterium]_nodatum_group_unclassified * Otu00256 0 0 0 0 47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 47
Leptotrichia_unclassified * Otu00250 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 34 0 12 0 0 0 46
Sphingobacterium_faecium Otu00213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 45 0 0 0 0 0 0 0 0 0 0 0 0 45
Bergeyella_unclassified * Otu00224 0 0 0 0 0 0 0 0 0 15 0 0 0 0 0 0 0 0 1 0 0 2 3 0 17 0 0 0 44
Pseudomonas_saponiphila 98.5 Otu00234 0 0 0 0 0 0 0 0 0 0 40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 44
Lactobacillus_unclassified Otu00216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 43 0 0 0 0 0 0 0 0 0 0 43
Microbacterium_hydrocarbonoxydans Otu00173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 42
Prevotella_shahii 97.6 Otu00237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 11 10 0 0 0 42
Saccharophagus_unclassified * Otu00245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 42
Treponema_socranskii 97.8 Otu00255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 42
Shinella_unclassified * Otu00269 0 0 0 0 0 0 0 0 0 0 0 0 0 40 0 2 0 0 0 0 0 0 0 0 0 0 0 0 42
Aggregatibacter_segnis 98.1 Otu00276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 41
Sphingomonas_paucimobilis 98.7 Otu00226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 36 1 0 0 0 0 0 0 0 0 0 39
Actinomyces_odontolyticus 97.5 Otu00231 0 0 0 0 0 2 1 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 16 0 0 14 0 0 39
Capnocytophaga_leadbetteri 98.1 Otu00240 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15 0 0 0 39
Pseudomonas_oryzihabitans 97.5 Otu00249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 39
Vibrio_brasiliensis 99.1 Otu00225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 38
Sphingobacterium_caeni 100 Otu00260 0 0 0 0 0 0 0 0 0 0 0 0 0 23 0 15 0 0 0 0 0 0 0 0 0 0 0 0 38
Bifidobacterium_animalis 98 Otu00257 0 0 0 0 0 4 22 0 0 0 0 0 0 0 0 7 0 0 0 0 0 0 0 0 0 0 0 0 37
Bacillus_wakoensis 98.3 Otu00235 0 0 0 0 32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 36
Prevotella_pallens 97.9 Otu00281 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2 25 0 0 0 36
Stenotrophomonas_maltophilia 97.9 Otu00254 0 0 3 0 0 0 0 0 0 0 1 0 0 1 13 17 0 0 0 0 0 0 0 0 0 0 0 0 35
Alloprevotella_rava Otu00261 0 0 0 0 0 5 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 35
Rhodococcus_globerulus 97.2 Otu00138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 34
Dyadobacter_unclassified * Otu00194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 34
Ideonella_sp. 97.5 Otu00264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 33
[Eubacterium]_nodatum_group_unclassified * Otu00282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 33
Dermacoccus_nishinomiyaensis 98.8 Otu00301 0 29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 30
Sphingobium_limneticum 98.7 Otu00308 0 0 0 0 0 0 0 0 0 0 0 0 0 30 0 0 0 0 0 0 0 0 0 0 0 0 0 0 30
Sphingobacterium_anhuiense 97.4 Otu00259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 29 0 0 0 0 0 0 0 0 0 0 0 0 29
Pelomonas_saccharophila 100 Otu00300 0 0 0 0 22 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 29
Sphingomonas_desiccabilis 98.3 Otu00280 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 28
Brevundimonas_unclassified * Otu00284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 28
Leucobacter_aridicollis 98.2 Otu00223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 27
Prevotella_unclassified * Otu00251 0 0 0 0 0 27 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 27
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Species_97 score Group S009_T S010_P S010_T S011_D S011_T S012_D S012_T S013_D S013_P S013_T S014_D S014_P S014_T S015_D S015_P S015_T S016_D S016_P S016_T S017_D S017_P S017_T S018_D S018_P S018_T S019_D S019_P S019_T Sum
Stenotrophomonas_maltophilia. 98.5 Otu00373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 12 0 0 0 0 0 0 0 0 0 0 0 0 14
Acinetobacter_lwoffii 97.2 Otu00415 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11 14
Bradyrhizobium_elkanii 98.3 Otu00291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13
Shewanella_putrefaciens 99.1 Otu00315 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13
Granulicatella_unclassified * Otu00323 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 5 0 0 0 0 0 1 0 0 0 13
Paracoccus_marinus 99.3 Otu00338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13
Prevotella_unclassified * Otu00359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 13
Pseudomonas_putida Otu00363 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13
Pseudochrobactrum_kiredjianiae 100 Otu00377 0 0 0 0 0 0 0 0 0 0 13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13
Sphingomonas_yanoikuyae. 98 Otu00222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12
Aureibacter_unclassified * Otu00258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12
Streptococcus_vestibularis Otu00306 0 0 0 4 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 3 12
Devosia_limi 97 Otu00314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12
Intestinibacter_unclassified Otu00324 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12
Aridibacter_unclassified * Otu00285 0 0 0 0 0 0 0 0 11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11
Uruburuella_suis 98.1 Otu00329 0 0 0 0 0 0 0 0 0 0 11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11
Brevundimonas_unclassified * Otu00337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11 0 0 0 0 0 0 11
Prevotella_micans 97.6 Otu00344 0 0 0 11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11
Centipeda_periodontii * Otu00354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11
Dermacoccus_nishinomiyaensis 98.8 Otu00413 0 11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11
Smithella_unclassified * Otu00265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10
Phenylobacterium_kunshanense * Otu00288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10
Prevotella_oulorum 99.4 Otu00348 0 0 0 0 0 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10
Capnocytophaga_sputigena 97.2 Otu00364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 10
Actinomyces_graevenitzii 97.5 Otu00366 0 0 0 0 0 1 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 10
Burkholderia_contaminans 99.1 Otu00371 0 0 0 4 1 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 10
Corynebacterium_aquatimens 98.4 Otu00395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10
Novosphingobium_resinovorum 98.7 Otu00399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10 0 0 0 0 0 0 10
Streptococcus_infantis Otu00418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 2 0 0 0 10
Streptococcus_unclassified Otu00426 0 0 0 0 0 0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10
Marinomonas_arenicola 98.5 Otu00430 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10
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Peer-reviewed published manuscript incorporating work from  
Chapters 2 and 4 
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Chapters 3 and 4 
 
Morse et al., (2018) 
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